
<html lang="en"     class="pb-page"  data-request-id="5a068447-fbf2-449c-9d51-eac3baa4c2db"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c02143;issue:issue:10.1021/jmcmar.2021.64.issue-8;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360" /></meta><meta name="dc.Creator" content="Heinrich  Rueeger" /></meta><meta name="dc.Creator" content="Rainer  Lueoend" /></meta><meta name="dc.Creator" content="Rainer  Machauer" /></meta><meta name="dc.Creator" content="Siem J.  Veenstra" /></meta><meta name="dc.Creator" content="Philipp  Holzer" /></meta><meta name="dc.Creator" content="Konstanze  Hurth" /></meta><meta name="dc.Creator" content="Markus  Voegtle" /></meta><meta name="dc.Creator" content="Mathias  Frederiksen" /></meta><meta name="dc.Creator" content="Jean-Michel  Rondeau" /></meta><meta name="dc.Creator" content="Marina  Tintelnot-Blomley" /></meta><meta name="dc.Creator" content="Laura H.  Jacobson" /></meta><meta name="dc.Creator" content="Matthias  Staufenbiel" /></meta><meta name="dc.Creator" content="Grit  Laue" /></meta><meta name="dc.Creator" content="Ulf  Neumann" /></meta><meta name="dc.Description" content="Starting from lead compound 4, the 1,4-oxazine headgroup was optimized to improve potency and brain penetration. Focusing at the 6-position of the 5-amino-1,4-oxazine, the insertion of a Me and a C..." /></meta><meta name="Description" content="Starting from lead compound 4, the 1,4-oxazine headgroup was optimized to improve potency and brain penetration. Focusing at the 6-position of the 5-amino-1,4-oxazine, the insertion of a Me and a C..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 12, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c02143" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02143" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c02143" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02143" /></link>
        
    
    

<title>Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c02143" /></meta><meta property="og:title" content="Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0039.jpeg" /></meta><meta property="og:description" content="Starting from lead compound 4, the 1,4-oxazine headgroup was optimized to improve potency and brain penetration. Focusing at the 6-position of the 5-amino-1,4-oxazine, the insertion of a Me and a CF3 group delivered an excellent pharmacological profile with a pKa of 7.1 and a very low P-gp efflux ratio enabling high central nervous system (CNS) penetration and exposure. Various synthetic routes to access BACE1 inhibitors bearing a 5-amino-6-methyl-6-(trifluoromethyl)-1,4-oxazine headgroup were investigated. Subsequent optimization of the P3 fragment provided the highly potent N-(3-((3R,6R)-5-amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2H-1,4-oxazin-3-yl)-4-fluorophenyl)-5-cyano-3-methylpicolinamide 54 (NB-360), able to reduce significantly Aβ levels in mice, rats, and dogs in acute and chronic treatment regimens." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c02143"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02143">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c02143&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c02143&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c02143&amp;href=/doi/10.1021/acs.jmedchem.0c02143" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 4677-4696</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02115" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c02069" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Heinrich Rueeger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heinrich Rueeger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heinrich++Rueeger">Heinrich Rueeger</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rainer Lueoend</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rainer Lueoend</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rainer++Lueoend">Rainer Lueoend</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rainer Machauer</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rainer Machauer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#1d6f7c7473786f33707c7e757c68786f5d73726b7c6f69746e337e7270"><span class="__cf_email__" data-cfemail="413320282f24336f2c20222920342433012f2e3720333528326f222e2c">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rainer++Machauer">Rainer Machauer</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5081-6268" title="Orcid link">http://orcid.org/0000-0001-5081-6268</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Siem J. Veenstra</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Siem J. Veenstra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Siem+J.++Veenstra">Siem J. Veenstra</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Philipp Holzer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philipp Holzer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philipp++Holzer">Philipp Holzer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Konstanze Hurth</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Konstanze Hurth</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Konstanze++Hurth">Konstanze Hurth</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Markus Voegtle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Markus Voegtle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Voegtle">Markus Voegtle</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mathias Frederiksen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mathias Frederiksen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mathias++Frederiksen">Mathias Frederiksen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jean-Michel Rondeau</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean-Michel Rondeau</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Proteomic Chemistry, Structural Biology Platform, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Michel++Rondeau">Jean-Michel Rondeau</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marina Tintelnot-Blomley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marina Tintelnot-Blomley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marina++Tintelnot-Blomley">Marina Tintelnot-Blomley</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laura H. Jacobson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura H. Jacobson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura+H.++Jacobson">Laura H. Jacobson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthias Staufenbiel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthias Staufenbiel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Staufenbiel">Matthias Staufenbiel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Grit Laue</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Grit Laue</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Metabolism and Pharmacokinetics, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Grit++Laue">Grit Laue</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ulf Neumann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ulf Neumann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ulf++Neumann">Ulf Neumann</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02143&amp;href=/doi/10.1021%2Facs.jmedchem.0c02143" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 4677–4696</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 12, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 December 2020</li><li><span class="item_label"><b>Published</b> online</span>12 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 April 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c02143" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02143</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4677%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHeinrich%2BRueeger%252C%2BRainer%2BLueoend%252C%2BRainer%2BMachauer%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D8%26contentID%3Dacs.jmedchem.0c02143%26title%3DSynthesis%2Bof%2Bthe%2BPotent%252C%2BSelective%252C%2Band%2BEfficacious%2B%25CE%25B2-Secretase%2B%2528BACE1%2529%2BInhibitor%2BNB-360%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4696%26publicationDate%3DApril%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c02143"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">993</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c02143" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Heinrich&quot;,&quot;last_name&quot;:&quot;Rueeger&quot;},{&quot;first_name&quot;:&quot;Rainer&quot;,&quot;last_name&quot;:&quot;Lueoend&quot;},{&quot;first_name&quot;:&quot;Rainer&quot;,&quot;last_name&quot;:&quot;Machauer&quot;},{&quot;first_name&quot;:&quot;Siem&quot;,&quot;last_name&quot;:&quot;J. Veenstra&quot;},{&quot;first_name&quot;:&quot;Philipp&quot;,&quot;last_name&quot;:&quot;Holzer&quot;},{&quot;first_name&quot;:&quot;Konstanze&quot;,&quot;last_name&quot;:&quot;Hurth&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Voegtle&quot;},{&quot;first_name&quot;:&quot;Mathias&quot;,&quot;last_name&quot;:&quot;Frederiksen&quot;},{&quot;first_name&quot;:&quot;Jean-Michel&quot;,&quot;last_name&quot;:&quot;Rondeau&quot;},{&quot;first_name&quot;:&quot;Marina&quot;,&quot;last_name&quot;:&quot;Tintelnot-Blomley&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;H. Jacobson&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Staufenbiel&quot;},{&quot;first_name&quot;:&quot;Grit&quot;,&quot;last_name&quot;:&quot;Laue&quot;},{&quot;first_name&quot;:&quot;Ulf&quot;,&quot;last_name&quot;:&quot;Neumann&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;4677-4696&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c02143&quot;},&quot;abstract&quot;:&quot;Starting from lead compound 4, the 1,4-oxazine headgroup was optimized to improve potency and brain penetration. Focusing at the 6-position of the 5-amino-1,4-oxazine, the insertion of a Me and a CF3 group delivered an excellent pharmacological profile with a pKa of 7.1 and a very low P-gp efflux ratio enabling high central nervous system (CNS) penetration and exposure. Various synthetic routes to access BACE1 inhibitors bearing a 5-amino-6-methyl-6-(trifluoromethyl)-1,4-oxazine headgroup were investigated. Subsequent optimization of the P3 fragment provided the highly potent N-(3-((3R,6R)-5-amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2H-1,4-oxazin-3-yl)-4-fluorophenyl)-5-cyano-3-methylpicolinamide 54 (NB-360), able to reduce significantly Aβ levels in mice, rats, and dogs in acute and chronic treatment regimens.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02143&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02143" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02143&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02143" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02143&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02143" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02143&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02143&amp;href=/doi/10.1021/acs.jmedchem.0c02143" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c02143" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c02143" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c02143%26sid%3Dliteratum%253Aachs%26pmid%3D33844524%26genre%3Darticle%26aulast%3DRueeger%26date%3D2021%26atitle%3DSynthesis%2Bof%2Bthe%2BPotent%252C%2BSelective%252C%2Band%2BEfficacious%2B%25CE%25B2-Secretase%2B%2528BACE1%2529%2BInhibitor%2BNB-360%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D8%26spage%3D4677%26epage%3D4696%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/jmcmar.2021.64.issue-8/20210422/jmcmar.2021.64.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0039.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Starting from lead compound <b>4</b>, the 1,4-oxazine headgroup was optimized to improve potency and brain penetration. Focusing at the 6-position of the 5-amino-1,4-oxazine, the insertion of a Me and a CF<sub>3</sub> group delivered an excellent pharmacological profile with a p<i>K</i><sub>a</sub> of 7.1 and a very low P-gp efflux ratio enabling high central nervous system (CNS) penetration and exposure. Various synthetic routes to access BACE1 inhibitors bearing a 5-amino-6-methyl-6-(trifluoromethyl)-1,4-oxazine headgroup were investigated. Subsequent optimization of the P3 fragment provided the highly potent <i>N</i>-(3-((3<i>R</i>,6<i>R</i>)-5-amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorophenyl)-5-cyano-3-methylpicolinamide <b>54</b> (<b>NB-360</b>), able to reduce significantly A<i>β</i> levels in mice, rats, and dogs in acute and chronic treatment regimens.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the world’s leading cause of dementia and the most prevalent neurodegenerative disease. AD currently constitutes a considerable unmet medical need and is expected to become a major challenge for the healthcare systems of both industrial and developing countries during the coming decades. Accumulation of amyloid-β (Aβ) in parenchymal plaques and the brain vasculature and hyperphosphorylated tau in neurofibrillary tangles is a pathological hallmark of the disease.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Neuroinflammation, driven by plaque-activated microglia and astrocytes, is a likely mediator between amyloid pathology and synaptic and neuronal dysfunction and neuron loss.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Currently available longitudinal data suggest that abnormal deposition of Aβ starts about two decades before the onset of clinical disease, while markers of neurodegeneration (elevated tau protein in cerebrospinal fluid (CSF)) can be detected several years before dementia diagnosis.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> Progress to identify patients with elevated AD risk in the presymptomatic stage has fueled therapeutic concepts that aim to start antiamyloid treatments already in the “preclinical” (only Aβ pathology present) or the “prodromal” (Aβ pathology plus signs of early neurodegeneration) stage of the disease.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> First clinical data indicating improved efficacy of the Aβ antibody solenazumab in patients with early, compared to advanced, AD further support the current ideas of preventive treatment.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Aβ is generated in the β-secretase pathway from the large transmembrane β-amyloid precursor protein (APP). The membrane-bound aspartic protease BACE1 (EC 3.4.23.46) initiates the pathway by cleaving APP at position one of Aβ, generating the secreted amino-terminal part of APP (sAPPβ) as well as the carboxy-terminal fragment C99. This transmembrane fragment is further cleaved by γ-secretase leading to Aβ. Alternatively, APP may also be processed <i>via</i> the non-amyloidogenic pathway, which is initiated by the metalloprotease α-secretase, which cleaves in the center of Aβ leading to sAPPα and C83.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a></div><div class="NLM_p">Knock out of the BACE1 gene blocks the generation of Aβ and C99, shifting the APP processing toward the α-secretase pathway as indicated by an increase in sAPPα and C83.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Interestingly, mice carrying only a single BACE1 allele showed a 50% reduction in BACE1 enzyme activity but a much smaller effect on Aβ.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Nevertheless, a moderate 12% Aβ decrease in transgenic mice carrying a single BACE1 allele translated into a pronounced (70–90%) long-term reduction of Aβ deposition.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">BACE2 is a closely related protein, with high similarity in sequence and three-dimensional structure, and its physiological role is not well understood.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Current BACE1 inhibitors show little or no selectivity over BACE2, and it was unknown whether such lack of selectivity would have consequences in chronic pharmacological treatment. BACE1 has a number of physiological substrates in addition to APP. Germ-line deletion of the BACE1 gene affected the processing of neuregulin1 (NRG1), resulting in hypomyelination,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> APP-like protein1 and 2 (APLP1/2),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> the close homologue of L1 (CHL1),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> seizure-6-protein (SEZ6),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and others. Nonetheless, general and consistent malfunction and sickness were not observed in mice lacking BACE1 activity. Thus, it seems necessary to elucidate in detail the relative importance of these BACE1 substrates during embryonal development and adult life. Moreover, it was shown that some BACE1 physiological substrates are processed in the trans Golgi network, while APP is primarily cleaved in the more acidic endosomal compartment. The intracellular inhibitor distribution may therefore contribute to the effects on different BACE1 substrates. While our understanding of BACE1 biology continues to evolve, careful monitoring of the safety of BACE1 inhibitors during clinical trials is critical. Recent clinical data show that strong pharmacological inhibition of BACE1 is accompanied by signs of worsening in some cognitive domains.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Therefore, safety and efficacy of doses leading to partial BACE1 inhibition need to be investigated carefully.</div><div class="NLM_p">BACE1 belongs to the aspartyl protease family with two aspartic acids constituting the catalytic dyad in the center of a large binding site extending over 6–8 substrate amino acid residues. Standard high-throughput screening (HTS) methods failed in many institutions to deliver suitable hits. Therefore, the initial phase of the BACE1 inhibitor design was dominated by peptidomimetic approaches, similar to those used for inhibitors of renin and HIV protease. These efforts produced potent inhibitors, which lacked significant brain penetration and <i>in vivo</i> CNS Aβ lowering activity at pharmacological doses.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> Consequently, the focus shifted to nonpeptidic BACE1 inhibitors with physicochemical properties within the CNS drug space. During lead optimization, special attention has to be paid to the blood–brain barrier (BBB) penetration capability, as well as cellular activity and metabolic stability.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> A moderate-to-high permeability (>50–150 nm/s) and minimal P-glycoprotein (P-gp) efflux (efflux/flux ratio (ER) less than 3-fold) in the MDCK-MDR1 assay have to be attained to achieve a good BBB penetration and is commonly observed for CNS drugs.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24−27)</a> Remaining within the boundaries of the CNS drug property space during the structure-based design (MW < 450 Da, PSA < 70 Å, clog <i>P</i> < 4, HBD < 2, number of oxygen and nitrogen atoms ∑(N + O) < 5 and p<i>K</i><sub>a</sub> < 8 to minimize P-gp<a onclick="showRef(event, 'ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31">(28−31)</a> and hERG channel<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> interactions) should lead to drug candidates with acceptable pharmacokinetics, brain exposure, and cardiosafety profiles. By considering these constraints in the design of cyclic hydroxyethylamine BACE1 inhibitors, we could demonstrate brain exposure but were unable to overcome the high metabolic clearance observed in the cyclic sulfone and cyclic sulfoxide hydroxyethylamine scaffolds.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a></div><div class="NLM_p">A key advancement in the BACE1 inhibitor design was the discovery of amidine- or guanidine-containing heterocycles by high-throughput or/and fragment-based screening.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38">(35−38)</a> An amidine embedded in a cyclic framework, which can form an optimal hydrogen-bonding network with both active site aspartyl moieties, was combined with ideal substitution vectors, derived from structural knowledge gained by X-ray crystallography and molecular modeling.</div><div class="NLM_p">This has led to a series of BACE1 inhibitors with high potency and ligand efficiency. Selective substitution of the amidine containing cyclic framework with moieties having a low P-gp interaction potential and the capability to reduce the p<i>K</i><sub>a</sub> to ∼7 has provided <i>in vivo</i> efficacious BACE1 inhibitors. Several compounds with slightly different substituted cyclic amidine headgroups with such a profile have advanced into clinical studies.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46">(39−46)</a></div><div class="NLM_p">Previously, various groups had disclosed frontrunner BACE1 inhibitors containing amidine headgroups <b>(1–3</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35−37)</a> Compound <b>3</b>, bearing an amino-thiazine headgroup, an aryl moiety in P1, and an extension into P3 <i>via</i> an amide linker, expanded the field beyond 5- and 6-membered acylguanidines <b>1–2</b> (nomenclature P1, P2, and P3 according to Schechter and Berger<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a>) while, at the same time, showing excellent cellular activity and a low efflux ratio (ER) compared to the amino-dihydropyrimidinone (<b>1</b>) and amino-hydantoin headgroup (<b>2</b>) containing inhibitors.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Examples of Early Disclosed BACE1 Inhibitors with Amidine Headgroups<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0011.gif" alt="" id="fx25" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center"><b>1</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><b>2</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"><b>3</b><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hBACE1 IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.49</td><td class="colsep0 rowsep0" align="left">0.033</td><td class="colsep0 rowsep0" align="left">0.044</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APP CHO IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="left">0.122</td><td class="colsep0 rowsep0" align="left">0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">9.5</td><td class="colsep0 rowsep0" align="left">6.6</td><td class="colsep0 rowsep0" align="left">8.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ER<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">59</td><td class="colsep0 rowsep0" align="left">6.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Values are means of at least three experiments.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">ER is the efflux ratio (<i>P</i><sub>BL-AP</sub>/<i>P</i><sub>AP-BL</sub>) in MDCK cells transfected with human MDR1.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Ref <a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a>.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Ref <a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a>.</p></div></div></div><div class="NLM_p">To assist in the design of novel 6-membered heterocyclic amidine headgroups, we co-crystallized compound <b>3</b> with BACE1. In <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, the topology of the active site of BACE1 bound to <b>3</b> is highlighted. Tight hydrogen bonds are formed between the protonated 2-amino-thiazine headgroup and the catalytic aspartates Asp32 (2.7 and 2.9 Å) and Asp228 (2.8 and 3.0 Å). In addition, the amide N–H forms a hydrogen bond with the backbone carbonyl of Gly230. The connecting phenyl ring is engaged in a network of van der Waals contacts with hydrophobic residues lining the S1 pocket (Ile118, Trp115, Phe108, and Tyr71 of the enzyme flap). The orientation of the 2-acyl-pyridine moiety projecting into the S3 pocket is stabilized by a favorable intramolecular electrostatic interaction between the NH of the amide bond and the pyridyl nitrogen. An sp<sup>2</sup> nitrogen at this position is preferred over an sp<sup>2</sup> carbon atom to minimize steric interaction with the backbone of Gly230. This bisarylamide has become a widely used fragment, especially in substituted 6-membered heterocyclic amidine BACE1 inhibitors, likely because of its optimal shape complementary with the S1 and S3 pockets and its discrimination against cathepsin D.<a onclick="showRef(event, 'ref42 ref43 ref45 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref45 ref48 ref49 ref50">(42,43,45,48−50)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Co-crystal structure of 2-amino-1,3-thiazine inhibitor <b>3</b> bound to human BACE1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1E">7B1E</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on the understanding of the binding mode of the 2-amino-1,3-thiazine <b>3</b>, the interactions of novel 6-membered amidine heterocycles were assessed together with their potential BBB penetration properties. From this evaluation, we selected the 5-amino-1,4-oxazine headgroup as our starting point.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The measured p<i>K</i><sub>a</sub> value of the 6-unsubstituted 5-amino-1,4-oxazine headgroup turned out to be too basic and outside of the target range (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Therefore, subsequent fine-tuning with different electron-withdrawing substituents at the 6- and/or 3-position was envisioned. Even weak electron-withdrawing substituents at these proximal positions would be expected to have a considerable p<i>K</i><sub>a</sub> lowering effect. In addition, steric shielding of the amidine headgroup was postulated to have a positive impact on activity and permeation by reduced solvation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Additional steric bulk at the 6-position was hypothesized to further increase the chemical and metabolic stability of the 5-amino-1,4-oxazine headgroup. Following this strategy, we were able to generate a series of potent BACE1 inhibitors with druglike properties.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Binding mode of 2-amino-1,3-thiazine <b>3</b> and (B) proposed binding mode of 5-amino-1,4-oxazine inhibitors <b>4</b> and compound series <b>A</b>. Not shielded areas (in blue) decrease with increasing bulk at position 6.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>In Vitro</i> Profile of the Initial 5-Amino-1,4-oxazine Lead Compounds<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a><a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0012.gif" alt="" id="fx26" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><i>rac</i>-<b>20</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>rac</i>-(3<i>R</i>*,6<i>R</i>*)-<b>38a</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>rac</i>-(3<i>R</i>*,6<i>S</i>*)-<b>38e</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>rac</i>-(3<i>R</i>*,6<i>R</i>*)-<b>38b</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hBACE1 IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.070</td><td class="colsep0 rowsep0" align="left">0.058</td><td class="colsep0 rowsep0" align="left">0.020</td><td class="colsep0 rowsep0" align="left">1.08</td><td class="colsep0 rowsep0" align="left">0.011</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">wtAPP-CHO IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.017</td><td class="colsep0 rowsep0" align="left">0.003</td><td class="colsep0 rowsep0" align="left">0.032</td><td class="colsep0 rowsep0" align="left">1.16</td><td class="colsep0 rowsep0" align="left">0.022</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hCathD IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">139</td><td class="colsep0 rowsep0" align="left">>250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">calculated p<i>K</i><sub>a</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">measured p<i>K</i><sub>a</sub><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">9.5</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDCK <i>P</i><sub>app</sub> [nm/s]<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">124</td><td class="colsep0 rowsep0" align="left">103</td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left">67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ER<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">8.2</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">1.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Racemic compounds.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Values are means of at least three experiments.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Calculated using Advanced Chemistry Development (ACD/Labs) Software V9.06 (1994-2005 ACD/Labs).</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Measured p<i>K</i><sub>a</sub> determined by potentiometric titration.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last"><i>P</i><sub>app</sub> is the permeability through an MDR1–MDCK cell monolayer.</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">ER is the efflux ratio (<i>P</i><sub>BL-AP</sub>/ <i>P</i><sub>AP-BL</sub>) in MDCK cells transfected with human MDR1.</p></div></div></div><div class="NLM_p last">To set the baseline for potency and physicochemical properties of this new class of 5-amino-1,4-oxazine inhibitors, the C6-unsubstituted prototype compound <b>4</b> was synthesized.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> At that time, the predictive power of our internal computational tools for p<i>K</i><sub>a</sub> values was not very strong and a large difference between the calculated and experimentally measured p<i>K</i><sub>a</sub> was observed (6.2 vs 9.5, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). To reduce the amidine p<i>K</i><sub>a</sub> to about 7, we favored small fluoroalkyl substitutions (CF<sub>3</sub>, CHF<sub>2</sub>, CH<sub>2</sub>F) over polar substituents.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The introduction of hydroxy, alkoxy, amino, amido, sulfone, and sulfonamide groups was assumed to bear the risk to increase P-gp-mediated efflux due to the increase in polarity (HBD > 2, number of oxygen and nitrogen atoms ∑(N + O) > 5). For estimation of the required fluorination level of a methyl group at C6, we tried to transfer p<i>K</i><sub>a</sub> shifts previously described in the literature. The established p<i>K</i><sub>a</sub> shifts of fluoroalkyl groups on amines (Δp<i>K</i><sub>a</sub> NHCH<sub>2</sub>CH2<b>CH</b><sub><b>3</b></sub> to NHCH<sub>2</sub>CH<sub>2</sub><b>CF</b><sub><b>3</b></sub> −2.0) have been investigated,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> which suggested the CF<sub>3</sub> group to be a good option to lower the amidine p<i>K</i><sub>a</sub> to around neutrality. Herein, we disclose our efforts to convert our initial 5-amino-1,4-oxazine lead compound <b>4</b> into the 5-amino-6-methyl-6-trifluoromethyl-1,4-oxazine containing inhibitors, a class of compounds (<b>A</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) with an improved physicochemical property profile (measured p<i>K</i><sub>a</sub> ∼ 7 and low efflux ratio) resulting in a robust oral effect in CNS Aβ lowering activity. Related approaches were also pursued by others.<a onclick="showRef(event, 'ref39 ref42 ref53'); return false;" href="javascript:void(0);" class="ref ref39 ref42 ref53">(39,42,53)</a> We present here, in more detail, the synthetic access to this highly substituted 5-amino-1,4-oxazine headgroup and structure–activity relationship (SAR) of P3 modifications (<b>64a–j</b>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> A detailed account of the pharmacokinetic properties and the pharmacological activity of <b>54</b> (<b>NB-360</b>) in preclinical studies has already been published elsewhere.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our retrosynthetic analysis is presented in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. An obvious disconnection for the C6-unsubstituted 5-amino-1,4-oxazine headgroup in <b>4</b> was to build the more accessible 1,6-ether linkage in the 1,4-oxazine scaffold from the corresponding <i>N</i>-chloroacetylated intermediate prepared from amino alcohol <b>B</b> (Path A). The final target compounds could then arise <i>via</i> amidine formation from the lactam and generation of the aniline for amide coupling with different P3 fragments. The same disconnection (Path A) for the 3,3,6,6-<i>tetra</i>-substituted 5-amino-1,4-oxazine headgroup in compound class <b>A</b> is not feasible, and alternative pathways had to be identified. The neopentylic 1,2-ether formation (Path B) was judged to be very difficult, and only an intramolecular bond forming process was given some consideration initially. We expected an intermolecular ether formation to <b>C</b> starting with the commercially available tertiary alcohol <b>D</b> and a sterically less demanding reactive electrophile (Path C) to be more promising. Subsequent asymmetric addition of a methyl group to a chiral sulfoximine intermediate derived from ketone <b>C</b> would install the chiral amine for lactam formation. Immediate addition of the C3 methyl group to the ketone and transformation of the tertiary alcohol into an amine with subsequent lactam formation would instead lead to the achiral 3,3,6,6-<i>tetra</i>-substituted 5-amino-1,4-oxazine headgroup, the common central intermediate of the different pathways. Alternatively, the attractive but somewhat more speculative 5-amino-1,4-oxazine formation by an intramolecular iodo-amidination reaction was considered as well (Path D), utilizing the amidine fragment (<b>E</b>), generated from <b>D</b><i>via</i> allylic ether formation and subsequent transformation of the ester moiety into the corresponding amidine fragment.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Retrosynthetic analysis of <b>4</b>, <i>rac</i>-<b>20</b>, and compound series <b>A</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">After identification of the required absolute configuration at C6, the development of a more versatile synthetic route to the chiral key intermediate <b>G</b> was required to facilitate the P3 optimization process. The formation of the neopentylic ether linkage with an advanced chiral P1 fragment together with the chiral <i>tert</i>-alcohol <b>D</b> was initially considered attractive, but no precedence for such transformation was found in the literature at the time this work was started. Determined to find a more efficient synthesis, we hypothesized that an activated aziridine might be sufficiently reactive for a nucleophilic ring-opening with the <i>tert</i>-alkoxyde <b>D</b> (Path E). By this unprecedented key transformation, the common key amidine intermediate <b>G</b> would become readily available <i>via</i> the corresponding amino-nitrile intermediate.</div><div class="NLM_p">The synthesis of the C6-unsubstituted 5-amino-1,4-oxazine lead compounds <b>4</b> (R<sup>1</sup> = H) and <i>rac-</i><b>20</b> (R<sup>1</sup> = F) is depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The chloroacylated amino alcohols <i>rac-</i><b>7a</b> and <i>rac-</i><b>7b</b> were easily obtained from the corresponding commercially available amino acids <i>rac-</i><b>5a</b> and <i>rac-</i><b>5b</b> by borane reduction and acylation with chloroacetyl chloride. Cyclization to the 3,3-disubstituted morpholin-5-one <i>rac-</i><b>8a</b> and <i>rac-</i><b>8b</b> with <i>t-</i>BuOK followed by thioamide formation with Lawesson’s reagent and oxidative-mediated transformation into the amidine with <i>tert</i>-butyl hydroperoxide/ammonia and subsequent <i>N</i>-Boc protection with Boc-anhydride provided the masked headgroup intermediates <i>rac-</i><b>11a</b> and <i>rac-</i><b>11b</b>. Transformation of the corresponding aryl-bromide into the anilide <b>13, 14</b>, and <i>rac-</i><b>16</b> was carried out <i>via</i> Cu-catalyzed azide substitution and subsequent catalytic reduction with the Lindlar catalyst followed by a separation of the enantiomers <b>13</b> and <b>14</b> on the chiral stationary phase (Chiralpak IA). Finally, the target compound <b>4</b> and the C4-fluorinated analogue <i>rac-</i><b>20</b> were obtained <i>via</i> 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)-mediated coupling with the P3 fragment <b>17</b> followed by <i>N</i>-Boc deprotection.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of <b>4</b> and <i>rac-</i><b>20</b>—Referring to Retrosynthetic Pathway A<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaBH<sub>4</sub>, BF<sub>3</sub>-Et<sub>2</sub>O, tetrahydrofuran (THF), 0–25 °C, 81/84%; (b) chloroacetyl chloride, Na<sub>2</sub>CO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>-H<sub>2</sub>O, 0–25 °C, 95/38%; (c) <i>t</i>-BuOK, <i>t-</i>BuOH, reflux, 32/52%; (d) Lawesson’s reagent, THF, reflux, 78/59%; (e) <i>t-</i>BuOOH, 7 N NH<sub>3</sub> in MeOH, NH<sub>3</sub> conc., THF, 25 °C, 50/90%; (f) (Boc)<sub>2</sub>O, <i>N,N</i>-diisopropylethylamine, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 93/49%; (g) NaN<sub>3</sub>, CuI, (1<i>R</i>,2<i>R</i>)-<i>N</i>1,<i>N</i>2-dimethylcyclohexane-1,2-diamine, Na-ascorbate, EtOH-H<sub>2</sub>O, 90 °C, 51/54%; (h) H<sub>2</sub>, Lindlar catalyst, EtOAc, 25 °C, 99/94%; (i) Chiralpak IA 250 mm × 4.6 mm, hexane/EtOH/MeOH 80:10:10, 1.5 mL/min, 39/41%; (j) <b>17</b>, EDC, HOAt, <i>N,N</i>-diisopropylethylamine, <i>N</i>,<i>N</i>-dimethylformamide (DMF), 25 °C, 93/79%; (k) 4 N HCl in dioxane, 25–40 °C, 99/65%.</p></p></figure><div class="NLM_p">The synthesis of the highly substituted 5-amino-3,6-dimethyl-6-trifluoromethyl-1,4-oxazine containing inhibitors <i>rac-</i>(3<i>R</i>*,6<i>R</i>*<i>)-</i><b>38a,e</b> (R<sup>1</sup> = H) and <i>rac-</i>(3<i>R</i>*,6<i>R</i>*<i>)-</i><b>38b–d</b> (R<sup>1</sup> = F) following path C in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> is depicted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Starting from the acid chlorides <b>21a</b> or <b>21b</b>, the diazoketones <b>22a</b> and <b>22b</b> were prepared with trimethylsilyldiazomethane. Subsequent Rh-catalyzed O–H insertion on the <i>tert</i>-alcohol <i>rac-</i><b>23</b> provided the <i>tert</i>-ethers <i>rac-</i><b>24a</b> and <i>rac-</i><b>24b</b>. Chemoselective addition of the methyl group was achieved with trimethylaluminium at low temperature. The resulting racemic diastereomeric tertiary benzylic alcohol <b>25a</b> or <b>25b</b> was converted into azide <b>26a</b> or <b>26b</b> with trimethylsilyl-azide and boron trifluoride diethyl etherate in toluene at a slightly elevated temperature. Indium-mediated reduction of the azides under acidic conditions at ambient temperature provided the <i>tert</i>-amino-ester <b>27a</b> or <b>27b</b>, which upon treatment with trimethylaluminium delivered the lactams <i>rac-</i>(2<i>S</i>*,5<i>R</i>*<i>)-</i><b>28a</b> and <i>rac-</i>(2<i>R</i>*,5<i>R</i>*<i>)-</i><b>29a</b> or <i>rac-</i>(2<i>S</i>*,5<i>R</i>*<i>)-</i><b>28b</b> and <i>rac-</i>(2<i>R</i>*,5<i>R</i>*<i>)-</i><b>29b</b>, respectively. The diastereoisomeric pairs could be easily separated by flash chromatography, and the relative configuration of the individual diastereoisomers was assigned by NMR. In analogy to the sequence for C6-unsubstituted amino-oxazines (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), the <i>N</i>-Boc protected amidines <i>rac-</i>(2<i>R</i>*,5<i>R</i>*<i>)-</i><b>31a</b> and <i>rac-</i>(2<i>R</i>*,5<i>R</i>*<i>)-</i><b>31b</b> were obtained <i>via</i> their thiolactams <i>rac-</i>(2<i>R</i>*,5<i>R</i>*<i>)-</i><b>30a</b> and <i>rac-</i>(2<i>R</i>*,5<i>R</i>*<i>)-</i><b>30b</b>, respectively, prepared with phosphorus pentasulfide and hexamethyldisiloxane in toluene.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Subsequent oxidative-mediated transformation into the amidine with <i>tert</i>-butyl hydroperoxide/ammonia followed by <i>N</i>-Boc protection completed the sequence. Cu-catalyzed substitution of the aryl-bromides by sodium azide followed by catalytic hydrogenation of <i>rac-</i>(2<i>R</i>*,5<i>R</i>*<i>)-</i><b>32a</b> and <i>rac-</i>(2<i>R</i>*,5<i>R</i>*<i>)-</i><b>32b</b> with palladium on carbon provided the anilines <i>rac-</i>(2<i>R</i>*,5<i>R</i>*<i>)-</i><b>33a</b> and <i>rac-</i>(2<i>R</i>*,5<i>R</i>*<i>)-</i><b>33b</b>, respectively. Amide formation with the P3 fragments <b>34, 35</b>, and <b>36</b> followed by acid-catalyzed <i>N</i>-Boc deprotection provided <i>rac-</i>(3<i>R</i>*,6<i>R</i>*<i>)-</i><b>38a,e</b> and the fluorinated analogues <i>rac-</i>(3<i>R</i>*,6<i>R</i>*<i>)-</i><b>38b–d</b>. Having determined the required relative configuration at C6 with the individual synthesis of <i>rac-(</i>3<i>R</i>*,6<i>R</i>*<i>)-</i><b>38a</b> and <i>rac-(</i>3<i>R</i>*,6<i>S</i>*<i>)-</i><b>38e</b>, a more viable synthesis of the 5-amino-6-methyl-6-trifluoromethyl-1,4-oxazine headgroup possessing the desired p<i>K</i><sub>a</sub> had to be identified.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Racemic <b>38a–e</b>—Referring to Retrosynthetic Pathway C<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TMSCH<sub>2</sub>N<sub>2</sub>, NEt<sub>3</sub>, THF, 0.25 °C, 73/88%; (b) <b>23</b>, Rh<sub>2</sub>(TFA)<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 35/34%; (c) MeLi, AlMe<sub>3</sub>, toluene, −78 °C, 69/65%; (d) TMSN<sub>3</sub>, BF<sub>3</sub>-Et<sub>2</sub>O, toluene, 35 °C, 78/63%; (e) In, 4 N HCl-THF, 25 °C, 76/71%; (f) AlMe<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 40 °C, (47/50%)/(38/44%); (g) P<sub>2</sub>S<sub>5</sub>, hexamethyldisiloxane, toluene, 100 °C, 95/85%; (h) <i>t-</i>BuOOH, NH<sub>3</sub>, THF, 0–25 °C; (i) (Boc)<sub>2</sub>O, NEt<sub>3</sub>, acetonitrile, 25 °C, two steps 56%/57%; (j) NaN<sub>3</sub>, CuI, (1<i>R</i>,2<i>R</i>)-<i>N</i>1,<i>N</i>2-dimethylcyclohexane-1,2-diamine, Na-ascorbate, EtOH-H<sub>2</sub>O, 70 °C, 82%/-; (k) H<sub>2</sub>, 10% Pd-C, EtOH, 25 °C, 61%/two steps 51%; (l) <b>34</b>, <b>35</b>, or <b>36</b>, EDC, HOAt, <i>N,N</i>-diisopropylethylamine, DMF, 25 °C; (m) 4 N HCl in dioxane, 40 °C, two steps 33–85%.</p></p></figure><div class="NLM_p">Starting from an allylic ether bearing already the chiral C5–C6 amidine fragment, an intramolecular iodo-amidination reaction was explored to assemble the 3,3,6,6-<i>tetra</i>-substituted 5-amino-1,4-oxazine scaffold <b>G</b> (Path D, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). As shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, the allylic ether <i>rac-</i><b>41</b> was prepared initially from racemic ethyl 3,3,3-trifluoro-2-hydroxy-2-methylpropanoate (<i>rac-</i><b>39</b>) and 2,3-dibromoprop-1-ene followed by a Suzuki coupling of <i>rac-</i><b>40</b> with 2-fluorophenylboronic acid. Conversion of the ethyl ester <i>rac-</i><b>41</b> to the amidine bearing allylic ether <i>rac-</i><b>44</b> was achieved by aminolysis with NH<sub>3</sub> in methanol, conversion of the amide <i>rac-</i><b>42</b> to the nitrile <i>rac-</i><b>43</b> with TFAA-NEt<sub>3</sub>, and final amidine formation with 7 N NH<sub>3</sub> and <i>N</i>-acetyl-<span class="smallcaps smallerCapital">l</span>-cysteine in methanol at 80 °C.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> All attempts to achieve an asymmetric intramolecular iodo-amidination with chiral oxazolidine and amino acid auxiliaries attached to the amidine moiety, as reported for the related iodo-lactamizations, failed.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of <b>54—</b>Referring to Retrosynthetic Pathway D<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, 2,3-dibromoprop-1-ene, DMF, 25 °C, 81%; (b) (2-fluorophenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, CsF, DMF-H<sub>2</sub>O 10:1, 65 °C, 64%; (c) 7 N NH<sub>3</sub> in MeOH, 55 °C, 98%; (d) trifluoroacetic anhydride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 5–25 °C, 93%; (e) 7 N NH<sub>3</sub> in MeOH, <i>N</i>-acetyl-<span class="smallcaps smallerCapital">l</span>-cysteine, 80 °C, 96%; (f) I<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, CHCl<sub>3</sub>, 100 °C, 44%; (g) H<sub>2</sub>, 10 Pd-C, NaOAc, MeOH, 25 °C, 97%; (h) KNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 0 °C, 39/46%; (i) CHIRALPAK AD-H 5, CO<sub>2</sub>-<i>i</i>-PrOH 90:10, 48/48%; (j) (Boc)<sub>2</sub>O, NEt<sub>3</sub>, acetonitrile, 25 °C, 90%; (k) H<sub>2</sub>, 5% Pd-C, <i>i</i>-PrOH-THF 2:1, 50 °C, 92%; (l) EDC, HOAt, <i>N,N</i>-diisopropylethylamine, DMF, 25 °C, 81%; (m) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 83%.</p></p></figure><div class="NLM_p">On the other hand, an achiral iodo-amidination with the unsubstituted amidine <i>rac-</i><b>44</b> using iodine and Na<sub>2</sub>CO<sub>3</sub> in chloroform at 100 °C led to the formation of a 1:1 mixture of racemic diastereoisomeric iodo-amidines <i>rac</i><b>-45</b> in moderate yield.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Hydrogenolytic removal of iodine with 5% Pd-C in methanol containing NaOAc and subsequent nitration of <i>rac</i><b>-46</b> with KNO<sub>3</sub> in H<sub>2</sub>SO<sub>4</sub> followed by chromatographic separation of the <i>rac-</i>(2<i>S</i>*,5<i>R</i>*)-<b>47</b> and <i>rac-</i>(2<i>R</i>*,5<i>R</i>*)-<b>48</b> diastereoisomers and separation of the enantiomers of <i>rac-</i>(2<i>R</i>*,5<i>R</i>*)-<b>48</b> by SFC provided <i>(</i>2<i>S</i>,5<i>S</i>)-<b>49</b> and <i>(</i>2<i>R</i>,5<i>R</i>)-<b>50</b>. The remaining transformation to the aniline (2<i>R</i>,5<i>R</i>)-<b>33b</b>, the key intermediate for the further evaluation of P3 SAR, consisted of <i>N</i>-Boc-protection of the nitro-amidine derivative <i>(</i>2<i>R</i>,5<i>R</i>)-<b>50</b> and catalytic reduction of the aryl-nitro group of (2<i>R</i>,5<i>R</i>)-<b>51</b>. The final conversion of aniline (2<i>R</i>,5<i>R</i>)-<b>33b</b> into inhibitor (3<i>R</i>,6<i>R</i>)-<b>54</b> was initiated by EDC-mediated coupling with the P3 fragment <b>52</b> followed by acid-catalyzed <i>N</i>-Boc deprotection of (2<i>R</i>,5<i>R</i>)-<b>53</b> with TFA in dichloromethane. To enable the quantification of a potential metabolite, some <b>33b</b> was converted into aniline <b>33c</b>.</div><div class="NLM_p">The most practical route to the key intermediate <b>33b</b> (Path E, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), exploiting the nucleophilic opening of a chiral aziridine with a chiral alkoxy C5–C6 fragment, is depicted in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The chiral amino alcohol <b>56</b>, prepared <i>via</i> borane reduction of <b>55</b>,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> was initially transformed by a one-step process with excess Ns-Cl and KHCO<sub>3</sub> in refluxing acetonitrile into the nosylated aziridine <b>59</b>. However, this procedure was not scalable and was replaced by a reproducible two- or three-step process requiring no chromatographic separation. Initial nosylation with Ns-Cl/NMM at 0–5 °C in acetonitrile provided selectively the <i>N</i>-nosylated amino alcohol <b>57</b>, which upon <i>O</i>-mesylation with Ms-Cl/NMM in acetonitrile at 0–5 °C delivered crystalline <b>58</b> in excellent yield. Addition of excess base and increasing the temperature to 30 °C led directly to the formation of nosylated aziridine <b>59</b>. Alternatively, <b>59</b> can be generated from <b>58</b> with 1,8-diazabicycloundec-7-ene (DBU) in dichloromethane at ambient temperature. The opening of aziridine <b>59</b> with the chiral <i>tert</i>-alcohol <b>39</b> worked best with <i>t</i>-BuOK as the base in anhydrous <i>N,N</i>-dimethylformamide at 35 °C. By a controlled acidic workup, the highly functionalized ether intermediate <b>60</b> can be obtained in the crystalline form. Alternatively, the ether intermediate <b>60</b> can be obtained directly from the crystalline mesylate <b>58</b> and chiral <i>tert</i>-alcohol <b>39</b> with excess <i>t</i>-BuOK in <i>N,N</i>-dimethylformamide. Conversion of the ethyl ester <b>60</b> to the nitrile bearing ether <b>62</b> was achieved by aminolysis with NH<sub>3</sub> in methanol and conversion of amide <b>61</b> to nitrile <b>62</b> with TFAA-NEt<sub>3</sub>. Removal of the nosyl protecting group and subsequent formation of the 3,3,6,6-<i>tetra</i>-substituted 3-amino-1,4-oxazine <b>46</b> were achieved in one step with K<sub>2</sub>CO<sub>3</sub> and <i>N</i>-acetyl-<span class="smallcaps smallerCapital">l</span>-cysteine in ethanol at 80 °C. The transformation of <b>46</b> into the key intermediate <b>33b</b> followed the same 3-step reaction sequence as previously described for the preparation of anilide <b>33b</b> in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The final conversion of <b>33b</b> into <b>64a–j</b>, bearing the different P3 fragments <b>63a–j</b>, followed the same 2-step reaction sequence previously described for (3<i>R</i>,6<i>R</i>)-<b>54</b> in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of <b>54</b> and <b>64a–j</b>—Referring to Retrosynthetic Pathway E<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) BH<sub>3</sub> Me<sub>2</sub>S, THF, 65 °C, 99%; (b) 4-nitrobenzene-1-sulfonyl chloride, KHCO<sub>3</sub>, and Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, 80 °C, 50%; (c) 4-nitrobenzene-1-sulfonyl chloride, NMM, acetonitrile, 0–25 °C, 88%; (d) (i) mesyl chloride, 4-methylmorpholine, acetonitrile, 0–5 °C, (ii) NMM, acetonitrile, 30 °C, 84%; (e) mesyl chloride, NMM, acetonitrile, 0–5 °C, 95%; (f) DBU, CH<sub>2</sub>Cl<sub>2</sub>, 5–30 °C, 73%; (g) (<i>R</i>)-ethyl 3,3,3-trifluoro-2-hydroxy-2-methylpropanoate, <i>t-</i>BuOK, DMF/THF, 35 °C, 87%; (h) (<i>R</i>)-ethyl 3,3,3-trifluoro-2-hydroxy-2-methylpropanoate, 1 M <i>t-</i>BuOK in THF, DMF, 20–35 °C, 72%; (i) 7 N NH<sub>3</sub> in MeOH, 50 °C, 99%; (j) trifluoroacetic anhydride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0–5 °C, 95%; (k) K<sub>2</sub>CO<sub>3</sub>, <i>N</i>-acetyl-<span class="smallcaps smallerCapital">l</span>-cysteine, EtOH, 80 °C, 92%; (l) KNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 0–5 °C, 81%; (m) (Boc)<sub>2</sub>O, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 90%; (n) H<sub>2</sub>, 5% Pd-C, dioxane, 45 °C, 92%; (o) <b>63a–j</b>, EDC, HOAt, <i>N,N</i>-diisopropylethylamine (DIPEA), DMF, 5–25 °C, 16–92%; (p) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 62–95%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The X-ray co-crystal structure of the initial 6-unsubstituted 5-amino-1,4-oxazine derivative <b>4</b> with BACE1 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) confirmed an optimal binding arrangement of the amidine with the catalytic aspartates Asp32 and Asp228 (2.7–2.9 Å).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In addition, we learnt that the NH of the amide of <b>4</b> formed an about equally strong hydrogen bond with the backbone carbonyl of Gly230 as the 2-amino-thiazine inhibitor <b>3</b> (3.0 Å for <b>3</b> vs 3.1 Å for <b>4</b>), in agreement with the nearly equal potency when the same P1–P3 fragment is used (IC<sub>50</sub> 44 nM for <b>3</b> vs 70 nM for <b>4</b>). Closer examination of the binding mode of the prototype compound <b>4</b> confirmed that a small electron-withdrawing substituent like a CF<sub>3</sub> group at C6, to reduce the p<i>K</i><sub>a</sub> from 9.5 to ∼7,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> could be tolerated. Since disubstitution at C6 was considered to be essential to ascertain sufficient configurational, chemical, and metabolic stability, the absolute stereochemistry at C6 could not entirely be predicted by modeling. Therefore, the diastereoisomeric pair <i>rac-</i>(3<i>R</i>*,6<i>R</i>*<i>)-</i><b>38a</b> and <i>rac-</i>(3<i>R</i>*,6<i>S</i>*<i>)-</i><b>38e</b> was synthesized. The inhibitor <i>rac-</i>(3<i>R</i>*,6<i>R</i>*<i>)-</i><b>38a</b> was found to be 50-fold more potent over <i>rac-</i>(3<i>R</i>*,6<i>S</i>*<i>)-</i><b>38e</b>. Subsequently, the optimal binding of the (6<i>R)-</i>configuration was confirmed in the co-crystal structure with BACE1 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). In addition, the insertion of fluorine at C4 of the P1 phenyl ring was considered to be beneficial to reduce the formation of a possibly toxic aniline metabolite (<b>33c</b>) by hydrolysis of the P3–amide bond <i>in vivo</i>. As expected, this remote modification had only a minor effect on the p<i>K</i><sub>a</sub> of the amidine (p<i>K</i><sub>a</sub> 9.5 for <b>4</b> vs 9.3 for <i>rac</i><b>-20</b>, respectively, and 7.3 for <i>rac-</i>(3<i>R</i>*,6<i>R</i>*)-<b>38a</b> vs 7.0 for <i>rac-</i>(3<i>R</i>*,6<i>R</i>*)-<b>38b</b>) but led to a ∼2-fold increased <i>in vitro</i> potency (IC<sub>50</sub> 20 nM for <i>rac-</i>(3<i>R</i>*,6<i>R</i>*)-<b>38a</b> vs 11 nM for <i>rac-</i>(3<i>R</i>*,6<i>R</i>*)-<b>38b</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The improvement in inhibitory potency may be driven by electrostatic interactions of the fluorine with Tyr71 and Phe108, which are in close proximity (3.0 Å), as observed in the co-crystal structure of <b>38a</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. Similar potentially beneficial electrostatic interactions of the fluorine atoms of the CF<sub>3</sub> group with the carbonyl of Asp228 (3.0 Å) and the surrounding water network interacting with Thr72 of the flap can be envisaged, besides shielding of the H-bonding network between the polar amidine headgroup and the two catalytic aspartates Asp228 and Asp32, providing a 5-fold increase in potency (IC<sub>50</sub> 58 nM for <i>rac-</i><b>20</b> vs 11 nM for <i>rac-</i>(3<i>R</i>*,6<i>R</i>*)-<b>38b</b>). The identification of this highly potent 6-methyl-6-trifluoromethyl-substituted 5-amino-1,4-oxazine headgroup with an optimal p<i>K</i><sub>a</sub> of 7.0, still allowing protonation in the acidic environment in which BACE1 is active, however, was set off by its rather demanding synthetic accessibility. Excellent BACE1 inhibition in its native cellular environment could be demonstrated with inhibitor <i>rac-</i>(3<i>R</i>*,6<i>R</i>*)-<b>38b</b> in wtAPP CHO cells (IC<sub>50</sub> 22 nM), as well as a very high selectivity against human cathepsin D (IC<sub>50</sub> > 250 μM), for this BACE inhibitor with an amide linker between P1 and P3 substituents, compared to shorter biaryl P1–P3 extensions.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Equally important, a good permeation (<i>P</i><sub>app</sub> = 67 nm/s) and a very low P-gp-mediated efflux (ER = 1.4) in MDCK cells transfected with human MDR1 could be observed, which could be pointing to good brain penetration.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Superimposition of cocrystal structures of compounds bound to BACE1. (A) 5-Amino-1,4-oxazine inhibitor <b>4</b> (blue) with 2-amino-1,3-thiazine inhibitor <b>3</b> (white); PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FGY">6FGY</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1E">7B1E</a>. (B) <b>4</b> (blue) with <b>38a</b> (white); PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FGY">6FGY</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1P">7B1P</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">During the course of our work, we as well as other groups<a onclick="showRef(event, 'ref39 ref49'); return false;" href="javascript:void(0);" class="ref ref39 ref49">(39,49)</a> explored a wide variety of oxazine-derived scaffolds to identify BACE1 inhibitor headgroups with a promising <i>in vitro</i> activity and physicochemical profile and better synthetic accessibility. However, in view of the difficulties in achieving a superior physicochemical profile, the 5-amino-6-methyl-6-trifluoromethyl-1,4-oxazine headgroup merited extra effort to identify a scalable synthesis. In parallel, the identification of the most efficacious and druglike P3 substituent was performed.<named-content content-type="anchor" rid="tbl2" type="simple"></named-content></div><div class="NLM_p">Early SAR exploration and the co-crystal structures of <b>4</b> and <i>rac</i>-<b>38a</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) suggested that the important amide NH hydrogen bond to the backbone carbonyl of Gly230 is impeded by an sp<sup>2</sup> C–H group <i>ortho</i> to the carbonyl of the amide linking the P3 to the P1 fragment. We therefore focused our P3 exploration on various 2-substituted pyridine, pyrazine, and pyrimidine fragments (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). At the beginning of our SAR exploration, the 5-bromopicoline fragment was used to compare the physicochemical and activity profiles of the different headgroups. However, this P3 fragment was not suitable for <i>in vivo</i> profiling due to the high <i>in vitro</i> clearance in rat liver microsomes (CL<sub>int</sub> 154 μL/min·mg for <i>rac</i>-<b>38a</b> and 62 μL/min mg for <i>rac</i>-<b>38b</b>) and inhibition of CYP450 isoforms 2D6 (IC<sub>50</sub> 0.9 μM for <i>rac</i>-<b>38b</b>) and 2C9 (IC<sub>50</sub> 3 μM for <i>rac</i>-<b>38b</b>). Only a partial improvement of the metabolic profile was observed by substituting the pyridine with the less lipophilic pyrimidine as shown in <b>64a</b>, preserving the potency but increasing the ER to 3.4. Substitution of the bromine with a cyano group in <i>rac</i>-<b>64b</b> produced a clean CYP450 enzyme inhibition profile, however at the expense of a large increase in the ER (3.4 to 17). The combination of the cyano group in <i>rac</i>-<b>64b</b> with the less efflux-prone pyridine fragment decreased the ER from 17 to 2. In addition, the high selectivity against human Cathepsin D (>40 000-fold) was retained and the cellular potency of <b>64c</b> was comparable (IC<sub>50</sub> 9 nM for <b>64c</b> vs 24 nM for <i>rac</i>-<b>64b</b>). Furthermore, a clean CYP450 profile was obtained (all IC<sub>50</sub> > 20 <i>μ</i>M), making <b>64c</b> the first valid candidate for a PK/PD experiment in rats. The introduction of a methyl group at C3 adjacent to the carbonyl moiety in the pyridine ring, to impede amide hydrolysis <i>in vivo</i>, was well-tolerated and gratifyingly led to a further improvement of the cellular potency (IC<sub>50</sub> 3 nM for <b>54</b> vs 9 nM for <b>64c</b>), preserving the clean CYP450 profile. In an attempt to further lower the lipophilicity, the pyrazine compound <b>64d</b> was prepared. Only a moderate increase in the ER was observed compared to the pyrimidine (3.5 for <b>64d</b> vs 17 for <i>rac</i>-<b>64b</b>), however, at the expense of a >5-fold lower cellular potency (IC<sub>50</sub> 24 nM for <i>rac</i><b>-64b</b> vs 105 nM for <b>64d</b>). Interestingly, <b>64d</b> showed as an only example a slight preference (2-fold) for inhibition of BACE1 over BACE2, while for all other examples, no or even 8-fold preference for inhibition of BACE2 (<b>64b,g</b>) was observed. Substitution of the methyl group at C3 of the pyridine by Cl (<b>64e)</b> and NH<sub>2</sub> (<b>64f</b>) produced the equipotent analogues <b>64e</b> and <b>64f</b>, however, with a less clean metabolic CYP450 profile. Replacement of the cyano group on the pyridine fragment with OMe (<b>64g</b>) and OCHF<sub>2</sub> (<b>64h,i)</b> delivered analogues of slightly lower potency and inferior metabolic profiles, especially for <b>64i</b>. Substitution of the cyano and the Me group with Cl produced a nearly equipotent analogue (IC<sub>50</sub> 8 nM for <b>64j</b> vs 6 nM for <b>54</b>), however, with lower cellular potency (IC<sub>50</sub> 3 nM for <b>54</b> vs 22 nM for <b>64j</b>) and only moderate metabolic stability for the rather lipophilic derivative (ΔC log <i>P</i> of 1) compared to the best inhibitor <b>54</b> in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. P3 Structure–Activity Relation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0013.gif" alt="" id="fx27" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center" char=".">BACE1 IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">BACE2 IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">CathD IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">wtAPP CHO IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">ER<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">CYP450 3A4/2D6/2C9 IC<sub>50</sub> [μM]</th><th class="colsep0 rowsep0" align="center">brain Aβ40 red.<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a> [%]</th><th class="colsep0 rowsep0" align="center">metabolite <b>33c</b><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a> [% of parent]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38b</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">17/0.9/3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64a</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="left">180</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">8/>20/>20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64b</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">0.034</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="char" char=".">0.024</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">>20/>20/>20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">>20/>20/>20</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">14.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">>20/>20/>20</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64d</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">0.062</td><td class="colsep0 rowsep0" align="char" char=".">0.130</td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="char" char=".">0.105</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">>20/>20/>20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64e</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">17/>20/>20</td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left"><0.2<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64f</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">7/12/>20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64g</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">0.033</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>20/9/>20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64h</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OCHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">20/4/>20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64i</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">OCHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">4/7/17</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left"><0.2<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64j</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">>20/11/>20</td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">0.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Racemic compounds.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Values are means of at least three experiments.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">ER is the efflux ratio (<i>P</i><sub>BL-AP</sub>/<i>P</i><sub>AP-BL</sub>) in MDCK cells transfected with human MDR1.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Percent brain Aβ reduction in rats (<i>n</i> = 5) 4 h post dosing of 10 μmol/kg p.o. relative to vehicle-treated animals.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">Below LLOQ of LC-MS quantification.</p></div></div></div><div class="NLM_p">Only compounds with a promising cellular potency (IC<sub>50</sub> < 10 nM), minimal <i>in vitro</i> P-gp efflux (ER < 5), and no metabolic liabilities were selected for <i>in vivo</i> PK/PD evaluation. Brain Aβ40-lowering was determined after oral administration in rats (Sprague-Dawley, <i>n</i> = 5) 4 h post dosing. Blood and brain samples were taken to assess compound levels as well as the percentage of Aβ reduction in the forebrain and optionally also in CSF. Concerned about the potential formation of the undesired aniline metabolite <b>33c</b> by metabolic cleavage of the amide moiety, the amounts of <b>33c</b> in blood were routinely coquantified with the parent compound. Indeed, considerable amounts of this metabolite were observed with our first PK/PD candidate <b>64c</b> (14.3%, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). With the insertion of a small substituent at C3 adjacent to the P3-P1 linking carboxamide of <b>64c</b>, for example, a methyl, chlorine, or NH<sub>2</sub> group (R<sup>2</sup> in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), formation of the aniline metabolite was almost eliminated, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> by comparison of compound <b>64c</b> with <b>54</b>, <b>64e</b>, <b>64i</b>, and <b>64j</b>. The most robust brain Aβ-lowering effect after 4 h was observed with <b>54</b> (−79%), <b>64e</b> (−71%), and <b>64j</b> (<b>−</b>66%) after application of an oral dose of 10 μmol/kg in rats (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Compound <b>54</b> possessed the most favorable <i>in vitro</i> properties (cellular IC<sub>50</sub> 3 nM, >50 000-fold selectivity over human Cathepsin D, inhibition constants for CYPs 3A4, 2D6, and 2C9 above 20 μM, and a low P-gp efflux ratio of 1.9). An extended overall profile of <b>54</b> is shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, and the binding to BACE1 is shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Co-crystal structure of <b>54</b> bound to human BACE1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1Q">7B1Q</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Extended Profile of <b>54</b> (<b>NB-360</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0014.gif" alt="" id="fx28" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hBACE1 IC<sub>50</sub> μM</td><td class="colsep0 rowsep0" align="left">0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hBACE2 IC<sub>50</sub> μM</td><td class="colsep0 rowsep0" align="left">0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pepsin, hCathD, hCathE IC<sub>50</sub> μM</td><td class="colsep0 rowsep0" align="left">>250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hAβ<sub>40</sub> wtAPP CHO cell IC<sub>50</sub> μM</td><td class="colsep0 rowsep0" align="left">0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hAβ<sub>40</sub> SweAPP CHO cell IC<sub>50</sub> μM</td><td class="colsep0 rowsep0" align="left">0.033</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hAβ<sub>42</sub> wtAPP CHO cell IC<sub>50</sub> μM</td><td class="colsep0 rowsep0" align="left">0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sAPPβ wtAPP CHO cell IC<sub>50</sub> μM</td><td class="colsep0 rowsep0" align="left">0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>P</i> (octanol/water)</td><td class="colsep0 rowsep0" align="left">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">7.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log PAMPA (log Pe pH 6.8) [cm/s]</td><td class="colsep0 rowsep0" align="left">-3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDR1–MDCK apical-basolateral (A–B) [nm/s]</td><td class="colsep0 rowsep0" align="left">141</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDR1–MDCK basolateral-apical (B–A) [nm/s]</td><td class="colsep0 rowsep0" align="left">263</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDR1–MDCK efflux ratio (B–A/A–B)</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP P450 (3A4, 2D6, 2D9) IC<sub>50</sub> μM</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG manual patch clamp IC<sub>50</sub> μM</td><td class="colsep0 rowsep0" align="left">>30</td></tr></tbody></table></div></div><div class="NLM_p">From the candidates selected for an <i>in vivo</i> efficacy experiment, compound <b>54</b> revealed also the best overall PK parameters (highest area under the curve (AUC) of 973, <i>C</i><sub>max</sub> of 128, medium CL, and low <i>V</i><sub>ss</sub>), as shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. PK studies of <b>54</b> in mice and dogs showed a lower clearance and volume of distribution in mice than in rats (mice vs rats: CL 16 vs 26, <i>V</i><sub>ss</sub> 4.6 vs 9.0) and even much lower values in dogs (dogs vs rats: CL 0.4 vs 26, <i>V</i><sub>ss</sub> 0.9 vs 9.0).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters in Rats, Mice, and Dogs</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">dose [μmol/kg]<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>(0-∞)</sub> [nM·h]<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> [nM]<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">%F</th><th class="colsep0 rowsep0" align="center">Hep. CL<sub>int</sub> [μL<i>/</i>min/10<sup>6</sup> cells]</th><th class="colsep0 rowsep0" align="center"><i>in vivo</i> clearance [mL<i>/</i>min<i>/</i>kg]<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> [L<i>/</i>kg]<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> [h]<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64e</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">6<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">511</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="char" char=".">8.6</td><td class="colsep0 rowsep0" align="left">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64i</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">6<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">873</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="left">97</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="char" char=".">7.6</td><td class="colsep0 rowsep0" align="left">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64j</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">6<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">564</td><td class="colsep0 rowsep0" align="char" char=".">83</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="left">74</td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">6<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">973</td><td class="colsep0 rowsep0" align="char" char=".">128</td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="char" char=".">9.0</td><td class="colsep0 rowsep0" align="left">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="char" char=".">882</td><td class="colsep0 rowsep0" align="char" char=".">152</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">0.67</td><td class="colsep0 rowsep0" align="char" char=".">67 370</td><td class="colsep0 rowsep0" align="char" char=".">1880</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="left">36</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Oral (6 μmol/kg for rats and mice, 0.3 mg/kg for dogs).</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Dose normalized.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Intravenous (2 μmol/kg for rats and mice, 0.1 mg/kg for dogs).</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Cassette of five compounds with 6 μmol/kg.</p></div></div></div><div class="NLM_p">Having achieved moderate-to-high oral bioavailability in mice, rats, and dogs (37, 77, and 62%, respectively), compound <b>54 (NB-360)</b> was further evaluated in animal models including those displaying characteristics of amyloid pathology.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> In summary, NB-360 reduced Aβ40 by >80% in the rat brain and CSF 8 h after oral doses (0.3–30 μmol/kg). The <b>NB-360</b> unbound fraction (AUC) was 0.63 μM·h in rat blood and 0.54 μM·h in rat brain, showing an almost equal distribution of the compound in both tissues and the absence of significant efflux at the blood–brain barrier. A single 0.5 mg/kg oral dose of <b>NB-360</b> in dogs carrying a ventricular port for repeated CSF collection reduced Aβ peptide 1–40 by more than 80% and remained significantly inhibited for at least 72 h.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p">Chronic treatment of APP-transgenic mice with 100 μmol/kg <b>NB-360</b> q.d. for 6 weeks led to a significant reduction of APP fragments C99, sAPPβ, Aβ 1–38, 1–40, and 1–42. Amyloid plaques were profoundly reduced compared to vehicle-treated animals, staying at baseline levels. Furthermore, treatment with <b>NB-360</b> strongly reduced the number of activated microglia cells and astrocytes, markers of neuroinflammation.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p">In mice chronically treated with <b>NB-360</b>, we observed the appearance of gray patches in the otherwise black fur. Others and we investigated this further, with data showing that inhibition of BACE2 is causally involved in hair depigmentation, probably <i>via</i> inhibition of the correct processing of the melanosome protein PMEL-17 and improper melanin distribution in the hair follicle.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64,65)</a></div><div class="NLM_p last">The risk of unknown physiological consequences due to inhibition of BACE2 led to a discontinuation of development efforts for <b>NB-360</b>, but the excellent PK/PD properties of this compound have facilitated research efforts in mechanistic animal models related to BACE1 inhibition in the context of AD. For example, a combined histology/magnetic resonance imaging study in old APP-transgenic mice with vascular amyloid pathology addressed the question of the possible occurrence of microhemorrhages as a potential consequence of treatment with BACE1 inhibitors.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Antiamyloid-β antibody treatment in AD patients frequently resulted in cerebral microbleeds. We did not observe such bleedings in APP23 mice treated with <b>NB-360</b>, indicating that microhemorrhages are a consequence of the specific mechanism of action of antibodies, but not a direct consequence of blocking the generation of amyloid-β peptides <i>via</i> direct inhibition of BACE1. Furthermore, chronic studies performed with <b>NB-360</b> in APP-transgenic mice showed that BACE1 inhibition markedly reduces the increase of downstream neurodegeneration markers Tau protein and the neurofilament light chain, as well as deposition of vascular amyloid-β.<a onclick="showRef(event, 'ref67 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref67 ref68 ref69">(67−69)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have reported the discovery of a novel 3-aryl substituted (3<i>R</i>,6<i>R</i>)-5-amino-3,6-dimethyl-6-trifluoromethyl-3,6-dihydro-2<i>H</i>-1,4-oxazine headgroup. Selective structural modifications at C6 of the 1,4-oxazine-based prototype compound <b>4</b> aimed at fine-tuning the p<i>K</i><sub>a</sub> and at shielding the amidine and ether oxygen as much as possible from undesired chemical and metabolic transformations. This resulted in the identification of a 3-aryl substituted (3<i>R</i>,6<i>R</i>)-5-amino-3,6-dimethyl-6-trifluoromethyl-3,6-dihydro-2<i>H</i>-1,4-oxazine headgroup bearing an optimal p<i>K</i><sub>a</sub> of ∼7.0. While retaining the good brain penetration properties of the initial lead compound <b>38a</b>, the potency, pharmacokinetics, and metabolic profile were further optimized by structure-based modifications of the P3 fragment. From the candidates with the best <i>in vitro</i> profile (cellular potency, minimal CYP and hERG liabilities, and low P-gp efflux ratio) and the most robust brain Aβ peptide reduction in rats (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), compound <b>54</b> (<b>NB-360</b>) demonstrated an excellent overall profile (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) and was selected for a more comprehensive PK/PD assessment in rats, dogs, and APP-transgenic mice. The lowering of p<i>K</i><sub>a</sub> of 1,4-oxazine with CF<sub>3</sub> substitution had a profound effect on activity and P-gp efflux. Further optimization of P3 improved metabolic stability, delivering with <b>NB-360</b> an orally active BACE1 inhibitor with an excellent PD profile in mice, rats, and dogs. Compound <b>NB-360</b> did not enter clinical trials in Alzheimer’s disease since hair discoloration observed in mice was considered a sign for off-target inhibition of BACE2 occurring at therapeutic doses. Involvement of BACE2 in pancreatic β-cell function and melanoma cell proliferation is documented, and BACE2 may have other, yet undetected physiological functions.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> This was considered a safety risk, in particular for long-term prevention trials. Another oxazine derivative, CNP520 (umibecestat), with a superior safety profile was identified and entered long-term trials in AD.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> However, we decided to make <b>NB-360</b> available to a large number of interested academic institutions for preclinical studies. Using a potent tool compound in a standardized way, in terms of source, doses, and formulations, contributed significantly to deepening our understanding of the physiological function of BACE1. Furthermore, <b>NB-360</b> treatment of APP-transgenic mice led to the discovery of various aspects of BACE1 inhibition on Alzheimer’s disease biomarkers, neuronal activity and networks, and to the kinetics of amyloid plaque growth.<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>In Vitro</i> Potency and Profiling Assays</h3><div class="NLM_p">Assays for human and mouse BACE1, human BACE2, porcine pepsin, and human cathepsin D and E were performed as described.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Cellular potency was determined in Chinese hamster ovary cells stably transfected with human APP751 as described.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p last">The octanol/water distribution coefficient was derived from the apparent permeability across an artificial liquid membrane.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The PAMPA assay was performed as described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> MDCK cells overexpressing human p-glycoprotein (MDR1–MDCK cells, obtained from Prof. A. Berns, Netherlands Cancer Institute) were grown on multiwell plates, 1 μm pore size (Becton Dickinson). After formation of a tight monolayer, test compounds were applied to either the upper or the lower chamber. After 1 h, liquid was removed from the upper and lower chambers and analyzed by high-performance liquid chromatography-mass spectrometry (HPLC-MS). Apical-to-basolateral and basolateral-to-apical transport rates were calculated.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Human CYP450 Enzymes Inhibition Assays</h3><div class="NLM_p last">The following substrates were used to assess the reversible inhibition of the CYP450 enzymes: CYP3A4, midazolam; CYP2D6, Bufuralol; and CYP2C9, Diclofenac. Assays were performed in human liver microsomes supplemented with NADPH. Test compounds were diluted to 0.5–20 μM final concentrations. The incubation time was 10 min in 50 mM sodium phosphate buffer (pH 7.5). After stopping and centrifugation, analysis was performed using a solid-phase-extraction (SPE) mass spectrometry system consisting of a TSQ Quantum Discovery MAX mass spectrometer controlled by Xcalibur 3.0 and equipped with an electrospray ion source (Ion Max electrospray interface) from Thermo Fisher Scientific (Reinach, Switzerland) and a RapidFire high-throughput SPE system from Agilent Technologies (Waldbronn, Germany).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Animal Experiments</h3><div class="NLM_p">All animals were maintained under standard housing conditions with access to standard pelleted food and water ad libitum, throughout the experiments. Animal experiments were conducted in accordance with Swiss national animal welfare regulations, under the ethically approved animal experimentation licenses authorized by the Cantonal Veterinary Authority of Basel City and the Federal Veterinary Office of Switzerland.</div><div class="NLM_p">Pharmacokinetic studies used male Sprague-Dawley rats, C57BL6 mice, and Beagle dogs, obtained from Charles River (France, rodents) and Marshall (Italy, dogs). Compounds were dosed intravenously as a solution (NMP/PEG200-based mixtures), whereas for oral dosing, compounds were suspended in methylcellulose 0.5% (w/v)/99.5% water/0.1% Tween 80 and applied <i>via</i> oral gavage. Mouse blood was collected by sublingual bleeding or at sacrifice, whereas a serial blood sampling allowed obtaining individual PK profiles in rats and dogs. Blood samples were taken between 5 min (intravenous) and 15 min (oral) intervals and then longer, subsequently up to 24 h (mice), 48 h (rat), and 408 h (dog). Brain exposures were determined in the pharmacological studies by collecting the brain after decapitation at selected time points after dosing.</div><div class="NLM_p">For bioanalytics, brain samples were homogenized with 2 mM KH<sub>2</sub>PO<sub>4</sub> buffer (approx. 1/2, w/v). A structurally similar internal standard was added to the blood or brain homogenate samples, and compounds were extracted by quenching with a fourfold volume of acetonitrile and an aliquot of the supernatant was directly injected into the LC/MS/MS system. Separation from endogenous components was achieved using a reverse-phase column and a gradient elution with water/1% formic acid and acetonitrile/1% formic acid. BACE1 inhibitors were ionized with the positive electrospray mode and quantified in the MRM mode.</div><div class="NLM_p last">For rat pharmacokinetic/pharmacodynamics studies, male Charles River Sprague-Dawley rats of approx. 300 g body weight were used, and experiments were done as described before.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> X-ray Analysis</h3><div class="NLM_p last">The catalytic domain of human BACE1 was expressed in <i>Escherichia coli</i> and refolded, as already described in Hanessian et al. (2015), <a href="/doi/suppl/10.1021/acs.jmedchem.0c02143/suppl_file/jm0c02143_si_001.pdf" class="ext-link">Supporting Information</a>.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The crystal structures of the complexes with <b>3</b>, <b>38a</b>, and <b>54</b> were obtained by soaking orthorhombic crystals of unliganded BACE1, grown at 19 °C from 15% PEG 1500 in water by the method of vapor diffusion in hanging drop using 15.0–16.4 mg/mL BACE1 (residues 46–447 of Uniprot entry <a href="https://P56817" class="ext-link">P56817</a>) in 10 mM Tris-HCl pH 7.4, 25 mM NaCl. The soaking buffer was 28.5–30.0% PEG 1500, 50 mM sodium citrate pH 5.2–5.5, with 1.0 mM compound and 0.9–1.8% DMSO. Crystals were directly flash-frozen, and diffraction data were collected either at the Swiss Light Source (SLS, in Villigen, Switzerland) beamline X10SA, with a MAR CCD 225 (compound <b>3</b>) or a Pilatus (compound <b>54</b>) detector, or in the laboratory (compound <b>38a</b>), using an FR-E superbright rotating anode X-ray generator and a SATURN92 CCD detector. All diffraction data were processed with XDS<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> as implemented in APRV.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The diffraction data extended to between 1.62 and 1.94 Å. All structures were determined by difference Fourier and refined using CNX<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> and Coot,<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> to crystallographic <i>R</i>-factors ranging from 18.6 to 18.9% (free <i>R</i>-factors ranging between 21.1 and 21.8%).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis</h3><div class="NLM_p">Unless otherwise mentioned, all reagents were obtained from commercial suppliers and used without further purification unless noted otherwise. Anhydrous solvents were obtained from Aldrich and used directly. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen or argon atmosphere. All microwave-assisted reactions were conducted with a Smith synthesizer from Personal Chemistry, Uppsala, Sweden. Silica gel chromatography was performed using either glass columns packed with silica gel (230–400 mesh) or prepacked silica gel cartridges from Isco. All NMR spectra were collected on a Bruker 360, 400, or 600 MHz or on a Varian 300 or 400 MHz spectrometer. The chemical shifts were expressed as ppm (δ units) with tetramethylsilane or residual protonated solvent used as the reference. All tested compounds were purified to ≥95% purity as determined by reverse-phase ultrahigh-pressure liquid chromatography (UPLC). UPLC analysis was obtained on a Waters ACQUITY UPLC and UPLC-MS. UPLC method A (2.0 min UPLC run): Acquity UPLC HSS T3 C18 column, 50 mm × 2.1 mm, 1.7 μm, 35 °C; mobile phase, <i>A</i> = 0.1% TFA in H<sub>2</sub>O, <i>B</i> = 0.1% TFA in AcCN; gradient, 0.0–1.5 min, 5–100% B; flow rate 1 mL/min; 218 and 254 nM; 1 min post time; 1 μL injection. UPLC-MS (2.0 min UPLC run): Acquity UPLC HSS T3 C18 column, 50 mm × 2.1 mm, 1.8 μm, 50 °C; mobile phase, <i>A</i> = 0.05% formic acid + 3.75 mM ammonium acetate in H<sub>2</sub>O, <i>B</i> = 0.04% formic acid in AcCN; gradient, 0.0–1.4 min, 2–100% B; flow rate 1.2 mL/min; 218 and 254 nM; 1 min post time; 1–5 μL injection. All assay compounds had a measured purity of ≥95% (by thin-layer chromatography (TLC) and UV) as determined using this analytical UPLC or UPLC-MS system. Low-resolution mass spectral (MS) data were determined on an Agilent 1100 mass spectrometer using ES ionization modes (positive and/or negative) and water-MeOH 3:7 + 2 of 25% ammonium hydroxide solution. High-resolution mass spectral (HRMS) analyses were performed using electrospray ionization in the positive ion mode after separation by liquid chromatography (Nexera from Shimadzu). The elemental composition was derived from the mass spectra acquired at the high resolution of about 30 000 on an LTQ Orbitrap XL mass spectrometer (Thermo Scientific). The high mass accuracy below 1 ppm was obtained using a lock mass.</div><div class="NLM_p last">The procedures for the syntheses of compounds <b>4</b> and <i>rac-</i><b>20</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, retrosynthetic pathway A), compounds <i>rac</i>-(3<i>R</i>*,6<i>R</i>*)-<b>38a–d</b> and <i>rac</i>-(3<i>R</i>*,6<i>S</i>*)-<b>38e</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, retrosynthetic pathway C), and compound <b>54</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, retrosynthetic pathway D) are available in the supplementary part including the separation of (<i>rac</i>-<b>49</b>) and <b>50</b>. The final steps to <b>51</b>, <b>33b</b>, <b>53</b>, and <b>54</b> are identical, as described in procedure E.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Procedure for the Synthesis of Compounds <b>54</b> and <b>64a</b>–<b>64j</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, Retrosynthetic Pathway E)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0015.gif" alt="" id="fx1" /></img><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>R</i>)-2-Amino-2-(2-fluorophenyl)propan-1-ol Hydrochloride (<b>56</b>)</h4><div class="NLM_p last">To a suspension of (<i>R</i>)-2-amino-2-(2-fluorophenyl)-propanoic acid hydrochloride (<b>55</b>) (34.0 g, 150 mmol) in THF (350 mL) was added under argon the BH<sub>3</sub> dimethylsulfide complex (42.7 mL, 450 mmol) at 50 °C over a period of 1 h. The reaction mixture was heated at reflux for 16 h. The excess borane was carefully destroyed by slow addition of MeOH at 25–35 °C. After multiple evaporations with MeOH, the residue was dissolved in 2 N aq. HCl (90 mL) and stirred at 80–90 °C for 0.5 h. The cold reaction mixture was extracted with <i>tert-</i>butylmethyl ether, and the aqueous phase was evaporated to dryness. Residual water was removed azeotropically with AcCN/toluene. The residual hydrochloride salt was dried under reduced pressure at 50 °C for 24 h to provide <b>56</b> (30.8 g, 99%) as a white solid, which was used without further purification. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.68 (s, 3H), 7.51–7.39 (m, 2H), 7.34–7.22 (m, 2H), 3.87–3.71 (m, 2H), 1.62 (s, 3H). MS <i>m</i>/<i>z</i> = 170 [M + H]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0016.gif" alt="" id="fx2" /></img></div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>R</i>)-<i>N</i>-(2-(2-Fluorophenyl)-1-hydroxypropan-2-yl)-4-nitrobenzenesulfonamide (<b>57</b>)</h4><div class="NLM_p last">To a suspension of (<i>R</i>)-2-amino-2-(2-fluorophenyl)propan-1-ol hydrochloride (<b>56</b>) (4.05 g,19.6 mmol) in AcCN (25 mL) were added 4-methylmorpholine (5.4 mL, 49.1 mmol) and 4-nitrobenzene-1-sulfonyl chloride (4.87 g, 21.56 mmol) at 0–5 °C. The reaction mixture was stirred for 0.5 h at 0–5 °C and 2 h at 25 °C. The reaction was diluted with water (100 mL), and the AcCN was slowly removed under reduced pressure. The remaining water mixture was stirred for 1 h in an ice bath before the precipitated product was filtered off and washed with cold water and a small amount of Et<sub>2</sub>O. The title compound <b>56</b> was obtained as a white solid (6.15 g, 88%) after drying under reduced pressure at 60 °C for 24 h and was used without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.12 (d, <i>J</i> = 8.6 Hz, 2H), 7.77 (d, <i>J</i> = 8.6 Hz, 2H), 7.34 (dd, <i>J</i> = 8.1, 1.5 Hz, 1H), 7.22–7.15 (m, 1H), 7.10 (td, <i>J</i> = 7.6, 1.4 Hz, 1H), 6.65 (ddd, <i>J</i> = 12.8, 8.1, 1.4 Hz, 1H), 5.57 (s, 1H), 4.26 (dd, <i>J</i> = 11.3, 5.4 Hz, 1H), 3.78 (dd, <i>J</i> = 11.3, 7.8 Hz, 1H), 2.17 (dd, <i>J</i> = 7.9, 5.6 Hz, 1H), 1.60 (s, 3 H). MS <i>m</i>/<i>z</i> = 372 [M + NH<sub>4</sub>]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0017.gif" alt="" id="fx3" /></img></div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>R</i>)-2-(2-Fluorophenyl)-2-(4-nitrophenylsulfonamido)propyl Methanesulfonate (<b>58</b>)</h4><div class="NLM_p last">To a suspension of (<i>R</i>)-<i>N</i>-(2-(2-fluorophenyl)-1-hydroxypropan-2-yl)-4-nitrobenzenesulfonamide (<b>57</b>) (5.7 g, 16 mmol) in AcCN (60 mL) were added 4-methylmorpholine (2.5 mL, 22.4 mmol) and a solution of methanesulfonyl chloride (1.62 mL, 20.8 mmol) in AcCN (5 mL) at 0–5 °C over a period of 20 min. After stirring for 0.5 h at 20 °C, the reaction mixture was poured onto ice-water and the AcCN was removed under reduced pressure. The aqueous phase was stirred for 1 h at 0–5 °C, and the crystallized product was filtered off. The residue was washed with Et<sub>2</sub>O and dried under reduced pressure at 50 °C for 24 h to provide <b>58</b> (6.62 g, 95%) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.99 (s, 1H), 8.23–8.14 (m, 2H), 7.66–7.58 (m, 2H), 7.37 (td, <i>J</i> = 8.1, 1.8 Hz, 1H), 7.26–7.18 (m, 1H), 7.13 (td, <i>J</i> = 7.6, 1.3 Hz, 1H), 6.69 (ddd, <i>J</i> = 12.9, 8.1, 1.3 Hz, 1H), 4.67 (d, <i>J</i> = 9.7 Hz, 1H), 4.61 (d, <i>J</i> = 9.7 Hz, 1H), 3.24 (s, 3H), 1.67 (s, 3H). MS <i>m</i>/<i>z</i> = 337 [M – MsOH]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0018.gif" alt="" id="fx4" /></img></div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>R</i>)-2-(2-Fluorophenyl)-2-methyl-1-((4-nitrophenyl)sulfonyl)aziridine (<b>59</b>)</h4><div id="sec5_6_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Method A</h5><div class="NLM_p last">To a solution of (<i>R</i>)-2-amino-2-(2-fluorophenyl)propan-1-ol hydrochloride (<b>56)</b> (200 mg, 0.875 mmol) in AcCN (5 mL) were added under argon 2-nitrobenzene-sulfonyl chloride (480 mg, 2.1 mmol) and KHCO<sub>3</sub> (442 mg, 4.38 mmol), and the reaction mixture was heated at reflux for 16 h. To accelerate the aziridine formation, Cs<sub>2</sub>CO<sub>3</sub> (285 mg, 0.875 mmol) was added and the reaction mixture was heated for another 6 h at reflux. The reaction mixture was added to cold sat. aq. NaHCO<sub>3</sub> solution, and the product was extracted with EtOAc. Combined extracts were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residual oil was purified by flash chromatography on silica gel (hexane/EtOAc 10) to provide <b>59</b> (152 mg, 50%) as a yellow oil. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ 8.33–8.28 (m, 2H), 8.14–8.09 (m, 2H), 7.38 (td, <i>J</i> = 7.6, 1.8 Hz, 1H), 7.26–7.19 (m, 1H), 7.07 (td, <i>J</i> = 7.5, 1.2 Hz, 1H), 6.96 (ddd, <i>J</i> = 10.5, 8.2, 1.2 Hz, 1H), 3.00 (s, 1H), 2.57 (s, 1H), 1.98 (s, 3H). MS <i>m</i>/<i>z</i> = 337 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> Method B</h5><div class="NLM_p last">To a suspension of (<i>R</i>)-<i>N</i>-(2-(2-fluorophenyl)-1-hydroxypropan-2-yl)-4-nitrobenzenesulfonamide (<b>57</b>) (5.0 g, 13.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (150 mL) were added at 0–5 °C NEt<sub>3</sub> (7.5 mL, 53.6 mmol) and at 0–5 °C a solution of methanesulfonyl chloride (2.1 mL, 26.8 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL). The reaction mixture was stirred for 0.5 h at 10–15 °C and for 2 h at 25–30 °C to complete aziridine formation and then poured onto cold 10% Na<sub>2</sub>H<sub>2</sub>PO<sub>4</sub> solution, and the product was extracted with EtOAc. Combined extracts were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was crystallized from EtOAc/hexane to provide <b>58</b> (3.8 g, 84%) as a yellow solid. TLC (hexane/EtOAc 1:1) <i>R<sub>f</sub></i> = 0.66. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ 8.33–8.28 (m, 2H), 8.14–8.09 (m, 2H), 7.38 (td, <i>J</i> = 7.6, 1.8 Hz, 1H), 7.26–7.19 (m, 1H), 7.07 (td, <i>J</i> = 7.5, 1.2 Hz, 1H), 6.96 (ddd, <i>J</i> = 10.5, 8.2, 1.2 Hz, 1H), 3.00 (s, 1H), 2.57 (s, 1H), 1.98 (s, 3H). MS <i>m</i>/<i>z</i> = 337 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> Method C</h5><div class="NLM_p last">To a solution of (<i>R</i>)-2-(2-fluorophenyl)-2-(4-nitrophenylsulfonamido)propyl methanesulfonate (<b>58</b>) (1.3 g, 3 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was added DBU (0.7 mL, 4.5 mmol) at 0–5 °C, and the reaction mixture was stirred for 2 h at 25 °C. The mixture was added to cold 10% Na<sub>2</sub>H<sub>2</sub>PO<sub>4</sub> solution, and the product was extracted with EtOAc. Combined extracts were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was crystallized from EtOAc/hexane to provide <b>59</b> (0.74 g, 73%) as a yellow solid. TLC (hexane/EtOAc 1:1) <i>R<sub>f</sub></i> = 0.66. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ 8.33–8.28 (m, 2H), 8.14–8.09 (m, 2H), 7.38 (td, <i>J</i> = 7.6, 1.8 Hz, 1H), 7.26–7.19 (m, 1H), 7.07 (td, <i>J</i> = 7.5, 1.2 Hz, 1H), 6.96 (ddd, <i>J</i> = 10.5, 8.2, 1.2 Hz, 1H), 3.00 (s, 1H), 2.57 (s, 1H), 1.98 (s, 3H). MS <i>m</i>/<i>z</i> = 337 [M + H]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0019.gif" alt="" id="fx5" /></img></div></div></div><div id="sec5_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>R</i>)-Ethyl 3,3,3-Trifluoro-2-hydroxy-2-methylpropanoate (<b>39</b>)</h4><div class="NLM_p last">To a solution of (<i>R</i>)-3,3,3-trifluoro-2-hydroxy-2-methylpropanoic acid (130.0 g, 822 mmol) in EtOH (420 mL) were added trimethyl-orthoformate (244.0 g, 1645 mmol) and H<sub>2</sub>SO<sub>4</sub> (9.2 mL, 173 mmol), and the reaction mixture was heated at reflux for 50 h. The reaction mixture was reduced to half of its volume, and the remaining solution was added to sat. aq. NaHCO<sub>3</sub> solution (300 mL), and the product was extracted with <i>tert-</i>butylmethyl ether. Combined extracts were washed with brine, filtered, and concentrated under normal pressure. The residual oil was purified by vacuum distillation at 200 mbar (b.p. 88–90 °C) to provide <b>39</b> (131.4 g, 86%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.44–4.26 (m, 2H), 3.82 (s, 1H), 1.58 (s, 3H), 1.34 (td, <i>J</i> = 7.1, 1.3 Hz, 3H).<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0020.gif" alt="" id="fx6" /></img></div></div><div id="sec5_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>R</i>)-Ethyl 3,3,3-Trifluoro-2-((<i>R</i>)-2-(2-fluorophenyl)-2-(4-nitrophenylsulfonamido)propoxy)-2-methylpropanoate (<b>60</b>)</h4><div id="sec5_6_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Method A</h5><div class="NLM_p last">To a solution of (<i>R</i>)-ethyl 3,3,3-trifluoro-2-hydroxy-2-methylpropanoate (<b>39</b>) (2.89 g, 15.5 mmol) in anhydrous DMF (20 mL) was added a 1 M solution of <i>tert-</i>butoxide in THF (15 mL, 15 mmol), and after 10 min of stirring, (<i>R</i>)-2-(2-fluorophenyl)-2-methyl-1-((4-nitrophenyl)sulfonyl)aziridine (<b>59</b>) (3.37 g, 10 mmol) was added at 35 °C and the reaction mixture was stirred for 6–10 h at 35 °C (monitored by HPLC). The reaction mixture was neutralized with 1 N aq. HCl at 0–5 °C to pH 7 and diluted with water (30 mL), and after stirring at 0–5 °C for 1 h, the precipitated product was collected and dried. Recrystallization from EtOAc-hexane gave <b>60</b> (4.54 g, 87%) as yellow crystals. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24–8.19 (m, 2H), 7.92–7.83 (m, 2H), 7.66 (td, <i>J</i> = 8.1, 1.8 Hz, 1H), 7.29–7.23 (m, 1H), 7.19 (td, <i>J</i> = 7.6, 1.4 Hz, 1H), 6.86 (s, 1H), 6.76 (ddd, <i>J</i> = 12.7, 8.1, 1.4 Hz, 1H), 4.42 (qq, <i>J</i> = 10.7, 7.1 Hz, 2H), 3.82 (d, <i>J</i> = 8.9 Hz, 1H), 3.67 (d, <i>J</i> = 8.9 Hz, 1H), 1.62 (s, 3H), 1.60 (s, 3H), 1.40 (t, <i>J</i> = 7.1 Hz, 3H). MS <i>m</i>/<i>z</i> = 540 [M + NH<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec5_6_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Method B</h5><div class="NLM_p last">To a solution of (<i>R</i>)-2-(2-fluorophenyl)-2-(4-nitrophenylsulfonamido)propyl methanesulfonate (<b>58</b>) (4.0 g, 9.1 mmol) in anhydrous DMF (60 mL) were added under argon (<i>R</i>)-ethyl 3,3,3-trifluoro-2-hydroxy-2-methylpropanoate (<b>39</b>) (3.05 g, 16.38 mmol) and at 20–25 °C a 1 M solution of potassium <i>tert</i>-butoxide in THF (27.3 mL, 15 mmol). The reaction mixture was stirred for 30 min at 35 °C and then quenched by slow addition to cold 1 N aq. 1 N HCl, and the product was extracted with <i>tert-</i>butylmethyl ether. Combined extracts were washed with sat. aq. NaHCO<sub>3</sub> solution and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was recrystallized from EtOAc/diisopropylether/hexane to provide <b>69</b> (4.73 g, 72%) as a crystalline yellow solid. TLC (hexane/EtOAc 1:1) <i>R<sub>f</sub></i> =0.59. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24–8.19 (m, 2H), 7.92–7.83 (m, 2H), 7.66 (td, <i>J</i> = 8.1, 1.8 Hz, 1H), 7.29–7.23 (m, 1H), 7.19 (td, <i>J</i> = 7.6, 1.4 Hz, 1H), 6.86 (s, 1H), 6.76 (ddd, <i>J</i> = 12.7, 8.1, 1.4 Hz, 1H), 4.42 (qq, <i>J</i> = 10.7, 7.1 Hz, 2H), 3.82 (d, <i>J</i> = 8.9 Hz, 1H), 3.67 (d, <i>J</i> = 8.9 Hz, 1H), 1.62 (s, 3H), 1.60 (s, 3H), 1.40 (t, <i>J</i> = 7.1 Hz, 3H). MS <i>m</i>/<i>z</i> = 540 [M + NH<sub>4</sub>]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0021.gif" alt="" id="fx7" /></img></div></div></div><div id="sec5_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>R</i>)-3,3,3-Trifluoro-2-((<i>R</i>)-2-(2-fluorophenyl)-2-(4-nitrophenylsulfonamido)propoxy)-2-methylpropanamide (<b>61</b>)</h4><div class="NLM_p last">A solution of (<i>R</i>)-ethyl 3,3,3-trifluoro-2-((<i>R</i>)-2-(2-fluorophenyl)-2-(4-nitrophenylsulfonamido)propoxy)-2-methylpropanoate (<b>60</b>) (4.5 g, 8.6 mmol) in 7 N NH<sub>3</sub> in MeOH was stirred in a sealed glass vessel at 50 °C for 36 h. The reaction mixture was concentrated, and the residual foam was dried under reduced pressure to afford the title compound <b>61</b> (4.4 g, 99%) as a yellow amorphous solid, which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.85(s, 1H), 8.20 (d, <i>J</i> = 8.8 Hz, 2H), 7.91 (s, 1H), 7.73 (d, <i>J</i> = 8.8 Hz, 2H), 7.63 (s, 1H), 7.44 (td, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.23 (m, 1H), 7.14 (td, <i>J</i> = 7.6, 1.4 Hz, 1H), 6.78 (m, 1H), 3.98 (d, <i>J</i> = 8.9 Hz, 1H), 3.72 (d, <i>J</i> = 8.9 Hz, 1H), 1.63 (s, 3H), 1.48 (s, 3H). MS <i>m</i>/<i>z</i> = 511 [M + NH<sub>4</sub>]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0022.gif" alt="" id="fx8" /></img></div></div><div id="sec5_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-((<i>R</i>)-1-(((<i>R</i>)-2-Cyano-1,1,1-trifluoropropan-2-yl)oxy)-2-(2-fluorophenyl)propan-2-yl)-4-nitrobenzenesulfonamide (<b>62</b>)</h4><div class="NLM_p last">To a solution of (<i>R</i>)-3,3,3-trifluoro-2-((<i>R</i>)-2-(2-fluorophenyl)-2-(4-nitrophenylsulfonamido)propoxy)-2-methylpropanamide (<b>61</b>) (4.28 g, 8.5 mmol) and NEt<sub>3</sub> (2.96 mL, 21.25 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added dropwise trifluoroacetic anhydride (1.45 mL, 10.2 mmol) over a period of 30 min. After stirring for 2 h at 0–5 °C, the reaction mixture was added to cold 5% aq. NaHCO<sub>3</sub> solution and the product was extracted with <i>tert-</i>butylmethyl ether. Combined extracts were washed with water, 0.1N aq. HCl, sat. aq. NaHCO<sub>3</sub> solution, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was crystallized from EtOAc/heptane to provide the title compound <b>62</b> (3.85 g, 95%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.87(s, 1H), 8.18 (d, <i>J</i> = 8.9 Hz, 2H), 7.65 (d, <i>J</i> = 8.8 Hz, 2H), 7.36 (td, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.20 (m, 1H), 7.12 (td, <i>J</i> = 7.6, 1.4 Hz, 1H), 6.69 (m, 1H), 4.29 (d, <i>J</i> = 8.9 Hz, 1H), 4.09 (d, <i>J</i> = 8.9 Hz, 1H), 1.78 (s, 3H), 1.62 (s, 3H). MS <i>m</i>/<i>z</i> = 493 [M + NH<sub>4</sub>]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0023.gif" alt="" id="fx9" /></img></div></div><div id="sec5_6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (2<i>R</i>,5<i>R</i>)-5-(2-Fluorophenyl)-2,5-dimethyl-2-(trifluoromethyl)-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-amine (<b>46</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-((<i>R</i>)-1-(((<i>R</i>)-2-cyano-1,1,1-trifluoropropan-2-yl)oxy)-2-(2-fluorophenyl)propan-2-yl)-4-nitrobenzenesulfonamide (<b>62</b>) (10.7 g, 22.5 mmol) in EtOH (70 mL) were added 2-acetamido-3-mercaptopropanoic acid (7.34 g, 45 mmol) and K<sub>2</sub>CO<sub>3</sub> (6.84 g, 49.5 mmol), and the reaction mixture was heated at reflux for 72 h. The reaction mixture was concentrated to one-third of its volume and added to 10% aq. K<sub>2</sub>CO<sub>3</sub> solution, and the product was extracted with <i>tert-</i>butylmethyl ether. Combined extracts were washed with brine, dried over MgSO<sub>4</sub>, filtered through a plug of silica gel, and concentrated. The residual foam was dried under reduced pressure at 50 °C for 16 h to afford the title compound <b>46</b> (6.05 g, 92%) as a yellow amorphous solid, which was used without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.46 (td, <i>J</i> = 8.1, 1.9 Hz, 1H), 7.23 (ddt, <i>J</i> = 9.7, 4.9, 2.4 Hz, 1H), 7.10 (td, <i>J</i> = 7.6, 1.3 Hz, 1H), 7.02 (ddd, <i>J</i> = 12.4, 8.1, 1.3 Hz, 1H), 4.36 (br s, 2H), 4.07 (d, <i>J</i> = 11.7 Hz, 1H), 3.98–3.90 (m, 1H), 1.54 (d, <i>J</i> = 1.3 Hz, 3H), 1.46 (s, 3H). MS <i>m</i>/<i>z</i> = 291 [M + H]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0024.gif" alt="" id="fx10" /></img></div></div><div id="sec5_6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (2<i>R</i>,5<i>R</i>)-5-(2-Fluoro-5-nitrophenyl)-2,5-dimethyl-2-(trifluoromethyl)-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-amine (<b>50</b>)</h4><div class="NLM_p last">To a solution of (2<i>R</i>,5<i>R</i>)-5-(2-fluorophenyl)-2,5-dimethyl-2-(trifluoromethyl)-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-amine (<b>46</b>) (6.0 g, 20.6 mmol) in 98% sulfuric acid (40 mL) was added in portions KNO<sub>3</sub> (2.19 g, 21.65 mmol) at 0–5 °C over a period of 0.5 h, and the reaction mixture was stirred for 3 h at 22 °C. The reaction mixture was added to ice-water and was basified to pH 8–9 at 15–25 °C with 30% aq. NaOH. The product was extracted with EtOAc. Combined extracts were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by flash chromatography on silica gel (hexane/EtOAc 10:1 to 1:1) to provide the title compound <b>50</b> (5.62 g, 81%) as a light-yellow solid. TLC (toluene/EtOAc 3:1) <i>R<sub>f</sub></i> = 0.34. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.52 (dd, <i>J</i> = 6.7, 3.0 Hz, 1H), 8.15 (dt, <i>J</i> = 8.9, 3.6 Hz, 1H), 7.17 (dd, <i>J</i> = 10.6, 8.9 Hz, 1H), 4.76 (s, 2H), 4.06 (d, <i>J</i> = 11.6 Hz, 1H), 3.92 (d, <i>J</i> = 11.7 Hz, 1H), 1.56 (s, 3H), 1.49 (s, 3H). MS <i>m</i>/<i>z</i> = 336 [M + H]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0025.gif" alt="" id="fx11" /></img></div></div><div id="sec5_6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>)-5-(2-Fluoro-5-nitrophenyl)-2,5-dimethyl-2-(trifluoromethyl)-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)carbamate (<b>51</b>)</h4><div class="NLM_p last">To a solution of (2<i>R</i>,5<i>R</i>)-5-(2-fluoro-5-nitrophenyl)-2,5-dimethyl-2-(trifluoromethyl)-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-amine (<b>50</b>) (5.4 g, 15.9 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) were added Boc<sub>2</sub>O (4.5 g, 20.63 mmol) and NEt<sub>3</sub> (4.42 mL, 31.7 mmol), and the reaction mixture was stirred overnight at 22 °C. The reaction mixture was added to 10% aq. NaH<sub>2</sub>PO<sub>4</sub> solution, and the product was extracted with CH<sub>2</sub>Cl<sub>2</sub>. Combined extracts were washed with water, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was crystallized from EtOAc/diisopropylether to provide the title compound <b>51</b> (6.38 g, 90%) as a light-yellow solid. TLC (hexane/EtOAc 3:1) <i>R<sub>f</sub></i> = 0.37. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.11 (s, 1H), 8.33–8.25 (m, 2H), 7.32 (t, <i>J</i> = 9.9 Hz, 1H), 4.43 (d, <i>J</i> = 12.4 Hz, 1H), 4.14 (d, <i>J</i> = 12.4 Hz, 1H), 1.73 (s, 3H), 1.57 (d, <i>J</i> = 1.9 Hz, 9H), 1.55 (s, 3H). MS <i>m</i>/<i>z</i> = 436 [M + H]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0026.gif" alt="" id="fx12" /></img></div></div><div id="sec5_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>)-5-(5-Amino-2-fluorophenyl)-2,5-dimethyl-2-(trifluoromethyl)-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)carbamate (<b>33b</b>)</h4><div class="NLM_p last">A solution of <i>tert</i>-butyl ((2<i>R</i>,5<i>R</i>)-5-(2-fluoro-5-nitrophenyl)-2,5-dimethyl-2-(trifluoromethyl)-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)carbamate (<b>51</b>) (6.2 g, 14.18 mmol) in dioxane (100 mL) was hydrogenated at atmospheric pressure with 5% Pd-C (1.5 g) for 3 h at 45 °C. The reaction mixture was filtered through Celite, and the filtrate was lyophilized. The white residue was recrystallized from <i>tert</i>-butylmethylether/hexane to provide the title compound <b>33b</b> (5.28 g, 92%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.85 (s, 1H), 6.84 (dd, <i>J</i> = 11.8, 8.5 Hz, 1H), 6.60–6.48 (m, 2H), 4.32 (d, <i>J</i> = 12.1 Hz, 1H), 4.00 (d, <i>J</i> = 12.1 Hz, 1H), 3.62 (s, 2H), 1.61 (s, 3H), 1.51 (s, 3H), 1.49 (s, 9H). MS <i>m</i>/<i>z</i> = 406 [M + H]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0027.gif" alt="" id="fx13" /></img></div></div><div id="sec5_6_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>tert</i>-Butyl ((2<i>R</i>,5<i>R</i>)-5-(2-Fluoro-5-(5-cyano-3-methylpicolinamido)phenyl)-2,5-dimethyl-2-(trifluoromethyl)-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)carbamate (<b>53</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl ((2<i>R</i>,5<i>R</i>)-5-(5-amino-2-fluorophenyl)-2,5-dimethyl-2-(trifluoromethyl)-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)carbamate (<b>33b</b>) (3.49 g, 8.6 mmol) in DMF (30 mL) were added at 0–5 °C 5-cyano-3-methylpicolinic acid (1.54 g, 9.46 mmol), EDC (1.74 g, 11.18 mmol), and HOAt (1.52 g, 11.18 mmol), and the reaction mixture was stirred overnight at 20 °C. The reaction mixture was added to sat. aq. NaHCO<sub>3</sub> solution, and the product was extracted with <i>tert</i>-butylmethylether. Combined extracts were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was 2× recrystallized with diisopropylether to provide the title compound <b>53</b> (3.88 g, 81%) as a white crystalline solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.08–11.03 (m, 1H), 10.03 (s, 1H), 8.72 (d, <i>J</i> = 1.9 Hz, 1H), 7.95 (d, <i>J</i> = 1.8 Hz, 1H), 7.77 (dt, <i>J</i> = 8.5, 3.4 Hz, 1H), 7.61 (dd, <i>J</i> = 7.1, 2.6 Hz, 1H), 7.13 (dd, <i>J</i> = 11.5, 8.8 Hz, 1H), 4.42 (d, <i>J</i> = 12.2 Hz, 1H), 4.09 (d, <i>J</i> = 12.1 Hz, 1H), 2.85 (s, 3H), 1.70 (s, 3H), 1.59–1.53 (m, 12H). MS <i>m</i>/<i>z</i> = 550 [M + H]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0028.gif" alt="" id="fx14" /></img></div></div><div id="sec5_6_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-(3-((3<i>R</i>,6<i>R</i>)-5-Amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorophenyl)-5-cyano-3-methylpicolinamide (<b>54</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl ((2<i>R</i>,5<i>R</i>)-5-(2-fluoro-5-(5-cyano-3-methylpicolinamido)phenyl)-2,5-dimethyl-2-(trifluoromethyl)-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)carbamate (<b>53</b>) (3.86 g, 7.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was added trifluoroacetic acid (5.1 mL, 70 mmol), and the reaction mixture was stirred for 2.5 h at 22 °C. The reaction mixture was added to excess 10% aq. NaHCO<sub>3</sub> solution, and the product was extracted with EtOAc. Combined extracts were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was 2× recrystallized from <i>i</i>PrOH and dried at 50 °C for 24 h to provide the title compound <b>54</b> (2.64 g, 83%) as a colorless solid. M.p. 101–102 °C. TLC (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 10:1) <i>R<sub>f</sub></i> =0.16. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.73 (s, 1H), 8.99 (s, 1H), 8.41 (s, 1H), 7.79 (dd, <i>J</i> = 7.4, 2.8 Hz, 1H), 7.72 (m, 1H), 7.16 (dd, <i>J</i> = 11.8, 8.7 Hz, 1H), 6.09 (s, 2H), 3.91 (d, <i>J</i> = 11.5 Hz, 1H), 3.81 (d, <i>J</i> = 11.4 Hz, 1H), 2.54 (s, 3H), 1.47 (s, 3H), 1.42 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.74, 156.17 (d, <sup>1</sup>J<sub>CF</sub> = 241.9 Hz), 153.68, 152.31, 148.78, 143.31, 134.19, 133.29 (d, <sup>2</sup>J<sub>CF</sub> = 13.1 Hz), 133.14, 124.65 (q, <sup>1</sup>J<sub>CF</sub> = 287.6 Hz), 121.93, 120.66 (<sup>3</sup>J<sub>CF</sub> = 8.5 Hz), 116.58, 115.99 (d, <sup>2</sup>J<sub>CF</sub> = 25.2 Hz), 110.03, 72.07 (q, <sup>2</sup>J<sub>CF</sub> = 27.2 Hz), 67.27, 54.97, 25.63, 18.53, 18.29. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ −74.67 (s, 3F), −117.10 (s, 1F). HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>19</sub>N<sub>5</sub>O<sub>2</sub>F<sub>4</sub> [M + H]<sup>+</sup> 450.15476, found 450.15485.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0029.gif" alt="" id="fx15" /></img></div></div><div id="sec5_6_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(3-((3<i>R</i>,6<i>R</i>)-5-Amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorophenyl)-5-bromopyrimidine-2-carboxamide Hydrochloride (<b>64a</b>)</h4><div class="NLM_p last"><b>64a</b> was obtained according to the procedure described for compounds <b>53</b> and <b>38a</b> starting from <b>33b</b> and 5-bromopyrimidine-2-carboxylic acid (<b>63a</b>) as an off-white solid (85, 88%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.7 (s, 1H), 11.1 (s, 1H), 9.61 (s, 2H), 9.32 (s, 2H), 7.99 (m, 1H), 7.93 (d, <i>J</i> = 3.2 Hz, 1H), 7.36 (dd, <i>J</i> = 11.8, 8.7 Hz, 1H), 4.34 (d, <i>J</i> = 11.5 Hz, 1H), 4.08 (d, <i>J</i> = 11.4 Hz, 1H), 1.65 (s, 3H), 1.59 (s, 3H). MS <i>m</i>/<i>z</i> = 490/492 [M + H]<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>17</sub>N<sub>5</sub>O<sub>2</sub>BrF<sub>4</sub> [M + H]<sup>+</sup> 490.04963, found 490.04965.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0030.gif" alt="" id="fx16" /></img></div></div><div id="sec5_6_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>rac-N</i>-(3-((3<i>R</i>*,6<i>R</i>*)-5-Amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorophenyl)-5-cyanopyrimidine-2-carboxamide Trifluoroacetate (<i>rac</i>-<b>64b</b>)</h4><div class="NLM_p last"><b><i>rac</i>-64b</b> was obtained according to the procedure described for compounds <b>53</b> and <b>54</b> starting from <i>rac</i>-<b>33b</b> and 5-cyano-3-methylpyrazine-2-carboxylic acid (<b>63b</b>) as an off-white solid (16, 94%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.16 (s, 1H), 9.95 (s, 1H), 9.18 (s, 2H), 8.96 (s, 2H), 7.95–7.87 (m, 1H), 7.57–7.49 (m, 1H), 7.10 (dd, <i>J</i> = 11.5, 8.7 Hz, 1H), 4.45 (d, <i>J</i> = 12.5 Hz, 1H), 4.01 (d, <i>J</i> = 12.5 Hz, 1H), 1.73 (s, 3H), 1.67 (s, 3H). MS <i>m</i>/<i>z</i> = 437 [M + H]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0031.gif" alt="" id="fx17" /></img></div></div><div id="sec5_6_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(3-((3<i>R</i>,6<i>R</i>)-5-Amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluoro-phenyl)-5-cyanopicolinamide Hydrochloride (<b>64c</b>)</h4><div class="NLM_p last"><b>64c</b> was obtained according to the procedure described for compounds <b>53</b> and <b>54</b> starting from <b>33b</b> and 5-cyano-3-methylpyrazine-2-carboxylic acid (<b>63c</b>) as an off-white solid (86, 91%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.85 (s, 1H), 9.26–9.10 (m, 1H), 8.56 (dd, <i>J</i> = 8.2, 2.2 Hz, 1H), 8.32–8.16 (m, 1H), 7.93 (dd, <i>J</i> = 7.4, 2.7 Hz, 1H), 7.84–7.62 (m, 1H), 7.16 (dd, <i>J</i> = 11.8, 8.9 Hz, 1H), 6,25 (br s, 2H), 3.94 (d, <i>J</i> = 11.5 Hz, 1H), 4.81 (d, <i>J</i> = 11.6 Hz, 1H), 1.49 (s, 3H), 1.43 (s, 3H). HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub>F<sub>4</sub> [M + H]<sup>+</sup> 436.13911, found 436.13904.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0032.gif" alt="" id="fx18" /></img></div></div><div id="sec5_6_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(3-((3<i>R</i>,6<i>R</i>)-5-Amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorophenyl)-5-cyano-3-methylpyrazine-2-carboxamide (<b>64d</b>)</h4><div class="NLM_p last"><b>64d</b> was obtained according to the procedure described for compounds <b>53</b> and <b>54</b> starting from <b>33b</b> and 5-cyano-3-methylpyrazine-2-carboxylic acid (<b>63d</b>) as an off-white solid (55, 79%). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 9.01 (s, 1H), 7.86 (dd, <i>J</i> = 7.4, 2.8 Hz, 1H), 7.74 (m, 1H), 7.20 (dd, <i>J</i> = 11.8, 7.7 Hz, 1H), 4.19 (d, <i>J</i> = 11.5 Hz, 1H), 3.35 (d, <i>J</i> = 11.4 Hz, 1H), 2.93 (s, 3H), 1.57 (s, 3H), 1.32 (s, 3H). HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>N<sub>6</sub>O<sub>2</sub>F<sub>4</sub> [M + H]<sup>+</sup> 451.15001, found 451.15018.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0033.gif" alt="" id="fx19" /></img></div></div><div id="sec5_6_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(3-((3<i>R</i>,6<i>R</i>)-5-Amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorophenyl)-3-chloro-5-cyanopicolinamide Hydrochloride (<b>64e</b>)</h4><div class="NLM_p last"><b>64e</b> was obtained according to the procedure described for compounds <b>53</b> and <b>54</b> starting from <b>33b</b> and 3-chloro-5-cyanopicolinic acid (<b>63e</b>) as a white solid (81, 95%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.92 (s, sH), 9.12 (d, <i>J</i> = 1.5 Hz, 1H), 8.82 (d, <i>J</i> = 1.5 Hz, 1H), 7.71 (d, <i>J</i> = 5.7 Hz, 2H), 7.25–7.08 (m, 1H), 6.11 (s, 2H), 3.93 (d, <i>J</i> = 11.5 Hz, 1H), 3.79 (d, <i>J</i> = 11.4 Hz, 1H), 1.46 (s, 3H), 1.42 (s, 3H). HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>17</sub>N<sub>5</sub>O<sub>2</sub>ClF<sub>4</sub> [M + H]<sup>+</sup> 470.10014, found 470.10043.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0034.gif" alt="" id="fx20" /></img></div></div><div id="sec5_6_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 3-Amino-<i>N</i>-(3-((3<i>R</i>,6<i>R</i>)-5-amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorophenyl)-5-cyanopicolinamide (<b>64f</b>)</h4><div class="NLM_p last"><b>64f</b> was obtained according to the procedure described for compounds <b>53</b> and <b>54</b> starting from <b>33b</b> and 3-amino-5-cyanopicolinic acid (<b>63f</b>) as a light-yellow foam (53, 77%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.51 (s, 1H), 8.21 (s, 1 H), 7.84 (m, 1H), 7.69 (m, 1H), 7.63 (s, 1H), 7.24 (s, 2H), 7.13 (dd, <i>J</i> = 11.2, 7.6 Hz, 1H), 6.08 (s, 1H), 3.80–3.92 (m, 2H), 1.48 (s, 3H), 1.39 (s, 3H). HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>17</sub>N<sub>5</sub>O<sub>2</sub>BrF<sub>4</sub> [M + H]<sup>+</sup> 451.15001, found 451.15012.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0035.gif" alt="" id="fx21" /></img></div></div><div id="sec5_6_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(3-((3<i>R</i>,6<i>R</i>)-5-Amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorophenyl)-5-methoxy-3-methylpicolinamide (<b>64g</b>)</h4><div class="NLM_p last"><b>64g</b> was obtained according to the procedure described for compounds <b>53</b> and <b>54</b> starting from <b>33b</b> and 5-methoxy-3-methylpicolinic acid (<b>63g</b>) as a light-yellow foam (62, 94%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.54 (s, 1H), 10.67 (s, 1H), 9.55 (m, 2H), 8.24 (d, <i>J</i> = 2.5 Hz, 1H), 7.98 (m, 1H), 7.89 (dd, <i>J</i> = 7.7, 2.4 Hz, 1H), 7.43 (d, <i>J</i> = 3.3 Hz, 1H), 7.30 (dd, <i>J</i> = 12.1, 8.8 Hz, 1H), 4.31 (d, <i>J</i> = 12.6 Hz, 1H), 4.07 (d, <i>J</i> = 12.8 Hz, 1H), 3.91 (s, 3H), 2.62 (s, 3H), 1.76 (s, 3H), 1.72 (s, 3H). HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>F<sub>4</sub> [M + H]<sup>+</sup> 455.17008, found 455.17020.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0036.gif" alt="" id="fx22" /></img></div></div><div id="sec5_6_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(3-((3<i>R</i>,6<i>R</i>)-5-Amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorophenyl)-5-(difluoromethoxy)-3-methylpicolinamide Hydrochloride (<b>64h</b>)</h4><div class="NLM_p last"><b>64h</b> was obtained according to the procedure described for compounds <b>53</b> and <b>54</b> starting from <b>33b</b> and 5-(difluoromethoxy)-3-methylpicolinic acid (<b>63h</b>) as a light-yellow foam (76, 62%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.53 (s, 1H), 10.78 (s, 1H), 9.54 (m, 2H), 8.45 (d, <i>J</i> = 2.5 Hz, 1H), 7.97 (m, 1H), 7.88 (dd, <i>J</i> = 7.5, 2.5 Hz, 1H), 7.75 (d, <i>J</i> = 2.3 Hz, 1H), 7.45 (t, 1H), 7.32 (dd, <i>J</i> = 12.1, 8.8 Hz, 1H), 4.32 (d, <i>J</i> = 12.6 Hz, 1H), 4.08 (d, <i>J</i> = 12.6 Hz, 1H), 2.60 (s, 3H), 1.75 (s, 3H), 1.72 (s, 3H). HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>F<sub>6</sub> [M + H]<sup>+</sup> 491.15124, found 491.15131.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0037.gif" alt="" id="fx23" /></img></div></div><div id="sec5_6_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(3-((3<i>R</i>,6<i>R</i>)-5-Amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorophenyl)-3-chloro-5-(difluoromethoxy)picolinamide (<b>64i</b>)</h4><div class="NLM_p last"><b>64i</b> was obtained according to the procedure described for compounds <b>53</b> and <b>54</b> starting from <b>33b</b> and 3-chloro-5-(difluoromethoxy)picolinic acid (<b>63i</b>) as a white solid (92, 86%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.74 (s, 1H), 8.59 (d, <i>J</i> = 2.3 Hz, 1H), 8.13 (d, <i>J</i> = 2.3 Hz, 1H), 7.74 (dd, <i>J</i> = 7.3, 2.7 Hz, 1H), 7.72–7.66 (m, 1H), 7.50 (t, <i>J</i> = 72.7 Hz, 1H), 7.17 (dd, <i>J</i> = 11.7, 8.8 Hz, 1H), 6.10 (s, 2H), 3.93 (d, <i>J</i> = 11.5 Hz, 1H), 3.79 (d, <i>J</i> = 11.5 Hz, 1H), 1.47 (s, 3H), 1.42 (s, 3H). HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>18</sub>N<sub>4</sub>O<sub>3</sub>ClF<sub>6</sub> [M + H]<sup>+</sup> 511.09661, found 511.09677.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0038.gif" alt="" id="fx24" /></img></div></div><div id="sec5_6_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(3-((3<i>R</i>,6<i>R</i>)-5-Amino-3,6-dimethyl-6-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorophenyl)-3,5-dichloropicolinamide Hydrochloride (<b>64j</b>)</h4><div class="NLM_p last"><b>64j</b> was obtained according to the procedure described for compounds <b>53</b> and <b>54</b> starting from <b>33b</b> and 3,5-dichloropicolinic acid (<b>63j</b>) as a white solid (90, 88%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.72 (s, 1H), 8.87–8.64 (m, 1H), 8.43 (d, <i>J</i> = 1.9 Hz, 1H), 7.84–7.59 (m, 2H), 7.29–7.04 (m, 1H), 6.05 (br s, 2H), 3.91 (d, <i>J</i> = 11.7 Hz, 1H), 3.77 (d, <i>J</i> = 11.3 Hz, 1H), 1.45 (s, 3H), 1.40 (s, 3H). HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>17</sub>N<sub>4</sub>O<sub>2</sub>Cl<sub>2</sub>F<sub>4</sub> [M + H]<sup>+</sup> 479.06592, found 479.06598.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51"><a href="/doi/suppl/10.1021/acs.jmedchem.0c02143" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58460" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58460" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c02143?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02143</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Preparation details and analytical data for compounds <b>4</b>, <i>rac-</i><b>20</b>, <i>rac</i>-(3<i>R</i>*,6<i>R</i>*)<i>-</i><b>38a–d</b>, <i>rac</i>-(3<i>R</i>*,6<i>S</i>*)<i>-</i><b>38e</b>, <i>rac</i><b>-49</b>, and <b>50</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02143/suppl_file/jm0c02143_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02143/suppl_file/jm0c02143_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02143/suppl_file/jm0c02143_si_001.pdf">jm0c02143_si_001.pdf (1.61 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02143/suppl_file/jm0c02143_si_002.csv">jm0c02143_si_002.csv (2.29 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Crystal structure coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with the accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1E">7B1E</a> (<b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1P">7B1P</a> (<b>38a</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1Q">7B1Q</a> (<b>54</b>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c02143" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rainer Machauer</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5081-6268" title="Orcid link">http://orcid.org/0000-0001-5081-6268</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0775666e696275296a66646f66726275476968716675736e742964686a"><span class="__cf_email__" data-cfemail="d6a4b7bfb8b3a4f8bbb7b5beb7a3b3a496b8b9a0b7a4a2bfa5f8b5b9bb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heinrich Rueeger</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rainer Lueoend</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Siem J. Veenstra</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philipp Holzer</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Konstanze Hurth</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Voegtle</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mathias Frederiksen</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Michel Rondeau</span> - <span class="hlFld-Affiliation affiliation">Center for Proteomic Chemistry,
Structural
Biology Platform, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marina Tintelnot-Blomley</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura H. Jacobson</span> - <span class="hlFld-Affiliation affiliation">Department of Neuroscience, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span>; 
    <span>Present Address:
                        Florey Institute of Neuroscience and Mental Health; Department of Pharmacology and Therapeutics; University of Melbourne, Parkville 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Staufenbiel</span> - <span class="hlFld-Affiliation affiliation">Department of Neuroscience, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span>; 
    <span>Present Address:
                        German Center for Neurodegenerative Diseases (DZNE), D-72076 Tübingen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grit Laue</span> - <span class="hlFld-Affiliation affiliation">Metabolism and Pharmacokinetics, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulf Neumann</span> - <span class="hlFld-Affiliation affiliation">Department of Neuroscience, , , and , Novartis Institutes for BioMedical Research, Novartis
Pharma AG, CH-4057 Basel, Switzerland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): H.R., R.L., R.M., S.J.V., P.H., K.H., M.V., M.F., J.-M.R., M.T.-B., L.H.J., M.S., G.L. and U.N. are current or former employees of Novartis Pharma AG, which has a commercial interest to develop BACE1 inhibitors.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6617-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank K. Barker, M. Furegati, C. Hartwieg, M. Hediger, S. Jacquier, P. Koeninger, C. Rolando, T. Ruppen, H. Schütz, U. Stauss, M. Vogt, J. Zadrobilek, and T. Zimmermann for synthetic support; T. Dittmar, V. Trappe, I. Brzak, L. Perrot, and U. Furrer for <i>in vitro</i> and <i>in vivo</i> studies; K. Beltz and R. Ramos for compound formulation support; S. Lehmann and E. Wirth for X-ray support; and R. Hemmig for the preparation of refolded BACE1. We are grateful to the machine and beamline groups at the Paul Scherrer Institute, Villigen, Switzerland, for the X-ray data collection of the BACE1 complexes with compounds <b>3</b> and <b>54</b>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">aq.</td><td class="NLM_def"><p class="first last">aqueous</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BACE</td><td class="NLM_def"><p class="first last">β-site APP-cleaving enzyme</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last">butyloxycarbonyl</p></td></tr><tr><td class="NLM_term"><i>t</i>-BuOK</td><td class="NLM_def"><p class="first last">potassium <i>tert</i>-butoxide</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450 enzyme</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">1,2-dimethoxyethane</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicycloundec-7-ene</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N,N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N,N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">ee</td><td class="NLM_def"><p class="first last">enantiomeric excess</p></td></tr><tr><td class="NLM_term">eq.</td><td class="NLM_def"><p class="first last">equivalent</p></td></tr><tr><td class="NLM_term">Et<sub>2</sub>O</td><td class="NLM_def"><p class="first last">diethylether</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go related gene</p></td></tr><tr><td class="NLM_term">HOAt</td><td class="NLM_def"><p class="first last">1-hydroxy-7-azabenzotriazole</p></td></tr><tr><td class="NLM_term">iPrOH</td><td class="NLM_def"><p class="first last"><i>iso</i>-propanol</p></td></tr><tr><td class="NLM_term">LC</td><td class="NLM_def"><p class="first last">liquid chromatography</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">MDR1</td><td class="NLM_def"><p class="first last">multidrug-resistance gene 1</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectrospopy</p></td></tr><tr><td class="NLM_term">Ms</td><td class="NLM_def"><p class="first last">methanesulfonyl</p></td></tr><tr><td class="NLM_term">Ms-Cl</td><td class="NLM_def"><p class="first last">methanesulfonyl chloride</p></td></tr><tr><td class="NLM_term">NaOAc</td><td class="NLM_def"><p class="first last">sodium acetate</p></td></tr><tr><td class="NLM_term">NMM</td><td class="NLM_def"><p class="first last"><i>N</i>-methylmorpholine</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-2-pyrrolidone</p></td></tr><tr><td class="NLM_term">Ns</td><td class="NLM_def"><p class="first last">nosyl</p></td></tr><tr><td class="NLM_term">Ns-Cl</td><td class="NLM_def"><p class="first last">nosyl chloride</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">poly(ethylene glycol)</p></td></tr><tr><td class="NLM_term"><i>i</i>-PrOH</td><td class="NLM_def"><p class="first last">2-propanol</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">sat.</td><td class="NLM_def"><p class="first last">saturated</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">chiral supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TFAA</td><td class="NLM_def"><p class="first last">trifluoroacetic anhydride</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72876" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72876" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 80 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ising, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span> <span> </span><span class="NLM_article-title">Current thinking on the mechanistic basis of Alzheimer’s and implications for drug development</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1002/cpt.200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Fcpt.200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=26250900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BC287gsFaqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2015&pages=469-471&author=C.+Isingauthor=M.+Stanleyauthor=D.+M.+Holtzman&title=Current+thinking+on+the+mechanistic+basis+of+Alzheimer%E2%80%99s+and+implications+for+drug+development&doi=10.1002%2Fcpt.200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current thinking on the mechanistic basis of Alzheimer's and implications for drug development</span></div><div class="casAuthors">Ising C; Stanley M; Holtzman D M</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">469-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer disease (AD) is the most common cause of dementia and is characterized by the aggregation and accumulation of two proteins in the brain, amyloid-β (Aβ) and tau.  Aβ and tau begin to buildup 15-20 years before the clinical onset of AD dementia.  Increasing evidence suggests that preventing or decreasing the amount of aggregated forms of both Aβ and tau in the brain can serve as potential disease-modifying treatments for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTdchZ1NHs08nwOGIfWJ7-GfW6udTcc2eZBI4Wdu4zpnLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287gsFaqsw%253D%253D&md5=96ec752d1a40171c8b2512a3ca379fc4</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fcpt.200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt.200%26sid%3Dliteratum%253Aachs%26aulast%3DIsing%26aufirst%3DC.%26aulast%3DStanley%26aufirst%3DM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26atitle%3DCurrent%2520thinking%2520on%2520the%2520mechanistic%2520basis%2520of%2520Alzheimer%25E2%2580%2599s%2520and%2520implications%2520for%2520drug%2520development%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2015%26volume%3D98%26spage%3D469%26epage%3D471%26doi%3D10.1002%2Fcpt.200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heneka, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoury, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landreth, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosseron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinstein, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyss-Coray, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitorica, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransohoff, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrup, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frautschy, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkhratsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koistinaho, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzold, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Town, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinohara, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deigendesch, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garaschuk, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boddeke, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinarello, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golenbock, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummer, M. P.</span></span> <span> </span><span class="NLM_article-title">Neuroinflammation in Alzheimer’s disease</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(15)70016-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2FS1474-4422%2815%2970016-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=25792098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvVSksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=388-405&author=M.+T.+Henekaauthor=M.+J.+Carsonauthor=J.+E.+Khouryauthor=G.+E.+Landrethauthor=F.+Brosseronauthor=D.+L.+Feinsteinauthor=A.+H.+Jacobsauthor=T.+Wyss-Corayauthor=J.+Vitoricaauthor=R.+M.+Ransohoffauthor=K.+Herrupauthor=S.+A.+Frautschyauthor=B.+Finsenauthor=G.+C.+Brownauthor=A.+Verkhratskyauthor=K.+Yamanakaauthor=J.+Koistinahoauthor=E.+Latzauthor=A.+Halleauthor=G.+C.+Petzoldauthor=T.+Townauthor=D.+Morganauthor=M.+L.+Shinoharaauthor=V.+H.+Perryauthor=C.+Holmesauthor=N.+G.+Bazanauthor=D.+J.+Brooksauthor=S.+Hunotauthor=B.+Josephauthor=N.+Deigendeschauthor=O.+Garaschukauthor=E.+Boddekeauthor=C.+A.+Dinarelloauthor=J.+C.+Breitnerauthor=G.+M.+Coleauthor=D.+T.+Golenbockauthor=M.+P.+Kummer&title=Neuroinflammation+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS1474-4422%2815%2970016-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroinflammation in Alzheimer's disease</span></div><div class="casAuthors">Heneka, Michael T.; Carson, Monica J.; El Khoury, Joseph; Landreth, Gary E.; Brosseron, Frederic; Feinstein, Douglas L.; Jacobs, Andreas H.; Wyss-Coray, Tony; Vitorica, Javier; Ransohoff, Richard M.; Herrup, Karl; Frautschy, Sally A.; Finsen, Bente; Brown, Guy C.; Verkhratsky, Alexei; Yamanaka, Koji; Koistinaho, Jari; Latz, Eicke; Halle, Annett; Petzold, Gabor C.; Town, Terrence; Morgan, Dave; Shinohara, Mari L.; Perry, V. Hugh; Holmes, Clive; Bazan, Nicolas G.; Brooks, David J.; Hunot, Stephane; Joseph, Bertrand; Deigendesch, Nikolaus; Garaschuk, Olga; Boddeke, Erik; Dinarello, Charles A.; Breitner, John C.; Cole, Greg M.; Golenbock, Douglas T.; Kummer, Markus P.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">388-405</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the neuronal compartment, but includes strong interactions with immunol. mechanisms in the brain.  Misfolded and aggregated proteins bind to pattern recognition receptors on microglia and astroglia, and trigger an innate immune response characterized by release of inflammatory mediators, which contribute to disease progression and severity.  Genome-wide anal. suggests that several genes that increase the risk for sporadic Alzheimer's disease encode factors that regulate glial clearance of misfolded proteins and the inflammatory reaction.  External factors, including systemic inflammation and obesity, are likely to interfere with immunol. processes of the brain and further promote disease progression.  Modulation of risk factors and targeting of these immune mechanisms could lead to future therapeutic or preventive strategies for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRpkMdO_rqlrVg90H21EOLACvtfcHk0ljhUeskWGS93g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvVSksrw%253D&md5=df821845eaf19cc6c6a9c6fdf1f805d6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2815%2970016-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252815%252970016-5%26sid%3Dliteratum%253Aachs%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DCarson%26aufirst%3DM.%2BJ.%26aulast%3DKhoury%26aufirst%3DJ.%2BE.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26aulast%3DBrosseron%26aufirst%3DF.%26aulast%3DFeinstein%26aufirst%3DD.%2BL.%26aulast%3DJacobs%26aufirst%3DA.%2BH.%26aulast%3DWyss-Coray%26aufirst%3DT.%26aulast%3DVitorica%26aufirst%3DJ.%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26aulast%3DHerrup%26aufirst%3DK.%26aulast%3DFrautschy%26aufirst%3DS.%2BA.%26aulast%3DFinsen%26aufirst%3DB.%26aulast%3DBrown%26aufirst%3DG.%2BC.%26aulast%3DVerkhratsky%26aufirst%3DA.%26aulast%3DYamanaka%26aufirst%3DK.%26aulast%3DKoistinaho%26aufirst%3DJ.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DHalle%26aufirst%3DA.%26aulast%3DPetzold%26aufirst%3DG.%2BC.%26aulast%3DTown%26aufirst%3DT.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DShinohara%26aufirst%3DM.%2BL.%26aulast%3DPerry%26aufirst%3DV.%2BH.%26aulast%3DHolmes%26aufirst%3DC.%26aulast%3DBazan%26aufirst%3DN.%2BG.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DHunot%26aufirst%3DS.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DDeigendesch%26aufirst%3DN.%26aulast%3DGaraschuk%26aufirst%3DO.%26aulast%3DBoddeke%26aufirst%3DE.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26aulast%3DBreitner%26aufirst%3DJ.%2BC.%26aulast%3DCole%26aufirst%3DG.%2BM.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26aulast%3DKummer%26aufirst%3DM.%2BP.%26atitle%3DNeuroinflammation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%2520Neurol.%26date%3D2015%26volume%3D14%26spage%3D388%26epage%3D405%26doi%3D10.1016%2FS1474-4422%2815%2970016-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villemagne, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chetelat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgeat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackermann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szoeke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Keefe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klunk, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, C. C.</span></span> <span> </span><span class="NLM_article-title">Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1002/ana.22248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Fana.22248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=21280088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BC3M7lsFejtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2011&pages=181-192&author=V.+L.+Villemagneauthor=K.+E.+Pikeauthor=G.+Chetelatauthor=K.+A.+Ellisauthor=R.+S.+Mulliganauthor=P.+Bourgeatauthor=U.+Ackermannauthor=G.+Jonesauthor=C.+Szoekeauthor=O.+Salvadoauthor=R.+Martinsauthor=G.+O%E2%80%99Keefeauthor=C.+A.+Mathisauthor=W.+E.+Klunkauthor=D.+Amesauthor=C.+L.+Mastersauthor=C.+C.+Rowe&title=Longitudinal+assessment+of+A%CE%B2+and+cognition+in+aging+and+Alzheimer+disease&doi=10.1002%2Fana.22248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease</span></div><div class="casAuthors">Villemagne Victor L; Pike Kerryn E; Chetelat Gael; Ellis Kathryn A; Mulligan Rachel S; Bourgeat Pierrick; Ackermann Uwe; Jones Gareth; Szoeke Cassandra; Salvado Olivier; Martins Ralph; O'Keefe Graeme; Mathis Chester A; Klunk William E; Ames David; Masters Colin L; Rowe Christopher C</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">181-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Assess Aβ deposition longitudinally and explore its relationship with cognition and disease progression.  METHODS:  Clinical follow-up was obtained 20 ± 3 months after [11C]Pittsburgh compound B (PiB)-positron emission tomography in 206 subjects: 35 with dementia of the Alzheimer type (DAT), 65 with mild cognitive impairment (MCI), and 106 age-matched healthy controls (HCs).  A second PiB scan was obtained at follow-up in 185 subjects and a third scan after 3 years in 57.  RESULTS:  At baseline, 97% of DAT, 69% of MCI, and 31% of HC subjects showed high PiB retention.  At 20-month follow-up, small but significant increases in PiB standardized uptake value ratios were observed in the DAT and MCI groups, and in HCs with high PiB retention at baseline (5.7%, 2.1%, and 1.5%, respectively).  Increases were associated with the number of apolipoprotein E ε4 alleles.  There was a weak correlation between PiB increases and decline in cognition when all groups were combined.  Progression to DAT occurred in 67% of MCI with high PiB versus 5% of those with low PiB, but 20% of the low PiB MCI subjects progressed to other dementias.  Of the high PiB HCs, 16% developed MCI or DAT by 20 months and 25% by 3 years.  One low PiB HC developed MCI.  INTERPRETATION:  Aβ deposition increases slowly from cognitive normality to moderate severity DAT.  Extensive Aβ deposition precedes cognitive impairment, and is associated with ApoE genotype and a higher risk of cognitive decline in HCs and progression from MCI to DAT over 1 to 2 years.  However, cognitive decline is only weakly related to change in Aβ burden, suggesting that downstream factors have a more direct effect on symptom progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQh46E6lWA4tL0AGQpJZWpJfW6udTcc2eaxRVufXdpLJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7lsFejtw%253D%253D&md5=e7a7f3ccddc64bfb16586a8f934aa3ec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fana.22248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22248%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DPike%26aufirst%3DK.%2BE.%26aulast%3DChetelat%26aufirst%3DG.%26aulast%3DEllis%26aufirst%3DK.%2BA.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DBourgeat%26aufirst%3DP.%26aulast%3DAckermann%26aufirst%3DU.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DSzoeke%26aufirst%3DC.%26aulast%3DSalvado%26aufirst%3DO.%26aulast%3DMartins%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DG.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DAmes%26aufirst%3DD.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26atitle%3DLongitudinal%2520assessment%2520of%2520A%25CE%25B2%2520and%2520cognition%2520in%2520aging%2520and%2520Alzheimer%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2011%26volume%3D69%26spage%3D181%26epage%3D192%26doi%3D10.1002%2Fana.22248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villemagne, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgeat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szoeke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macaulay, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span> <span> </span><span class="NLM_article-title">Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(13)70044-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2FS1474-4422%2813%2970044-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=23477989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFejsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=357-367&author=V.+L.+Villemagneauthor=S.+Burnhamauthor=P.+Bourgeatauthor=B.+Brownauthor=K.+A.+Ellisauthor=O.+Salvadoauthor=C.+Szoekeauthor=S.+L.+Macaulayauthor=R.+Martinsauthor=P.+Maruffauthor=D.+Amesauthor=C.+C.+Roweauthor=C.+L.+Masters&title=Amyloid+beta+deposition%2C+neurodegeneration%2C+and+cognitive+decline+in+sporadic+Alzheimer%E2%80%99s+disease%3A+a+prospective+cohort+study&doi=10.1016%2FS1474-4422%2813%2970044-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study</span></div><div class="casAuthors">Villemagne, Victor L.; Burnham, Samantha; Bourgeat, Pierrick; Brown, Belinda; Ellis, Kathryn A.; Salvado, Olivier; Szoeke, Cassandra; Macaulay, S. Lance; Martins, Ralph; Maruff, Paul; Ames, David; Rowe, Christopher C.; Masters, Colin L.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-367</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Similar to most chronic diseases, Alzheimer's disease (AD) develops slowly from a preclin. phase into a fully expressed clin. syndrome.  We aimed to use longitudinal data to calc. the rates of amyloid β (Aβ) deposition, cerebral atrophy, and cognitive decline.  In this prospective cohort study, healthy controls, patients with mild cognitive impairment (MCI), and patients with AD were assessed at enrolment and every 18 mo.  At every visit, participants underwent neuropsychol. examn., MRI, and a carbon-11-labeled Pittsburgh compd. B (11C-PiB) PET scan.  We included participants with three or more 11C-PiB PET follow-up assessments.  Aβ burden was expressed as 11C-PiB standardised uptake value ratio (SUVR) with the cerebellar cortex as ref. region.  An SUVR of 1·5 was used to discriminate high from low Aβ burdens.  The slope of the regression plots over 3-5 years was used to est. rates of change for Aβ deposition, MRI volumetrics, and cognition.  We included those participants with a pos. rate of Aβ deposition to calc. the trajectory of each variable over time.200 participants (145 healthy controls, 36 participants with MCI, and 19 participants with AD) were assessed at enrolment and every 18 mo for a mean follow-up of 3·8 (95% CI CI 3·6-3·9) years.  At baseline, significantly higher Aβ burdens were noted in patients with AD (2·27, SD 0·43) and those with MCI (1·94, 0·64) than in healthy controls (1·38, 0·39).  At follow-up, 163 (82%) of the 200 participants showed pos. rates of Aβ accumulation.  Aβ deposition was estd. to take 19·2 (95% CI 16·8-22·5) years in an almost linear fashion-with a mean increase of 0·043 (95% CI 0·037-0·049) SUVR per yr-to go from the threshold of 11C-PiB positivity (1·5 SUVR) to the levels obsd. in AD.  It was estd. to take 12·0 (95% CI 10·1-14·9) years from the levels obsd. in healthy controls with low Aβ deposition (1·2 [SD 0·1] SUVR) to the threshold of 11C-PiB positivity.  As AD progressed, the rate of Aβ deposition slowed towards a plateau.  Our projections suggest a prolonged preclin. phase of AD in which Aβ deposition reaches our threshold of positivity at 17·0 (95% CI 14·9-19·9) years, hippocampal atrophy at 4·2 (3·6-5·1) years, and memory impairment at 3·3 (2·5-4·5) years before the onset of dementia (clin. dementia rating score 1).  Aβ deposition is slow and protracted, likely to extend for more than two decades.  Such predictions of the rate of preclin. changes and the onset of the clin. phase of AD will facilitate the design and timing of therapeutic interventions aimed at modifying the course of this illness.  Science and Industry Endowment Fund (Australia), The Commonwealth Scientific and Industrial Research Organization (Australia), The National Health and Medical Research Council of Australia Program and Project Grants, the Austin Hospital Medical Research Foundation, Victorian State Government, The Alzheimer's Drug Discovery Foundation, and the Alzheimer's Assocn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH2O2TjFkaAbVg90H21EOLACvtfcHk0lgxsCgTb9Zvlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFejsrw%253D&md5=2e325131e69aea18b4f6a7cc756bcc55</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970044-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970044-9%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DBurnham%26aufirst%3DS.%26aulast%3DBourgeat%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DEllis%26aufirst%3DK.%2BA.%26aulast%3DSalvado%26aufirst%3DO.%26aulast%3DSzoeke%26aufirst%3DC.%26aulast%3DMacaulay%26aufirst%3DS.%2BL.%26aulast%3DMartins%26aufirst%3DR.%26aulast%3DMaruff%26aufirst%3DP.%26aulast%3DAmes%26aufirst%3DD.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26atitle%3DAmyloid%2520beta%2520deposition%252C%2520neurodegeneration%252C%2520and%2520cognitive%2520decline%2520in%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520prospective%2520cohort%2520study%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D357%26epage%3D367%26doi%3D10.1016%2FS1474-4422%2813%2970044-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jack, C. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knopman, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagust, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span> <span> </span><span class="NLM_article-title">Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(09)70299-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2FS1474-4422%2809%2970299-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=20083042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFeru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=119-128&author=C.+R.+Jackauthor=D.+S.+Knopmanauthor=W.+J.+Jagustauthor=L.+M.+Shawauthor=P.+S.+Aisenauthor=M.+W.+Weinerauthor=R.+C.+Petersenauthor=J.+Q.+Trojanowski&title=Hypothetical+model+of+dynamic+biomarkers+of+the+Alzheimer%E2%80%99s+pathological+cascade&doi=10.1016%2FS1474-4422%2809%2970299-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade</span></div><div class="casAuthors">Jack, Clifford R., Jr.; Knopman, David S.; Jagust, William J.; Shaw, Leslie M.; Aisen, Paul S.; Weiner, Michael W.; Petersen, Ronald C.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Currently available evidence strongly supports the position that the initiating event in Alzheimer's disease (AD) is related to abnormal processing of β-amyloid (Aβ) peptide, ultimately leading to formation of Aβ plaques in the brain.  This process occurs while individuals are still cognitively normal.  Biomarkers of brain β-amyloidosis are redns. in CSF Aβ42 and increased amyloid PET tracer retention.  After a lag period, which varies from patient to patient, neuronal dysfunction and neurodegeneration become the dominant pathol. processes.  Biomarkers of neuronal injury and neurodegeneration are increased CSF tau and structural MRI measures of cerebral atrophy.  Neurodegeneration is accompanied by synaptic dysfunction, which is indicated by decreased fluorodeoxyglucose uptake on PET.  We propose a model that relates disease stage to AD biomarkers in which Aβ biomarkers become abnormal first, before neurodegenerative biomarkers and cognitive symptoms, and neurodegenerative biomarkers become abnormal later, and correlate with clin. symptom severity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOnmdY1Eeez7Vg90H21EOLACvtfcHk0lgxsCgTb9Zvlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFeru74%253D&md5=5337b3e576ab1e8c58292c2572fb62f6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2809%2970299-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252809%252970299-6%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DWeiner%26aufirst%3DM.%2BW.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DHypothetical%2520model%2520of%2520dynamic%2520biomarkers%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520pathological%2520cascade%26jtitle%3DLancet%2520Neurol.%26date%3D2010%26volume%3D9%26spage%3D119%26epage%3D128%26doi%3D10.1016%2FS1474-4422%2809%2970299-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mormino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span> <span> </span><span class="NLM_article-title">The evolution of preclinical Alzheimer’s disease: implications for prevention trials</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2014.10.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.neuron.2014.10.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=25442939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2mtrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=608-622&author=R.+Sperlingauthor=E.+Morminoauthor=K.+Johnson&title=The+evolution+of+preclinical+Alzheimer%E2%80%99s+disease%3A+implications+for+prevention+trials&doi=10.1016%2Fj.neuron.2014.10.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials</span></div><div class="casAuthors">Sperling, Reisa; Mormino, Elizabeth; Johnson, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">608-622</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">As the field begins to test the concept of a "preclin." stage of neurodegenerative disease, when the pathophysiol. process has begun in the brain, but clin. symptoms are not yet manifest, a no. of intriguing questions have already arisen.  In particular, in preclin. Alzheimer's disease (AD), the temporal relationship of amyloid markers to markers of neurodegeneration and their relative utility in the prediction of cognitive decline among clin. normal older individuals remains to be fully elucidated.  Secondary prevention trials in AD have already begun in both genetic at-risk and amyloid at-risk cohorts, with several more trials in the planning stages, and should provide crit. answers about whether intervention at this very early stage of disease can truly bend the curve of clin. progression.  This review will highlight recent progress in cognitive, imaging, and biomarker outcomes in the field of preclin. AD, and the remaining gaps in knowledge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-LC1zcm6IDLVg90H21EOLACvtfcHk0lgxsCgTb9Zvlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2mtrfL&md5=f73caaba195d2e18aeae9dde4151ac4d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2014.10.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2014.10.038%26sid%3Dliteratum%253Aachs%26aulast%3DSperling%26aufirst%3DR.%26aulast%3DMormino%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DK.%26atitle%3DThe%2520evolution%2520of%2520preclinical%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520prevention%2520trials%26jtitle%3DNeuron%26date%3D2014%26volume%3D84%26spage%3D608%26epage%3D622%26doi%3D10.1016%2Fj.neuron.2014.10.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siemers, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundell, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethuraman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu-Seifert, H.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer’s disease patients</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2015.06.1893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.jalz.2015.06.1893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=26238576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BC28%252Fpt1OltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=110-120&author=E.+R.+Siemersauthor=K.+L.+Sundellauthor=C.+Carlsonauthor=M.+Caseauthor=G.+Sethuramanauthor=H.+Liu-Seifert&title=Phase+3+solanezumab+trials%3A+secondary+outcomes+in+mild+Alzheimer%E2%80%99s+disease+patients&doi=10.1016%2Fj.jalz.2015.06.1893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients</span></div><div class="casAuthors">Siemers Eric R; Sundell Karen L; Carlson Christopher; Case Michael; Sethuraman Gopalan; Liu-Seifert Hong; Dowsett Sherie A; Dean Robert A; Demattos Ronald; Pontecorvo Michael J</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">110-120</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  EXPEDITION and EXPEDITION2 were identically designed placebo-controlled phase 3 studies assessing effects of solanezumab, an antiamyloid monoclonal antibody binding soluble amyloid-β peptide, on cognitive and functional decline over 80 weeks in patients with mild-to-moderate Alzheimer's disease (AD).  Primary findings for both studies have been published.  METHODS:  Secondary analyses of efficacy, biomarker, and safety endpoints in the pooled (EXPEDTION + EXPEDITION2) mild AD population were performed.  RESULTS:  In the mild AD population, less cognitive and functional decline was observed with solanezumab (n = 659) versus placebo (n = 663), measured by Alzheimer's Disease Assessment Scale Cognitive subscale, Mini-Mental State Examination, and Alzheimer's Disease Cooperative Study-Activities of Daily Living functional scale Instrumental ADLs.  Baseline-to-endpoint changes did not differ between treatment groups for Alzheimer's Disease Cooperative Study-Activities of Daily Living functional scale, basic items of the ADCS-ADL, and Clinical Dementia Rating Sum of Boxes.  Plasma/cerebrospinal fluid biomarker findings indicated target engagement by solanezumab.  Solanezumab demonstrated acceptable safety.  Efficacy findings for the moderate AD population are also provided.  DISCUSSION:  These findings describe solanezumab effects on efficacy/safety measures in a mild AD population.  Another phase 3 study, EXPEDITION3, will investigate solanezumab's effects in a mild AD population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlFLS6U1rwcEkUaC_kzhvyfW6udTcc2eZTuF5QWdM0DLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252Fpt1OltA%253D%253D&md5=ff277c9a751f5ce37ea36c1a67402a65</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2015.06.1893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2015.06.1893%26sid%3Dliteratum%253Aachs%26aulast%3DSiemers%26aufirst%3DE.%2BR.%26aulast%3DSundell%26aufirst%3DK.%2BL.%26aulast%3DCarlson%26aufirst%3DC.%26aulast%3DCase%26aufirst%3DM.%26aulast%3DSethuraman%26aufirst%3DG.%26aulast%3DLiu-Seifert%26aufirst%3DH.%26atitle%3DPhase%25203%2520solanezumab%2520trials%253A%2520secondary%2520outcomes%2520in%2520mild%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2016%26volume%3D12%26spage%3D110%26epage%3D120%26doi%3D10.1016%2Fj.jalz.2015.06.1893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Biochemistry of amyloid beta-protein and amyloid deposits in Alzheimer disease</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">a006262</span> <span class="refDoi"> DOI: 10.1101/cshperspect.a006262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1101%2Fcshperspect.a006262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=22675658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlemtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&author=C.+L.+Mastersauthor=D.+J.+Selkoe&title=Biochemistry+of+amyloid+beta-protein+and+amyloid+deposits+in+Alzheimer+disease&doi=10.1101%2Fcshperspect.a006262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease</span></div><div class="casAuthors">Masters, Colin L.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">a006262/1-a006262/24</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Progressive cerebral deposition of the amyloid β-protein (Aβ) in brain regions serving memory and cognition is an invariant and defining feature of Alzheimer disease.  A highly similar but less robust process accompanies brain aging in many nondemented humans, lower primates, and some other mammals.  The discovery of Aβ as the subunit of the amyloid fibrils in meningocerebral blood vessels and parenchymal plaques has led to innumerable studies of its biochem. and potential cytotoxic properties.  Here we will review the discovery of Aβ, numerous aspects of its complex biochem., and current attempts to understand how a range of Aβ assemblies, including sol. oligomers and insol. fibrils, may ppt. and promote neuronal and glial alterations that underlie the development of dementia.  Although the role of Aβ as a key mol. factor in the etiol. of Alzheimer disease remains controversial, clin. trials of amyloid-lowering agents, reviewed elsewhere in this book, are poised to resolve the question of its pathogenic primacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-U4pTuictTrVg90H21EOLACvtfcHk0lhi_V0SXF9MeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlemtbc%253D&md5=133fd25f26d01f1c46456744d486bde2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006262%26sid%3Dliteratum%253Aachs%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DBiochemistry%2520of%2520amyloid%2520beta-protein%2520and%2520amyloid%2520deposits%2520in%2520Alzheimer%2520disease%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26doi%3D10.1101%2Fcshperspect.a006262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Resolving controversies on the path to Alzheimer’s therapeutics</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1065</span>, <span class="refDoi"> DOI: 10.1038/nm.2460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1038%2Fnm.2460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=21900936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCntL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1060-1065&author=D.+J.+Selkoe&title=Resolving+controversies+on+the+path+to+Alzheimer%E2%80%99s+therapeutics&doi=10.1038%2Fnm.2460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Resolving controversies on the path to Alzheimer's therapeutics</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1060-1065</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease constitutes a personal and societal tragedy of immense proportions.  Since 1960, research in labs. and clinics worldwide has elucidated many features of this insidious and ultimately fatal syndrome, and this progress has led to initial human trials of potentially disease-modifying agents.  However, some of these agents have already failed.  Gnawing controversies and important gaps in our knowledge seem to cast addnl. doubt on the ability of the field to move forward effectively.  Here I discuss some of these looming concerns and offer possible explanations for the major trial failures that suggest they are not predictive of the future.  Rigorous preclin. validation of mechanism-based therapeutic agents followed by meticulously designed trials that focus on the cardinal cognitive symptoms and their assocd. biomarkers in the mild or presymptomatic phases of Alzheimer's disease are likely to lead to success, perhaps in the not-too-distant future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9e3VIkcVvWrVg90H21EOLACvtfcHk0lhi_V0SXF9MeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCntL7E&md5=501720027a4b1e4fd2a838f94aecd667</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnm.2460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2460%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DResolving%2520controversies%2520on%2520the%2520path%2520to%2520Alzheimer%25E2%2580%2599s%2520therapeutics%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D1060%26epage%3D1065%26doi%3D10.1038%2Fnm.2460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abramowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederhold, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furrer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaton, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuenschwander, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runser, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichwald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammaturo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staab, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoeckli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span> <span> </span><span class="NLM_article-title">Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>327</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">424</span>, <span class="refDoi"> DOI: 10.1124/jpet.108.140327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1124%2Fjpet.108.140327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=18687920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWns73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=411-424&author=D.+Abramowskiauthor=K.+H.+Wiederholdauthor=U.+Furrerauthor=A.+L.+Jatonauthor=A.+Neuenschwanderauthor=M.+J.+Runserauthor=S.+Dannerauthor=J.+Reichwaldauthor=D.+Ammaturoauthor=D.+Staabauthor=M.+Stoeckliauthor=H.+Rueegerauthor=U.+Neumannauthor=M.+Staufenbiel&title=Dynamics+of+Abeta+turnover+and+deposition+in+different+beta-amyloid+precursor+protein+transgenic+mouse+models+following+gamma-secretase+inhibition&doi=10.1124%2Fjpet.108.140327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamics of Aβ turnover and deposition in different β-amyloid precursor protein transgenic mouse models following γ-secretase inhibition</span></div><div class="casAuthors">Abramowski, Dorothee; Wiederhold, Karl-Heinz; Furrer, Ulrich; Jaton, Anne-Lise; Neuenschwander, Anton; Runser, Marie-Josephine; Danner, Simone; Reichwald, Julia; Ammaturo, Domenico; Staab, Dieter; Stoeckli, Markus; Rueeger, Heinrich; Neumann, Ulf; Staufenbiel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">411-424</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Human β-amyloid precursor protein (APP) transgenic mice are commonly used to test potential therapeutics for Alzheimer's disease.  We have characterized the dynamics of β-amyloid (Aβ) generation and deposition following γ-secretase inhibition with compd. LY-411575 [N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide].  Kinetic studies in preplaque mice distinguished a detergent-sol. Aβ pool in brain with rapid turnover (half-lives for Aβ40 and Aβ42 were 0.7 and 1.7 h) and a much more stable, less sol. pool.  Aβ in cerebrospinal fluid (CSF) reflected the changes in the sol. brain Aβ pool, whereas plasma Aβ turned over more rapidly.  In brain, APP C-terminal fragments (CTF) accumulated differentially.  The half-lives for γ-secretase degrdn. were estd. as 0.4 and 0.1 h for C99 and C83, resp.  Three different APP transgenic lines responded very similarly to γ-secretase inhibition regardless of the familial Alzheimer's disease mutations in APP.  Amyloid deposition started with Aβ42, whereas Aβ38 and Aβ40 continued to turn over.  Chronic γ-secretase inhibition lowered amyloid plaque formation to a different degree in different brain regions of the same mice.  The extent was inversely related to the initial amyloid load in the region analyzed.  No evidence for plaque removal below baseline was obtained.  γ-Secretase inhibition led to a redistribution of intracellular Aβ and an elevation of CTFs in neuronal fibers.  In CSF, Aβ showed a similar turnover as in preplaque animals demonstrating its suitability as marker of newly generated, sol. Aβ in plaque-bearing brain.  This study supports the use of APP transgenic mice as translational models to characterize Aβ-lowering therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYc2zQZlag7rVg90H21EOLACvtfcHk0lhi_V0SXF9MeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWns73E&md5=0080a9a9603113e270a4eb4b650a7cd6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.140327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.140327%26sid%3Dliteratum%253Aachs%26aulast%3DAbramowski%26aufirst%3DD.%26aulast%3DWiederhold%26aufirst%3DK.%2BH.%26aulast%3DFurrer%26aufirst%3DU.%26aulast%3DJaton%26aufirst%3DA.%2BL.%26aulast%3DNeuenschwander%26aufirst%3DA.%26aulast%3DRunser%26aufirst%3DM.%2BJ.%26aulast%3DDanner%26aufirst%3DS.%26aulast%3DReichwald%26aufirst%3DJ.%26aulast%3DAmmaturo%26aufirst%3DD.%26aulast%3DStaab%26aufirst%3DD.%26aulast%3DStoeckli%26aufirst%3DM.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DStaufenbiel%26aufirst%3DM.%26atitle%3DDynamics%2520of%2520Abeta%2520turnover%2520and%2520deposition%2520in%2520different%2520beta-amyloid%2520precursor%2520protein%2520transgenic%2520mouse%2520models%2520following%2520gamma-secretase%2520inhibition%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D411%26epage%3D424%26doi%3D10.1124%2Fjpet.108.140327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichwald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammaturo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saftig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span> <span> </span><span class="NLM_article-title">The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2011.07412.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1111%2Fj.1471-4159.2011.07412.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=21812781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyiurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2011&pages=231-239&author=S.+Rabeauthor=J.+Reichwaldauthor=D.+Ammaturoauthor=B.+de+Strooperauthor=P.+Saftigauthor=U.+Neumannauthor=M.+Staufenbiel&title=The+Swedish+APP+mutation+alters+the+effect+of+genetically+reduced+BACE1+expression+on+the+APP+processing&doi=10.1111%2Fj.1471-4159.2011.07412.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing</span></div><div class="casAuthors">Rabe, Sabine; Reichwald, Julia; Ammaturo, Domenico; de Strooper, Bart; Saftig, Paul; Neumann, Ulf; Staufenbiel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">231-239</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Inhibition of β-secretase (BACE1) is a key therapeutic approach in Alzheimer's disease (AD), as BACE1 initiates amyloid-β (Aβ) cleavage from the β-amyloid precursor protein (APP).  As Aβ redns. in mice lacking one BACE1 allele diverged considerably between studies we investigated the effect of BACE1 knock-out in more detail.  With both BACE1 alleles the Swedish mutation (APP23 mice) increased APP processing and shifted it towards the β-secretase pathway as compared with non-mutated APP expressed at a similar level (APP51/16 mice).  This effect was much smaller then obsd. in cell culture.  An about 50% decrease in BACE1 enzyme activity resulted in a sub-proportional Aβ redn. with the Swedish mutation (-20%) and even less for non-mutated APP (-16%).  In wild-type mice, the Aβ redn. may be even further diminished.  Other metabolites of the β-secretase pathway decreased accordingly while the alternative α-secretase pathway increased.  Complete BACE1 deletion strongly enhanced these changes.  The remaining Aβ signal also described by others can be explained by assay cross-reactivity with other APP metabolites supporting BACE1 as the major β-secretase.  These data indicate that BACE1 is in excess over APP at the cleavage site(s).  Alterations in APP expression or substrate properties, therefore, quant. change its cleavage and Aβ generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZYEql_9yVqrVg90H21EOLACvtfcHk0lgBwWYcvslydg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyiurvL&md5=d223b3798846f8ca59fce1bb03525ec8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07412.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07412.x%26sid%3Dliteratum%253Aachs%26aulast%3DRabe%26aufirst%3DS.%26aulast%3DReichwald%26aufirst%3DJ.%26aulast%3DAmmaturo%26aufirst%3DD.%26aulast%3Dde%2BStrooper%26aufirst%3DB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DStaufenbiel%26aufirst%3DM.%26atitle%3DThe%2520Swedish%2520APP%2520mutation%2520alters%2520the%2520effect%2520of%2520genetically%2520reduced%2520BACE1%2520expression%2520on%2520the%2520APP%2520processing%26jtitle%3DJ.%2520Neurochem.%26date%3D2011%26volume%3D119%26spage%3D231%26epage%3D239%26doi%3D10.1111%2Fj.1471-4159.2011.07412.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McConlogue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buttini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brigham, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Games, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson-Wood, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span> <span> </span><span class="NLM_article-title">Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">26326</span>– <span class="NLM_lpage">26334</span>, <span class="refDoi"> DOI: 10.1074/jbc.M611687200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1074%2Fjbc.M611687200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=17616527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpslGjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=26326-26334&author=L.+McConlogueauthor=M.+Buttiniauthor=J.+P.+Andersonauthor=E.+F.+Brighamauthor=K.+S.+Chenauthor=S.+B.+Freedmanauthor=D.+Gamesauthor=K.+Johnson-Woodauthor=M.+Leeauthor=M.+Zellerauthor=W.+Liuauthor=R.+Motterauthor=S.+Sinha&title=Partial+reduction+of+BACE1+has+dramatic+effects+on+Alzheimer+plaque+and+synaptic+pathology+in+APP+transgenic+mice&doi=10.1074%2Fjbc.M611687200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice</span></div><div class="casAuthors">McConlogue, Lisa; Buttini, Manuel; Anderson, John P.; Brigham, Elizabeth F.; Chen, Karen S.; Freedman, Stephen B.; Games, Dora; Johnson-Wood, Kelly; Lee, Michael; Zeller, Michelle; Liu, Weiqun; Motter, Ruth; Sinha, Sukanto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">26326-26334</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The aspartyl protease β-site amyloid precursor protein cleaving enzyme 1 (BACE1) initiates processing of amyloid precursor protein (APP) into amyloid β (Aβ) peptide, the major component of Alzheimer disease (AD) plaques.  To det. the role that BACE1 plays in the development of Aβ-driven AD-like pathol., we have crossed PDAPP mice, a transgenic mouse model of AD overexpressing human mutated APP, onto mice with either a homozygous or heterozygous BACE1 gene knockout.  Anal. of PDAPP/BACE(-/-) mice demonstrated that BACE1 is absolutely required for both Aβ generation and the development of age-assocd. plaque pathol.  Furthermore, synaptic deficits, a neurodegenerative pathol. characteristic of AD, were also reversed in the bigenic mice.  To det. the extent of BACE1 redn. required to significantly inhibit pathol., PDAPP mice having a heterozygous BACE1 gene knock-out were evaluated for Aβ generation and for the development of pathol.  Although the 50% redn. in BACE1 enzyme levels caused only a 12% decrease in Aβ levels in young mice, it nonetheless resulted in a dramatic redn. in Aβ plaques, neuritic burden, and synaptic deficits in older mice.  Quant. analyses indicate that brain Aβ levels in young APP transgenic mice are not the sole determinant for the changes in plaque pathol. mediated by reduced BACE1.  These observations demonstrate that partial redns. of BACE1 enzyme activity and concomitant Aβ levels lead to dramatic inhibition of Aβ-driven AD-like pathol., making BACE1 an excellent target for therapeutic intervention in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolXkPkhLFworVg90H21EOLACvtfcHk0lgBwWYcvslydg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpslGjt74%253D&md5=5cd1df8e7c16473d8116de3226c78cd4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M611687200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M611687200%26sid%3Dliteratum%253Aachs%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DButtini%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBrigham%26aufirst%3DE.%2BF.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DJohnson-Wood%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DZeller%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DSinha%26aufirst%3DS.%26atitle%3DPartial%2520reduction%2520of%2520BACE1%2520has%2520dramatic%2520effects%2520on%2520Alzheimer%2520plaque%2520and%2520synaptic%2520pathology%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D26326%26epage%3D26334%26doi%3D10.1074%2Fjbc.M611687200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidhoff, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassiepen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worpenberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhartz, B.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human BACE2 in complex with a hydroxyethylamine transition-state inhibitor</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.jmb.2005.10.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=16305800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSjt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=249-261&author=N.+Ostermannauthor=J.+Ederauthor=U.+Eidhoffauthor=F.+Zinkauthor=U.+Hassiepenauthor=S.+Worpenbergauthor=J.+Maibaumauthor=O.+Simicauthor=U.+Hommelauthor=B.+Gerhartz&title=Crystal+structure+of+human+BACE2+in+complex+with+a+hydroxyethylamine+transition-state+inhibitor&doi=10.1016%2Fj.jmb.2005.10.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Human BACE2 in Complex with a Hydroxyethylamine Transition-state Inhibitor</span></div><div class="casAuthors">Ostermann, Nils; Eder, Joerg; Eidhoff, Ulf; Zink, Florence; Hassiepen, Ulrich; Worpenberg, Susanne; Maibaum, Juergen; Simic, Oliver; Hommel, Ulrich; Gerhartz, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-261</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">BACE2 is a membrane-bound aspartic protease of the A1 family with a high level of sequence homol. to BACE1.  While BACE1 is involved in the generation of amyloid plaques in Alzheimer's disease by cleaving Aβ-peptides from the amyloid precursor protein, the physiol. function of BACE2 is not well understood.  BACE2 appears to be assocd. with the early onset of dementia in patients with Down's syndrome, and it has been shown to be highly expressed in breast cancers.  Further, it may participate in the function of normal and abnormal processes of human muscle biol.  Similar to other aspartic proteases, BACE2 is expressed as an inactive zymogen requiring the cleavage of its pro-sequence during the maturation process.  We have produced mature BACE2 by expression of pro-BACE2 in Escherichia coli as inclusion bodies, followed by refolding and autocatalytic activation at pH 3.4.  Using a C and N-terminally truncated BACE2 variant, we were able to crystallize and det. the crystal structure of mature BACE2 in complex with a hydroxyethylamine transition-state mimetic inhibitor at 3.1 Å resoln.  The structure of BACE2 follows the general fold of A1 aspartic proteases.  However, similar to BACE1, its C-terminal domain is significantly larger than that of the other family members.  Furthermore, the structure of BACE2 reveals differences in the S3, S2, S1' and S2' active site substrate pockets as compared to BACE1, and allows, therefore, for a deeper understanding of the structural features that may facilitate the design of selective BACE1 or BACE2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpagbhk8u5oybVg90H21EOLACvtfcHk0lgBwWYcvslydg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSjt7bO&md5=74ae4bbd058acf333ea11fba486f10b2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DEidhoff%26aufirst%3DU.%26aulast%3DZink%26aufirst%3DF.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DWorpenberg%26aufirst%3DS.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DSimic%26aufirst%3DO.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DGerhartz%26aufirst%3DB.%26atitle%3DCrystal%2520structure%2520of%2520human%2520BACE2%2520in%2520complex%2520with%2520a%2520hydroxyethylamine%2520transition-state%2520inhibitor%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D355%26spage%3D249%26epage%3D261%26doi%3D10.1016%2Fj.jmb.2005.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garratt, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rittger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeStrooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saftig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span> <span> </span><span class="NLM_article-title">Control of peripheral nerve myelination by the beta-secretase BACE1</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>314</i></span>,  <span class="NLM_fpage">664</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1126/science.1132341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1126%2Fscience.1132341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=16990514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFeitr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=664-676&author=M.+Willemauthor=A.+N.+Garrattauthor=B.+Novakauthor=M.+Citronauthor=S.+Kaufmannauthor=A.+Rittgerauthor=B.+DeStrooperauthor=P.+Saftigauthor=C.+Birchmeierauthor=C.+Haass&title=Control+of+peripheral+nerve+myelination+by+the+beta-secretase+BACE1&doi=10.1126%2Fscience.1132341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Control of Peripheral Nerve Myelination by the β-Secretase BACE1</span></div><div class="casAuthors">Willem, Michael; Garratt, Alistair N.; Novak, Bozidar; Citron, Martin; Kaufmann, Steve; Rittger, Andrea; DeStrooper, Bart; Saftig, Paul; Birchmeier, Carmen; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">5799</span>),
    <span class="NLM_cas:pages">664-666</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Although BACE1 (beta-site amyloid precursor protein-cleaving enzyme 1) is essential for the generation of amyloid-β peptide in Alzheimer's disease, its physiol. function is unclear.  We found that very high levels of BACE1 were expressed at time points when peripheral nerves become myelinated.  Deficiency of BACE1 resulted in the accumulation of unprocessed neuregulin 1 (NRG1), an axonally expressed factor required for glial cell development and myelination.  BACE1-/- mice displayed hypo-myelination of peripheral nerves and aberrant axonal segregation of small-diam. afferent fibers, very similar to that seen in mice with mutations in type III NRG1 or Schwann cell-specific ErbB2 knockouts.  Thus, BACE1 is required for myelination and correct bundling of axons by Schwann cells, probably through processing of type III NRG1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjcnSaaIIaUrVg90H21EOLACvtfcHk0lg8E0Xe7_E3Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFeitr7J&md5=17a0d1600dfb2b59b8055fc18ff47b59</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.1132341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1132341%26sid%3Dliteratum%253Aachs%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DNovak%26aufirst%3DB.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DKaufmann%26aufirst%3DS.%26aulast%3DRittger%26aufirst%3DA.%26aulast%3DDeStrooper%26aufirst%3DB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DControl%2520of%2520peripheral%2520nerve%2520myelination%2520by%2520the%2520beta-secretase%2520BACE1%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D664%26epage%3D676%26doi%3D10.1126%2Fscience.1132341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velanac, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unterbarnscheidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gummert, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trimarco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brivio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taveggia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobius, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nave, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, M. H.</span></span> <span> </span><span class="NLM_article-title">Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination</span>. <i>Glia</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1002/glia.21255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Fglia.21255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=22052506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FltValsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=203-217&author=V.+Velanacauthor=T.+Unterbarnscheidtauthor=W.+Hinrichsauthor=M.+N.+Gummertauthor=T.+M.+Fischerauthor=M.+J.+Rossnerauthor=A.+Trimarcoauthor=V.+Brivioauthor=C.+Taveggiaauthor=M.+Willemauthor=C.+Haassauthor=W.+Mobiusauthor=K.+A.+Naveauthor=M.+H.+Schwab&title=Bace1+processing+of+NRG1+type+III+produces+a+myelin-inducing+signal+but+is+not+essential+for+the+stimulation+of+myelination&doi=10.1002%2Fglia.21255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination</span></div><div class="casAuthors">Velanac Viktorija; Unterbarnscheidt Tilmann; Hinrichs Wilko; Gummert Maike N; Fischer Tobias M; Rossner Moritz J; Trimarco Amelia; Brivio Veronica; Taveggia Carla; Willem Michael; Haass Christian; Mobius Wiebke; Nave Klaus-Armin; Schwab Markus H</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Myelin sheath thickness is precisely adjusted to axon caliber, and in the peripheral nervous system, neuregulin 1 (NRG1) type III is a key regulator of this process.  It has been proposed that the protease BACE1 activates NRG1 dependent myelination.  Here, we characterize the predicted product of BACE1-mediated NRG1 type III processing in transgenic mice.  Neuronal overexpression of a NRG1 type III-variant, designed to mimic prior cleavage in the juxtamembrane stalk region, induces hypermyelination in vivo and is sufficient to restore myelination of NRG1 type III-deficient neurons.  This observation implies that the NRG1 cytoplasmic domain is dispensable and that processed NRG1 type III is sufficient for all steps of myelination.  Surprisingly, transgenic neuronal overexpression of full-length NRG1 type III promotes hypermyelination also in BACE1 null mutant mice.  Moreover, NRG1 processing is impaired but not abolished in BACE1 null mutants.  Thus, BACE1 is not essential for the activation of NRG1 type III to promote myelination.  Taken together, these findings suggest that multiple neuronal proteases collectively regulate NRG1 processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLFOgusWONs8kU0YCbOU3EfW6udTcc2eYQ46ZbQQgVy7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FltValsw%253D%253D&md5=b3f76b0261c36a558f902349a20615f0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fglia.21255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.21255%26sid%3Dliteratum%253Aachs%26aulast%3DVelanac%26aufirst%3DV.%26aulast%3DUnterbarnscheidt%26aufirst%3DT.%26aulast%3DHinrichs%26aufirst%3DW.%26aulast%3DGummert%26aufirst%3DM.%2BN.%26aulast%3DFischer%26aufirst%3DT.%2BM.%26aulast%3DRossner%26aufirst%3DM.%2BJ.%26aulast%3DTrimarco%26aufirst%3DA.%26aulast%3DBrivio%26aufirst%3DV.%26aulast%3DTaveggia%26aufirst%3DC.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DMobius%26aufirst%3DW.%26aulast%3DNave%26aufirst%3DK.%2BA.%26aulast%3DSchwab%26aufirst%3DM.%2BH.%26atitle%3DBace1%2520processing%2520of%2520NRG1%2520type%2520III%2520produces%2520a%2520myelin-inducing%2520signal%2520but%2520is%2520not%2520essential%2520for%2520the%2520stimulation%2520of%2520myelination%26jtitle%3DGlia%26date%3D2012%26volume%3D60%26spage%3D203%26epage%3D217%26doi%3D10.1002%2Fglia.21255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eggert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paliga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidemann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyreuther, K.</span></span> <span> </span><span class="NLM_article-title">The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">18146</span>– <span class="NLM_lpage">18156</span>, <span class="refDoi"> DOI: 10.1074/jbc.M311601200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1074%2Fjbc.M311601200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=14970212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVKnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=18146-18156&author=S.+Eggertauthor=K.+Paligaauthor=P.+Sobaauthor=G.+Evinauthor=C.+L.+Mastersauthor=A.+Weidemannauthor=K.+Beyreuther&title=The+proteolytic+processing+of+the+amyloid+precursor+protein+gene+family+members+APLP-1+and+APLP-2+involves+alpha-%2C+beta-%2C+gamma-%2C+and+epsilon-like+cleavages%3A+modulation+of+APLP-1+processing+by+n-glycosylation&doi=10.1074%2Fjbc.M311601200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The Proteolytic Processing of the Amyloid Precursor Protein Gene Family Members APLP-1 and APLP-2 Involves α-, β-, γ-, and ε-Like Cleavages: Modulation of APLP-1 Processing by N-Glycosylation</span></div><div class="casAuthors">Eggert, Simone; Paliga, Krzysztof; Soba, Peter; Evin, Genevieve; Masters, Colin L.; Weidemann, Andreas; Beyreuther, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">18146-18156</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Amyloid precursor protein (APP) processing is of major interest in Alzheimer's disease research, since sequential cleavages by β- and γ-secretase lead to the formation of the 4-kDa amyloid Aβ protein peptide that accumulates in Alzheimer's disease brain.  The processing of APP involves proteolytic conversion by different secretases leading to α-, β-, γ-, δ-, and ε-cleavages.  Since modulation of these cleavages represents a rational therapeutic approach to control amyloid formation, its interference with the processing of the members of the APP gene family is of considerable importance.  By using C-terminally tagged constructs of APLP-1 and APLP-2 and the untagged proteins, we have characterized their proteolytic C-terminal fragments produced in stably transfected SH-SY5Y cells.  Pharmacol. manipulation with specific protease inhibitors revealed that both homologues are processed by α- and γ-secretase-like cleavages, and that their intracellular domains can be released by cleavage at ε-sites.  APLP-2 processing appears to be the most elaborate and to involve alternative cleavage sites.  We show that APLP-1 is the only member of the APP gene family for which processing can be influenced by N-glycosylation.  Addnl., we were able to detect p3-like fragments of APLP-1 and p3-like and Aβ-like fragments of APLP-2 in the media of stably transfected SH-SY5Y cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkAzx8LDhsJLVg90H21EOLACvtfcHk0lgAvXfWyfINMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVKnt70%253D&md5=66af6f411aed4c5ee10185af97e02836</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M311601200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M311601200%26sid%3Dliteratum%253Aachs%26aulast%3DEggert%26aufirst%3DS.%26aulast%3DPaliga%26aufirst%3DK.%26aulast%3DSoba%26aufirst%3DP.%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DWeidemann%26aufirst%3DA.%26aulast%3DBeyreuther%26aufirst%3DK.%26atitle%3DThe%2520proteolytic%2520processing%2520of%2520the%2520amyloid%2520precursor%2520protein%2520gene%2520family%2520members%2520APLP-1%2520and%2520APLP-2%2520involves%2520alpha-%252C%2520beta-%252C%2520gamma-%252C%2520and%2520epsilon-like%2520cleavages%253A%2520modulation%2520of%2520APLP-1%2520processing%2520by%2520n-glycosylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D18146%26epage%3D18156%26doi%3D10.1074%2Fjbc.M311601200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barão, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gärtner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyva-Díaz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demyanenko, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutvin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schachner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Bendito, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maness, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span> <span> </span><span class="NLM_article-title">, Patricia, F.;, B. Antagonistic effects of BACE1 and APH1B-γ-secretase control axonal guidance by regulating growth cone collapse</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1367</span>– <span class="NLM_lpage">1376</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.07.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.celrep.2015.07.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=26299962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOmtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=1367-1376&author=S.+Bar%C3%A3oauthor=A.+G%C3%A4rtnerauthor=E.+Leyva-D%C3%ADazauthor=G.+Demyanenkoauthor=S.+Munckauthor=T.+Vanhoutvinauthor=L.+Zhouauthor=M.+Schachnerauthor=G.+L%C3%B3pez-Benditoauthor=P.+F.+Manessauthor=B.+De+Strooper&title=%2C+Patricia%2C+F.%3B%2C+B.+Antagonistic+effects+of+BACE1+and+APH1B-%CE%B3-secretase+control+axonal+guidance+by+regulating+growth+cone+collapse&doi=10.1016%2Fj.celrep.2015.07.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonistic Effects of BACE1 and APH1B-γ-Secretase Control Axonal Guidance by Regulating Growth Cone Collapse</span></div><div class="casAuthors">Barao, Soraia; Gartner, Annette; Leyva-Diaz, Eduardo; Demyanenko, Galina; Munck, Sebastian; Vanhoutvin, Tine; Zhou, Lujia; Schachner, Melitta; Lopez-Bendito, Guillermina; Maness, Patricia F.; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1367-1376</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">ΒACE1 is the major drug target for Alzheimer's disease, but we know surprisingly little about its normal function in the CNS.  Here, we show that this protease is critically involved in semaphorin 3A (Sema3A)-mediated axonal guidance processes in thalamic and hippocampal neurons.  An active membrane-bound proteolytic CHL1 fragment is generated by BACE1 upon Sema3A binding.  This fragment relays the Sema3A signal via ezrin-radixin-moesin (ERM) proteins to the neuronal cytoskeleton.  APH1B-γ-secretase-mediated degrdn. of this fragment stops the Sema3A-induced collapse and sensitizes the growth cone for the next axonal guidance cue.  Thus, we reveal a cycle of proteolytic activity underlying growth cone collapse and restoration used by axons to find their correct trajectory in the brain.  Our data also suggest that BACE1 and γ-secretase inhibition have physiol. opposite effects in this process, supporting the idea that combination therapy might attenuate some of the side effects assocd. with these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFAjldKIuigrVg90H21EOLACvtfcHk0lgAvXfWyfINMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOmtbnE&md5=e158a18250e0656b5496d53cf4c561fe</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.07.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.07.059%26sid%3Dliteratum%253Aachs%26aulast%3DBar%25C3%25A3o%26aufirst%3DS.%26aulast%3DG%25C3%25A4rtner%26aufirst%3DA.%26aulast%3DLeyva-D%25C3%25ADaz%26aufirst%3DE.%26aulast%3DDemyanenko%26aufirst%3DG.%26aulast%3DMunck%26aufirst%3DS.%26aulast%3DVanhoutvin%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DSchachner%26aufirst%3DM.%26aulast%3DL%25C3%25B3pez-Bendito%26aufirst%3DG.%26aulast%3DManess%26aufirst%3DP.%2BF.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3D%252C%2520Patricia%252C%2520F.%253B%252C%2520B.%2520Antagonistic%2520effects%2520of%2520BACE1%2520and%2520APH1B-%25CE%25B3-secretase%2520control%2520axonal%2520guidance%2520by%2520regulating%2520growth%2520cone%2520collapse%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D12%26spage%3D1367%26epage%3D1376%26doi%3D10.1016%2Fj.celrep.2015.07.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koroniak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeitschel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volbracht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepers, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmeister, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span> <span> </span><span class="NLM_article-title">Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">3157</span>– <span class="NLM_lpage">3168</span>, <span class="refDoi"> DOI: 10.1038/emboj.2012.173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1038%2Femboj.2012.173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=22728825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFyru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=3157-3168&author=P.+H.+Kuhnauthor=K.+Koroniakauthor=S.+Hoglauthor=A.+Colomboauthor=U.+Zeitschelauthor=M.+Willemauthor=C.+Volbrachtauthor=U.+Schepersauthor=A.+Imhofauthor=A.+Hoffmeisterauthor=C.+Haassauthor=S.+Rossnerauthor=S.+Braseauthor=S.+F.+Lichtenthaler&title=Secretome+protein+enrichment+identifies+physiological+BACE1+protease+substrates+in+neurons&doi=10.1038%2Femboj.2012.173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons</span></div><div class="casAuthors">Kuhn, Peer-Hendrik; Koroniak, Katarzyna; Hogl, Sebastian; Colombo, Alessio; Zeitschel, Ulrike; Willem, Michael; Volbracht, Christiane; Schepers, Ute; Imhof, Axel; Hoffmeister, Albrecht; Haass, Christian; Rossner, Steffen; Brase, Stefan; Lichtenthaler, Stefan F.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3157-3168</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cell surface proteolysis is essential for communication between cells and results in the shedding of membrane-protein ectodomains.  However, physiol. substrates of the contributing proteases are largely unknown.  We developed the secretome protein enrichment with click sugars (SPECS) method, which allows proteome-wide identification of shedding substrates and secreted proteins from primary cells, even in the presence of serum proteins.  SPECS combines metabolic glycan labeling and click chem.-mediated biotinylation and distinguishes between cellular and serum proteins.  SPECS identified 34, mostly novel substrates of the Alzheimer protease BACE1 in primary neurons, making BACE1 a major sheddase in the nervous system.  Selected BACE1 substrates- seizure protein 6, L1, CHL1 and contactin-2 -were validated in brains of BACE1 inhibitor-treated and BACE1 knock-out mice.  For some substrates, BACE1 was the major sheddase, whereas for other substrates addnl. proteases contributed to total substrate shedding.  The new substrates point to a central function of BACE1 in neurite outgrowth and synapse formation.  SPECS is also suitable for quant. secretome analyses of primary cells and may be used for the discovery of biomarkers secreted from tumor or stem cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVPr6CAqExQ7Vg90H21EOLACvtfcHk0ljYuzKe6pr5-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFyru7g%253D&md5=460beb4f3c08023d54c72e7c772464b1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Femboj.2012.173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2012.173%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DP.%2BH.%26aulast%3DKoroniak%26aufirst%3DK.%26aulast%3DHogl%26aufirst%3DS.%26aulast%3DColombo%26aufirst%3DA.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DVolbracht%26aufirst%3DC.%26aulast%3DSchepers%26aufirst%3DU.%26aulast%3DImhof%26aufirst%3DA.%26aulast%3DHoffmeister%26aufirst%3DA.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DBrase%26aufirst%3DS.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26atitle%3DSecretome%2520protein%2520enrichment%2520identifies%2520physiological%2520BACE1%2520protease%2520substrates%2520in%2520neurons%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D3157%26epage%3D3168%26doi%3D10.1038%2Femboj.2012.173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wessels, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lines, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozley, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furtek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupre, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shering, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M. F.</span></span> <span> </span><span class="NLM_article-title">Cognitive outcomes in trials of two BACE inhibitors in Alzheimer’s disease</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1002/alz.12164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Falz.12164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=33049114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BB3s7gslelsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&pages=1483-1492&author=A.+M.+Wesselsauthor=C.+Linesauthor=R.+A.+Sternauthor=J.+Kostauthor=T.+Vossauthor=L.+H.+Mozleyauthor=C.+Furtekauthor=Y.+Mukaiauthor=P.+S.+Aisenauthor=J.+L.+Cummingsauthor=P.+N.+Tariotauthor=B.+Vellasauthor=N.+Dupreauthor=C.+Randolphauthor=D.+Michelsonauthor=S.+W.+Andersenauthor=C.+Sheringauthor=J.+R.+Simsauthor=M.+F.+Egan&title=Cognitive+outcomes+in+trials+of+two+BACE+inhibitors+in+Alzheimer%E2%80%99s+disease&doi=10.1002%2Falz.12164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease</span></div><div class="casAuthors">Wessels Alette M; Andersen Scott W; Sims John R; Lines Christopher; Kost James; Voss Tiffini; Mozley Lyn Harper; Furtek Christine; Mukai Yuki; Dupre Nicole; Michelson David; Egan Michael F; Stern Robert A; Aisen Paul S; Cummings Jeffrey L; Tariot Pierre N; Vellas Bruno; Randolph Christopher; Shering Craig</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1483-1492</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  The APECS and AMARANTH trials showed that beta-secretase (BACE) inhibitors verubecestat and lanabecestat failed to slow cognitive and functional decline in individuals with prodromal or early Alzheimer's disease.  Here, the performance on secondary and exploratory cognitive measures in both studies is reported.  METHODS:  APECS (verubecestat) and AMARANTH (lanabecestat) were randomized, double-blind, placebo-controlled, parallel-group, 104-week clinical trials conducted by different sponsors.  Measures included the 3-Domain Composite Cognition Score (CCS-3D), Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), Letter/Category Fluency, and Digit Symbol Coding.  RESULTS:  Verubecestat showed worsening on the CCS-3D Total Score, Episodic Memory, and Attention/Processing Speed domains.  Lanabecestat showed worsening on the RBANS Total Score, Immediate Memory, and Visuospatial/Constructional Indexes.  Both BACE inhibitors showed worsening on Digit Symbol Coding and improvements on Letter/Category Fluency.  DISCUSSION:  In both studies, many measures showed treatment-associated cognitive worsening, whereas verbal fluency tasks showed improvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDzIKAQTpERszK395ZObgVfW6udTcc2eZLooSkGCcKMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3s7gslelsA%253D%253D&md5=a6283201cc86fea79a538948fc730e31</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Falz.12164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Falz.12164%26sid%3Dliteratum%253Aachs%26aulast%3DWessels%26aufirst%3DA.%2BM.%26aulast%3DLines%26aufirst%3DC.%26aulast%3DStern%26aufirst%3DR.%2BA.%26aulast%3DKost%26aufirst%3DJ.%26aulast%3DVoss%26aufirst%3DT.%26aulast%3DMozley%26aufirst%3DL.%2BH.%26aulast%3DFurtek%26aufirst%3DC.%26aulast%3DMukai%26aufirst%3DY.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DDupre%26aufirst%3DN.%26aulast%3DRandolph%26aufirst%3DC.%26aulast%3DMichelson%26aufirst%3DD.%26aulast%3DAndersen%26aufirst%3DS.%2BW.%26aulast%3DShering%26aufirst%3DC.%26aulast%3DSims%26aufirst%3DJ.%2BR.%26aulast%3DEgan%26aufirst%3DM.%2BF.%26atitle%3DCognitive%2520outcomes%2520in%2520trials%2520of%2520two%2520BACE%2520inhibitors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2020%26volume%3D16%26spage%3D1483%26epage%3D1492%26doi%3D10.1002%2Falz.12164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H. L.</span></span> <span> </span><span class="NLM_article-title">BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer’s disease</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6765</span>– <span class="NLM_lpage">6813</span>, <span class="refDoi"> DOI: 10.1039/C3CS60460H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1039%2FC3CS60460H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=24691405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6765-6813&author=A.+K.+Ghoshauthor=H.+L.+Osswald&title=BACE1+%28beta-secretase%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC3CS60460H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Osswald, Heather L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6765-6813</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">BACE1 (β-secretase, memapsin 2, Asp2) has emerged as a promising target for the treatment of Alzheimer's disease.  BACE1 is an aspartic protease which functions in the first step of the pathway leading to the prodn. and deposition of amyloid-β peptide (Aβ).  Its gene deletion showed only mild phenotypes.  BACE1 inhibition has direct implications in the Alzheimer's disease pathol. without largely affecting viability.  However, inhibiting BACE1 selectively in vivo has presented many challenges to medicinal chemists.  Since its identification in 2000, inhibitors covering many different structural classes have been designed and developed.  These inhibitors can be largely classified as either peptidomimetic or non-peptidic inhibitors.  Progress in these fields resulted in inhibitors that contain many targeted drug-like characteristics.  In this review, we describe structure-based design strategies and evolution of a wide range of BACE1 inhibitors including compds. that have been shown to reduce brain Aβ, rescue the cognitive decline in transgenic AD mice and inhibitor drug candidates that are currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri59_pgGAbxLVg90H21EOLACvtfcHk0ljYuzKe6pr5-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ&md5=dab445bf7efb6fdc0c80e032d3bb0071</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2FC3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60460H%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DBACE1%2520%2528beta-secretase%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6765%26epage%3D6813%26doi%3D10.1039%2FC3CS60460H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeever, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of beta-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4156</span>– <span class="NLM_lpage">4180</span>, <span class="refDoi"> DOI: 10.1021/jm301659n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure-based+design+of+beta-site+APP+cleaving+enzyme+1+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301659n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Yuan, Jing; Venkatraman, Shankar; Zheng, Yajun; McKeever, Brian M.; Dillard, Lawrence W.; Singh, Suresh B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4156-4180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis asserts that excess prodn. or reduced clearance of the amyloid-β (Aβ) peptides in the brain initiates a sequence of events that ultimately lead to Alzheimer's disease dementia.  The Aβ hypothesis has identified BACE1 as a therapeutic target to treat Alzheimer's and led to medicinal chem. efforts to design its inhibitors both in the pharmaceutical industry and in academia.  This review summarizes two distinct categories of inhibitors designed based on conformational states of "closed" and "open" forms of the enzyme.  In each category the inhibitors are classified based on the core catalytic interaction group or the aspartyl binding motif (ABM).  This review covers the description of inhibitors in each ABM class with X-ray crystal structures of key compds., their binding modes, related structure-activity data highlighting potency advances, and addnl. properties such as selectivity profile, P-gp efflux, pharmacokinetic, and pharmacodynamic data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLs7KN_eIzbVg90H21EOLACvtfcHk0li4uapRFzDlzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D&md5=b703f57572b737b47658d86f5b730087</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520beta-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180%26doi%3D10.1021%2Fjm301659n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C. L.</span></span> <span> </span><span class="NLM_article-title">Strategies to optimize the brain availability of central nervous system drug candidates</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1517/17460441.2011.564158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1517%2F17460441.2011.564158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=22646015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVKmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=371-381&author=T.+T.+Wagerauthor=A.+Villalobosauthor=P.+R.+Verhoestauthor=X.+Houauthor=C.+L.+Shaffer&title=Strategies+to+optimize+the+brain+availability+of+central+nervous+system+drug+candidates&doi=10.1517%2F17460441.2011.564158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies to optimize the brain availability of central nervous system drug candidates</span></div><div class="casAuthors">Wager, Travis T.; Villalobos, Anabella; Verhoest, Patrick R.; Hou, Xinjun; Shaffer, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-381</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Access to the CNS is essential for most neurotherapeutics to elicit their effects.  Leveraging design strategies incorporating physicochem. properties, in vitro and in vivo assays to predict and measure brain penetration, and brain delivery approaches may enable the drug discovery community to improve access of drug candidates into the CNS compartment.Areas covered: This article reviews aspects of the most recent mol. design, in vitro and in vivo strategies, and delivery technologies to optimize the unbound brain concns. (C b,u) of CNS mols.  Through this, the article provides insight into recent ideas and concepts in CNS drug mol. design, methods for evaluating CNS drug exposures and alternative approaches to maximize drug access to neurocompartments.Expert opinion: The most pharmacol. relevant measure in assessing a compd.'s pharmacodynamic response in the CNS is its C b,u.  The utilization of emerging design strategies, together with in vitro and in vivo assays, may enable the design of mols. with optimal C b,u:C p,u (C p,u, unbound plasma concn.) and appropriate C b,u, to elicit a biol. response from the neurotherapeutic target.  Where drug properties intrinsically render a compd. CNS impaired, using novel CNS delivery approaches may result in sufficient C b,u to furnish a biol. response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs2ijS8dIydLVg90H21EOLACvtfcHk0li4uapRFzDlzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVKmsbw%253D&md5=09a2b8b06bdbdc63db728416cb01081f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F17460441.2011.564158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2011.564158%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DStrategies%2520to%2520optimize%2520the%2520brain%2520availability%2520of%2520central%2520nervous%2520system%2520drug%2520candidates%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D371%26epage%3D381%26doi%3D10.1517%2F17460441.2011.564158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekaran, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Will, Y.</span></span> <span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">434</span>, <span class="refDoi"> DOI: 10.1021/cn100007x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes&doi=10.1021%2Fcn100007x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0ljqHpx1Wrm_vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434%26doi%3D10.1021%2Fcn100007x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mireles, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Morais, S. M.</span></span> <span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1124/dmd.107.017434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system&doi=10.1124%2Fdmd.107.017434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0ljqHpx1Wrm_vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275%26doi%3D10.1124%2Fdmd.107.017434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosea, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callegari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianfrogna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hop, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasman, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laperle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maclin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedza, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahematpura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raunig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spracklin, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Deusen, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walens, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasgar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span> <span> </span><span class="NLM_article-title">The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1124/dmd.104.001230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1124%2Fdmd.104.001230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=15502009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlentw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=165-174&author=A.+Doranauthor=R.+S.+Obachauthor=B.+J.+Smithauthor=N.+A.+Hoseaauthor=S.+Beckerauthor=E.+Callegariauthor=C.+Chenauthor=X.+Chenauthor=E.+Chooauthor=J.+Cianfrognaauthor=L.+M.+Coxauthor=J.+P.+Gibbsauthor=M.+A.+Gibbsauthor=H.+Hatchauthor=C.+E.+Hopauthor=I.+N.+Kasmanauthor=J.+Laperleauthor=J.+Liuauthor=X.+Liuauthor=M.+Logmanauthor=D.+Maclinauthor=F.+M.+Nedzaauthor=F.+Nelsonauthor=E.+Olsonauthor=S.+Rahematpuraauthor=D.+Raunigauthor=S.+Rogersauthor=K.+Schmidtauthor=D.+K.+Spracklinauthor=M.+Szewcauthor=M.+Troutmanauthor=E.+Tsengauthor=M.+Tuauthor=J.+W.+Van+Deusenauthor=K.+Venkatakrishnanauthor=G.+Walensauthor=E.+Q.+Wangauthor=D.+Wongauthor=A.+S.+Yasgarauthor=C.+Zhang&title=The+impact+of+P-glycoprotein+on+the+disposition+of+drugs+targeted+for+indications+of+the+central+nervous+system%3A+evaluation+using+the+MDR1A%2F1B+knockout+mouse+model&doi=10.1124%2Fdmd.104.001230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model</span></div><div class="casAuthors">Doran, Angela; Obach, R. Scott; Smith, Bill J.; Hosea, Natilie A.; Becker, Stacey; Callegari, Ernesto; Chen, Cuiping; Chen, Xi; Choo, Edna; Cianfrogna, Julie; Cox, Loretta M.; Gibbs, John P.; Gibbs, Megan A.; Hatch, Heather; Hop, Cornelis E. C. A.; Kasman, Ilana N.; LaPerle, Jennifer; Liu, JianHua; Liu, Xingrong; Logman, Michael; Maclin, Debra; Nedza, Frank M.; Nelson, Frederick; Olson, Emily; Rahematpura, Sandhya; Raunig, David; Rogers, Sabrinia; Schmidt, Kari; Spracklin, Douglas K.; Szewc, Mark; Troutman, Matthew; Tseng, Elaine; Tu, Meihua; Van Deusen, Jeffrey W.; Venkatakrishnan, Karthik; Walens, Gary; Wang, Ellen Q.; Wong, Diane; Yasgar, Adam S.; Zhang, Chenghong</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-174</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-two structurally diverse drugs used for the treatment of various conditions of the central nervous system (CNS), along with two active metabolites, and eight non-CNS drugs were measured in brain, plasma, and cerebrospinal fluid in the P-glycoprotein (P-gp) knockout mouse model after s.c. administration, and the data were compared with corresponding data obtained in wild-type mice.  Total brain-to-plasma (B/P) ratios for the CNS agents ranged from 0.060 to 24.  Of the 34 CNS-active agents, only 7 demonstrated B/P area under the plasma concn. curve ratios between P-gp knockout and wild-type mice that did not differ significantly from unity.  Most of the remaining drugs demonstrated 1.1- to 2.6-fold greater B/P ratios in P-gp knockout mice vs. wild-type mice.  Three, risperidone, its active metabolite 9-hydroxyrisperidone, and metoclopramide, showed marked differences in B/P ratios between knockout and wild-type mice (6.6- to 17-fold).  Differences in B/P ratios and cerebrospinal fluid/plasma ratios between wild-type and knockout animals were correlated.  Through the use of this model, it appears that most CNS-active agents demonstrate at least some P-gp-mediated transport that can affect brain concns.  However, the impact for the majority of agents is probably minor.  The example of risperidone illustrates that even good P-gp substrates can still be clin. useful CNS-active agents.  However, for such agents, unbound plasma concns. may need to be greater than values projected using receptor affinity data to achieve adequate receptor occupancy for effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCLikZvvYtAbVg90H21EOLACvtfcHk0lihdJ_JjySJVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlentw%253D%253D&md5=58acf489206dfeaaa96da4329e403710</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001230%26sid%3Dliteratum%253Aachs%26aulast%3DDoran%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DHosea%26aufirst%3DN.%2BA.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DCox%26aufirst%3DL.%2BM.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DGibbs%26aufirst%3DM.%2BA.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DHop%26aufirst%3DC.%2BE.%26aulast%3DKasman%26aufirst%3DI.%2BN.%26aulast%3DLaperle%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLogman%26aufirst%3DM.%26aulast%3DMaclin%26aufirst%3DD.%26aulast%3DNedza%26aufirst%3DF.%2BM.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DOlson%26aufirst%3DE.%26aulast%3DRahematpura%26aufirst%3DS.%26aulast%3DRaunig%26aufirst%3DD.%26aulast%3DRogers%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DSzewc%26aufirst%3DM.%26aulast%3DTroutman%26aufirst%3DM.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DVan%2BDeusen%26aufirst%3DJ.%2BW.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26aulast%3DWalens%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DE.%2BQ.%26aulast%3DWong%26aufirst%3DD.%26aulast%3DYasgar%26aufirst%3DA.%2BS.%26aulast%3DZhang%26aufirst%3DC.%26atitle%3DThe%2520impact%2520of%2520P-glycoprotein%2520on%2520the%2520disposition%2520of%2520drugs%2520targeted%2520for%2520indications%2520of%2520the%2520central%2520nervous%2520system%253A%2520evaluation%2520using%2520the%2520MDR1A%252F1B%2520knockout%2520mouse%2520model%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D165%26epage%3D174%26doi%3D10.1124%2Fdmd.104.001230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raub, T. J.</span></span> <span> </span><span class="NLM_article-title">P-glycoprotein recognition of substrates and circumvention through rational drug design</span>. <i>Mol. Pharmceutics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1021/mp0500871</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp0500871" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlagu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=3-25&author=T.+J.+Raub&title=P-glycoprotein+recognition+of+substrates+and+circumvention+through+rational+drug+design&doi=10.1021%2Fmp0500871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design</span></div><div class="casAuthors">Raub, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is now well recognized that membrane efflux transporters, esp. P-glycoprotein (P-gp; ABCB1), play a role in detg. the absorption, distribution, metab., excretion, and toxicol. behaviors of some drugs and mols. in development.  An investment in screening structure-activity relation (SAR) is warranted in early discovery when exposure and/or target activity in an in vivo efficacy model is not achieved and P-gp efflux is identified as a rate-limiting factor.  However, the amt. of investment in SAR must be placed into perspective by assessing the risks assocd. with the intended therapeutic target, the potency and margin of safety of the compd., the intended patient population(s), and the market competition.  The task of rationally designing a chem. strategy for circumventing a limiting P-gp interaction can be daunting.  The necessity of retaining biol. potency and metabolic stability places restrictions on what can be done, and the factors for P-gp recognition of substrates are complicated and poorly understood.  The parameters within the assays that affect overall pump efficiency or net efflux, such as passive diffusion, membrane partitioning, and mol. interaction between pump and substrate, should be understood when interpreting data sets assocd. with chem. around a scaffold.  No single, functional group alone is often the cause, but one group can accentuate the recognition points existing within a scaffold.  This can be likened to a rheostat, rather than an on/off switch, where addn. or removal of a key group can increase or decrease the pumping efficiency.  The most practical approach to de-emphasize the limiting effects of P-gp on a particular scaffold is to increase passive diffusion.  Efflux pumping efficiency may be overcome when passive diffusion is fast enough.  Eliminating, or substituting with fewer, groups that solvate in water, or decreasing their hydrogen bonding capacity, and adding halogen groups can increase passive diffusion.  Reducing mol. size, replacing electroneg. atoms, blocking or masking H-bond donors with N-alkylation or bulky flanking groups, introducing constrained conformation, or by promoting intramol. hydrogen bonds are all examples of steps to take.  This review discusses our understanding of how P-gp recognizes and pumps compds. as substrates and describes cases where structural changes were made in a chem. scaffold to circumvent the effects of P-gp interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRbEgPosNnxrVg90H21EOLACvtfcHk0lihdJ_JjySJVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlagu7%252FP&md5=cc89be920dfa0e32edb994be94626aa5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fmp0500871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp0500871%26sid%3Dliteratum%253Aachs%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26atitle%3DP-glycoprotein%2520recognition%2520of%2520substrates%2520and%2520circumvention%2520through%2520rational%2520drug%2520design%26jtitle%3DMol.%2520Pharmceutics%26date%3D2006%26volume%3D3%26spage%3D3%26epage%3D25%26doi%3D10.1021%2Fmp0500871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahar
Doan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wring, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shampine, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serabjit-Singh, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adkison, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polli, J. W.</span></span> <span> </span><span class="NLM_article-title">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">1029</span>– <span class="NLM_lpage">1037</span>, <span class="refDoi"> DOI: 10.1124/jpet.102.039255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1124%2Fjpet.102.039255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=12438524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=1029-1037&author=K.+M.+Mahar%0ADoanauthor=J.+E.+Humphreysauthor=L.+O.+Websterauthor=S.+A.+Wringauthor=L.+J.+Shampineauthor=C.+J.+Serabjit-Singhauthor=K.+K.+Adkisonauthor=J.+W.+Polli&title=Passive+permeability+and+P-glycoprotein-mediated+efflux+differentiate+central+nervous+system+%28CNS%29+and+non-CNS+marketed+drugs&doi=10.1124%2Fjpet.102.039255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span></div><div class="casAuthors">Mahar Doan Kelly M; Humphreys Joan E; Webster Lindsey O; Wring Stephen A; Shampine Larry J; Serabjit-Singh Cosette J; Adkison Kimberly K; Polli Joseph W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1029-37</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Membrane permeability and P-glycoprotein (Pgp) can be limiting factors for blood-brain barrier penetration.  The objectives of this study were to determine whether there are differences in the in vitro permeability, Pgp substrate profiles, and physicochemical properties of drugs for central nervous system (CNS) and non-CNS indications, and whether these differences are useful criteria in selecting compounds for drug development.  Apparent permeability (P(app)) and Pgp substrate profiles for 93 CNS (n = 48) and non-CNS (n = 45) drugs were determined by monolayer efflux.  Calcein-AM inhibition assays were used to supplement the efflux results.  The CNS set (2 of 48, 4.2%) had a 7-fold lower incidence of passive permeability values <150 nm/s compared with the non-CNS set (13 of 45, 28.9%).  The majority of drugs (72.0%, 67 of 93) were not Pgp substrates; however, 49.5% (46 of 93) were positive in the calcein-AM assay when tested at 100 microM.  The CNS drug set (n = 7 of 48, 14.6%) had a 3-fold lower incidence of Pgp-mediated efflux than the non-CNS drug set (n = 19 of 45, 42.2%).  Analysis of 18 physicochemical properties revealed that the CNS drug set had fewer hydrogen bond donors, fewer positive charges, greater lipophilicity, lower polar surface area, and reduced flexibility compared with the non-CNS group (p < 0.05), properties that enhance membrane permeability.  This study on a large, diverse set of marketed compounds clearly demonstrates that permeability, Pgp-mediated efflux, and certain physicochemical properties are factors that differentiate CNS and non-CNS drugs.  For CNS delivery, a drug should ideally have an in vitro passive permeability >150 nm/s and not be a good (B --> A/A --> B ratio <2.5) Pgp substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_HiV1Xqt18Vf1XRtfYM0dfW6udTcc2eYnzvPD2NipU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D&md5=b841902aa8502de47c1e1603c80e09fb</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039255%26sid%3Dliteratum%253Aachs%26aulast%3DMahar%2BDoan%26aufirst%3DK.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DShampine%26aufirst%3DL.%2BJ.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26aulast%3DAdkison%26aufirst%3DK.%2BK.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DPassive%2520permeability%2520and%2520P-glycoprotein-mediated%2520efflux%2520differentiate%2520central%2520nervous%2520system%2520%2528CNS%2529%2520and%2520non-CNS%2520marketed%2520drugs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D1029%26epage%3D1037%26doi%3D10.1124%2Fjpet.102.039255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span> <span> </span><span class="NLM_article-title">Structural modifications that alter the P-glycoprotein efflux properties of compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4877</span>– <span class="NLM_lpage">4895</span>, <span class="refDoi"> DOI: 10.1021/jm201136z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=S.+A.+Hitchcock&title=Structural+modifications+that+alter+the+P-glycoprotein+efflux+properties+of+compounds&doi=10.1021%2Fjm201136z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span></div><div class="casAuthors">Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4877-4895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This perspective is focused on structural modifications and strategies that can be applied during compd. optimization in order to modulate the P-glycoprotein efflux properties of small mols. with a particular emphasis on implications for CNS penetration. The precise mol. interactions that confer P-glycoprotein efflux remain relatively poorly defined. The promiscuous nature of P-glycoprotein efflux renders the rational circumvention of efflux, while simultaneously optimizing compds. for eficacy, safety, and pharmacokinetic properties, an extremely challenging undertaking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_5RBtwgb-rVg90H21EOLACvtfcHk0ljHigS-u8bUrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D&md5=6c5dffbb11db6fa893ff3c50fe7778cc</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-glycoprotein%2520efflux%2520properties%2520of%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895%26doi%3D10.1021%2Fjm201136z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Didziapetris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Japertas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrauskas, A.</span></span> <span> </span><span class="NLM_article-title">Classification analysis of P-glycoprotein substrate specificity</span>. <i>J. Drug Targeting</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1080/10611860310001648248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1080%2F10611860310001648248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=15203928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFOjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=391-406&author=R.+Didziapetrisauthor=P.+Japertasauthor=A.+Avdeefauthor=A.+Petrauskas&title=Classification+analysis+of+P-glycoprotein+substrate+specificity&doi=10.1080%2F10611860310001648248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Classification Analysis of P-Glycoprotein Substrate Specificity</span></div><div class="casAuthors">Didziapetris, Remigijus; Japertas, Pranas; Avdeef, Alex; Petrauskas, Alanas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">391-406</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Prediction of P-glycoprotein substrate specificity (SPGP) can be viewed as a constituent part of a compd.'s "pharmaceutical profiling" in drug design.  This task is difficult to achieve due to several factors that raised many contradictory opinions: (i) the disparity between the SPGP values obtained in different assays, (ii) the confusion between Pgp substrates and inhibitors, (iii) the confusion between lipophilicity and amphiphilicity of Pgp substrates, and (iv) the dilemma of describing class-specific relationships when Pgp has no binding sites of high ligand specificity.  In this work, the authors compiled SPGP data for 1000 compds.  All data were represented in a binary format, assigning SPGP = 1 for substrates and SPGP = 0 for nonsubstrates.  Each value was ranked according to the reliability of exptl. assay.  Two data sets were considered.  Set 1 included 220 compds. with SPGP from polarized transport across MDR1 transfected cell monolayers.  Set 2 included the entire list of 1000 compds., with SPGP values of generally lower reliability.  Both sets were analyzed using a stepwise classification structure-activity relationship (C-SAR) method, leading to derivation of simple rules for crude estn. of SPGP values.  The obtained rules are based on the following factors: (i) compd.'s size expressed through molar wt. or vol., (ii) H-accepting given by the Abraham's β (that can be crudely approximated by the sum of O and N atoms), and (iii) ionization given by the acid and base pKa values.  Very roughly, SPGP can be estd. by the "rule of fours".  Compds. with (N + O) ≥ 8, MW > 400 and acid pKa > 4 are likely to be Pgp substrates, whereas compds. with (N+O) ≤ 4, MW < 400 and base pKa < 8 are likely to be nonsubstrates.  The obtained results support the view that Pgp functioning can be compared to a complex "mini-pharmacokinetic" system with fuzzy specificity.  This system can be described by a probabilistic version of Abraham's solvation equation, suggesting a certain similarity between Pgp transport and chromatog. retention.  The chromatog. model does not work in the case of "marginal" compds. with properties close to the "global" physicochem. cut-offs.  In the latter case various class-specific rules must be considered.  These can be assocd. with the "amphiphilicity" and "biol. similarity" of compds.  The definition of class-specific effects entails construction of the knowledge base that can be very useful in ADME profiling of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsvKJmruZ7RLVg90H21EOLACvtfcHk0ljHigS-u8bUrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFOjs7k%253D&md5=5b7ea95eb2d9faded5645481c1330f03</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1080%2F10611860310001648248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10611860310001648248%26sid%3Dliteratum%253Aachs%26aulast%3DDidziapetris%26aufirst%3DR.%26aulast%3DJapertas%26aufirst%3DP.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DPetrauskas%26aufirst%3DA.%26atitle%3DClassification%2520analysis%2520of%2520P-glycoprotein%2520substrate%2520specificity%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D2003%26volume%3D11%26spage%3D391%26epage%3D406%26doi%3D10.1080%2F10611860310001648248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norinder, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, M.</span></span> <span> </span><span class="NLM_article-title">Computational approaches to the prediction of the blood-brain distribution</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(02)00005-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2FS0169-409X%2802%2900005-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=11922949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD38Xitlartbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=291-313&author=U.+Norinderauthor=M.+Haeberlein&title=Computational+approaches+to+the+prediction+of+the+blood-brain+distribution&doi=10.1016%2FS0169-409X%2802%2900005-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Computational approaches to the prediction of the blood-brain distribution</span></div><div class="casAuthors">Norinder, Ulf; Haeberlein, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-313</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  This review attempts to summarize present knowledge related to the theor. modeling of drug transport across the blood-brain barrier.  Several computational protocols are described ranging from quantum mechanics-based approaches through mol. mechanics-related techniques to simple and fast procedures based on only the 2-D graph of the investigated structures.  Amazingly, few descriptors have been shown to influence the derived relationships in a significant manner and a cornerstone in most of the described models are terms describing hydrogen bonding.  A very quick quant. assessment of the brain partitioning of a compd. has also been devised using the following two rules: If N+O (the no. of nitrogen and oxygen atoms) in a mol. is less than or equal to five, it has a high chance of entering the brain.  The second rule predicts that if log P-(N+O) is pos. then log BB is pos.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy9Yd_Pc0M07Vg90H21EOLACvtfcHk0ljHigS-u8bUrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xitlartbg%253D&md5=cc689594714a0afb9f67917c77530d8c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2802%2900005-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252802%252900005-4%26sid%3Dliteratum%253Aachs%26aulast%3DNorinder%26aufirst%3DU.%26aulast%3DHaeberlein%26aufirst%3DM.%26atitle%3DComputational%2520approaches%2520to%2520the%2520prediction%2520of%2520the%2520blood-brain%2520distribution%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D291%26epage%3D313%26doi%3D10.1016%2FS0169-409X%2802%2900005-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, D. E.</span></span> <span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. prediction of intestinal absorption</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">814</span>, <span class="refDoi"> DOI: 10.1021/js9804011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1021%2Fjs9804011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10430547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVCqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=807-814&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+1.+prediction+of+intestinal+absorption&doi=10.1021%2Fjs9804011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Calculation of Polar Molecular Surface Area and Its Application to the Prediction of Transport Phenomena. 1. Prediction of Intestinal Absorption</span></div><div class="casAuthors">Clark, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">807-814</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A method for the rapid computation of polar mol. surface area (PSA) is described.  It is shown that consideration of only a single conformer when computing PSA gives an excellent correlation with intestinal absorption data-as good as previously reported methods employing multiple conformers.  Circumventing a time-consuming conformational anal. opens the possibility of computationally screening large nos. of compds. for problems relating to absorption prior to synthesis.  The robustness of the criterion for identifying poorly absorbed compds. (PSA ≥ 140 Å2) is illustrated through its application to a diverse test set of 74 drugs.  The PSA-based method is also compared to an exptl. method for absorption prediction recently described in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQFZqLLPfnWLVg90H21EOLACvtfcHk0lgVeYU1EPSwSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVCqtbw%253D&md5=8692bd27f4b5b5c5f250379678a75693</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjs9804011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs9804011%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25201.%2520prediction%2520of%2520intestinal%2520absorption%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D807%26epage%3D814%26doi%3D10.1021%2Fjs9804011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aronov, A. M.</span></span> <span> </span><span class="NLM_article-title">Ligand structural aspects of hERG channel blockade</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1113</span>– <span class="NLM_lpage">1127</span>, <span class="refDoi"> DOI: 10.2174/156802608785700061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.2174%2F156802608785700061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=18782007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1113-1127&author=A.+M.+Aronov&title=Ligand+structural+aspects+of+hERG+channel+blockade&doi=10.2174%2F156802608785700061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand structural aspects of hERG channel blockade</span></div><div class="casAuthors">Aronov, Alex M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1113-1127</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sudden death as a side effect of action of non-antiarrhythmic drugs is a major pharmacol. safety concern facing the pharmaceutical industry and the health regulatory authorities.  A no. of drugs have been withdrawn from the market in recent years due to cardiovascular toxicity assocd. with undesirable blockade of hERG potassium channel.  Pharmaceuticals of widely varying structure have been shown to interact with hERG.  Defining the mol. features that confer hERG inhibitory activity has therefore become a focus of considerable computational and statistical modeling efforts.  Some of the approaches are aimed primarily at filtering out potential hERG blockers in the context of virtual libraries, while others involve understanding structure-activity relationships governing hERG-drug interactions.  The ability of models to produce structural hypotheses that can be tested by the project teams has become the key prerequisite driving their organization-wide adoption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOveNNzD-TbLVg90H21EOLACvtfcHk0lgVeYU1EPSwSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrjE&md5=86bf7e5819d6ce234f850e17b7f397dd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F156802608785700061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785700061%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26atitle%3DLigand%2520structural%2520aspects%2520of%2520hERG%2520channel%2520blockade%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1113%26epage%3D1127%26doi%3D10.2174%2F156802608785700061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möbitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desrayaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Discovery of cyclic sulfone hydroxyethylamines as potent and selective beta-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid beta-peptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3364</span>– <span class="NLM_lpage">3386</span>, <span class="refDoi"> DOI: 10.1021/jm300069y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300069y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVCqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3364-3386&author=H.+Rueegerauthor=R.+Lueoendauthor=O.+Rogelauthor=J.+M.+Rondeauauthor=H.+M%C3%B6bitzauthor=R.+Machauerauthor=L.+Jacobsonauthor=M.+Staufenbielauthor=S.+Desrayaudauthor=U.+Neumann&title=Discovery+of+cyclic+sulfone+hydroxyethylamines+as+potent+and+selective+beta-site+APP-cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+structure-based+design+and+in+vivo+reduction+of+amyloid+beta-peptides&doi=10.1021%2Fjm300069y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Cyclic Sulfone Hydroxyethylamines as Potent and Selective β-Site APP-Cleaving Enzyme 1 (BACE1) Inhibitors: Structure-Based Design and in Vivo Reduction of Amyloid β-Peptides</span></div><div class="casAuthors">Rueeger, Heinrich; Lueoend, Rainer; Rogel, Olivier; Rondeau, Jean-Michel; Mobitz, Henrik; Machauer, Rainer; Jacobson, Laura; Staufenbiel, Matthias; Desrayaud, Sandrine; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3364-3386</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based design of a series of cyclic hydroxyethylamine BACE1 inhibitors allowed the rational incorporation of prime- and nonprime-side fragments to a central core template without any amide functionality.  The core scaffold selection and the structure-activity relationship development were supported by mol. modeling studies and by x-ray anal. of BACE1 complexes with various ligands to expedite the optimization of the series.  The direct extension from P1-aryl- and heteroaryl moieties into the S3 binding pocket allowed the enhancement of potency and selectivity over cathepsin D.  Restraining the design and synthesis of compds. to a physicochem. property space consistent with central nervous system drugs led to inhibitors with improved blood-brain barrier permeability.  Guided by structure-based optimization, highly potent compds. were obtained, such as I, with enzymic and cellular IC50 values of 2 and 50 nM, resp., and with >200-fold selectivity over cathepsin D.  Pharmacodynamic studies in APP51/16 transgenic mice at oral doses of 180 μmol/kg demonstrated significant redn. of brain Aβ levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9V9NMxnGHFbVg90H21EOLACvtfcHk0lgVeYU1EPSwSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVCqsLs%253D&md5=f7f4862b9ce1c682dfc2c7dba52d904f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm300069y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300069y%26sid%3Dliteratum%253Aachs%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DLueoend%26aufirst%3DR.%26aulast%3DRogel%26aufirst%3DO.%26aulast%3DRondeau%26aufirst%3DJ.%2BM.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DJacobson%26aufirst%3DL.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DDiscovery%2520of%2520cyclic%2520sulfone%2520hydroxyethylamines%2520as%2520potent%2520and%2520selective%2520beta-site%2520APP-cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520structure-based%2520design%2520and%2520in%2520vivo%2520reduction%2520of%2520amyloid%2520beta-peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3364%26epage%3D3386%26doi%3D10.1021%2Fjm300069y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desrayaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möbitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure based design and in vivo reduction of amyloid β-peptides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5300</span>– <span class="NLM_lpage">5306</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.07.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.bmcl.2013.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=23981898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKqsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5300-5306&author=H.+Rueegerauthor=R.+Lueoendauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=L.+H.+Jacobsonauthor=M.+Staufenbielauthor=S.+Desrayaudauthor=J.-M.+Rondeauauthor=H.+M%C3%B6bitzauthor=U.+Neumann&title=Discovery+of+cyclic+sulfoxide+hydroxyethylamines+as+potent+and+selective+%CE%B2-site+APP-cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+structure+based+design+and+in+vivo+reduction+of+amyloid+%CE%B2-peptides&doi=10.1016%2Fj.bmcl.2013.07.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: Structure based design and in vivo reduction of amyloid β-peptides</span></div><div class="casAuthors">Rueeger, Heinrich; Lueoend, Rainer; Machauer, Rainer; Veenstra, Siem Jacob; Jacobson, Laura Helen; Staufenbiel, Matthias; Desrayaud, Sandrine; Rondeau, Jean-Michel; Mobitz, Henrik; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5300-5306</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous structure based optimization in our labs. led to the identification of a novel, high-affinity cyclic sulfone hydroxyethylamine-derived inhibitor such as 1 that lowers CNS-derived Aβ following oral administration to transgenic APP51/16 mice.  Herein we report SAR development in the S3 and S2' subsites of BACE1 for cyclic sulfoxide hydroxyethyl amine inhibitors, the synthetic approaches employed in this effort, and in vivo data for optimized compd. such as 11d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbOR1eszn-oLVg90H21EOLACvtfcHk0lheWTV3Ua82dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKqsbnM&md5=76495275df6859f9ec9dcee05eebb25e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DLueoend%26aufirst%3DR.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DRondeau%26aufirst%3DJ.-M.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DDiscovery%2520of%2520cyclic%2520sulfoxide%2520hydroxyethylamines%2520as%2520potent%2520and%2520selective%2520%25CE%25B2-site%2520APP-cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520structure%2520based%2520design%2520and%2520in%2520vivo%2520reduction%2520of%2520amyloid%2520%25CE%25B2-peptides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5300%26epage%3D5306%26doi%3D10.1016%2Fj.bmcl.2013.07.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylvester, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aharony, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andisik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folmer, R. H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geschwindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koether, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumrine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauger, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spear, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, G.</span></span> <span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5912</span>– <span class="NLM_lpage">5925</span>, <span class="refDoi"> DOI: 10.1021/jm070829p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+A.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.-L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency&doi=10.1021%2Fjm070829p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0lheWTV3Ua82dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%2BA.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925%26doi%3D10.1021%2Fjm070829p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span> <span> </span><span class="NLM_article-title">Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6314</span>– <span class="NLM_lpage">6323</span>, <span class="refDoi"> DOI: 10.1021/jm9006752</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjtrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichaud&title=Aminoimidazoles+as+potent+and+selective+human+beta-secretase+%28BACE1%29+inhibitors&doi=10.1021%2Fjm9006752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoimidazoles as potent and selective human β-secretase (BACE1) inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Barnes, Keith; Johnson, Matthew; Hui, Yu; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Olland, Andrea; Bard, Jonathan; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6314-6323</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminoimidazoles as potent and selective human β-secretase inhibitors was reported.  These analogs demonstrated low nanomolar potency for BACE1 in a FRET assay, exhibited comparable activity in a cell-based (ELISA) assay, and showed >100× selectivity for the other structurally related aspartyl proteases BACE2, cathepsin D, renin, and pepsin.  The design strategy was supported by mol. modeling studies based on the co-crystal structure of HTS-hit I (R1 = R2 = H) in the BACE1 active site.  These strategies enabled integration of pyridine and pyrimidine groups onto I (R1 = R2 = H) extending deep into the S3 region of the BACE1 binding pocket and enhancing the ligand's potency.  Compd. (R)-I (R1 = CF3O, R2 = 2-fluoro-3-pyridinyl) displayed an IC50 value for BACE1 of 20 nM, cellular activity of 90 nM, and >100-fold selectivity over related aspartyl proteases.  Acute oral administration of (R)-I (R1 = CF3O, R2 = 2-fluoro-3-pyridinyl) at 30 mg/kg resulted in a significant 71% redn. of plasma Aβ40 measured at the 6 h time point in a Tg2576 mouse model (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFckRJKaaEOrVg90H21EOLACvtfcHk0lihy_WIkFEvJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjtrvM&md5=ffab7cd593b9574711891bded74bf486</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520selective%2520human%2520beta-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323%26doi%3D10.1021%2Fjm9006752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, N.</span>; <span class="NLM_string-name">Ueda, K.</span>; <span class="NLM_string-name">Itoh, N.</span>; <span class="NLM_string-name">Suzuki, S.</span>; <span class="NLM_string-name">Sakaguchi, G.</span>; <span class="NLM_string-name">Kato, A.</span>; <span class="NLM_string-name">Yukimasa, A.</span>; <span class="NLM_string-name">Hori, A.</span>; <span class="NLM_string-name">Koriyama, Y.</span>; <span class="NLM_string-name">Haraguchi, H.</span>; <span class="NLM_string-name">Yasui, K.</span>; <span class="NLM_string-name">Kanda, Y.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-aminodihydrothiazine derivatives as β-secretase inhibitors</span>. <span class="NLM_patent">WO2007049532A1</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=N.+Kobayashi&author=K.+Ueda&author=N.+Itoh&author=S.+Suzuki&author=G.+Sakaguchi&author=A.+Kato&author=A.+Yukimasa&author=A.+Hori&author=Y.+Koriyama&author=H.+Haraguchi&author=K.+Yasui&author=Y.+Kanda&title=Preparation+of+2-aminodihydrothiazine+derivatives+as+%CE%B2-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DN.%26atitle%3DPreparation%2520of%25202-aminodihydrothiazine%2520derivatives%2520as%2520%25CE%25B2-secretase%2520inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukhdeo, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellingboe, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manas, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohse, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, J.</span></span> <span> </span><span class="NLM_article-title">Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1′ substrate binding pocket</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">771</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.bmcl.2007.11.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=18068983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFWrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=767-771&author=L.+D.+Jenningsauthor=D.+C.+Coleauthor=J.+R.+Stockauthor=M.+N.+Sukhdeoauthor=J.+W.+Ellingboeauthor=R.+Cowlingauthor=G.+Jinauthor=E.+S.+Manasauthor=K.+Y.+Fanauthor=M.+S.+Malamasauthor=B.+L.+Harrisonauthor=S.+Jacobsenauthor=R.+Chopraauthor=P.+A.+Lohseauthor=W.+J.+Mooreauthor=M.+M.+O%E2%80%99Donnellauthor=Y.+Huauthor=A.+J.+Robichaudauthor=M.+J.+Turnerauthor=E.+Wagnerauthor=J.+Bard&title=Acylguanidine+inhibitors+of+beta-secretase%3A+optimization+of+the+pyrrole+ring+substituents+extending+into+the+S1%E2%80%B2+substrate+binding+pocket&doi=10.1016%2Fj.bmcl.2007.11.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Acylguanidine inhibitors of β-secretase: Optimization of the pyrrole ring substituents extending into the S'1 substrate binding pocket</span></div><div class="casAuthors">Jennings, Lee D.; Cole, Derek C.; Stock, Joseph R.; Sukhdeo, Mohani N.; Ellingboe, John W.; Cowling, Rebecca; Jin, Guixian; Manas, Eric S.; Fan, Kristi Y.; Malamas, Michael S.; Harrison, Boyd L.; Jacobsen, Steve; Chopra, Rajiv; Lohse, Peter A.; Moore, William J.; O'Donnell, Mary-Margaret; Hu, Yun; Robichaud, Albert J.; Turner, M. James; Wagner, Erik; Bard, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">767-771</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The proteolytic enzyme β-secretase (BACE-1) produces amyloid β (Aβ) peptide, the primary constituent of neurofibrillary plaques, implicated in Alzheimer's disease, by cleavage of the amyloid precursor protein.  A small mol. inhibitor of BACE-1, (diaminomethylene)-2,5-diphenyl-1H-pyrrole-1-acetamide (1, BACE-1 IC50 = 3.7 μM), was recently described, representing a new small mol. lead.  Initial SAR investigation demonstrated the potential of accessing the nearby S3 and S 1 ' substrate binding pockets of the BACE-1 enzyme by building substituents off one of the Ph substituents and guanidinyl functional group.  We report here the optimization of guanidinyl functional group substituents on 1, leading to potent submicromolar BACE-1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg9cKbJVVi2rVg90H21EOLACvtfcHk0lihy_WIkFEvJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFWrsQ%253D%253D&md5=3e06401a53234f4c8ad63d896e29e0f6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.043%26sid%3Dliteratum%253Aachs%26aulast%3DJennings%26aufirst%3DL.%2BD.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DStock%26aufirst%3DJ.%2BR.%26aulast%3DSukhdeo%26aufirst%3DM.%2BN.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DManas%26aufirst%3DE.%2BS.%26aulast%3DFan%26aufirst%3DK.%2BY.%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DLohse%26aufirst%3DP.%2BA.%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DM.%2BM.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26aulast%3DTurner%26aufirst%3DM.%2BJ.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DBard%26aufirst%3DJ.%26atitle%3DAcylguanidine%2520inhibitors%2520of%2520beta-secretase%253A%2520optimization%2520of%2520the%2520pyrrole%2520ring%2520substituents%2520extending%2520into%2520the%2520S1%25E2%2580%25B2%2520substrate%2520binding%2520pocket%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D767%26epage%3D771%26doi%3D10.1016%2Fj.bmcl.2007.11.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0lihy_WIkFEvJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borders, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brier, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevorkyan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komjathy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaught, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winneroski, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span> <span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Abeta pharmacodynamic responses in mice, dogs, and humans</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1210</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4129-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1523%2FJNEUROSCI.4129-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=25609634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1199-1210&author=P.+C.+Mayauthor=B.+A.+Willisauthor=S.+L.+Loweauthor=R.+A.+Deanauthor=S.+A.+Monkauthor=P.+J.+Cockeauthor=J.+E.+Audiaauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+A.+Brierauthor=D.+O.+Calligaroauthor=T.+A.+Dayauthor=L.+Ereshefskyauthor=J.+A.+Ericksonauthor=H.+Gevorkyanauthor=C.+R.+Gonzalesauthor=D.+E.+Jamesauthor=S.+S.+Jheeauthor=S.+F.+Komjathyauthor=L.+Liauthor=T.+D.+Lindstromauthor=B.+M.+Mathesauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=G.+M.+Vaughtauthor=B.+M.+Watsonauthor=L.+L.+Winneroskiauthor=Z.+Yangauthor=D.+J.+Mergott&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+Abeta+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.4129-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span></div><div class="casAuthors">May, Patrick C.; Willis, Brian A.; Lowe, Stephen L.; Dean, Robert A.; Monk, Scott A.; Cocke, Patrick J.; Audia, James E.; Boggs, Leonard N.; Borders, Anthony R.; Brier, Richard A.; Calligaro, David O.; Day, Theresa A.; Ereshefsky, Larry; Erickso, Jon A.; Gevorkyan, Hykop; Gonzales, Celedon R.; James, Douglas E.; Jhee, Stanford S.; Komjathy, Steven F.; Li, Linglin; Lindstrom, Terry D.; Mathe, Brian M.; Martenyi, Ferenc; Sheehan, Scott M.; Stout, Stephanie L.; Timm, David E.; Vaught, Grant M.; Watson, Brian M.; Winneroski, Leonard L.; Yang, Zhixiang; Mergott, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1199-1210, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).  Therefore, the development of potent and selective inhibitors of BACE1 has been a focus of many drug discovery efforts in academia and industry.  Herein, we report the nonclin. and early clin. development of LY2886721, a BACE1 active site inhibitor that reached phase 2 clin. trials in AD.  LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclin. animal models.  Similar potent and persistent amyloid β lowering was obsd. in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects.  Collectively, these data add support for BACE1 inhibition as an effective means of amyloid lowering and as an attractive target for potential disease modification therapy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDFLhcsiUDLVg90H21EOLACvtfcHk0li8ji2A-zT6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D&md5=7e16cc00767a8af4da7dd17b6e40e8f5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4129-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4129-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26aulast%3DGevorkyan%26aufirst%3DH.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DJames%26aufirst%3DD.%2BE.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DKomjathy%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DVaught%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520Abeta%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D1199%26epage%3D1210%26doi%3D10.1523%2FJNEUROSCI.4129-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith
Labell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greg Hall, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span> <span> </span><span class="NLM_article-title">Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">16507</span>– <span class="NLM_lpage">16516</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith%0ALabellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-beta+in+humans+with+an+orally+available%2C+non-peptidic+beta-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0li8ji2A-zT6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLabell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-beta%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520beta-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">1,4-Oxazine beta-secretase 1 (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8216</span>– <span class="NLM_lpage">8235</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Martinez-Lamencaauthor=M.+Van+Goolauthor=A.+Garcia-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+beta-secretase+1+%28BACE1%29+inhibitors%3A+from+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0lg9phNIn0Vr9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarcia-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520beta-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931) - a beta-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29+-+a+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0lg9phNIn0Vr9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529%2520-%2520a%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2678</span>– <span class="NLM_lpage">2702</span>, <span class="refDoi"> DOI: 10.1021/jm501833t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501833t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2678-2702&author=C.+R.+Butlerauthor=M.+A.+Brodneyauthor=E.+M.+Beckauthor=G.+Barreiroauthor=C.+E.+Nolanauthor=F.+Panauthor=F.+Vajdosauthor=K.+Parrisauthor=A.+H.+Vargheseauthor=C.+J.+Helalauthor=R.+Liraauthor=S.+D.+Doranauthor=D.+R.+Riddellauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=L.+A.+Martinez-Alsinaauthor=K.+Ogilvieauthor=J.+C.+Murrayauthor=J.+M.+Youngauthor=K.+Atchisonauthor=A.+Robshawauthor=C.+Gonzalesauthor=J.+Wangauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Discovery+of+a+series+of+efficient%2C+centrally+efficacious+BACE1+inhibitors+through+structure-based+drug+design&doi=10.1021%2Fjm501833t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></div><div class="casAuthors">Butler, Christopher R.; Brodney, Michael A.; Beck, Elizabeth M.; Barreiro, Gabriela; Nolan, Charles E.; Pan, Feng; Vajdos, Felix; Parris, Kevin; Varghese, Alison H.; Helal, Christopher J.; Lira, Ricardo; Doran, Shawn D.; Riddell, David R.; Buzon, Leanne M.; Dutra, Jason K.; Martinez-Alsina, Luis A.; Ogilvie, Kevin; Murray, John C.; Young, Joseph M.; Atchison, Kevin; Robshaw, Ashley; Gonzales, Cathleen; Wang, Jinlong; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metab., and excretion (ADME) properties.  In this paper, the authors describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or neg. impacting brain penetration and ADME alignment, as exemplified by I.  Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog.  In addn., chronic treatment in aged PS1/APP mice effects a decrease in the no. and size of Aβ-derived plaques.  Most importantly, evaluation of I in a 2-wk exploratory toxicol. study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histol. findings in the eye, issues obsd. with earlier BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNT62AGyml7Vg90H21EOLACvtfcHk0ljgyyWdrNAUFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D&md5=ac2a6fd661f7e9fd8b925deffd5e1010</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520efficient%252C%2520centrally%2520efficacious%2520BACE1%2520inhibitors%2520through%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2678%26epage%3D2702%26doi%3D10.1021%2Fjm501833t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, R. T.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harried, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minatti, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span> <span> </span><span class="NLM_article-title">An orally available BACE1 inhibitor that affords robust CNS Abeta reduction without cardiovascular liabilities</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1021/ml500458t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500458t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=210-215&author=Y.+Chengauthor=J.+Brownauthor=T.+C.+Juddauthor=P.+Lopezauthor=W.+Qianauthor=T.+S.+Powersauthor=J.+J.+Chenauthor=M.+D.+Bartbergerauthor=K.+Chenauthor=R.+T.+Dunnauthor=O.+Epsteinauthor=R.+T.+Fremeauauthor=S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=Y.+Luoauthor=A.+E.+Minattiauthor=V.+F.+Patelauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=M.+M.+Weissauthor=P.+H.+Wenauthor=R.+D.+Whiteauthor=D.+A.+Whittingtonauthor=X.+M.+Zhengauthor=S.+Wood&title=An+orally+available+BACE1+inhibitor+that+affords+robust+CNS+Abeta+reduction+without+cardiovascular+liabilities&doi=10.1021%2Fml500458t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities</span></div><div class="casAuthors">Cheng, Yuan; Brown, James; Judd, Ted C.; Lopez, Patricia; Qian, Wenyuan; Powers, Timothy S.; Chen, Jian Jeffrey; Bartberger, Michael D.; Chen, Kui; Dunn, Robert T.; Epstein, Oleg; Fremeau, Robert T.; Harried, Scott; Hickman, Dean; Hitchcock, Stephen A.; Luo, Yi; Minatti, Ana Elena; Patel, Vinod F.; Vargas, Hugo M.; Wahl, Robert C.; Weiss, Matthew M.; Wen, Paul H.; White, Ryan D.; Whittington, Douglas A.; Zheng, Xiao Mei; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-215</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 inhibition to prevent Aβ peptide formation is considered to be a potential route to a disease-modifying treatment for Alzheimer's disease.  Previous efforts in our lab. using a combined structure- and property-based approach have resulted in the identification of aminooxazoline xanthenes as potent BACE1 inhibitors.  Herein, we report further optimization leading to the discovery of inhibitor 15 as an orally available and highly efficacious BACE1 inhibitor that robustly reduces CSF and brain Aβ levels in both rats and nonhuman primates.  In addn., compd. 15 exhibited low activity on the hERG ion channel and was well tolerated in an integrated cardiovascular safety model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbH-0fLNUlbrVg90H21EOLACvtfcHk0ljgyyWdrNAUFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI&md5=bd8e5a33d06a51646873c4c43d01b003</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fml500458t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500458t%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHarried%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMinatti%26aufirst%3DA.%2BE.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZheng%26aufirst%3DX.%2BM.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DAn%2520orally%2520available%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520Abeta%2520reduction%2520without%2520cardiovascular%2520liabilities%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D210%26epage%3D215%26doi%3D10.1021%2Fml500458t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlstrom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustavsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radesater, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploeger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueters, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falting, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">41245</span>– <span class="NLM_lpage">41257</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.409110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1074%2Fjbc.M112.409110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=23048024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGjs7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=41245-41257&author=F.+Jeppssonauthor=S.+Eketjallauthor=J.+Jansonauthor=S.+Karlstromauthor=S.+Gustavssonauthor=L.+L.+Olssonauthor=A.+C.+Radesaterauthor=B.+Ploegerauthor=G.+Cebersauthor=K.+Kolmodinauthor=B.+M.+Swahnauthor=S.+von+Bergauthor=T.+Buetersauthor=J.+Falting&title=Discovery+of+AZD3839%2C+a+potent+and+selective+BACE1+inhibitor+clinical+candidate+for+the+treatment+of+Alzheimer+disease&doi=10.1074%2Fjbc.M112.409110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease</span></div><div class="casAuthors">Jeppsson, Fredrik; Eketjaell, Susanna; Janson, Juliette; Karlstroem, Sofia; Gustavsson, Susanne; Olsson, Lise-Lotte; Radesaeter, Ann-Cathrine; Ploeger, Bart; Cebers, Gvido; Kolmodin, Karin; Swahn, Britt-Marie; von Berg, Stefan; Bueters, Tjerk; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">41245-41257</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is one of the key enzymes involved in the processing of the amyloid precursor protein (APP) and formation of amyloid β peptide (Aβ) species.  Because cerebral deposition of Aβ species might be crit. for the pathogenesis of Alzheimer disease, BACE1 has emerged as a key target for the treatment of this disease.  Here, the authors report the discovery and comprehensive preclin. characterization of AZD3839, a potent and selective inhibitor of human BACE1.  AZD3839 was identified using fragment-based screening and structure-based design.  In a concn.-dependent manner, AZD3839 inhibited BACE1 activity in a biochem. fluorescence resonance energy transfer (FRET) assay, Aβ and sAPPβ release from modified and wild-type human SH-SY5Y cells and mouse N2A cells as well as from mouse and guinea pig primary cortical neurons.  Selectivity against BACE2 and cathepsin D was 14 and >1000-fold, resp.  AZD3839 exhibited dose- and time-dependent lowering of plasma, brain, and cerebrospinal fluid Aβ levels in mouse, guinea pig, and non-human primate.  Pharmacokinetic/pharmacodynamic analyses of mouse and guinea pig data showed a good correlation between the potency of AZD3839 in primary cortical neurons and in vivo brain effects.  These results suggest that AZD3839 effectively reduces the levels of Aβ in brain, CSF, and plasma in several preclin. species.  It might, therefore, have disease-modifying potential in the treatment of Alzheimer disease and related dementias.  Based on the overall pharmacol. profile and its drug like properties, AZD3839 has been progressed into Phase 1 clin. trials in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi56XzYm8WhLVg90H21EOLACvtfcHk0libtSWJBvUc_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGjs7fE&md5=dd328c2e0b3de730de30f1e249f2403e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.409110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.409110%26sid%3Dliteratum%253Aachs%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DEketjall%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKarlstrom%26aufirst%3DS.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DRadesater%26aufirst%3DA.%2BC.%26aulast%3DPloeger%26aufirst%3DB.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DFalting%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520AZD3839%252C%2520a%2520potent%2520and%2520selective%2520BACE1%2520inhibitor%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D41245%26epage%3D41257%26doi%3D10.1074%2Fjbc.M112.409110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schechter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A.</span></span> <span> </span><span class="NLM_article-title">On the size of the active site in proteases. I. papain</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(67)80055-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2FS0006-291X%2867%2980055-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=6035483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1967&pages=157-162&author=I.+Schechterauthor=A.+Berger&title=On+the+size+of+the+active+site+in+proteases.+I.+papain&doi=10.1016%2FS0006-291X%2867%2980055-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">On the size of the active site in proteases.  I.  Papain</span></div><div class="casAuthors">Schechter, Israel; Berger, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-62</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The action of papain on 40 diastereoisomeric peptides of alanine, ranging in length from Ala2 to Ala6, was studied to investigate the size of the active site.  The variations observed in the rates of hydrolysis lead to the conclusion that papain has a large active site which extends over ∼25 A. and can be divided into 7 "subsites," each accommodating 1 amino acid residue of the peptide substrate.  The subsites are located on both sides of the catalytic site, 4 on the one side and 3 on the other.  It is postulated that a long "groove" analogous to that found by x-ray analysis in lysozyme is present.  The substrate is believed to fit into the groove, binding to several subsites of specific geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_kZeRVAOVyrVg90H21EOLACvtfcHk0libtSWJBvUc_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D&md5=a58ceccdbb5cc5c021af06912835f77c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2867%2980055-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252867%252980055-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DOn%2520the%2520size%2520of%2520the%2520active%2520site%2520in%2520proteases.%2520I.%2520papain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1967%26volume%3D27%26spage%3D157%26epage%3D162%26doi%3D10.1016%2FS0006-291X%2867%2980055-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlijanian, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albright, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span> <span> </span><span class="NLM_article-title">Targeting the BACE1 active site flap leads to a potent inhibitor that elicits robust brain Aβ reduction in rodents</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00432</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00432" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=271-276&author=Y.-J.+Wuauthor=J.+Guernonauthor=F.+Yangauthor=L.+Snyderauthor=J.+Shiauthor=A.+McClureauthor=R.+Rajamaniauthor=H.+Parkauthor=A.+Ngauthor=H.+Lewisauthor=C.+Y.+Changauthor=D.+Camacauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Targeting+the+BACE1+active+site+flap+leads+to+a+potent+inhibitor+that+elicits+robust+brain+A%CE%B2+reduction+in+rodents&doi=10.1021%2Facsmedchemlett.5b00432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Yang, Fukang; Snyder, Lawrence; Shi, Jianliang; McClure, Andrea; Rajamani, Ramkumar; Park, Hyunsoo; Ng, Alicia; Lewis, Hal; Chang, Chieh Ying; Camac, Dan; Toyn, Jeremy H.; Ahlijanian, Michael K.; Albright, Charles F.; Macor, John E.; Thompson, Lorin A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-276</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By targeting the flap backbone of the BACE1 active site, the authors discovered 6-dimethylisoxazole-substituted biaryl aminothiazine I with 34-fold improved BACE1 inhibitory activity over the lead compd.  The cocrystal structure of I bound to the active site indicated two hydrogen-bond interactions between the dimethylisoxazole and threonine 72 and glutamine 73 of the flap.  Incorporation of the dimethylisoxazole substitution onto the related aminothiazine carboxamide series led to pyrazine-carboxamide II as a very potent BACE1 inhibitor (IC50 < 1 nM).  This compd. demonstrated robust brain Aβ redn. in rat dose-response studies.  Thus, compd. II may be useful in testing the amyloid hypothesis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9dTGWVgGmmrVg90H21EOLACvtfcHk0lj1qOPnScajbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D&md5=b1bd7b0b6cb22ca8d2f49807b905daa9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00432%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DSnyder%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DTargeting%2520the%2520BACE1%2520active%2520site%2520flap%2520leads%2520to%2520a%2520potent%2520inhibitor%2520that%2520elicits%2520robust%2520brain%2520A%25CE%25B2%2520reduction%2520in%2520rodents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D271%26epage%3D276%26doi%3D10.1021%2Facsmedchemlett.5b00432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travagli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollastrini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabellieri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Power, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">BACE1 inhibitors: a head group scan on a series of amides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4239</span>– <span class="NLM_lpage">4243</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.bmcl.2013.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=23735744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFaktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4239-4243&author=T.+J.+Wolteringauthor=W.+Wostlauthor=H.+Hilpertauthor=M.+Rogers-Evansauthor=E.+Pinardauthor=A.+Maywegauthor=M.+Gobelauthor=D.+W.+Bannerauthor=J.+Benzauthor=M.+Travagliauthor=M.+Pollastriniauthor=G.+Marconiauthor=E.+Gabellieriauthor=W.+Gubaauthor=H.+Mauserauthor=M.+Andreiniauthor=H.+Jacobsenauthor=E.+Powerauthor=R.+Narquizian&title=BACE1+inhibitors%3A+a+head+group+scan+on+a+series+of+amides&doi=10.1016%2Fj.bmcl.2013.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 inhibitors: A head group scan on a series of amides</span></div><div class="casAuthors">Woltering, Thomas J.; Wostl, Wolfgang; Hilpert, Hans; Rogers-Evans, Mark; Pinard, Emmanuel; Mayweg, Alexander; Gobel, Martin; Banner, David W.; Benz, Jorg; Travagli, Massimiliano; Pollastrini, Martina; Marconi, Guido; Gabellieri, Emanuele; Guba, Wolfgang; Mauser, Harald; Andreini, Matteo; Jacobsen, Helmut; Power, Eoin; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4239-4243</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of amides bearing a variety of amidine head groups was investigated as BACE1 inhibitors with respect to inhibitory activity in a BACE1 enzyme as well as a cell-based assay.  Detn. of their basicity as well as their properties as substrates of P-glycoprotein revealed that a 2-amino-1,3-oxazine head group would be a suitable starting point for further development of brain penetrating compds. for potential Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEF94wd3_rd7Vg90H21EOLACvtfcHk0lj1qOPnScajbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFaktLk%253D&md5=3da315c76199617083b762ea111057fd</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMayweg%26aufirst%3DA.%26aulast%3DGobel%26aufirst%3DM.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DTravagli%26aufirst%3DM.%26aulast%3DPollastrini%26aufirst%3DM.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DGabellieri%26aufirst%3DE.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DPower%26aufirst%3DE.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3DBACE1%2520inhibitors%253A%2520a%2520head%2520group%2520scan%2520on%2520a%2520series%2520of%2520amides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4239%26epage%3D4243%26doi%3D10.1016%2Fj.bmcl.2013.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krummenacher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozmen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergadano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochstrasser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David-Pierson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">beta-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3980</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=beta-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0lj1qOPnScajbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3Dbeta-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voegtle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2195</span>– <span class="NLM_lpage">2200</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.bmcl.2018.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=29764741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1Crt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2195-2200&author=S.+J.+Veenstraauthor=H.+Rueegerauthor=M.+Voegtleauthor=R.+Lueoendauthor=P.+Holzerauthor=K.+Hurthauthor=M.+Tintelnot-Blomleyauthor=M.+Frederiksenauthor=J.+M.+Rondeauauthor=L.+Jacobsonauthor=M.+Staufenbielauthor=U.+Neumannauthor=R.+Machauer&title=Discovery+of+amino-1%2C4-oxazines+as+potent+BACE-1+inhibitors&doi=10.1016%2Fj.bmcl.2018.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors</span></div><div class="casAuthors">Veenstra, Siem Jakob; Rueeger, Heinrich; Voegtle, Markus; Lueoend, Rainer; Holzer, Philipp; Hurth, Konstanze; Tintelnot-Blomley, Marina; Frederiksen, Mathias; Rondeau, Jean-Michel; Jacobson, Laura; Staufenbiel, Matthias; Neumann, Ulf; Machauer, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2195-2200</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">(Pyridinecarbonylamino)phenyl aminooxazine-derived β-site amyloid precursor protein-cleaving enzyme 1 (BACE-1) inhibitors such as I were prepd. as potential anti-Alzheimer's agents and tested for inhibition of BACE-1 and for their efflux ratio in human p-glycoprotein-contg. cells as a measure of permeation through the blood-brain barrier.  The crystal structure of the complex of a racemic aminooxazine with BACE-1 was detd. by X-ray crystallog.  I reduced Aβ levels in the forebrains of mice by 20% and 63% at 30 μmol/kg and 100 μmol/kg oral doses, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJdRw9y0Bfc7Vg90H21EOLACvtfcHk0lhZRZPQtw4tKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1Crt7s%253D&md5=af32916a3a27b475aa0e9264a3217a8f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DVoegtle%26aufirst%3DM.%26aulast%3DLueoend%26aufirst%3DR.%26aulast%3DHolzer%26aufirst%3DP.%26aulast%3DHurth%26aufirst%3DK.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DRondeau%26aufirst%3DJ.%2BM.%26aulast%3DJacobson%26aufirst%3DL.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DMachauer%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520amino-1%252C4-oxazines%2520as%2520potent%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2195%26epage%3D2200%26doi%3D10.1016%2Fj.bmcl.2018.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann-Roder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span> <span> </span><span class="NLM_article-title">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Fcmdc.200700059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=17530727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1100-1115&author=M.+Morgenthalerauthor=E.+Schweizerauthor=A.+Hoffmann-Roderauthor=F.+Beniniauthor=R.+E.+Martinauthor=G.+Jaeschkeauthor=B.+Wagnerauthor=H.+Fischerauthor=S.+Bendelsauthor=D.+Zimmerliauthor=J.+Schneiderauthor=F.+Diederichauthor=M.+Kansyauthor=K.+Muller&title=Predicting+and+tuning+physicochemical+properties+in+lead+optimization%3A+amine+basicities&doi=10.1002%2Fcmdc.200700059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span></div><div class="casAuthors">Morgenthaler, Martin; Schweizer, Eliane; Hoffmann-Roder, Anja; Benini, Fausta; Martin, Rainer E.; Jaeschke, Georg; Wagner, Bjorn; Fischer, Holger; Bendels, Stefanie; Zimmerli, Daniel; Schneider, Josef; Diederich, Francois; Kansy, Manfred; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1100-1115</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  This review describes simple and useful concepts for predicting and tuning the pKa values of basic amine centers, a crucial step in the optimization of phys. and ADME properties of many lead structures in drug-discovery research.  The article starts with a case study of tricyclic thrombin inhibitors featuring a tertiary amine center with pKa values that can be tuned over a wide range, from the usual value of around 10 to below 2 by (remote) neighboring functionalities commonly encountered in medicinal chem.  Next, the changes in pKa of acyclic and cyclic amines upon substitution by fluorine, oxygen, nitrogen, and sulfur functionalities, as well as carbonyl and carboxyl derivs. are systematically analyzed, leading to the derivation of simple rules for pKa prediction.  Electronic and stereoelectronic effects in cyclic amines are discussed, and the emerging computational methods for pKa predictions are briefly surveyed.  The rules for tuning amine basicities should not only be of interest in drug-discovery research, but also to the development of new crop-protection agents, new amine ligands for organometallic complexes, and in particular, to the growing field of amine-based organocatalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodsWRMtrxWPbVg90H21EOLACvtfcHk0lhZRZPQtw4tKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D&md5=478b70744312c01d3a43cf435d9598de</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700059%26sid%3Dliteratum%253Aachs%26aulast%3DMorgenthaler%26aufirst%3DM.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DHoffmann-Roder%26aufirst%3DA.%26aulast%3DBenini%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DPredicting%2520and%2520tuning%2520physicochemical%2520properties%2520in%2520lead%2520optimization%253A%2520amine%2520basicities%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1100%26epage%3D1115%26doi%3D10.1002%2Fcmdc.200700059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den Bossche, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span> <span> </span><span class="NLM_article-title">Optimization of 1,4-oxazine beta-secretase 1 (BACE1) inhibitors toward a clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5292</span>– <span class="NLM_lpage">5303</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00304</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVCgt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5292-5303&author=H.+J.+M.+Gijsenauthor=S.+A.+Alonso+de+Diegoauthor=M.+De+Cleynauthor=A.+Garcia-Molinaauthor=G.+J.+Macdonaldauthor=C.+Martinez-Lamencaauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=F.+J.+R.+Romboutsauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=S.+Van+Brandtauthor=D.+Van+den+Bosscheauthor=M.+Van+Goolauthor=N.+Austinauthor=H.+Borghysauthor=D.+Dhuyvetterauthor=D.+Moechars&title=Optimization+of+1%2C4-oxazine+beta-secretase+1+%28BACE1%29+inhibitors+toward+a+clinical+candidate&doi=10.1021%2Facs.jmedchem.8b00304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate</span></div><div class="casAuthors">Gijsen, Harrie J. M.; Alonso de Diego, Sergio A.; De Cleyn, Michel; Garcia-Molina, Aranzazu; Macdonald, Gregor J.; Martinez-Lamenca, Carolina; Oehlrich, Daniel; Prokopcova, Hana; Rombouts, Frederik J. R.; Surkyn, Michel; Trabanco, Andres A.; Van Brandt, Sven; Van den Bossche, Dries; Van Gool, Michiel; Austin, Nigel; Borghys, Herman; Dhuyvetter, Deborah; Moechars, Diederik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5292-5303</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In previous studies, the introduction of electron withdrawing groups to 1,4-oxazine BACE1 inhibitors reduced the pKa of the amidine group, resulting in compd. 2 that showed excellent in vivo efficacy, lowering Aβ levels in brain and CSF.  However, a suboptimal cardiovascular safety margin, based on QTc prolongation, prevented further progression.  Further optimization resulted in the replacement of the 2-fluoro substituent by a CF3-group, which reduced hERG inhibition.  This has led to compd. 3, with an improved cardiovascular safety margin and sufficiently safe in GLP toxicity studies to progress into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF682roZxPn7Vg90H21EOLACvtfcHk0lhK6ABPqwmTzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVCgt7zP&md5=f6e061004a3c5ad98b817ddd198940c7</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00304%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DGarcia-Molina%26aufirst%3DA.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVan%2Bden%2BBossche%26aufirst%3DD.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DMoechars%26aufirst%3DD.%26atitle%3DOptimization%2520of%25201%252C4-oxazine%2520beta-secretase%25201%2520%2528BACE1%2529%2520inhibitors%2520toward%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5292%26epage%3D5303%26doi%3D10.1021%2Facs.jmedchem.8b00304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Badiger, S.</span>; <span class="NLM_string-name">Chebrolu, M.</span>; <span class="NLM_string-name">Hurth, K.</span>; <span class="NLM_string-name">Jacquier, S.</span>; <span class="NLM_string-name">Lueoend, R. M.</span>; <span class="NLM_string-name">Machauer, R.</span>; <span class="NLM_string-name">Rueeger, H.</span>; <span class="NLM_string-name">Tintelnot-Blomley, M.</span>; <span class="NLM_string-name">Veenstra, S. J.</span>; <span class="NLM_string-name">Voegtle, M.</span></span> <span> </span><span class="NLM_article-title">Novel heterocyclic derivatives as BACE inhibitors and their preparation and use in the treatment of neurological disorders</span>. <span class="NLM_patent">WO2012095469A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+Badiger&author=M.+Chebrolu&author=K.+Hurth&author=S.+Jacquier&author=R.+M.+Lueoend&author=R.+Machauer&author=H.+Rueeger&author=M.+Tintelnot-Blomley&author=S.+J.+Veenstra&author=M.+Voegtle&title=Novel+heterocyclic+derivatives+as+BACE+inhibitors+and+their+preparation+and+use+in+the+treatment+of+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBadiger%26aufirst%3DS.%26atitle%3DNovel%2520heterocyclic%2520derivatives%2520as%2520BACE%2520inhibitors%2520and%2520their%2520preparation%2520and%2520use%2520in%2520the%2520treatment%2520of%2520neurological%2520disorders%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanja, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jivkov, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacology of BACE inhibitor CNP520</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">P433</span>– <span class="NLM_lpage">P434</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2016.06.831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.jalz.2016.06.831" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=P433-P434&author=U.+Neumannauthor=L.+H.+Jacobsonauthor=L.+Perrotauthor=K.+Beltzauthor=B.+Voggauthor=I.+Brzakauthor=D.+Tanjaauthor=V.+Trappeauthor=C.+Kollyauthor=W.+Frieauffauthor=V.+Dubostauthor=M.+N.+Jivkovauthor=D.+Theilauthor=M.+Staufenbielauthor=D.+R.+Shimshek&title=Preclinical+pharmacology+of+BACE+inhibitor+CNP520&doi=10.1016%2Fj.jalz.2016.06.831"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2016.06.831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2016.06.831%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DTanja%26aufirst%3DD.%26aulast%3DTrappe%26aufirst%3DV.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DDubost%26aufirst%3DV.%26aulast%3DJivkov%26aufirst%3DM.%2BN.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26atitle%3DPreclinical%2520pharmacology%2520of%2520BACE%2520inhibitor%2520CNP520%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2016%26volume%3D12%26spage%3DP433%26epage%3DP434%26doi%3D10.1016%2Fj.jalz.2016.06.831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curphey, T. J.</span></span> <span> </span><span class="NLM_article-title">Thionation with the reagent combination of phosphorus pentasulfide and hexamethyldisiloxane</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">6461</span>– <span class="NLM_lpage">6473</span>, <span class="refDoi"> DOI: 10.1021/jo0256742</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0256742" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVyms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=6461-6473&author=T.+J.+Curphey&title=Thionation+with+the+reagent+combination+of+phosphorus+pentasulfide+and+hexamethyldisiloxane&doi=10.1021%2Fjo0256742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Thionation with the reagent combination of phosphorus pentasulfide and hexamethyldisiloxane</span></div><div class="casAuthors">Curphey, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6461-6473</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The combination of P4S10 and hexamethyldisiloxane efficiently converts esters, lactones, amides, lactams, and ketones to their corresponding thiono derives.  In the presence of elemental sulfur, 3-oxo esters are converted to dithiolethiones by this reagent.  Yields are comparable to or superior to those obtained with Lawesson's reagent.  The method has the advantage that reagent-derived byproducts may be removed by a simple hydrolytic workup or by filtration through silica gel, rather than by chromatog., as required for Lawesson's reagent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotz2rC56sh4rVg90H21EOLACvtfcHk0lgMKlyjsBLOOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVyms7o%253D&md5=25e6316aefe299e38b0c531dac7d9a2c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjo0256742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0256742%26sid%3Dliteratum%253Aachs%26aulast%3DCurphey%26aufirst%3DT.%2BJ.%26atitle%3DThionation%2520with%2520the%2520reagent%2520combination%2520of%2520phosphorus%2520pentasulfide%2520and%2520hexamethyldisiloxane%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D6461%26epage%3D6473%26doi%3D10.1021%2Fjo0256742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fliri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eschenmoser, A.</span></span> <span> </span><span class="NLM_article-title">Poly(dipeptamidinium)-Salze: Definition und Methoden zur präparativen Herstellung</span>. <i>Helv. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1224</span>– <span class="NLM_lpage">1262</span>, <span class="refDoi"> DOI: 10.1002/hlca.19860690530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Fhlca.19860690530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADyaL2sXkvFOju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1986&pages=1224-1262&author=H.+Moserauthor=A.+Fliriauthor=A.+Steigerauthor=G.+Costelloauthor=J.+Schreiberauthor=A.+Eschenmoser&title=Poly%28dipeptamidinium%29-Salze%3A+Definition+und+Methoden+zur+pr%C3%A4parativen+Herstellung&doi=10.1002%2Fhlca.19860690530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(dipeptamidinium) salts:  definition and methods of preparation</span></div><div class="casAuthors">Moser, Heinz; Fliri, Anton; Steiger, Arthur; Costello, Gerard; Schreiber, Jakob; Eschenmoser, Albert</div><div class="citationInfo"><span class="NLM_cas:title">Helvetica Chimica Acta</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1224-62</span>CODEN:
                <span class="NLM_cas:coden">HCACAV</span>;
        ISSN:<span class="NLM_cas:issn">0018-019X</span>.
    </div><div class="casAbstract">Poly(dipeptamidines) are polypeptide derivs. in which the carbonyl O of each second backbone amide group is replaced by an imine N atom.  Homodipeptidic poly(dipeptamidinium) salts in the Ala-Gly and Phe-Gly series, e.g. I (n = 1-5) and II (n = 1, 2, 3), resp., were prepd. and they were characterized by 1H and 13C NMR spectroscopy.  The method of prepn. included a stepwise construction of defined lower oligomers.  In the Ala-Gly series, a one-step polycondensation procedure gave polymers contg. an av. of ca. 20 dipeptamidinium units.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2aOIuFCSID7Vg90H21EOLACvtfcHk0lgMKlyjsBLOOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXkvFOju7w%253D&md5=b3a71ba731b834dfda6433229c2ed6ee</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fhlca.19860690530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.19860690530%26sid%3Dliteratum%253Aachs%26aulast%3DMoser%26aufirst%3DH.%26aulast%3DFliri%26aufirst%3DA.%26aulast%3DSteiger%26aufirst%3DA.%26aulast%3DCostello%26aufirst%3DG.%26aulast%3DSchreiber%26aufirst%3DJ.%26aulast%3DEschenmoser%26aufirst%3DA.%26atitle%3DPoly%2528dipeptamidinium%2529-Salze%253A%2520Definition%2520und%2520Methoden%2520zur%2520pr%25C3%25A4parativen%2520Herstellung%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D1986%26volume%3D69%26spage%3D1224%26epage%3D1262%26doi%3D10.1002%2Fhlca.19860690530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span> <span> </span><span class="NLM_article-title">Asymmetric iodolactamization induced by chiral oxazolidine auxiliary</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">7906</span>– <span class="NLM_lpage">7909</span>, <span class="refDoi"> DOI: 10.1021/jo0488006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0488006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlSis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=7906-7909&author=M.+Shenauthor=C.+Li&title=Asymmetric+iodolactamization+induced+by+chiral+oxazolidine+auxiliary&doi=10.1021%2Fjo0488006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric iodolactamization induced by chiral oxazolidine auxiliary</span></div><div class="casAuthors">Shen, Meihua; Li, Chaozhong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7906-7909</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Asym. iodolactamization reaction of unsatd. amides with oxazolidines as the chiral auxiliaries were investigated.  With (4S)-4-((2R)-2-butyl)-2,2-dimethyloxazolidine as the auxiliary and LiH as the base, a no. of unsatd. amides underwent iodolactamization smoothly to afford γ- and δ-lactams, e.g., I, in good yields and diastereoselectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS6M8I-IBERbVg90H21EOLACvtfcHk0lgMKlyjsBLOOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlSis74%253D&md5=b9a5f2ccb6f79bd3dab59f710ab3cfff</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjo0488006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0488006%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DAsymmetric%2520iodolactamization%2520induced%2520by%2520chiral%2520oxazolidine%2520auxiliary%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D7906%26epage%3D7909%26doi%3D10.1021%2Fjo0488006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gataullin, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afon’kin, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatykhov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spirikhin, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdrakhmanov, I. B.</span></span> <span> </span><span class="NLM_article-title">Iodocyclization of N-(2-nitrophenyl)- and N-phenyl-N′-[2-(alk-1-enyl)phenyl]ethanimidamides</span>. <i>Mendeleev Commun.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1070/MC2001v011n05ABEH001490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1070%2FMC2001v011n05ABEH001490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=201-202&author=R.+R.+Gataullinauthor=I.+S.+Afon%E2%80%99kinauthor=A.+A.+Fatykhovauthor=L.+V.+Spirikhinauthor=I.+B.+Abdrakhmanov&title=Iodocyclization+of+N-%282-nitrophenyl%29-+and+N-phenyl-N%E2%80%B2-%5B2-%28alk-1-enyl%29phenyl%5Dethanimidamides&doi=10.1070%2FMC2001v011n05ABEH001490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1070%2FMC2001v011n05ABEH001490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1070%252FMC2001v011n05ABEH001490%26sid%3Dliteratum%253Aachs%26aulast%3DGataullin%26aufirst%3DR.%2BR.%26aulast%3DAfon%25E2%2580%2599kin%26aufirst%3DI.%2BS.%26aulast%3DFatykhov%26aufirst%3DA.%2BA.%26aulast%3DSpirikhin%26aufirst%3DL.%2BV.%26aulast%3DAbdrakhmanov%26aufirst%3DI.%2BB.%26atitle%3DIodocyclization%2520of%2520N-%25282-nitrophenyl%2529-%2520and%2520N-phenyl-N%25E2%2580%25B2-%255B2-%2528alk-1-enyl%2529phenyl%255Dethanimidamides%26jtitle%3DMendeleev%2520Commun.%26date%3D2001%26volume%3D11%26spage%3D201%26epage%3D202%26doi%3D10.1070%2FMC2001v011n05ABEH001490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brauer, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roßenbach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepper, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stelzer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häusler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, W. S.</span></span> <span> </span><span class="NLM_article-title">Water soluble phosphines: part XIII. chiral phosphine ligands with amino acid moieties</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>598</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/S0022-328X(99)00689-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2FS0022-328X%2899%2900689-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslyrs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=598&publication_year=2000&pages=116-126&author=D.+J.+Brauerauthor=S.+Schenkauthor=S.+Ro%C3%9Fenbachauthor=M.+Tepperauthor=O.+Stelzerauthor=T.+H%C3%A4uslerauthor=W.+S.+Sheldrick&title=Water+soluble+phosphines%3A+part+XIII.+chiral+phosphine+ligands+with+amino+acid+moieties&doi=10.1016%2FS0022-328X%2899%2900689-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Water soluble phosphines. Part XIII. Chiral phosphine ligands with amino acid moieties</span></div><div class="casAuthors">Brauer, D. J.; Schenk, S.; Rossenbach, S.; Tepper, M.; Stelzer, O.; Hausler, T.; Sheldrick, W. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">598</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">116-126</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">Nucleophilic phosphination of the potassium or sodium salt of the fluorophenylalanines or -glycines with potassium phosphides Ph(R)PK (R = Me, Ph) yields chiral phosphine ligands, e.g. 2-Ph2PC6H4CH(NH2)CO2H (I), with amino acid moieties.  The x-ray structure of I.2H2O (space group Pbca) has been detd. showing a betaine type structure for the amino acid moiety.  The α-Me derivs. of the phosphinophenylglycines were obtained in an analogous manner.  Ortho- and para-Fluoroacetophenones have been employed as starting material for the syntheses of α-[4-fluorophenyl]-α-methylglycine and its ortho-isomer, the x-ray structure of monohydrate of 2-FC6H4C(Me)(NH2)CO2H has been detd. (space group P‾1).  The N-acetyl and ester derivs. are accessible using std. procedures.  Resoln. of the diastereomeric salt obtained from (S)-(+)-2-hydroxymethylpyrrolidine and racem-2-FC6H4C(Me)(NHAc)CO2H (II) by fractionated crystn. yielded the (S,R)-isomer.  The abs. configuration of (S,R)-II salt with 2-hydroxymethylpyrrolidine was detd. by x-ray structural anal. (space group P212121).  Cleavage of (S,R)-salt with hydrochloric acid gave enantiopure (R)-II [α]d20 = -30.9° (c = 1, CH3OH).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzKurCzbmH6rVg90H21EOLACvtfcHk0ljDpzoXBg9tBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslyrs78%253D&md5=1b7dc678adbc68c91c931b6906bc7bd8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS0022-328X%2899%2900689-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-328X%252899%252900689-0%26sid%3Dliteratum%253Aachs%26aulast%3DBrauer%26aufirst%3DD.%2BJ.%26aulast%3DSchenk%26aufirst%3DS.%26aulast%3DRo%25C3%259Fenbach%26aufirst%3DS.%26aulast%3DTepper%26aufirst%3DM.%26aulast%3DStelzer%26aufirst%3DO.%26aulast%3DH%25C3%25A4usler%26aufirst%3DT.%26aulast%3DSheldrick%26aufirst%3DW.%2BS.%26atitle%3DWater%2520soluble%2520phosphines%253A%2520part%2520XIII.%2520chiral%2520phosphine%2520ligands%2520with%2520amino%2520acid%2520moieties%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2000%26volume%3D598%26spage%3D116%26epage%3D126%26doi%3D10.1016%2FS0022-328X%2899%2900689-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9156</span>– <span class="NLM_lpage">9169</span>, <span class="refDoi"> DOI: 10.1021/jm300598e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.+H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm300598e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Huang, Hongbing; La, Daniel S.; Cheng, Alan C.; Whittington, Douglas A.; Patel, Vinod F.; Chen, Kui; Dineen, Thomas A.; Epstein, Oleg; Graceffa, Russell; Hickman, Dean; Kiang, Y.-H.; Louie, Steven; Luo, Yi; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9156-9169</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure- and property-based drug design approach was employed to identify aminooxazoline xanthenes as potent and selective human β-secretase inhibitors.  These compds. exhibited good isolated enzyme, cell potency, and selectivity against the structurally related aspartyl protease cathepsin D.  Our efforts resulted in the identification of a potent, orally bioavailable CNS penetrant compd. that exhibited in vivo efficacy.  A single oral dose of compd. (I) resulted in a significant redn. of CNS Aβ40 in naive rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDEYfU4moxMbVg90H21EOLACvtfcHk0ljDpzoXBg9tBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ&md5=0ecd50ec1ea82a058e499bb712c45272</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.%2BH.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169%26doi%3D10.1021%2Fjm300598e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Box, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, D.</span></span> <span> </span><span class="NLM_article-title">High-throughput measurement of pKa values in a mixed-buffer linear pH gradient system</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">892</span>, <span class="refDoi"> DOI: 10.1021/ac020329y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac020329y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1yksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2003&pages=883-892&author=K.+Boxauthor=C.+Bevanauthor=J.+Comerauthor=A.+Hillauthor=R.+Allenauthor=D.+Reynolds&title=High-throughput+measurement+of+pKa+values+in+a+mixed-buffer+linear+pH+gradient+system&doi=10.1021%2Fac020329y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Measurement of pKa Values in a Mixed-Buffer Linear pH Gradient System</span></div><div class="casAuthors">Box, Karl; Bevan, Christopher; Comer, John; Hill, Alan; Allen, Ruth; Reynolds, Derek</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">883-892</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A procedure is described for measuring pKa values in a short time, e.g., 4 min/assay.  Samples, as 10 mM solns., are prepd. in DMSO in 96-well plates.  A flowing pH gradient is produced by mixing two buffer solns. contg. mixts. of weak acids and bases that do not absorb significantly in the UV above 250 nm.  The sample soln. is dild. with water and then injected directly into the flowing gradient, which then passes through a diode array spectrophotometer measuring in the UV wavelength range.  The buffer has been formulated so that its acid-base titrn. curve is linear over a wide pH range, such that the pH of the gradient is a linear function of time.  The soln. pH in the measurement flow cell is therefore proportional to the time elapsed since the start of gradient generation.  The sample's pKa values are calcd. from the change in UV absorbance at multiple wavelengths as a function of pH.  The pKa values of 71 drugs have been measured, and results compare well with values measured by pH-metric or traditional UV methods.  Rules are suggested for the rapid inspection of data and the choice of method for the calcn. of pKa from the data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGtjb6-Ri9arVg90H21EOLACvtfcHk0ljDpzoXBg9tBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1yksg%253D%253D&md5=4050d66a7c92550c1efd346e76c392d9</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fac020329y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac020329y%26sid%3Dliteratum%253Aachs%26aulast%3DBox%26aufirst%3DK.%26aulast%3DBevan%26aufirst%3DC.%26aulast%3DComer%26aufirst%3DJ.%26aulast%3DHill%26aufirst%3DA.%26aulast%3DAllen%26aufirst%3DR.%26aulast%3DReynolds%26aufirst%3DD.%26atitle%3DHigh-throughput%2520measurement%2520of%2520pKa%2520values%2520in%2520a%2520mixed-buffer%2520linear%2520pH%2520gradient%2520system%26jtitle%3DAnal.%2520Chem.%26date%3D2003%26volume%3D75%26spage%3D883%26epage%3D892%26doi%3D10.1021%2Fac020329y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span> <span> </span><span class="NLM_article-title">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-beta and neuroinflammation in APP transgenic mice</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">44</span> <span class="refDoi"> DOI: 10.1186/s13024-015-0033-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1186%2Fs13024-015-0033-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=26336937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=U.+Neumannauthor=H.+Rueegerauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=R.+M.+Lueoendauthor=M.+Tintelnot-Blomleyauthor=G.+Laueauthor=K.+Beltzauthor=B.+Voggauthor=P.+Schmidauthor=W.+Frieauffauthor=D.+R.+Shimshekauthor=M.+Staufenbielauthor=L.+H.+Jacobson&title=A+novel+BACE+inhibitor+NB-360+shows+a+superior+pharmacological+profile+and+robust+reduction+of+amyloid-beta+and+neuroinflammation+in+APP+transgenic+mice&doi=10.1186%2Fs13024-015-0033-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice</span></div><div class="casAuthors">Neumann, Ulf; Rueeger, Heinrich; Machauer, Rainer; Veenstra, Siem Jacob; Lueoend, Rainer M.; Tintelnot-Blomley, Marina; Laue, Grit; Beltz, Karen; Vogg, Barbara; Schmid, Peter; Frieauff, Wilfried; Shimshek, Derya R.; Staufenbiel, Matthias; Jacobson, Laura H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44/1-44/15</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease (AD) is the most common form of dementia, the no. of affected individuals is rising, with significant impacts for healthcare systems.  Current symptomatic treatments delay, but do not halt, disease progression.  Genetic evidence points to aggregation and deposition of amyloid-β (Aβ) in the brain being causal for the neurodegeneration and dementia typical of AD.  Approaches to target Aβ via inhibition of γ-secretase or passive antibody therapy have not yet resulted in substantial clin. benefits.  Inhibition of BACE1 (β-secretase) has proven a challenging concept, but recent BACE1inhibitors can enter the brain sufficiently well to lower Aβ.  However, failures with the first clin. BACE1 inhibitors have highlighted the need to generate compds. with appropriate efficacy and safety profiles, since long treatment periods are expected to be necessary in humans.  Results: Treatment with NB-360, a potent and brain penetrable BACE-1 inhibitor can completely block the progression of Aβ deposition in the brains of APP transgenic mice, a model for amyloid pathol.  We furthermore show that almost complete redn. of Aβ was achieved also in rats and in dogs, suggesting that these findings are translational across species and can be extrapolated to humans.  Amyloid pathol. may be an initial step in a complex pathol. cascade; therefore we investigated the effect of BACE-1 inhibition on neuroinflammation, a prominent downstream feature of the disease.  NB-360 stopped accumulation of activated inflammatory cells in the brains of APP transgenic mice.  Upon chronic treatment of APP transgenic mice, patches of gray hairs appeared.  Conclusions: In a rapidly developing field, the data on NB-360 broaden the chem. space and expand knowledge on the properties that are needed to make a BACE-1 inhibitor potent and safe enough for long-term use in patients.  Due to its excellent brain penetration, reasonable oral doses of NB-360 were sufficient to completely block amyloid-β deposition in an APP transgenic mouse model.  Data across species suggest similar treatment effects can possibly be achieved in humans.  The reduced neuroinflammation upon amyloid redn. by NB-360 treatment supports the notion that targeting amyloid-β pathol. can have beneficial downstream effects on the progression of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJLgu8zl8_LVg90H21EOLACvtfcHk0lireZvGP95fxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D&md5=728407859709d7de57d68bfdc374fe85</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1186%2Fs13024-015-0033-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-015-0033-8%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DLueoend%26aufirst%3DR.%2BM.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DLaue%26aufirst%3DG.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26atitle%3DA%2520novel%2520BACE%2520inhibitor%2520NB-360%2520shows%2520a%2520superior%2520pharmacological%2520profile%2520and%2520robust%2520reduction%2520of%2520amyloid-beta%2520and%2520neuroinflammation%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DMol.%2520Neurodegener.%26date%3D2015%26volume%3D10%26doi%3D10.1186%2Fs13024-015-0033-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serneels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fort, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span> <span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10658</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0lireZvGP95fxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawiec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">21917</span> <span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+K.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0lireZvGP95fxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doelemeyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurbrugg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neddermann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span> <span> </span><span class="NLM_article-title">Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor-treated APP transgenic mice</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2016.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.neurobiolaging.2016.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=27459925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BC2s3ks1Gntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=50-60&author=N.+Beckmannauthor=A.+Doelemeyerauthor=S.+Zurbruggauthor=K.+Bigotauthor=D.+Theilauthor=W.+Frieauffauthor=C.+Kollyauthor=P.+Moulinauthor=D.+Neddermannauthor=R.+Kreutzerauthor=L.+Perrotauthor=I.+Brzakauthor=L.+H.+Jacobsonauthor=M.+Staufenbielauthor=U.+Neumannauthor=D.+R.+Shimshek&title=Longitudinal+noninvasive+magnetic+resonance+imaging+of+brain+microhemorrhages+in+BACE+inhibitor-treated+APP+transgenic+mice&doi=10.1016%2Fj.neurobiolaging.2016.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor-treated APP transgenic mice</span></div><div class="casAuthors">Beckmann Nicolau; Doelemeyer Arno; Bigot Karine; Theil Diethilde; Frieauff Wilfried; Kolly Carine; Moulin Pierre; Kreutzer Robert; Zurbruegg Stefan; Perrot Ludovic; Brzak Irena; Jacobson Laura H; Staufenbiel Matthias; Neumann Ulf; Neddermann Daniel; Shimshek Derya R</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of aging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Currently, several immunotherapies and BACE (Beta Site APP Cleaving Enzyme) inhibitor approaches are being tested in the clinic for the treatment of Alzheimer's disease.  A crucial mechanism-related safety concern is the exacerbation of microhemorrhages, which are already present in the majority of Alzheimer patients.  To investigate potential safety liabilities of long-term BACE inhibitor therapy, we used aged amyloid precursor protein (APP) transgenic mice (APP23), which robustly develop cerebral amyloid angiopathy.  T2*-weighted magnetic resonance imaging (MRI), a translational method applicable in preclinical and clinical studies, was used for the detection of microhemorrhages throughout the entire brain, with subsequent histological validation.  Three-dimensional reconstruction based on in vivo MRI and serial Perls' stained sections demonstrated a one-to-one matching of the lesions thus allowing for their histopathological characterization.  MRI detected small Perls' positive areas with a high spatial resolution.  Our data demonstrate that volumetric assessment by noninvasive MRI is well suited to monitor cerebral microhemorrhages in vivo.  Furthermore, 3 months treatment of aged APP23 with the potent BACE-inhibitor NB-360 did not exacerbate microhemorrhages in contrast to Aβ-antibody β1.  These results substantiate the safe use of BACE inhibitors regarding microhemorrhages in long-term clinical studies for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeVeW4ul5-qOvW160gIxP_fW6udTcc2eayGTNEUTQ0_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3ks1Gntw%253D%253D&md5=4cffb9cbd7b2bb606e702c9fa01506b4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2016.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2016.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DBeckmann%26aufirst%3DN.%26aulast%3DDoelemeyer%26aufirst%3DA.%26aulast%3DZurbrugg%26aufirst%3DS.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DMoulin%26aufirst%3DP.%26aulast%3DNeddermann%26aufirst%3DD.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26atitle%3DLongitudinal%2520noninvasive%2520magnetic%2520resonance%2520imaging%2520of%2520brain%2520microhemorrhages%2520in%2520BACE%2520inhibitor-treated%2520APP%2520transgenic%2520mice%26jtitle%3DNeurobiol.%2520Aging%26date%3D2016%26volume%3D45%26spage%3D50%26epage%3D60%26doi%3D10.1016%2Fj.neurobiolaging.2016.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasler, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopfert, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joos, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderstichele, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoops, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaeser, S. A.</span></span> <span> </span><span class="NLM_article-title">Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">701</span>– <span class="NLM_lpage">709</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2016.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.jalz.2016.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=27750032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BC2srhtlGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=701-709&author=J.+Schelleauthor=L.+M.+Haslerauthor=J.+C.+Gopfertauthor=T.+O.+Joosauthor=H.+Vandersticheleauthor=E.+Stoopsauthor=E.+M.+Mandelkowauthor=U.+Neumannauthor=D.+R.+Shimshekauthor=M.+Staufenbielauthor=M.+Juckerauthor=S.+A.+Kaeser&title=Prevention+of+tau+increase+in+cerebrospinal+fluid+of+APP+transgenic+mice+suggests+downstream+effect+of+BACE1+inhibition&doi=10.1016%2Fj.jalz.2016.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition</span></div><div class="casAuthors">Schelle Juliane; Hasler Lisa M; Gopfert Jens C; Joos Thomas O; Vanderstichele Hugo; Stoops Erik; Mandelkow Eva-Maria; Neumann Ulf; Shimshek Derya R; Staufenbiel Matthias; Jucker Mathias; Kaeser Stephan A</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">701-709</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  The inhibition of the β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) is a main therapeutic approach for the treatment of Alzheimer's disease (AD).  We previously reported an age-related increase of tau protein in the cerebrospinal fluid (CSF) of amyloid β (Aβ) precursor protein (APP) transgenic mice.  METHODS:  APP transgenic mice were treated with a potent BACE1 inhibitor.  CSF tau and CSF Aβ levels were assessed.  A novel high-sensitivity tau sandwich immunoassay was developed.  RESULTS:  We demonstrate that long-term BACE1 inhibition prevents CSF tau increase both in early-depositing APP transgenic mice and APP transgenic mice with moderate Aβ pathology.  DISCUSSION:  Our results demonstrate that BACE1 inhibition not only reduces Aβ generation but also downstream AD pathophysiology.  The tight correlation between Aβ aggregation in brain and CSF tau levels renders CSF tau a valuable marker to predict the effectiveness of BACE1 inhibitors in current clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcReT51ZB6VkgMuCWE5mhx1RfW6udTcc2eayGTNEUTQ0_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srhtlGiuw%253D%253D&md5=4bd6f56822620e536fc53e4727d1ae70</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2016.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2016.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DHasler%26aufirst%3DL.%2BM.%26aulast%3DGopfert%26aufirst%3DJ.%2BC.%26aulast%3DJoos%26aufirst%3DT.%2BO.%26aulast%3DVanderstichele%26aufirst%3DH.%26aulast%3DStoops%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DKaeser%26aufirst%3DS.%2BA.%26atitle%3DPrevention%2520of%2520tau%2520increase%2520in%2520cerebrospinal%2520fluid%2520of%2520APP%2520transgenic%2520mice%2520suggests%2520downstream%2520effect%2520of%2520BACE1%2520inhibition%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2017%26volume%3D13%26spage%3D701%26epage%3D709%26doi%3D10.1016%2Fj.jalz.2016.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bacioglu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maia, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preische, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaeser, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweighauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eninger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahle, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maetzler, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span> <span> </span><span class="NLM_article-title">Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2016.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.neuron.2016.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=27292537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWlt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2016&pages=56-66&author=M.+Baciogluauthor=L.+F.+Maiaauthor=O.+Preischeauthor=J.+Schelleauthor=A.+Apelauthor=S.+A.+Kaeserauthor=M.+Schweighauserauthor=T.+Eningerauthor=M.+Lambertauthor=A.+Pilottoauthor=D.+R.+Shimshekauthor=U.+Neumannauthor=P.+J.+Kahleauthor=M.+Staufenbielauthor=M.+Neumannauthor=W.+Maetzlerauthor=J.+Kuhleauthor=M.+Jucker&title=Neurofilament+light+chain+in+blood+and+CSF+as+marker+of+disease+progression+in+mouse+models+and+in+neurodegenerative+diseases&doi=10.1016%2Fj.neuron.2016.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases</span></div><div class="casAuthors">Bacioglu, Mehtap; Maia, Luis F.; Preische, Oliver; Schelle, Juliane; Apel, Anja; Kaeser, Stephan A.; Schweighauser, Manuel; Eninger, Timo; Lambert, Marius; Pilotto, Andrea; Shimshek, Derya R.; Neumann, Ulf; Kahle, Philipp J.; Staufenbiel, Matthias; Neumann, Manuela; Maetzler, Walter; Kuhle, Jens; Jucker, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-66</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A majority of current disease-modifying therapeutic approaches for age-related neurodegenerative diseases target their characteristic proteopathic lesions (α-synuclein, Tau, Aβ).  To monitor such treatments, fluid biomarkers reflecting the underlying disease process are crucial.  We found robust increases of neurofilament light chain (NfL) in CSF and blood in murine models of α-synucleinopathies, tauopathy, and β-amyloidosis.  Blood and CSF NfL levels were strongly correlated, and NfL increases coincided with the onset and progression of the corresponding proteopathic lesions in brain.  Exptl. induction of α-synuclein lesions increased CSF and blood NfL levels, while blocking Aβ lesions attenuated the NfL increase.  Consistently, we also found NfL increases in CSF and blood of human α-synucleinopathies, tauopathies, and Alzheimer's disease.  Our results suggest that CSF and particularly blood NfL can serve as a reliable and easily accessible biomarker to monitor disease progression and treatment response in mouse models and potentially in human proteopathic neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf8eoPBMrdhLVg90H21EOLACvtfcHk0lhSwAGJ-p4tHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWlt7k%253D&md5=0a712222ac53afcaf6d1a6b998389978</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DBacioglu%26aufirst%3DM.%26aulast%3DMaia%26aufirst%3DL.%2BF.%26aulast%3DPreische%26aufirst%3DO.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DApel%26aufirst%3DA.%26aulast%3DKaeser%26aufirst%3DS.%2BA.%26aulast%3DSchweighauser%26aufirst%3DM.%26aulast%3DEninger%26aufirst%3DT.%26aulast%3DLambert%26aufirst%3DM.%26aulast%3DPilotto%26aufirst%3DA.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DKahle%26aufirst%3DP.%2BJ.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DNeumann%26aufirst%3DM.%26aulast%3DMaetzler%26aufirst%3DW.%26aulast%3DKuhle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26atitle%3DNeurofilament%2520light%2520chain%2520in%2520blood%2520and%2520CSF%2520as%2520marker%2520of%2520disease%2520progression%2520in%2520mouse%2520models%2520and%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNeuron%26date%3D2016%26volume%3D91%26spage%3D56%26epage%3D66%26doi%3D10.1016%2Fj.neuron.2016.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegenast-Braun, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritschi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaeser, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jährling, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eicke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skodras, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beschorner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermueller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häsler, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfer, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueggler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodt, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span> <span> </span><span class="NLM_article-title">Early Aβ reduction prevents progression of cerebral amyloid angiopathy</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1002/ana.25562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Fana.25562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=31359452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsl2htrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2019&pages=561-571&author=J.+Schelleauthor=B.+M.+Wegenast-Braunauthor=S.+K.+Fritschiauthor=S.+A.+Kaeserauthor=N.+J%C3%A4hrlingauthor=D.+Eickeauthor=A.+Skodrasauthor=N.+Beschornerauthor=U.+Obermuellerauthor=L.+M.+H%C3%A4slerauthor=D.+P.+Wolferauthor=T.+Muegglerauthor=D.+R.+Shimshekauthor=U.+Neumannauthor=H.+U.+Dodtauthor=M.+Staufenbielauthor=M.+Jucker&title=Early+A%CE%B2+reduction+prevents+progression+of+cerebral+amyloid+angiopathy&doi=10.1002%2Fana.25562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Early Aβ reduction prevents progression of cerebral amyloid angiopathy</span></div><div class="casAuthors">Schelle, Juliane; Wegenast-Braun, Bettina M.; Fritschi, Sarah K.; Kaeser, Stephan A.; Jaehrling, Nina; Eicke, Daniel; Skodras, Angelos; Beschorner, Natalie; Obermueller, Ulrike; Haesler, Lisa M.; Wolfer, David P.; Mueggler, Thomas; Shimshek, Derya R.; Neumann, Ulf; Dodt, Hans-Ulrich; Staufenbiel, Matthias; Jucker, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">561-571</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : Clin. trials targeting β-amyloid peptides (Aβ) for Alzheimer disease (AD) failed for arguable reasons that include selecting the wrong stages of AD pathophysiol. or Aβ being the wrong target.  Targeting Aβ to prevent cerebral amyloid angiopathy (CAA) has not been rigorously followed, although the causal role of Aβ for CAA and related hemorrhages is undisputed.  CAA occurs with normal aging and to various degrees in AD, where its impact and treatment is confounded by the presence of parenchymal Aβ deposition.  Methods : APPDutch mice develop CAA in the absence of parenchymal amyloid, mimicking hereditary cerebral hemorrhage with amyloidosis Dutch type (HCHWA-D).  Mice were treated with a β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor.  We used 3-dimensional ultramicroscopy and immunoassays for visualizing CAA and assessing Aβ in cerebrospinal fluid (CSF) and brain.  Results : CAA onset in mice was at 22 to 24 mo, first in frontal leptomeningeal and superficial cortical vessels followed by vessels penetrating the cortical layers.  CSF Aβ increased with aging followed by a decrease of both Aβ40 and Aβ42 upon CAA onset, supporting the idea that combined redn. of CSF Aβ40 and Aβ42 is a specific biomarker for vascular amyloid.  BACE1 inhibitor treatment starting at CAA onset and continuing for 4 mo revealed a 90% Aβ redn. in CSF and largely prevented CAA progression and assocd. pathologies.  Interpretation : This is the first study showing that Aβ redn. at early disease time points largely prevents CAA in the absence of parenchymal amyloid.  Our observation provides a preclin. basis for Aβ-reducing treatments in patients at risk of CAA and in presymptomatic HCHWA-D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfJpMLjOqMAbVg90H21EOLACvtfcHk0lhSwAGJ-p4tHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsl2htrfI&md5=d22a231201c9b8132160be8a1bc0b56a</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fana.25562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.25562%26sid%3Dliteratum%253Aachs%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DWegenast-Braun%26aufirst%3DB.%2BM.%26aulast%3DFritschi%26aufirst%3DS.%2BK.%26aulast%3DKaeser%26aufirst%3DS.%2BA.%26aulast%3DJ%25C3%25A4hrling%26aufirst%3DN.%26aulast%3DEicke%26aufirst%3DD.%26aulast%3DSkodras%26aufirst%3DA.%26aulast%3DBeschorner%26aufirst%3DN.%26aulast%3DObermueller%26aufirst%3DU.%26aulast%3DH%25C3%25A4sler%26aufirst%3DL.%2BM.%26aulast%3DWolfer%26aufirst%3DD.%2BP.%26aulast%3DMueggler%26aufirst%3DT.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DDodt%26aufirst%3DH.%2BU.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJucker%26aufirst%3DM.%26atitle%3DEarly%2520A%25CE%25B2%2520reduction%2520prevents%2520progression%2520of%2520cerebral%2520amyloid%2520angiopathy%26jtitle%3DAnn.%2520Neurol.%26date%3D2019%26volume%3D86%26spage%3D561%26epage%3D571%26doi%3D10.1002%2Fana.25562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esterházy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutzer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechsteiner, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobeli, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prummer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieske, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marselli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr-Conte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebersold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliorini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, M.</span></span> <span> </span><span class="NLM_article-title">Bace2 is a beta cell-enriched protease that regulates pancreatic beta cell function and mass</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2011.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.cmet.2011.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=21907142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=365-377&author=D.+Esterh%C3%A1zyauthor=I.+Stutzerauthor=H.+Wangauthor=M.+P.+Rechsteinerauthor=J.+Beauchampauthor=H.+Dobeliauthor=H.+Hilpertauthor=H.+Matileauthor=M.+Prummerauthor=A.+Schmidtauthor=N.+Lieskeauthor=B.+Boehmauthor=L.+Marselliauthor=D.+Boscoauthor=J.+Kerr-Conteauthor=R.+Aebersoldauthor=G.+A.+Spinasauthor=H.+Mochauthor=C.+Miglioriniauthor=M.+Stoffel&title=Bace2+is+a+beta+cell-enriched+protease+that+regulates+pancreatic+beta+cell+function+and+mass&doi=10.1016%2Fj.cmet.2011.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass</span></div><div class="casAuthors">Esterhazy, Daria; Stuetzer, Ina; Wang, Haiyan; Rechsteiner, Markus P.; Beauchamp, Jeremy; Doebeli, Heinz; Hilpert, Hans; Matile, Hugues; Prummer, Michael; Schmidt, Alexander; Lieske, Nora; Boehm, Bernhard; Marselli, Lorella; Bosco, Domenico; Kerr-Conte, Julie; Aebersold, Ruedi; Spinas, Giatgen Andreia; Moch, Holger; Migliorini, Cristiano; Stoffel, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Decreased β cell mass and function are hallmarks of type 2 diabetes.  Here we identified, through a siRNA screen, beta site amyloid precursor protein cleaving enzyme 2 (Bace2) as the sheddase of the proproliferative plasma membrane protein Tmem27 in murine and human β cells.  Mice with functionally inactive Bace2 and insulin-resistant mice treated with a newly identified Bace2 inhibitor both display augmented β cell mass and improved control of glucose homeostasis due to increased insulin levels.  These results implicate Bace2 in the control of β cell maintenance and provide a rational strategy to inhibit this protease for the expansion of functional pancreatic β cell mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNmw-BllVxx7Vg90H21EOLACvtfcHk0lhSwAGJ-p4tHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM&md5=489e20b2d997eb0cbaff195819e35d64</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DEsterh%25C3%25A1zy%26aufirst%3DD.%26aulast%3DStutzer%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRechsteiner%26aufirst%3DM.%2BP.%26aulast%3DBeauchamp%26aufirst%3DJ.%26aulast%3DDobeli%26aufirst%3DH.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DPrummer%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DLieske%26aufirst%3DN.%26aulast%3DBoehm%26aufirst%3DB.%26aulast%3DMarselli%26aufirst%3DL.%26aulast%3DBosco%26aufirst%3DD.%26aulast%3DKerr-Conte%26aufirst%3DJ.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSpinas%26aufirst%3DG.%2BA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DMigliorini%26aufirst%3DC.%26aulast%3DStoffel%26aufirst%3DM.%26atitle%3DBace2%2520is%2520a%2520beta%2520cell-enriched%2520protease%2520that%2520regulates%2520pancreatic%2520beta%2520cell%2520function%2520and%2520mass%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D14%26spage%3D365%26epage%3D377%26doi%3D10.1016%2Fj.cmet.2011.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matafora, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farris, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restuccia, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonoldi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachi, A.</span></span> <span> </span><span class="NLM_article-title">Amyloid aggregates accumulate in melanoma metastasis modulating YAP activity</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>, <span class="NLM_elocation-id">e50446</span> <span class="refDoi"> DOI: 10.15252/embr.202050446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.15252%2Fembr.202050446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=32749065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFWiurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&author=V.+Mataforaauthor=F.+Farrisauthor=U.+Restucciaauthor=S.+Tamburriauthor=G.+Martanoauthor=C.+Bernardelliauthor=A.+Sofiaauthor=F.+Pisatiauthor=F.+Casagrandeauthor=L.+Lazzariauthor=S.+Marsoniauthor=E.+Bonoldiauthor=A.+Bachi&title=Amyloid+aggregates+accumulate+in+melanoma+metastasis+modulating+YAP+activity&doi=10.15252%2Fembr.202050446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid aggregates accumulate in melanoma metastasis modulating YAP activity</span></div><div class="casAuthors">Matafora, Vittoria; Farris, Francesco; Restuccia, Umberto; Tamburri, Simone; Martano, Giuseppe; Bernardelli, Clara; Sofia, Andrea; Pisati, Federica; Casagrande, Francesca; Lazzari, Luca; Marsoni, Silvia; Bonoldi, Emanuela; Bachi, Angela</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e50446</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Melanoma progression is generally assocd. with increased transcriptional activity mediated by the Yes-assocd. protein (YAP).  Mech. signals from the extracellular matrix are sensed by YAP, which then activates the expression of proliferative genes, promoting melanoma progression and drug resistance.  Which extracellular signals induce mechanotransduction, and how this is mediated, is not completely understood.  Here, using secretome analyses, we reveal the extracellular accumulation of amyloidogenic proteins, i.e. premelanosome protein (PMEL), in metastatic melanoma, together with proteins that assist amyloid maturation into fibrils.  We also confirm the accumulation of amyloid-like aggregates, similar to those detected in Alzheimer disease, in metastatic cell lines, as well as in human melanoma biopsies.  Mechanistically, beta-secretase 2 (BACE2) regulates the maturation of these aggregates, which in turn induce YAP activity.  We also demonstrate that recombinant PMEL fibrils are sufficient to induce mechanotransduction, triggering YAP signaling.  Finally, we demonstrate that BACE inhibition affects cell proliferation and increases drug sensitivity, highlighting the importance of amyloids for melanoma survival, and the use of beta-secretase inhibitors as potential therapeutic approach for metastatic melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL7-L9ZX0oZLVg90H21EOLACvtfcHk0lj647BTnMXIxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFWiurzN&md5=373c8a8cf3a71e67edeec495049b8e9d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.15252%2Fembr.202050446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembr.202050446%26sid%3Dliteratum%253Aachs%26aulast%3DMatafora%26aufirst%3DV.%26aulast%3DFarris%26aufirst%3DF.%26aulast%3DRestuccia%26aufirst%3DU.%26aulast%3DTamburri%26aufirst%3DS.%26aulast%3DMartano%26aufirst%3DG.%26aulast%3DBernardelli%26aufirst%3DC.%26aulast%3DSofia%26aufirst%3DA.%26aulast%3DPisati%26aufirst%3DF.%26aulast%3DCasagrande%26aufirst%3DF.%26aulast%3DLazzari%26aufirst%3DL.%26aulast%3DMarsoni%26aufirst%3DS.%26aulast%3DBonoldi%26aufirst%3DE.%26aulast%3DBachi%26aufirst%3DA.%26atitle%3DAmyloid%2520aggregates%2520accumulate%2520in%2520melanoma%2520metastasis%2520modulating%2520YAP%2520activity%26jtitle%3DEMBO%2520Rep.%26date%3D2020%26volume%3D21%26doi%3D10.15252%2Fembr.202050446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ufer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouzade-Dominguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huledal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lüönd, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avrameas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezous, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vormfelde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Lopez, C.</span></span> <span> </span><span class="NLM_article-title">The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer’s disease</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e9316</span> <span class="refDoi"> DOI: 10.15252/emmm.201809316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.15252%2Femmm.201809316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=30224383" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=U.+Neumannauthor=M.+Uferauthor=L.+H.+Jacobsonauthor=M.+L.+Rouzade-Dominguezauthor=G.+Huledalauthor=C.+Kollyauthor=R.+M.+L%C3%BC%C3%B6ndauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=K.+Hurthauthor=H.+Rueegerauthor=M.+Tintelnot-Blomleyauthor=M.+Staufenbielauthor=D.+R.+Shimshekauthor=L.+Perrotauthor=W.+Frieauffauthor=V.+Dubostauthor=H.+Schillerauthor=B.+Voggauthor=K.+Beltzauthor=A.+Avrameasauthor=S.+Kretzauthor=N.+Pezousauthor=J.+M.+Rondeauauthor=N.+Beckmannauthor=A.+Hartmannauthor=S.+Vormfeldeauthor=O.+J.+Davidauthor=B.+Galliauthor=R.+Ramosauthor=A.+Grafauthor=C.+Lopez+Lopez&title=The+BACE-1+inhibitor+CNP520+for+prevention+trials+in+Alzheimer%E2%80%99s+disease&doi=10.15252%2Femmm.201809316"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.15252%2Femmm.201809316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201809316%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DUfer%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DRouzade-Dominguez%26aufirst%3DM.%2BL.%26aulast%3DHuledal%26aufirst%3DG.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DL%25C3%25BC%25C3%25B6nd%26aufirst%3DR.%2BM.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DHurth%26aufirst%3DK.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DDubost%26aufirst%3DV.%26aulast%3DSchiller%26aufirst%3DH.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DAvrameas%26aufirst%3DA.%26aulast%3DKretz%26aufirst%3DS.%26aulast%3DPezous%26aufirst%3DN.%26aulast%3DRondeau%26aufirst%3DJ.%2BM.%26aulast%3DBeckmann%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DVormfelde%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DO.%2BJ.%26aulast%3DGalli%26aufirst%3DB.%26aulast%3DRamos%26aufirst%3DR.%26aulast%3DGraf%26aufirst%3DA.%26aulast%3DLopez%2BLopez%26aufirst%3DC.%26atitle%3DThe%2520BACE-1%2520inhibitor%2520CNP520%2520for%2520prevention%2520trials%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2018%26volume%3D10%26doi%3D10.15252%2Femmm.201809316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinkovic, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorostkar, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rammes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunnersen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herms, J.</span></span> <span> </span><span class="NLM_article-title">Beta-site amyloid precursor protein cleaving enzyme 1 inhibition impairs synaptic plasticity via seizure protein 6</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2016.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.biopsych.2016.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=28129943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Wmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2018&pages=428-437&author=K.+Zhuauthor=X.+Xiangauthor=S.+Filserauthor=P.+Marinkovicauthor=M.+M.+Dorostkarauthor=S.+Cruxauthor=U.+Neumannauthor=D.+R.+Shimshekauthor=G.+Rammesauthor=C.+Haassauthor=S.+F.+Lichtenthalerauthor=J.+M.+Gunnersenauthor=J.+Herms&title=Beta-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibition+impairs+synaptic+plasticity+via+seizure+protein+6&doi=10.1016%2Fj.biopsych.2016.12.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6</span></div><div class="casAuthors">Zhu, Kaichuan; Xiang, Xianyuan; Filser, Severin; Marinkovic, Petar; Dorostkar, Mario M.; Crux, Sophie; Neumann, Ulf; Shimshek, Derya R.; Rammes, Gerhard; Haass, Christian; Lichtenthaler, Stefan F.; Gunnersen, Jenny M.; Herms, Jochen</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">428-437</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) is a promising drug target for the treatment of Alzheimer's disease.  Prolonged BACE1 inhibition interferes with structural and functional synaptic plasticity in mice, most likely by altering the metab. of BACE1 substrates.  Seizure protein 6 (SEZ6) is predominantly cleaved by BACE1, and Sez6 knockout mice share some phenotypes with BACE1 inhibitor-treated mice.  We investigated whether SEZ6 is involved in BACE1 inhibition-induced structural and functional synaptic alterations.  The function of NB-360, a novel blood-brain barrier penetrant and orally available BACE1 inhibitor, was verified by immunoblotting.  In vivo microscopy was applied to monitor the impact of long-term pharmacol. BACE1 inhibition on dendritic spines in the cerebral cortex of constitutive and conditional Sez6 knockout mice.  Finally, synaptic functions were characterized using electrophysiol. field recordings in hippocampal slices.  BACE1 enzymic activity was strongly suppressed by NB-360.  Prolonged NB-360 treatment caused a reversible spine d. redn. in wild-type mice, but it did not affect Sez6-/- mice.  Knocking out Sez6 in a small subset of mature neurons also prevented the structural postsynaptic changes induced by BACE1 inhibition.  Hippocampal long-term potentiation was decreased in both chronic BACE1 inhibitor-treated wild-type mice and vehicle-treated Sez6-/- mice.  However, chronic NB-360 treatment did not alter long-term potentiation in CA1 neurons of Sez6-/- mice.  Our results suggest that SEZ6 plays an important role in maintaining normal dendritic spine dynamics.  Furthermore, SEZ6 is involved in BACE1 inhibition-induced structural and functional synaptic alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbwoQtwevkW7Vg90H21EOLACvtfcHk0liivNzItwSMnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Wmur0%253D&md5=ae10070b21bd6bc8e425d5cdadcf24ed</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2016.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2016.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DXiang%26aufirst%3DX.%26aulast%3DFilser%26aufirst%3DS.%26aulast%3DMarinkovic%26aufirst%3DP.%26aulast%3DDorostkar%26aufirst%3DM.%2BM.%26aulast%3DCrux%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DRammes%26aufirst%3DG.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DGunnersen%26aufirst%3DJ.%2BM.%26aulast%3DHerms%26aufirst%3DJ.%26atitle%3DBeta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibition%2520impairs%2520synaptic%2520plasticity%2520via%2520seizure%2520protein%25206%26jtitle%3DBiol.%2520Psychiatry%26date%3D2018%26volume%3D83%26spage%3D428%26epage%3D437%26doi%3D10.1016%2Fj.biopsych.2016.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span> <span> </span><span class="NLM_article-title">The β-secretase (BACE) inhibitor NB-360 in preclinical models: from amyloid-β reduction to downstream disease-relevant effects</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">3435</span>– <span class="NLM_lpage">3446</span>, <span class="refDoi"> DOI: 10.1111/bph.14582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1111%2Fbph.14582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=30657591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksVKgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=3435-3446&author=U.+Neumannauthor=R.+Machauerauthor=D.+R.+Shimshek&title=The+%CE%B2-secretase+%28BACE%29+inhibitor+NB-360+in+preclinical+models%3A+from+amyloid-%CE%B2+reduction+to+downstream+disease-relevant+effects&doi=10.1111%2Fbph.14582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">The beta-secretase (BACE) inhibitor NB-360 in preclinical models: From amyloid-beta reduction to downstream disease-relevant effects</span></div><div class="casAuthors">Neumann, Ulf; Machauer, Rainer; Shimshek, Derya R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3435-3446</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Inhibition of beta-secretase 1 (BACE-1; also known as beta-site amyloid precursor protein-cleaving enzyme-1) is a current approach to fight the amyloid-beta deposition in the brains of patients with Alzheimer's disease, and a no. of BACE-1 inhibitors are being tested in clin. trials.  The BACE-1 inhibitor NB-360, although not a clin. compd., turned out to be a valuable pharmacol. tool to investigate the effects of BACE-1 inhibition on the deposition of different Abeta species in amyloid precursor protein (APP) transgenic mice.  Furthermore, chronic animal studies with NB-360 revealed relationships between BACE-1 inhibition, Abeta deposition, and Abeta-related downstream effects on neuroinflammation, neuronal function, and markers of neurodegeneration.  NB-360 effects on the processing of physiol. BACE-1 substrates as well as on nonenzymic BACE-1 functions have been investigated, complementing studies in BACE-1 knockout mice.  Because NB-360 is also an inhibitor for BACE-2, nonclin. studies in adult animals revealed physiol. effects of BACE-2 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt8UxHHDJ5W7Vg90H21EOLACvtfcHk0liivNzItwSMnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksVKgtbc%253D&md5=c4eb569d90d8627fafbffd59a0577b88</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1111%2Fbph.14582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14582%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26atitle%3DThe%2520%25CE%25B2-secretase%2520%2528BACE%2529%2520inhibitor%2520NB-360%2520in%2520preclinical%2520models%253A%2520from%2520amyloid-%25CE%25B2%2520reduction%2520to%2520downstream%2520disease-relevant%2520effects%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D176%26spage%3D3435%26epage%3D3446%26doi%3D10.1111%2Fbph.14582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wohnsland, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, B.</span></span> <span> </span><span class="NLM_article-title">High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">930</span>, <span class="refDoi"> DOI: 10.1021/jm001020e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm001020e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFSltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=923-930&author=F.+Wohnslandauthor=B.+Faller&title=High-throughput+permeability+pH+profile+and+high-throughput+alkane%2Fwater+log+P+with+artificial+membranes&doi=10.1021%2Fjm001020e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Permeability pH Profile and High-Throughput Alkane/Water log P with Artificial Membranes</span></div><div class="casAuthors">Wohnsland, Frank; Faller, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">923-930</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This study reports on a novel, high-throughput assay, designed to predict passive, transcellular permeability in early drug discovery.  The assay is carried out in 96-well microtiterplates and measures the ability of compds. to diffuse from a donor to an acceptor compartment which are sepd. by a 9-10 μm hexadecane liq. layer.  A set of 32 well-characterized, chem. diverse drugs was used to validate the method.  The permeability values derived from the flux factors between donor and acceptor compartments show a good correlation with gastrointestinal absorption in humans.  For comparison, correlations based on exptl. or calcd. octanol/water distribution coeffs. (log Do/w,6.8) were significantly lower.  In addn., this simple and robust assay allows detn. of pH permeability profiles, crit. information to predict gastrointestinal absorption of ionizable drugs and difficult to obtain from cell culture expts.  Correction for the unstirred water layer effect allows to differentiate between effective and intrinsic membrane permeability and opens up the dynamic range of the method.  In addn., alkane/water partition coeffs. can be derived from intrinsic membrane permeabilities, making this assay the first high-throughput method able to measure alkane/water log P in the microtiterplate format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXoYADWFOUn7Vg90H21EOLACvtfcHk0liivNzItwSMnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFSltA%253D%253D&md5=de19e881e03d62d48a8acfea729790b4</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm001020e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001020e%26sid%3Dliteratum%253Aachs%26aulast%3DWohnsland%26aufirst%3DF.%26aulast%3DFaller%26aufirst%3DB.%26atitle%3DHigh-throughput%2520permeability%2520pH%2520profile%2520and%2520high-throughput%2520alkane%252Fwater%2520log%2520P%2520with%2520artificial%2520membranes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D923%26epage%3D930%26doi%3D10.1021%2Fjm001020e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanessian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayrakdarian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moitessier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roggo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermeier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paganetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betschart, C.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5175</span>– <span class="NLM_lpage">5190</span>, <span class="refDoi"> DOI: 10.1021/jm050142+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050142%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtV2ltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5175-5190&author=S.+Hanessianauthor=H.+Yunauthor=Y.+Houauthor=G.+Yangauthor=M.+Bayrakdarianauthor=E.+Therrienauthor=N.+Moitessierauthor=S.+Roggoauthor=S.+Veenstraauthor=M.+Tintelnot-Blomleyauthor=J.+M.+Rondeauauthor=C.+Ostermeierauthor=A.+Straussauthor=P.+Ramageauthor=P.+Paganettiauthor=U.+Neumannauthor=C.+Betschart&title=Structure-based+design%2C+synthesis%2C+and+memapsin+2+%28BACE%29+inhibitory+activity+of+carbocyclic+and+heterocyclic+peptidomimetics&doi=10.1021%2Fjm050142%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design, Synthesis, and Memapsin 2 (BACE) Inhibitory Activity of Carbocyclic and Heterocyclic Peptidomimetics</span></div><div class="casAuthors">Hanessian, Stephen; Yun, Hongying; Hou, Yihua; Yang, Gaoqiang; Bayrakdarian, Malken; Therrien, Eric; Moitessier, Nicolas; Roggo, Silvio; Veenstra, Siem; Tintelnot-Blomley, Marina; Rondeau, Jean-Michel; Ostermeier, Christian; Strauss, Andre; Ramage, Paul; Paganetti, Paolo; Neumann, Ulf; Betschart, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5175-5190</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. modeling based on the x-ray crystal structure of the Tang-Ghosh heptapeptide inhibitor I (OM99-2) of BACE led to the design and synthesis of a series of constrained P1' analogs.  A cyclopentane ring was incorporated in I spanning the P1' Ala Me group and the adjacent methylene carbon atom of the chain.  Progressive truncation at the P2'-P4' sites led to a potent truncated analog II with good selectivity over cathepsin D.  Using the same backbone replacement concept, a series of cyclopentane, cyclopentanone, THF, pyrrolidine, and pyrrolidinone analogs were synthesized with considerable variation at the P and P' sites.  For example, the cyclopentanone and 2-pyrrolidinone analogs III and IV, resp., showed low nM BACE inhibition.  X-ray cocrystal structures of II and III revealed excellent convergence with the original inhibitor I structure while providing new insights into other interactions which could be exploited for future modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv6Z9WHgqtN7Vg90H21EOLACvtfcHk0liivNzItwSMnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtV2ltb0%253D&md5=64c7ab4dd70d22e01f26900d325520f4</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm050142%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050142%252B%26sid%3Dliteratum%253Aachs%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DYun%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DBayrakdarian%26aufirst%3DM.%26aulast%3DTherrien%26aufirst%3DE.%26aulast%3DMoitessier%26aufirst%3DN.%26aulast%3DRoggo%26aufirst%3DS.%26aulast%3DVeenstra%26aufirst%3DS.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DRondeau%26aufirst%3DJ.%2BM.%26aulast%3DOstermeier%26aufirst%3DC.%26aulast%3DStrauss%26aufirst%3DA.%26aulast%3DRamage%26aufirst%3DP.%26aulast%3DPaganetti%26aufirst%3DP.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DBetschart%26aufirst%3DC.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520memapsin%25202%2520%2528BACE%2529%2520inhibitory%2520activity%2520of%2520carbocyclic%2520and%2520heterocyclic%2520peptidomimetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5175%26epage%3D5190%26doi%3D10.1021%2Fjm050142%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">795</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1107/S0021889893005588</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1107%2FS0021889893005588" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADyaK2cXptFeltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1993&pages=795-800&author=W.+Kabsch&title=Automatic+processing+of+rotation+diffraction+data+from+crystals+of+initially+unknown+symmetry+and+cell+constants&doi=10.1107%2FS0021889893005588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">795-800</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    </div><div class="casAbstract">An algorithm was developed for the automatic interpretation of a given set of obsd. reciprocal-lattice points.  It exts. a reduced cell and assigns indexes to each reflection by a graph-theor. implementation of the local indexing method.  All possible symmetries of the obsd. lattice compatible with the metric of the reduced cell are recognized and reported, together with the unit-cell consts. and the linear index transformation relating the conventional to the reduced cell.  This algorithm was incorporated into the program XDS (K., 1988), which is now able to process single-crystal area-detector data without prior knowledge of the symmetry and the unit-cell consts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD1lV8_7cDv7Vg90H21EOLACvtfcHk0liMVfetakC5Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXptFeltw%253D%253D&md5=2b703225206ce99af0d7e38acf6d75b3</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1107%2FS0021889893005588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889893005588%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DAutomatic%2520processing%2520of%2520rotation%2520diffraction%2520data%2520from%2520crystals%2520of%2520initially%2520unknown%2520symmetry%2520and%2520cell%2520constants%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1993%26volume%3D26%26spage%3D795%26epage%3D800%26doi%3D10.1107%2FS0021889893005588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreyer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, K. U.</span></span> <span> </span><span class="NLM_article-title">APRV - a program for automated data processing, refinement and visualization</span>. <i>Acta Crystallogr. D Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1679</span>– <span class="NLM_lpage">1682</span>, <span class="refDoi"> DOI: 10.1107/S0907444904015215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1107%2FS0907444904015215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=15333953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvF2jtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1679-1682&author=M.+Kroemerauthor=M.+K.+Dreyerauthor=K.+U.+Wendt&title=APRV+-+a+program+for+automated+data+processing%2C+refinement+and+visualization&doi=10.1107%2FS0907444904015215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">APRV - a program for automated data processing, refinement and visualization</span></div><div class="casAuthors">Kroemer, Markus; Dreyer, Matthias K.; Wendt, K. Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1679-1682</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">APRV (Automatic Processing, Refinement and Visualization) is a new program that enables high-throughput batch processing of crystallog. data.  The program combines processing of raw diffraction images, initial structure refinement and visual inspection of resulting electron d. into a seamless one-step procedure, during which all relevant parameters are refined automatically.  It is controlled by a user-friendly graphical interface, facilitating operation by non-experts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDNt2Xkbqo2rVg90H21EOLACvtfcHk0liMVfetakC5Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvF2jtbs%253D&md5=11d9bb311938b7b53a32e5fba6d56724</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1107%2FS0907444904015215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904015215%26sid%3Dliteratum%253Aachs%26aulast%3DKroemer%26aufirst%3DM.%26aulast%3DDreyer%26aufirst%3DM.%2BK.%26aulast%3DWendt%26aufirst%3DK.%2BU.%26atitle%3DAPRV%2520-%2520a%2520program%2520for%2520automated%2520data%2520processing%252C%2520refinement%2520and%2520visualization%26jtitle%3DActa%2520Crystallogr.%2520D%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1679%26epage%3D1682%26doi%3D10.1107%2FS0907444904015215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brünger, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clore, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLano, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gros, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuszewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilges, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, G. L.</span></span> <span> </span><span class="NLM_article-title">Crystallography & NMR system: A new software suite for macromolecular structure determination</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">921</span>, <span class="refDoi"> DOI: 10.1107/S0907444998003254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1107%2FS0907444998003254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=9757107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADyaK1cvjslKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=905-921&author=A.+T.+Br%C3%BCngerauthor=P.+D.+Adamsauthor=G.+M.+Cloreauthor=W.+L.+DeLanoauthor=P.+Grosauthor=R.+W.+Grosse-Kunstleveauthor=J.+S.+Jiangauthor=J.+Kuszewskiauthor=M.+Nilgesauthor=N.+S.+Pannuauthor=R.+J.+Readauthor=L.+M.+Riceauthor=T.+Simonsonauthor=G.+L.+Warren&title=Crystallography+%26+NMR+system%3A+A+new+software+suite+for+macromolecular+structure+determination&doi=10.1107%2FS0907444998003254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallography & NMR system: A new software suite for macromolecular structure determination</span></div><div class="casAuthors">Brunger A T; Adams P D; Clore G M; DeLano W L; Gros P; Grosse-Kunstleve R W; Jiang J S; Kuszewski J; Nilges M; Pannu N S; Read R J; Rice L M; Simonson T; Warren G L</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">905-21</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">A new software suite, called Crystallography & NMR System (CNS), has been developed for macromolecular structure determination by X-ray crystallography or solution nuclear magnetic resonance (NMR) spectroscopy.  In contrast to existing structure-determination programs, the architecture of CNS is highly flexible, allowing for extension to other structure-determination methods, such as electron microscopy and solid-state NMR spectroscopy.  CNS has a hierarchical structure: a high-level hypertext markup language (HTML) user interface, task-oriented user input files, module files, a symbolic structure-determination language (CNS language), and low-level source code.  Each layer is accessible to the user.  The novice user may just use the HTML interface, while the more advanced user may use any of the other layers.  The source code will be distributed, thus source-code modification is possible.  The CNS language is sufficiently powerful and flexible that many new algorithms can be easily implemented in the CNS language without changes to the source code.  The CNS language allows the user to perform operations on data structures, such as structure factors, electron-density maps, and atomic properties.  The power of the CNS language has been demonstrated by the implementation of a comprehensive set of crystallographic procedures for phasing, density modification and refinement.  User-friendly task-oriented input files are available for nearly all aspects of macromolecular structure determination by X-ray crystallography and solution NMR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAeLCFcGBdlx0LsK7uFuY7fW6udTcc2eZjbpPZYilwG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvjslKhsw%253D%253D&md5=37afee1b07ac44d3f3730a39061b4e79</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1107%2FS0907444998003254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444998003254%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCnger%26aufirst%3DA.%2BT.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DClore%26aufirst%3DG.%2BM.%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26aulast%3DGros%26aufirst%3DP.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DJiang%26aufirst%3DJ.%2BS.%26aulast%3DKuszewski%26aufirst%3DJ.%26aulast%3DNilges%26aufirst%3DM.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRice%26aufirst%3DL.%2BM.%26aulast%3DSimonson%26aufirst%3DT.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26atitle%3DCrystallography%2520%2526%2520NMR%2520system%253A%2520A%2520new%2520software%2520suite%2520for%2520macromolecular%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1998%26volume%3D54%26spage%3D905%26epage%3D921%26doi%3D10.1107%2FS0907444998003254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr. D Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lhcx8PRf3Bx7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%2520D%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0039.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Co-crystal structure of 2-amino-1,3-thiazine inhibitor <b>3</b> bound to human BACE1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1E">7B1E</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Binding mode of 2-amino-1,3-thiazine <b>3</b> and (B) proposed binding mode of 5-amino-1,4-oxazine inhibitors <b>4</b> and compound series <b>A</b>. Not shielded areas (in blue) decrease with increasing bulk at position 6.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Retrosynthetic analysis of <b>4</b>, <i>rac</i>-<b>20</b>, and compound series <b>A</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of <b>4</b> and <i>rac-</i><b>20</b>—Referring to Retrosynthetic Pathway A<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaBH<sub>4</sub>, BF<sub>3</sub>-Et<sub>2</sub>O, tetrahydrofuran (THF), 0–25 °C, 81/84%; (b) chloroacetyl chloride, Na<sub>2</sub>CO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>-H<sub>2</sub>O, 0–25 °C, 95/38%; (c) <i>t</i>-BuOK, <i>t-</i>BuOH, reflux, 32/52%; (d) Lawesson’s reagent, THF, reflux, 78/59%; (e) <i>t-</i>BuOOH, 7 N NH<sub>3</sub> in MeOH, NH<sub>3</sub> conc., THF, 25 °C, 50/90%; (f) (Boc)<sub>2</sub>O, <i>N,N</i>-diisopropylethylamine, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 93/49%; (g) NaN<sub>3</sub>, CuI, (1<i>R</i>,2<i>R</i>)-<i>N</i>1,<i>N</i>2-dimethylcyclohexane-1,2-diamine, Na-ascorbate, EtOH-H<sub>2</sub>O, 90 °C, 51/54%; (h) H<sub>2</sub>, Lindlar catalyst, EtOAc, 25 °C, 99/94%; (i) Chiralpak IA 250 mm × 4.6 mm, hexane/EtOH/MeOH 80:10:10, 1.5 mL/min, 39/41%; (j) <b>17</b>, EDC, HOAt, <i>N,N</i>-diisopropylethylamine, <i>N</i>,<i>N</i>-dimethylformamide (DMF), 25 °C, 93/79%; (k) 4 N HCl in dioxane, 25–40 °C, 99/65%.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Racemic <b>38a–e</b>—Referring to Retrosynthetic Pathway C<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TMSCH<sub>2</sub>N<sub>2</sub>, NEt<sub>3</sub>, THF, 0.25 °C, 73/88%; (b) <b>23</b>, Rh<sub>2</sub>(TFA)<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 35/34%; (c) MeLi, AlMe<sub>3</sub>, toluene, −78 °C, 69/65%; (d) TMSN<sub>3</sub>, BF<sub>3</sub>-Et<sub>2</sub>O, toluene, 35 °C, 78/63%; (e) In, 4 N HCl-THF, 25 °C, 76/71%; (f) AlMe<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 40 °C, (47/50%)/(38/44%); (g) P<sub>2</sub>S<sub>5</sub>, hexamethyldisiloxane, toluene, 100 °C, 95/85%; (h) <i>t-</i>BuOOH, NH<sub>3</sub>, THF, 0–25 °C; (i) (Boc)<sub>2</sub>O, NEt<sub>3</sub>, acetonitrile, 25 °C, two steps 56%/57%; (j) NaN<sub>3</sub>, CuI, (1<i>R</i>,2<i>R</i>)-<i>N</i>1,<i>N</i>2-dimethylcyclohexane-1,2-diamine, Na-ascorbate, EtOH-H<sub>2</sub>O, 70 °C, 82%/-; (k) H<sub>2</sub>, 10% Pd-C, EtOH, 25 °C, 61%/two steps 51%; (l) <b>34</b>, <b>35</b>, or <b>36</b>, EDC, HOAt, <i>N,N</i>-diisopropylethylamine, DMF, 25 °C; (m) 4 N HCl in dioxane, 40 °C, two steps 33–85%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of <b>54—</b>Referring to Retrosynthetic Pathway D<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, 2,3-dibromoprop-1-ene, DMF, 25 °C, 81%; (b) (2-fluorophenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, CsF, DMF-H<sub>2</sub>O 10:1, 65 °C, 64%; (c) 7 N NH<sub>3</sub> in MeOH, 55 °C, 98%; (d) trifluoroacetic anhydride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 5–25 °C, 93%; (e) 7 N NH<sub>3</sub> in MeOH, <i>N</i>-acetyl-<span class="smallcaps smallerCapital">l</span>-cysteine, 80 °C, 96%; (f) I<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, CHCl<sub>3</sub>, 100 °C, 44%; (g) H<sub>2</sub>, 10 Pd-C, NaOAc, MeOH, 25 °C, 97%; (h) KNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 0 °C, 39/46%; (i) CHIRALPAK AD-H 5, CO<sub>2</sub>-<i>i</i>-PrOH 90:10, 48/48%; (j) (Boc)<sub>2</sub>O, NEt<sub>3</sub>, acetonitrile, 25 °C, 90%; (k) H<sub>2</sub>, 5% Pd-C, <i>i</i>-PrOH-THF 2:1, 50 °C, 92%; (l) EDC, HOAt, <i>N,N</i>-diisopropylethylamine, DMF, 25 °C, 81%; (m) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 83%.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of <b>54</b> and <b>64a–j</b>—Referring to Retrosynthetic Pathway E<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) BH<sub>3</sub> Me<sub>2</sub>S, THF, 65 °C, 99%; (b) 4-nitrobenzene-1-sulfonyl chloride, KHCO<sub>3</sub>, and Cs<sub>2</sub>CO<sub>3</sub>, acetonitrile, 80 °C, 50%; (c) 4-nitrobenzene-1-sulfonyl chloride, NMM, acetonitrile, 0–25 °C, 88%; (d) (i) mesyl chloride, 4-methylmorpholine, acetonitrile, 0–5 °C, (ii) NMM, acetonitrile, 30 °C, 84%; (e) mesyl chloride, NMM, acetonitrile, 0–5 °C, 95%; (f) DBU, CH<sub>2</sub>Cl<sub>2</sub>, 5–30 °C, 73%; (g) (<i>R</i>)-ethyl 3,3,3-trifluoro-2-hydroxy-2-methylpropanoate, <i>t-</i>BuOK, DMF/THF, 35 °C, 87%; (h) (<i>R</i>)-ethyl 3,3,3-trifluoro-2-hydroxy-2-methylpropanoate, 1 M <i>t-</i>BuOK in THF, DMF, 20–35 °C, 72%; (i) 7 N NH<sub>3</sub> in MeOH, 50 °C, 99%; (j) trifluoroacetic anhydride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0–5 °C, 95%; (k) K<sub>2</sub>CO<sub>3</sub>, <i>N</i>-acetyl-<span class="smallcaps smallerCapital">l</span>-cysteine, EtOH, 80 °C, 92%; (l) KNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 0–5 °C, 81%; (m) (Boc)<sub>2</sub>O, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 90%; (n) H<sub>2</sub>, 5% Pd-C, dioxane, 45 °C, 92%; (o) <b>63a–j</b>, EDC, HOAt, <i>N,N</i>-diisopropylethylamine (DIPEA), DMF, 5–25 °C, 16–92%; (p) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 62–95%.</p></p></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Superimposition of cocrystal structures of compounds bound to BACE1. (A) 5-Amino-1,4-oxazine inhibitor <b>4</b> (blue) with 2-amino-1,3-thiazine inhibitor <b>3</b> (white); PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FGY">6FGY</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1E">7B1E</a>. (B) <b>4</b> (blue) with <b>38a</b> (white); PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FGY">6FGY</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1P">7B1P</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/medium/jm0c02143_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Co-crystal structure of <b>54</b> bound to human BACE1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1Q">7B1Q</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02143/20210415/images/large/jm0c02143_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02143&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 80 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ising, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span> <span> </span><span class="NLM_article-title">Current thinking on the mechanistic basis of Alzheimer’s and implications for drug development</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1002/cpt.200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Fcpt.200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=26250900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BC287gsFaqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2015&pages=469-471&author=C.+Isingauthor=M.+Stanleyauthor=D.+M.+Holtzman&title=Current+thinking+on+the+mechanistic+basis+of+Alzheimer%E2%80%99s+and+implications+for+drug+development&doi=10.1002%2Fcpt.200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current thinking on the mechanistic basis of Alzheimer's and implications for drug development</span></div><div class="casAuthors">Ising C; Stanley M; Holtzman D M</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">469-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer disease (AD) is the most common cause of dementia and is characterized by the aggregation and accumulation of two proteins in the brain, amyloid-β (Aβ) and tau.  Aβ and tau begin to buildup 15-20 years before the clinical onset of AD dementia.  Increasing evidence suggests that preventing or decreasing the amount of aggregated forms of both Aβ and tau in the brain can serve as potential disease-modifying treatments for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTdchZ1NHs08nwOGIfWJ7-GfW6udTcc2eYU10ApTJLtA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287gsFaqsw%253D%253D&md5=96ec752d1a40171c8b2512a3ca379fc4</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fcpt.200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt.200%26sid%3Dliteratum%253Aachs%26aulast%3DIsing%26aufirst%3DC.%26aulast%3DStanley%26aufirst%3DM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26atitle%3DCurrent%2520thinking%2520on%2520the%2520mechanistic%2520basis%2520of%2520Alzheimer%25E2%2580%2599s%2520and%2520implications%2520for%2520drug%2520development%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2015%26volume%3D98%26spage%3D469%26epage%3D471%26doi%3D10.1002%2Fcpt.200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heneka, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoury, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landreth, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosseron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinstein, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyss-Coray, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitorica, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransohoff, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrup, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frautschy, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkhratsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koistinaho, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzold, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Town, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinohara, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deigendesch, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garaschuk, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boddeke, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinarello, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golenbock, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummer, M. P.</span></span> <span> </span><span class="NLM_article-title">Neuroinflammation in Alzheimer’s disease</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(15)70016-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2FS1474-4422%2815%2970016-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=25792098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvVSksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=388-405&author=M.+T.+Henekaauthor=M.+J.+Carsonauthor=J.+E.+Khouryauthor=G.+E.+Landrethauthor=F.+Brosseronauthor=D.+L.+Feinsteinauthor=A.+H.+Jacobsauthor=T.+Wyss-Corayauthor=J.+Vitoricaauthor=R.+M.+Ransohoffauthor=K.+Herrupauthor=S.+A.+Frautschyauthor=B.+Finsenauthor=G.+C.+Brownauthor=A.+Verkhratskyauthor=K.+Yamanakaauthor=J.+Koistinahoauthor=E.+Latzauthor=A.+Halleauthor=G.+C.+Petzoldauthor=T.+Townauthor=D.+Morganauthor=M.+L.+Shinoharaauthor=V.+H.+Perryauthor=C.+Holmesauthor=N.+G.+Bazanauthor=D.+J.+Brooksauthor=S.+Hunotauthor=B.+Josephauthor=N.+Deigendeschauthor=O.+Garaschukauthor=E.+Boddekeauthor=C.+A.+Dinarelloauthor=J.+C.+Breitnerauthor=G.+M.+Coleauthor=D.+T.+Golenbockauthor=M.+P.+Kummer&title=Neuroinflammation+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS1474-4422%2815%2970016-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroinflammation in Alzheimer's disease</span></div><div class="casAuthors">Heneka, Michael T.; Carson, Monica J.; El Khoury, Joseph; Landreth, Gary E.; Brosseron, Frederic; Feinstein, Douglas L.; Jacobs, Andreas H.; Wyss-Coray, Tony; Vitorica, Javier; Ransohoff, Richard M.; Herrup, Karl; Frautschy, Sally A.; Finsen, Bente; Brown, Guy C.; Verkhratsky, Alexei; Yamanaka, Koji; Koistinaho, Jari; Latz, Eicke; Halle, Annett; Petzold, Gabor C.; Town, Terrence; Morgan, Dave; Shinohara, Mari L.; Perry, V. Hugh; Holmes, Clive; Bazan, Nicolas G.; Brooks, David J.; Hunot, Stephane; Joseph, Bertrand; Deigendesch, Nikolaus; Garaschuk, Olga; Boddeke, Erik; Dinarello, Charles A.; Breitner, John C.; Cole, Greg M.; Golenbock, Douglas T.; Kummer, Markus P.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">388-405</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the neuronal compartment, but includes strong interactions with immunol. mechanisms in the brain.  Misfolded and aggregated proteins bind to pattern recognition receptors on microglia and astroglia, and trigger an innate immune response characterized by release of inflammatory mediators, which contribute to disease progression and severity.  Genome-wide anal. suggests that several genes that increase the risk for sporadic Alzheimer's disease encode factors that regulate glial clearance of misfolded proteins and the inflammatory reaction.  External factors, including systemic inflammation and obesity, are likely to interfere with immunol. processes of the brain and further promote disease progression.  Modulation of risk factors and targeting of these immune mechanisms could lead to future therapeutic or preventive strategies for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRpkMdO_rqlrVg90H21EOLACvtfcHk0liLVx-gOUvPSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvVSksrw%253D&md5=df821845eaf19cc6c6a9c6fdf1f805d6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2815%2970016-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252815%252970016-5%26sid%3Dliteratum%253Aachs%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DCarson%26aufirst%3DM.%2BJ.%26aulast%3DKhoury%26aufirst%3DJ.%2BE.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26aulast%3DBrosseron%26aufirst%3DF.%26aulast%3DFeinstein%26aufirst%3DD.%2BL.%26aulast%3DJacobs%26aufirst%3DA.%2BH.%26aulast%3DWyss-Coray%26aufirst%3DT.%26aulast%3DVitorica%26aufirst%3DJ.%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26aulast%3DHerrup%26aufirst%3DK.%26aulast%3DFrautschy%26aufirst%3DS.%2BA.%26aulast%3DFinsen%26aufirst%3DB.%26aulast%3DBrown%26aufirst%3DG.%2BC.%26aulast%3DVerkhratsky%26aufirst%3DA.%26aulast%3DYamanaka%26aufirst%3DK.%26aulast%3DKoistinaho%26aufirst%3DJ.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DHalle%26aufirst%3DA.%26aulast%3DPetzold%26aufirst%3DG.%2BC.%26aulast%3DTown%26aufirst%3DT.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DShinohara%26aufirst%3DM.%2BL.%26aulast%3DPerry%26aufirst%3DV.%2BH.%26aulast%3DHolmes%26aufirst%3DC.%26aulast%3DBazan%26aufirst%3DN.%2BG.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DHunot%26aufirst%3DS.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DDeigendesch%26aufirst%3DN.%26aulast%3DGaraschuk%26aufirst%3DO.%26aulast%3DBoddeke%26aufirst%3DE.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26aulast%3DBreitner%26aufirst%3DJ.%2BC.%26aulast%3DCole%26aufirst%3DG.%2BM.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26aulast%3DKummer%26aufirst%3DM.%2BP.%26atitle%3DNeuroinflammation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%2520Neurol.%26date%3D2015%26volume%3D14%26spage%3D388%26epage%3D405%26doi%3D10.1016%2FS1474-4422%2815%2970016-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villemagne, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chetelat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgeat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackermann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szoeke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Keefe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klunk, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, C. C.</span></span> <span> </span><span class="NLM_article-title">Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1002/ana.22248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Fana.22248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=21280088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BC3M7lsFejtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2011&pages=181-192&author=V.+L.+Villemagneauthor=K.+E.+Pikeauthor=G.+Chetelatauthor=K.+A.+Ellisauthor=R.+S.+Mulliganauthor=P.+Bourgeatauthor=U.+Ackermannauthor=G.+Jonesauthor=C.+Szoekeauthor=O.+Salvadoauthor=R.+Martinsauthor=G.+O%E2%80%99Keefeauthor=C.+A.+Mathisauthor=W.+E.+Klunkauthor=D.+Amesauthor=C.+L.+Mastersauthor=C.+C.+Rowe&title=Longitudinal+assessment+of+A%CE%B2+and+cognition+in+aging+and+Alzheimer+disease&doi=10.1002%2Fana.22248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease</span></div><div class="casAuthors">Villemagne Victor L; Pike Kerryn E; Chetelat Gael; Ellis Kathryn A; Mulligan Rachel S; Bourgeat Pierrick; Ackermann Uwe; Jones Gareth; Szoeke Cassandra; Salvado Olivier; Martins Ralph; O'Keefe Graeme; Mathis Chester A; Klunk William E; Ames David; Masters Colin L; Rowe Christopher C</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">181-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Assess Aβ deposition longitudinally and explore its relationship with cognition and disease progression.  METHODS:  Clinical follow-up was obtained 20 ± 3 months after [11C]Pittsburgh compound B (PiB)-positron emission tomography in 206 subjects: 35 with dementia of the Alzheimer type (DAT), 65 with mild cognitive impairment (MCI), and 106 age-matched healthy controls (HCs).  A second PiB scan was obtained at follow-up in 185 subjects and a third scan after 3 years in 57.  RESULTS:  At baseline, 97% of DAT, 69% of MCI, and 31% of HC subjects showed high PiB retention.  At 20-month follow-up, small but significant increases in PiB standardized uptake value ratios were observed in the DAT and MCI groups, and in HCs with high PiB retention at baseline (5.7%, 2.1%, and 1.5%, respectively).  Increases were associated with the number of apolipoprotein E ε4 alleles.  There was a weak correlation between PiB increases and decline in cognition when all groups were combined.  Progression to DAT occurred in 67% of MCI with high PiB versus 5% of those with low PiB, but 20% of the low PiB MCI subjects progressed to other dementias.  Of the high PiB HCs, 16% developed MCI or DAT by 20 months and 25% by 3 years.  One low PiB HC developed MCI.  INTERPRETATION:  Aβ deposition increases slowly from cognitive normality to moderate severity DAT.  Extensive Aβ deposition precedes cognitive impairment, and is associated with ApoE genotype and a higher risk of cognitive decline in HCs and progression from MCI to DAT over 1 to 2 years.  However, cognitive decline is only weakly related to change in Aβ burden, suggesting that downstream factors have a more direct effect on symptom progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQh46E6lWA4tL0AGQpJZWpJfW6udTcc2eY2txSCDM4rvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7lsFejtw%253D%253D&md5=e7a7f3ccddc64bfb16586a8f934aa3ec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fana.22248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22248%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DPike%26aufirst%3DK.%2BE.%26aulast%3DChetelat%26aufirst%3DG.%26aulast%3DEllis%26aufirst%3DK.%2BA.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DBourgeat%26aufirst%3DP.%26aulast%3DAckermann%26aufirst%3DU.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DSzoeke%26aufirst%3DC.%26aulast%3DSalvado%26aufirst%3DO.%26aulast%3DMartins%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DG.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DAmes%26aufirst%3DD.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26atitle%3DLongitudinal%2520assessment%2520of%2520A%25CE%25B2%2520and%2520cognition%2520in%2520aging%2520and%2520Alzheimer%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2011%26volume%3D69%26spage%3D181%26epage%3D192%26doi%3D10.1002%2Fana.22248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villemagne, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgeat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szoeke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macaulay, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span> <span> </span><span class="NLM_article-title">Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(13)70044-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2FS1474-4422%2813%2970044-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=23477989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFejsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=357-367&author=V.+L.+Villemagneauthor=S.+Burnhamauthor=P.+Bourgeatauthor=B.+Brownauthor=K.+A.+Ellisauthor=O.+Salvadoauthor=C.+Szoekeauthor=S.+L.+Macaulayauthor=R.+Martinsauthor=P.+Maruffauthor=D.+Amesauthor=C.+C.+Roweauthor=C.+L.+Masters&title=Amyloid+beta+deposition%2C+neurodegeneration%2C+and+cognitive+decline+in+sporadic+Alzheimer%E2%80%99s+disease%3A+a+prospective+cohort+study&doi=10.1016%2FS1474-4422%2813%2970044-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study</span></div><div class="casAuthors">Villemagne, Victor L.; Burnham, Samantha; Bourgeat, Pierrick; Brown, Belinda; Ellis, Kathryn A.; Salvado, Olivier; Szoeke, Cassandra; Macaulay, S. Lance; Martins, Ralph; Maruff, Paul; Ames, David; Rowe, Christopher C.; Masters, Colin L.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-367</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Similar to most chronic diseases, Alzheimer's disease (AD) develops slowly from a preclin. phase into a fully expressed clin. syndrome.  We aimed to use longitudinal data to calc. the rates of amyloid β (Aβ) deposition, cerebral atrophy, and cognitive decline.  In this prospective cohort study, healthy controls, patients with mild cognitive impairment (MCI), and patients with AD were assessed at enrolment and every 18 mo.  At every visit, participants underwent neuropsychol. examn., MRI, and a carbon-11-labeled Pittsburgh compd. B (11C-PiB) PET scan.  We included participants with three or more 11C-PiB PET follow-up assessments.  Aβ burden was expressed as 11C-PiB standardised uptake value ratio (SUVR) with the cerebellar cortex as ref. region.  An SUVR of 1·5 was used to discriminate high from low Aβ burdens.  The slope of the regression plots over 3-5 years was used to est. rates of change for Aβ deposition, MRI volumetrics, and cognition.  We included those participants with a pos. rate of Aβ deposition to calc. the trajectory of each variable over time.200 participants (145 healthy controls, 36 participants with MCI, and 19 participants with AD) were assessed at enrolment and every 18 mo for a mean follow-up of 3·8 (95% CI CI 3·6-3·9) years.  At baseline, significantly higher Aβ burdens were noted in patients with AD (2·27, SD 0·43) and those with MCI (1·94, 0·64) than in healthy controls (1·38, 0·39).  At follow-up, 163 (82%) of the 200 participants showed pos. rates of Aβ accumulation.  Aβ deposition was estd. to take 19·2 (95% CI 16·8-22·5) years in an almost linear fashion-with a mean increase of 0·043 (95% CI 0·037-0·049) SUVR per yr-to go from the threshold of 11C-PiB positivity (1·5 SUVR) to the levels obsd. in AD.  It was estd. to take 12·0 (95% CI 10·1-14·9) years from the levels obsd. in healthy controls with low Aβ deposition (1·2 [SD 0·1] SUVR) to the threshold of 11C-PiB positivity.  As AD progressed, the rate of Aβ deposition slowed towards a plateau.  Our projections suggest a prolonged preclin. phase of AD in which Aβ deposition reaches our threshold of positivity at 17·0 (95% CI 14·9-19·9) years, hippocampal atrophy at 4·2 (3·6-5·1) years, and memory impairment at 3·3 (2·5-4·5) years before the onset of dementia (clin. dementia rating score 1).  Aβ deposition is slow and protracted, likely to extend for more than two decades.  Such predictions of the rate of preclin. changes and the onset of the clin. phase of AD will facilitate the design and timing of therapeutic interventions aimed at modifying the course of this illness.  Science and Industry Endowment Fund (Australia), The Commonwealth Scientific and Industrial Research Organization (Australia), The National Health and Medical Research Council of Australia Program and Project Grants, the Austin Hospital Medical Research Foundation, Victorian State Government, The Alzheimer's Drug Discovery Foundation, and the Alzheimer's Assocn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH2O2TjFkaAbVg90H21EOLACvtfcHk0liLVx-gOUvPSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFejsrw%253D&md5=2e325131e69aea18b4f6a7cc756bcc55</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970044-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970044-9%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DBurnham%26aufirst%3DS.%26aulast%3DBourgeat%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DEllis%26aufirst%3DK.%2BA.%26aulast%3DSalvado%26aufirst%3DO.%26aulast%3DSzoeke%26aufirst%3DC.%26aulast%3DMacaulay%26aufirst%3DS.%2BL.%26aulast%3DMartins%26aufirst%3DR.%26aulast%3DMaruff%26aufirst%3DP.%26aulast%3DAmes%26aufirst%3DD.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26atitle%3DAmyloid%2520beta%2520deposition%252C%2520neurodegeneration%252C%2520and%2520cognitive%2520decline%2520in%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520prospective%2520cohort%2520study%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D357%26epage%3D367%26doi%3D10.1016%2FS1474-4422%2813%2970044-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jack, C. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knopman, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagust, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span> <span> </span><span class="NLM_article-title">Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(09)70299-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2FS1474-4422%2809%2970299-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=20083042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFeru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=119-128&author=C.+R.+Jackauthor=D.+S.+Knopmanauthor=W.+J.+Jagustauthor=L.+M.+Shawauthor=P.+S.+Aisenauthor=M.+W.+Weinerauthor=R.+C.+Petersenauthor=J.+Q.+Trojanowski&title=Hypothetical+model+of+dynamic+biomarkers+of+the+Alzheimer%E2%80%99s+pathological+cascade&doi=10.1016%2FS1474-4422%2809%2970299-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade</span></div><div class="casAuthors">Jack, Clifford R., Jr.; Knopman, David S.; Jagust, William J.; Shaw, Leslie M.; Aisen, Paul S.; Weiner, Michael W.; Petersen, Ronald C.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Currently available evidence strongly supports the position that the initiating event in Alzheimer's disease (AD) is related to abnormal processing of β-amyloid (Aβ) peptide, ultimately leading to formation of Aβ plaques in the brain.  This process occurs while individuals are still cognitively normal.  Biomarkers of brain β-amyloidosis are redns. in CSF Aβ42 and increased amyloid PET tracer retention.  After a lag period, which varies from patient to patient, neuronal dysfunction and neurodegeneration become the dominant pathol. processes.  Biomarkers of neuronal injury and neurodegeneration are increased CSF tau and structural MRI measures of cerebral atrophy.  Neurodegeneration is accompanied by synaptic dysfunction, which is indicated by decreased fluorodeoxyglucose uptake on PET.  We propose a model that relates disease stage to AD biomarkers in which Aβ biomarkers become abnormal first, before neurodegenerative biomarkers and cognitive symptoms, and neurodegenerative biomarkers become abnormal later, and correlate with clin. symptom severity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOnmdY1Eeez7Vg90H21EOLACvtfcHk0lgK2XUGN_eksQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFeru74%253D&md5=5337b3e576ab1e8c58292c2572fb62f6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2809%2970299-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252809%252970299-6%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DWeiner%26aufirst%3DM.%2BW.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DHypothetical%2520model%2520of%2520dynamic%2520biomarkers%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520pathological%2520cascade%26jtitle%3DLancet%2520Neurol.%26date%3D2010%26volume%3D9%26spage%3D119%26epage%3D128%26doi%3D10.1016%2FS1474-4422%2809%2970299-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mormino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span> <span> </span><span class="NLM_article-title">The evolution of preclinical Alzheimer’s disease: implications for prevention trials</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2014.10.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.neuron.2014.10.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=25442939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2mtrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=608-622&author=R.+Sperlingauthor=E.+Morminoauthor=K.+Johnson&title=The+evolution+of+preclinical+Alzheimer%E2%80%99s+disease%3A+implications+for+prevention+trials&doi=10.1016%2Fj.neuron.2014.10.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials</span></div><div class="casAuthors">Sperling, Reisa; Mormino, Elizabeth; Johnson, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">608-622</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">As the field begins to test the concept of a "preclin." stage of neurodegenerative disease, when the pathophysiol. process has begun in the brain, but clin. symptoms are not yet manifest, a no. of intriguing questions have already arisen.  In particular, in preclin. Alzheimer's disease (AD), the temporal relationship of amyloid markers to markers of neurodegeneration and their relative utility in the prediction of cognitive decline among clin. normal older individuals remains to be fully elucidated.  Secondary prevention trials in AD have already begun in both genetic at-risk and amyloid at-risk cohorts, with several more trials in the planning stages, and should provide crit. answers about whether intervention at this very early stage of disease can truly bend the curve of clin. progression.  This review will highlight recent progress in cognitive, imaging, and biomarker outcomes in the field of preclin. AD, and the remaining gaps in knowledge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-LC1zcm6IDLVg90H21EOLACvtfcHk0lgK2XUGN_eksQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2mtrfL&md5=f73caaba195d2e18aeae9dde4151ac4d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2014.10.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2014.10.038%26sid%3Dliteratum%253Aachs%26aulast%3DSperling%26aufirst%3DR.%26aulast%3DMormino%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DK.%26atitle%3DThe%2520evolution%2520of%2520preclinical%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520prevention%2520trials%26jtitle%3DNeuron%26date%3D2014%26volume%3D84%26spage%3D608%26epage%3D622%26doi%3D10.1016%2Fj.neuron.2014.10.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siemers, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundell, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethuraman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu-Seifert, H.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer’s disease patients</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2015.06.1893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.jalz.2015.06.1893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=26238576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BC28%252Fpt1OltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=110-120&author=E.+R.+Siemersauthor=K.+L.+Sundellauthor=C.+Carlsonauthor=M.+Caseauthor=G.+Sethuramanauthor=H.+Liu-Seifert&title=Phase+3+solanezumab+trials%3A+secondary+outcomes+in+mild+Alzheimer%E2%80%99s+disease+patients&doi=10.1016%2Fj.jalz.2015.06.1893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients</span></div><div class="casAuthors">Siemers Eric R; Sundell Karen L; Carlson Christopher; Case Michael; Sethuraman Gopalan; Liu-Seifert Hong; Dowsett Sherie A; Dean Robert A; Demattos Ronald; Pontecorvo Michael J</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">110-120</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  EXPEDITION and EXPEDITION2 were identically designed placebo-controlled phase 3 studies assessing effects of solanezumab, an antiamyloid monoclonal antibody binding soluble amyloid-β peptide, on cognitive and functional decline over 80 weeks in patients with mild-to-moderate Alzheimer's disease (AD).  Primary findings for both studies have been published.  METHODS:  Secondary analyses of efficacy, biomarker, and safety endpoints in the pooled (EXPEDTION + EXPEDITION2) mild AD population were performed.  RESULTS:  In the mild AD population, less cognitive and functional decline was observed with solanezumab (n = 659) versus placebo (n = 663), measured by Alzheimer's Disease Assessment Scale Cognitive subscale, Mini-Mental State Examination, and Alzheimer's Disease Cooperative Study-Activities of Daily Living functional scale Instrumental ADLs.  Baseline-to-endpoint changes did not differ between treatment groups for Alzheimer's Disease Cooperative Study-Activities of Daily Living functional scale, basic items of the ADCS-ADL, and Clinical Dementia Rating Sum of Boxes.  Plasma/cerebrospinal fluid biomarker findings indicated target engagement by solanezumab.  Solanezumab demonstrated acceptable safety.  Efficacy findings for the moderate AD population are also provided.  DISCUSSION:  These findings describe solanezumab effects on efficacy/safety measures in a mild AD population.  Another phase 3 study, EXPEDITION3, will investigate solanezumab's effects in a mild AD population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlFLS6U1rwcEkUaC_kzhvyfW6udTcc2eafssUniHVo7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252Fpt1OltA%253D%253D&md5=ff277c9a751f5ce37ea36c1a67402a65</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2015.06.1893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2015.06.1893%26sid%3Dliteratum%253Aachs%26aulast%3DSiemers%26aufirst%3DE.%2BR.%26aulast%3DSundell%26aufirst%3DK.%2BL.%26aulast%3DCarlson%26aufirst%3DC.%26aulast%3DCase%26aufirst%3DM.%26aulast%3DSethuraman%26aufirst%3DG.%26aulast%3DLiu-Seifert%26aufirst%3DH.%26atitle%3DPhase%25203%2520solanezumab%2520trials%253A%2520secondary%2520outcomes%2520in%2520mild%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2016%26volume%3D12%26spage%3D110%26epage%3D120%26doi%3D10.1016%2Fj.jalz.2015.06.1893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Biochemistry of amyloid beta-protein and amyloid deposits in Alzheimer disease</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">a006262</span> <span class="refDoi"> DOI: 10.1101/cshperspect.a006262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1101%2Fcshperspect.a006262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=22675658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlemtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&author=C.+L.+Mastersauthor=D.+J.+Selkoe&title=Biochemistry+of+amyloid+beta-protein+and+amyloid+deposits+in+Alzheimer+disease&doi=10.1101%2Fcshperspect.a006262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease</span></div><div class="casAuthors">Masters, Colin L.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">a006262/1-a006262/24</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Progressive cerebral deposition of the amyloid β-protein (Aβ) in brain regions serving memory and cognition is an invariant and defining feature of Alzheimer disease.  A highly similar but less robust process accompanies brain aging in many nondemented humans, lower primates, and some other mammals.  The discovery of Aβ as the subunit of the amyloid fibrils in meningocerebral blood vessels and parenchymal plaques has led to innumerable studies of its biochem. and potential cytotoxic properties.  Here we will review the discovery of Aβ, numerous aspects of its complex biochem., and current attempts to understand how a range of Aβ assemblies, including sol. oligomers and insol. fibrils, may ppt. and promote neuronal and glial alterations that underlie the development of dementia.  Although the role of Aβ as a key mol. factor in the etiol. of Alzheimer disease remains controversial, clin. trials of amyloid-lowering agents, reviewed elsewhere in this book, are poised to resolve the question of its pathogenic primacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-U4pTuictTrVg90H21EOLACvtfcHk0lj-cFvnNquiAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlemtbc%253D&md5=133fd25f26d01f1c46456744d486bde2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006262%26sid%3Dliteratum%253Aachs%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DBiochemistry%2520of%2520amyloid%2520beta-protein%2520and%2520amyloid%2520deposits%2520in%2520Alzheimer%2520disease%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26doi%3D10.1101%2Fcshperspect.a006262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Resolving controversies on the path to Alzheimer’s therapeutics</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1065</span>, <span class="refDoi"> DOI: 10.1038/nm.2460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1038%2Fnm.2460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=21900936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCntL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1060-1065&author=D.+J.+Selkoe&title=Resolving+controversies+on+the+path+to+Alzheimer%E2%80%99s+therapeutics&doi=10.1038%2Fnm.2460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Resolving controversies on the path to Alzheimer's therapeutics</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1060-1065</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease constitutes a personal and societal tragedy of immense proportions.  Since 1960, research in labs. and clinics worldwide has elucidated many features of this insidious and ultimately fatal syndrome, and this progress has led to initial human trials of potentially disease-modifying agents.  However, some of these agents have already failed.  Gnawing controversies and important gaps in our knowledge seem to cast addnl. doubt on the ability of the field to move forward effectively.  Here I discuss some of these looming concerns and offer possible explanations for the major trial failures that suggest they are not predictive of the future.  Rigorous preclin. validation of mechanism-based therapeutic agents followed by meticulously designed trials that focus on the cardinal cognitive symptoms and their assocd. biomarkers in the mild or presymptomatic phases of Alzheimer's disease are likely to lead to success, perhaps in the not-too-distant future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9e3VIkcVvWrVg90H21EOLACvtfcHk0lj-cFvnNquiAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCntL7E&md5=501720027a4b1e4fd2a838f94aecd667</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnm.2460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2460%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DResolving%2520controversies%2520on%2520the%2520path%2520to%2520Alzheimer%25E2%2580%2599s%2520therapeutics%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D1060%26epage%3D1065%26doi%3D10.1038%2Fnm.2460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abramowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederhold, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furrer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaton, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuenschwander, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runser, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichwald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammaturo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staab, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoeckli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span> <span> </span><span class="NLM_article-title">Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>327</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">424</span>, <span class="refDoi"> DOI: 10.1124/jpet.108.140327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1124%2Fjpet.108.140327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=18687920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWns73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=411-424&author=D.+Abramowskiauthor=K.+H.+Wiederholdauthor=U.+Furrerauthor=A.+L.+Jatonauthor=A.+Neuenschwanderauthor=M.+J.+Runserauthor=S.+Dannerauthor=J.+Reichwaldauthor=D.+Ammaturoauthor=D.+Staabauthor=M.+Stoeckliauthor=H.+Rueegerauthor=U.+Neumannauthor=M.+Staufenbiel&title=Dynamics+of+Abeta+turnover+and+deposition+in+different+beta-amyloid+precursor+protein+transgenic+mouse+models+following+gamma-secretase+inhibition&doi=10.1124%2Fjpet.108.140327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamics of Aβ turnover and deposition in different β-amyloid precursor protein transgenic mouse models following γ-secretase inhibition</span></div><div class="casAuthors">Abramowski, Dorothee; Wiederhold, Karl-Heinz; Furrer, Ulrich; Jaton, Anne-Lise; Neuenschwander, Anton; Runser, Marie-Josephine; Danner, Simone; Reichwald, Julia; Ammaturo, Domenico; Staab, Dieter; Stoeckli, Markus; Rueeger, Heinrich; Neumann, Ulf; Staufenbiel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">411-424</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Human β-amyloid precursor protein (APP) transgenic mice are commonly used to test potential therapeutics for Alzheimer's disease.  We have characterized the dynamics of β-amyloid (Aβ) generation and deposition following γ-secretase inhibition with compd. LY-411575 [N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide].  Kinetic studies in preplaque mice distinguished a detergent-sol. Aβ pool in brain with rapid turnover (half-lives for Aβ40 and Aβ42 were 0.7 and 1.7 h) and a much more stable, less sol. pool.  Aβ in cerebrospinal fluid (CSF) reflected the changes in the sol. brain Aβ pool, whereas plasma Aβ turned over more rapidly.  In brain, APP C-terminal fragments (CTF) accumulated differentially.  The half-lives for γ-secretase degrdn. were estd. as 0.4 and 0.1 h for C99 and C83, resp.  Three different APP transgenic lines responded very similarly to γ-secretase inhibition regardless of the familial Alzheimer's disease mutations in APP.  Amyloid deposition started with Aβ42, whereas Aβ38 and Aβ40 continued to turn over.  Chronic γ-secretase inhibition lowered amyloid plaque formation to a different degree in different brain regions of the same mice.  The extent was inversely related to the initial amyloid load in the region analyzed.  No evidence for plaque removal below baseline was obtained.  γ-Secretase inhibition led to a redistribution of intracellular Aβ and an elevation of CTFs in neuronal fibers.  In CSF, Aβ showed a similar turnover as in preplaque animals demonstrating its suitability as marker of newly generated, sol. Aβ in plaque-bearing brain.  This study supports the use of APP transgenic mice as translational models to characterize Aβ-lowering therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYc2zQZlag7rVg90H21EOLACvtfcHk0lj-cFvnNquiAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWns73E&md5=0080a9a9603113e270a4eb4b650a7cd6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.140327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.140327%26sid%3Dliteratum%253Aachs%26aulast%3DAbramowski%26aufirst%3DD.%26aulast%3DWiederhold%26aufirst%3DK.%2BH.%26aulast%3DFurrer%26aufirst%3DU.%26aulast%3DJaton%26aufirst%3DA.%2BL.%26aulast%3DNeuenschwander%26aufirst%3DA.%26aulast%3DRunser%26aufirst%3DM.%2BJ.%26aulast%3DDanner%26aufirst%3DS.%26aulast%3DReichwald%26aufirst%3DJ.%26aulast%3DAmmaturo%26aufirst%3DD.%26aulast%3DStaab%26aufirst%3DD.%26aulast%3DStoeckli%26aufirst%3DM.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DStaufenbiel%26aufirst%3DM.%26atitle%3DDynamics%2520of%2520Abeta%2520turnover%2520and%2520deposition%2520in%2520different%2520beta-amyloid%2520precursor%2520protein%2520transgenic%2520mouse%2520models%2520following%2520gamma-secretase%2520inhibition%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D411%26epage%3D424%26doi%3D10.1124%2Fjpet.108.140327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichwald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammaturo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saftig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span> <span> </span><span class="NLM_article-title">The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2011.07412.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1111%2Fj.1471-4159.2011.07412.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=21812781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyiurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2011&pages=231-239&author=S.+Rabeauthor=J.+Reichwaldauthor=D.+Ammaturoauthor=B.+de+Strooperauthor=P.+Saftigauthor=U.+Neumannauthor=M.+Staufenbiel&title=The+Swedish+APP+mutation+alters+the+effect+of+genetically+reduced+BACE1+expression+on+the+APP+processing&doi=10.1111%2Fj.1471-4159.2011.07412.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing</span></div><div class="casAuthors">Rabe, Sabine; Reichwald, Julia; Ammaturo, Domenico; de Strooper, Bart; Saftig, Paul; Neumann, Ulf; Staufenbiel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">231-239</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Inhibition of β-secretase (BACE1) is a key therapeutic approach in Alzheimer's disease (AD), as BACE1 initiates amyloid-β (Aβ) cleavage from the β-amyloid precursor protein (APP).  As Aβ redns. in mice lacking one BACE1 allele diverged considerably between studies we investigated the effect of BACE1 knock-out in more detail.  With both BACE1 alleles the Swedish mutation (APP23 mice) increased APP processing and shifted it towards the β-secretase pathway as compared with non-mutated APP expressed at a similar level (APP51/16 mice).  This effect was much smaller then obsd. in cell culture.  An about 50% decrease in BACE1 enzyme activity resulted in a sub-proportional Aβ redn. with the Swedish mutation (-20%) and even less for non-mutated APP (-16%).  In wild-type mice, the Aβ redn. may be even further diminished.  Other metabolites of the β-secretase pathway decreased accordingly while the alternative α-secretase pathway increased.  Complete BACE1 deletion strongly enhanced these changes.  The remaining Aβ signal also described by others can be explained by assay cross-reactivity with other APP metabolites supporting BACE1 as the major β-secretase.  These data indicate that BACE1 is in excess over APP at the cleavage site(s).  Alterations in APP expression or substrate properties, therefore, quant. change its cleavage and Aβ generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZYEql_9yVqrVg90H21EOLACvtfcHk0lj0u_ngbqI2lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyiurvL&md5=d223b3798846f8ca59fce1bb03525ec8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07412.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07412.x%26sid%3Dliteratum%253Aachs%26aulast%3DRabe%26aufirst%3DS.%26aulast%3DReichwald%26aufirst%3DJ.%26aulast%3DAmmaturo%26aufirst%3DD.%26aulast%3Dde%2BStrooper%26aufirst%3DB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DStaufenbiel%26aufirst%3DM.%26atitle%3DThe%2520Swedish%2520APP%2520mutation%2520alters%2520the%2520effect%2520of%2520genetically%2520reduced%2520BACE1%2520expression%2520on%2520the%2520APP%2520processing%26jtitle%3DJ.%2520Neurochem.%26date%3D2011%26volume%3D119%26spage%3D231%26epage%3D239%26doi%3D10.1111%2Fj.1471-4159.2011.07412.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McConlogue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buttini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brigham, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Games, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson-Wood, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span> <span> </span><span class="NLM_article-title">Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">26326</span>– <span class="NLM_lpage">26334</span>, <span class="refDoi"> DOI: 10.1074/jbc.M611687200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1074%2Fjbc.M611687200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=17616527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpslGjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=26326-26334&author=L.+McConlogueauthor=M.+Buttiniauthor=J.+P.+Andersonauthor=E.+F.+Brighamauthor=K.+S.+Chenauthor=S.+B.+Freedmanauthor=D.+Gamesauthor=K.+Johnson-Woodauthor=M.+Leeauthor=M.+Zellerauthor=W.+Liuauthor=R.+Motterauthor=S.+Sinha&title=Partial+reduction+of+BACE1+has+dramatic+effects+on+Alzheimer+plaque+and+synaptic+pathology+in+APP+transgenic+mice&doi=10.1074%2Fjbc.M611687200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice</span></div><div class="casAuthors">McConlogue, Lisa; Buttini, Manuel; Anderson, John P.; Brigham, Elizabeth F.; Chen, Karen S.; Freedman, Stephen B.; Games, Dora; Johnson-Wood, Kelly; Lee, Michael; Zeller, Michelle; Liu, Weiqun; Motter, Ruth; Sinha, Sukanto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">26326-26334</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The aspartyl protease β-site amyloid precursor protein cleaving enzyme 1 (BACE1) initiates processing of amyloid precursor protein (APP) into amyloid β (Aβ) peptide, the major component of Alzheimer disease (AD) plaques.  To det. the role that BACE1 plays in the development of Aβ-driven AD-like pathol., we have crossed PDAPP mice, a transgenic mouse model of AD overexpressing human mutated APP, onto mice with either a homozygous or heterozygous BACE1 gene knockout.  Anal. of PDAPP/BACE(-/-) mice demonstrated that BACE1 is absolutely required for both Aβ generation and the development of age-assocd. plaque pathol.  Furthermore, synaptic deficits, a neurodegenerative pathol. characteristic of AD, were also reversed in the bigenic mice.  To det. the extent of BACE1 redn. required to significantly inhibit pathol., PDAPP mice having a heterozygous BACE1 gene knock-out were evaluated for Aβ generation and for the development of pathol.  Although the 50% redn. in BACE1 enzyme levels caused only a 12% decrease in Aβ levels in young mice, it nonetheless resulted in a dramatic redn. in Aβ plaques, neuritic burden, and synaptic deficits in older mice.  Quant. analyses indicate that brain Aβ levels in young APP transgenic mice are not the sole determinant for the changes in plaque pathol. mediated by reduced BACE1.  These observations demonstrate that partial redns. of BACE1 enzyme activity and concomitant Aβ levels lead to dramatic inhibition of Aβ-driven AD-like pathol., making BACE1 an excellent target for therapeutic intervention in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolXkPkhLFworVg90H21EOLACvtfcHk0lj0u_ngbqI2lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpslGjt74%253D&md5=5cd1df8e7c16473d8116de3226c78cd4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M611687200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M611687200%26sid%3Dliteratum%253Aachs%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DButtini%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBrigham%26aufirst%3DE.%2BF.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DJohnson-Wood%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DZeller%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DSinha%26aufirst%3DS.%26atitle%3DPartial%2520reduction%2520of%2520BACE1%2520has%2520dramatic%2520effects%2520on%2520Alzheimer%2520plaque%2520and%2520synaptic%2520pathology%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D26326%26epage%3D26334%26doi%3D10.1074%2Fjbc.M611687200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidhoff, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassiepen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worpenberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhartz, B.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human BACE2 in complex with a hydroxyethylamine transition-state inhibitor</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.jmb.2005.10.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=16305800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSjt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=249-261&author=N.+Ostermannauthor=J.+Ederauthor=U.+Eidhoffauthor=F.+Zinkauthor=U.+Hassiepenauthor=S.+Worpenbergauthor=J.+Maibaumauthor=O.+Simicauthor=U.+Hommelauthor=B.+Gerhartz&title=Crystal+structure+of+human+BACE2+in+complex+with+a+hydroxyethylamine+transition-state+inhibitor&doi=10.1016%2Fj.jmb.2005.10.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Human BACE2 in Complex with a Hydroxyethylamine Transition-state Inhibitor</span></div><div class="casAuthors">Ostermann, Nils; Eder, Joerg; Eidhoff, Ulf; Zink, Florence; Hassiepen, Ulrich; Worpenberg, Susanne; Maibaum, Juergen; Simic, Oliver; Hommel, Ulrich; Gerhartz, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-261</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">BACE2 is a membrane-bound aspartic protease of the A1 family with a high level of sequence homol. to BACE1.  While BACE1 is involved in the generation of amyloid plaques in Alzheimer's disease by cleaving Aβ-peptides from the amyloid precursor protein, the physiol. function of BACE2 is not well understood.  BACE2 appears to be assocd. with the early onset of dementia in patients with Down's syndrome, and it has been shown to be highly expressed in breast cancers.  Further, it may participate in the function of normal and abnormal processes of human muscle biol.  Similar to other aspartic proteases, BACE2 is expressed as an inactive zymogen requiring the cleavage of its pro-sequence during the maturation process.  We have produced mature BACE2 by expression of pro-BACE2 in Escherichia coli as inclusion bodies, followed by refolding and autocatalytic activation at pH 3.4.  Using a C and N-terminally truncated BACE2 variant, we were able to crystallize and det. the crystal structure of mature BACE2 in complex with a hydroxyethylamine transition-state mimetic inhibitor at 3.1 Å resoln.  The structure of BACE2 follows the general fold of A1 aspartic proteases.  However, similar to BACE1, its C-terminal domain is significantly larger than that of the other family members.  Furthermore, the structure of BACE2 reveals differences in the S3, S2, S1' and S2' active site substrate pockets as compared to BACE1, and allows, therefore, for a deeper understanding of the structural features that may facilitate the design of selective BACE1 or BACE2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpagbhk8u5oybVg90H21EOLACvtfcHk0lj0u_ngbqI2lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSjt7bO&md5=74ae4bbd058acf333ea11fba486f10b2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DEidhoff%26aufirst%3DU.%26aulast%3DZink%26aufirst%3DF.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DWorpenberg%26aufirst%3DS.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DSimic%26aufirst%3DO.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DGerhartz%26aufirst%3DB.%26atitle%3DCrystal%2520structure%2520of%2520human%2520BACE2%2520in%2520complex%2520with%2520a%2520hydroxyethylamine%2520transition-state%2520inhibitor%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D355%26spage%3D249%26epage%3D261%26doi%3D10.1016%2Fj.jmb.2005.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garratt, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rittger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeStrooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saftig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span> <span> </span><span class="NLM_article-title">Control of peripheral nerve myelination by the beta-secretase BACE1</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>314</i></span>,  <span class="NLM_fpage">664</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1126/science.1132341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1126%2Fscience.1132341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=16990514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFeitr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=664-676&author=M.+Willemauthor=A.+N.+Garrattauthor=B.+Novakauthor=M.+Citronauthor=S.+Kaufmannauthor=A.+Rittgerauthor=B.+DeStrooperauthor=P.+Saftigauthor=C.+Birchmeierauthor=C.+Haass&title=Control+of+peripheral+nerve+myelination+by+the+beta-secretase+BACE1&doi=10.1126%2Fscience.1132341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Control of Peripheral Nerve Myelination by the β-Secretase BACE1</span></div><div class="casAuthors">Willem, Michael; Garratt, Alistair N.; Novak, Bozidar; Citron, Martin; Kaufmann, Steve; Rittger, Andrea; DeStrooper, Bart; Saftig, Paul; Birchmeier, Carmen; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">5799</span>),
    <span class="NLM_cas:pages">664-666</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Although BACE1 (beta-site amyloid precursor protein-cleaving enzyme 1) is essential for the generation of amyloid-β peptide in Alzheimer's disease, its physiol. function is unclear.  We found that very high levels of BACE1 were expressed at time points when peripheral nerves become myelinated.  Deficiency of BACE1 resulted in the accumulation of unprocessed neuregulin 1 (NRG1), an axonally expressed factor required for glial cell development and myelination.  BACE1-/- mice displayed hypo-myelination of peripheral nerves and aberrant axonal segregation of small-diam. afferent fibers, very similar to that seen in mice with mutations in type III NRG1 or Schwann cell-specific ErbB2 knockouts.  Thus, BACE1 is required for myelination and correct bundling of axons by Schwann cells, probably through processing of type III NRG1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjcnSaaIIaUrVg90H21EOLACvtfcHk0liRGjEAjzukEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFeitr7J&md5=17a0d1600dfb2b59b8055fc18ff47b59</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.1132341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1132341%26sid%3Dliteratum%253Aachs%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DNovak%26aufirst%3DB.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DKaufmann%26aufirst%3DS.%26aulast%3DRittger%26aufirst%3DA.%26aulast%3DDeStrooper%26aufirst%3DB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DControl%2520of%2520peripheral%2520nerve%2520myelination%2520by%2520the%2520beta-secretase%2520BACE1%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D664%26epage%3D676%26doi%3D10.1126%2Fscience.1132341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velanac, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unterbarnscheidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gummert, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trimarco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brivio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taveggia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobius, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nave, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, M. H.</span></span> <span> </span><span class="NLM_article-title">Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination</span>. <i>Glia</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1002/glia.21255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Fglia.21255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=22052506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FltValsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=203-217&author=V.+Velanacauthor=T.+Unterbarnscheidtauthor=W.+Hinrichsauthor=M.+N.+Gummertauthor=T.+M.+Fischerauthor=M.+J.+Rossnerauthor=A.+Trimarcoauthor=V.+Brivioauthor=C.+Taveggiaauthor=M.+Willemauthor=C.+Haassauthor=W.+Mobiusauthor=K.+A.+Naveauthor=M.+H.+Schwab&title=Bace1+processing+of+NRG1+type+III+produces+a+myelin-inducing+signal+but+is+not+essential+for+the+stimulation+of+myelination&doi=10.1002%2Fglia.21255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination</span></div><div class="casAuthors">Velanac Viktorija; Unterbarnscheidt Tilmann; Hinrichs Wilko; Gummert Maike N; Fischer Tobias M; Rossner Moritz J; Trimarco Amelia; Brivio Veronica; Taveggia Carla; Willem Michael; Haass Christian; Mobius Wiebke; Nave Klaus-Armin; Schwab Markus H</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Myelin sheath thickness is precisely adjusted to axon caliber, and in the peripheral nervous system, neuregulin 1 (NRG1) type III is a key regulator of this process.  It has been proposed that the protease BACE1 activates NRG1 dependent myelination.  Here, we characterize the predicted product of BACE1-mediated NRG1 type III processing in transgenic mice.  Neuronal overexpression of a NRG1 type III-variant, designed to mimic prior cleavage in the juxtamembrane stalk region, induces hypermyelination in vivo and is sufficient to restore myelination of NRG1 type III-deficient neurons.  This observation implies that the NRG1 cytoplasmic domain is dispensable and that processed NRG1 type III is sufficient for all steps of myelination.  Surprisingly, transgenic neuronal overexpression of full-length NRG1 type III promotes hypermyelination also in BACE1 null mutant mice.  Moreover, NRG1 processing is impaired but not abolished in BACE1 null mutants.  Thus, BACE1 is not essential for the activation of NRG1 type III to promote myelination.  Taken together, these findings suggest that multiple neuronal proteases collectively regulate NRG1 processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLFOgusWONs8kU0YCbOU3EfW6udTcc2eZLcP9oVQUzlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FltValsw%253D%253D&md5=b3f76b0261c36a558f902349a20615f0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fglia.21255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.21255%26sid%3Dliteratum%253Aachs%26aulast%3DVelanac%26aufirst%3DV.%26aulast%3DUnterbarnscheidt%26aufirst%3DT.%26aulast%3DHinrichs%26aufirst%3DW.%26aulast%3DGummert%26aufirst%3DM.%2BN.%26aulast%3DFischer%26aufirst%3DT.%2BM.%26aulast%3DRossner%26aufirst%3DM.%2BJ.%26aulast%3DTrimarco%26aufirst%3DA.%26aulast%3DBrivio%26aufirst%3DV.%26aulast%3DTaveggia%26aufirst%3DC.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DMobius%26aufirst%3DW.%26aulast%3DNave%26aufirst%3DK.%2BA.%26aulast%3DSchwab%26aufirst%3DM.%2BH.%26atitle%3DBace1%2520processing%2520of%2520NRG1%2520type%2520III%2520produces%2520a%2520myelin-inducing%2520signal%2520but%2520is%2520not%2520essential%2520for%2520the%2520stimulation%2520of%2520myelination%26jtitle%3DGlia%26date%3D2012%26volume%3D60%26spage%3D203%26epage%3D217%26doi%3D10.1002%2Fglia.21255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eggert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paliga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidemann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyreuther, K.</span></span> <span> </span><span class="NLM_article-title">The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">18146</span>– <span class="NLM_lpage">18156</span>, <span class="refDoi"> DOI: 10.1074/jbc.M311601200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1074%2Fjbc.M311601200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=14970212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVKnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=18146-18156&author=S.+Eggertauthor=K.+Paligaauthor=P.+Sobaauthor=G.+Evinauthor=C.+L.+Mastersauthor=A.+Weidemannauthor=K.+Beyreuther&title=The+proteolytic+processing+of+the+amyloid+precursor+protein+gene+family+members+APLP-1+and+APLP-2+involves+alpha-%2C+beta-%2C+gamma-%2C+and+epsilon-like+cleavages%3A+modulation+of+APLP-1+processing+by+n-glycosylation&doi=10.1074%2Fjbc.M311601200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The Proteolytic Processing of the Amyloid Precursor Protein Gene Family Members APLP-1 and APLP-2 Involves α-, β-, γ-, and ε-Like Cleavages: Modulation of APLP-1 Processing by N-Glycosylation</span></div><div class="casAuthors">Eggert, Simone; Paliga, Krzysztof; Soba, Peter; Evin, Genevieve; Masters, Colin L.; Weidemann, Andreas; Beyreuther, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">18146-18156</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Amyloid precursor protein (APP) processing is of major interest in Alzheimer's disease research, since sequential cleavages by β- and γ-secretase lead to the formation of the 4-kDa amyloid Aβ protein peptide that accumulates in Alzheimer's disease brain.  The processing of APP involves proteolytic conversion by different secretases leading to α-, β-, γ-, δ-, and ε-cleavages.  Since modulation of these cleavages represents a rational therapeutic approach to control amyloid formation, its interference with the processing of the members of the APP gene family is of considerable importance.  By using C-terminally tagged constructs of APLP-1 and APLP-2 and the untagged proteins, we have characterized their proteolytic C-terminal fragments produced in stably transfected SH-SY5Y cells.  Pharmacol. manipulation with specific protease inhibitors revealed that both homologues are processed by α- and γ-secretase-like cleavages, and that their intracellular domains can be released by cleavage at ε-sites.  APLP-2 processing appears to be the most elaborate and to involve alternative cleavage sites.  We show that APLP-1 is the only member of the APP gene family for which processing can be influenced by N-glycosylation.  Addnl., we were able to detect p3-like fragments of APLP-1 and p3-like and Aβ-like fragments of APLP-2 in the media of stably transfected SH-SY5Y cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkAzx8LDhsJLVg90H21EOLACvtfcHk0liRGjEAjzukEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVKnt70%253D&md5=66af6f411aed4c5ee10185af97e02836</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M311601200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M311601200%26sid%3Dliteratum%253Aachs%26aulast%3DEggert%26aufirst%3DS.%26aulast%3DPaliga%26aufirst%3DK.%26aulast%3DSoba%26aufirst%3DP.%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DWeidemann%26aufirst%3DA.%26aulast%3DBeyreuther%26aufirst%3DK.%26atitle%3DThe%2520proteolytic%2520processing%2520of%2520the%2520amyloid%2520precursor%2520protein%2520gene%2520family%2520members%2520APLP-1%2520and%2520APLP-2%2520involves%2520alpha-%252C%2520beta-%252C%2520gamma-%252C%2520and%2520epsilon-like%2520cleavages%253A%2520modulation%2520of%2520APLP-1%2520processing%2520by%2520n-glycosylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D18146%26epage%3D18156%26doi%3D10.1074%2Fjbc.M311601200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barão, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gärtner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyva-Díaz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demyanenko, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutvin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schachner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Bendito, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maness, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span> <span> </span><span class="NLM_article-title">, Patricia, F.;, B. Antagonistic effects of BACE1 and APH1B-γ-secretase control axonal guidance by regulating growth cone collapse</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1367</span>– <span class="NLM_lpage">1376</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.07.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.celrep.2015.07.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=26299962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOmtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=1367-1376&author=S.+Bar%C3%A3oauthor=A.+G%C3%A4rtnerauthor=E.+Leyva-D%C3%ADazauthor=G.+Demyanenkoauthor=S.+Munckauthor=T.+Vanhoutvinauthor=L.+Zhouauthor=M.+Schachnerauthor=G.+L%C3%B3pez-Benditoauthor=P.+F.+Manessauthor=B.+De+Strooper&title=%2C+Patricia%2C+F.%3B%2C+B.+Antagonistic+effects+of+BACE1+and+APH1B-%CE%B3-secretase+control+axonal+guidance+by+regulating+growth+cone+collapse&doi=10.1016%2Fj.celrep.2015.07.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonistic Effects of BACE1 and APH1B-γ-Secretase Control Axonal Guidance by Regulating Growth Cone Collapse</span></div><div class="casAuthors">Barao, Soraia; Gartner, Annette; Leyva-Diaz, Eduardo; Demyanenko, Galina; Munck, Sebastian; Vanhoutvin, Tine; Zhou, Lujia; Schachner, Melitta; Lopez-Bendito, Guillermina; Maness, Patricia F.; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1367-1376</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">ΒACE1 is the major drug target for Alzheimer's disease, but we know surprisingly little about its normal function in the CNS.  Here, we show that this protease is critically involved in semaphorin 3A (Sema3A)-mediated axonal guidance processes in thalamic and hippocampal neurons.  An active membrane-bound proteolytic CHL1 fragment is generated by BACE1 upon Sema3A binding.  This fragment relays the Sema3A signal via ezrin-radixin-moesin (ERM) proteins to the neuronal cytoskeleton.  APH1B-γ-secretase-mediated degrdn. of this fragment stops the Sema3A-induced collapse and sensitizes the growth cone for the next axonal guidance cue.  Thus, we reveal a cycle of proteolytic activity underlying growth cone collapse and restoration used by axons to find their correct trajectory in the brain.  Our data also suggest that BACE1 and γ-secretase inhibition have physiol. opposite effects in this process, supporting the idea that combination therapy might attenuate some of the side effects assocd. with these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFAjldKIuigrVg90H21EOLACvtfcHk0lg0H_znKrKK-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOmtbnE&md5=e158a18250e0656b5496d53cf4c561fe</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.07.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.07.059%26sid%3Dliteratum%253Aachs%26aulast%3DBar%25C3%25A3o%26aufirst%3DS.%26aulast%3DG%25C3%25A4rtner%26aufirst%3DA.%26aulast%3DLeyva-D%25C3%25ADaz%26aufirst%3DE.%26aulast%3DDemyanenko%26aufirst%3DG.%26aulast%3DMunck%26aufirst%3DS.%26aulast%3DVanhoutvin%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DSchachner%26aufirst%3DM.%26aulast%3DL%25C3%25B3pez-Bendito%26aufirst%3DG.%26aulast%3DManess%26aufirst%3DP.%2BF.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3D%252C%2520Patricia%252C%2520F.%253B%252C%2520B.%2520Antagonistic%2520effects%2520of%2520BACE1%2520and%2520APH1B-%25CE%25B3-secretase%2520control%2520axonal%2520guidance%2520by%2520regulating%2520growth%2520cone%2520collapse%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D12%26spage%3D1367%26epage%3D1376%26doi%3D10.1016%2Fj.celrep.2015.07.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koroniak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeitschel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volbracht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepers, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmeister, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span> <span> </span><span class="NLM_article-title">Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">3157</span>– <span class="NLM_lpage">3168</span>, <span class="refDoi"> DOI: 10.1038/emboj.2012.173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1038%2Femboj.2012.173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=22728825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFyru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=3157-3168&author=P.+H.+Kuhnauthor=K.+Koroniakauthor=S.+Hoglauthor=A.+Colomboauthor=U.+Zeitschelauthor=M.+Willemauthor=C.+Volbrachtauthor=U.+Schepersauthor=A.+Imhofauthor=A.+Hoffmeisterauthor=C.+Haassauthor=S.+Rossnerauthor=S.+Braseauthor=S.+F.+Lichtenthaler&title=Secretome+protein+enrichment+identifies+physiological+BACE1+protease+substrates+in+neurons&doi=10.1038%2Femboj.2012.173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons</span></div><div class="casAuthors">Kuhn, Peer-Hendrik; Koroniak, Katarzyna; Hogl, Sebastian; Colombo, Alessio; Zeitschel, Ulrike; Willem, Michael; Volbracht, Christiane; Schepers, Ute; Imhof, Axel; Hoffmeister, Albrecht; Haass, Christian; Rossner, Steffen; Brase, Stefan; Lichtenthaler, Stefan F.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3157-3168</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cell surface proteolysis is essential for communication between cells and results in the shedding of membrane-protein ectodomains.  However, physiol. substrates of the contributing proteases are largely unknown.  We developed the secretome protein enrichment with click sugars (SPECS) method, which allows proteome-wide identification of shedding substrates and secreted proteins from primary cells, even in the presence of serum proteins.  SPECS combines metabolic glycan labeling and click chem.-mediated biotinylation and distinguishes between cellular and serum proteins.  SPECS identified 34, mostly novel substrates of the Alzheimer protease BACE1 in primary neurons, making BACE1 a major sheddase in the nervous system.  Selected BACE1 substrates- seizure protein 6, L1, CHL1 and contactin-2 -were validated in brains of BACE1 inhibitor-treated and BACE1 knock-out mice.  For some substrates, BACE1 was the major sheddase, whereas for other substrates addnl. proteases contributed to total substrate shedding.  The new substrates point to a central function of BACE1 in neurite outgrowth and synapse formation.  SPECS is also suitable for quant. secretome analyses of primary cells and may be used for the discovery of biomarkers secreted from tumor or stem cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVPr6CAqExQ7Vg90H21EOLACvtfcHk0lg0H_znKrKK-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFyru7g%253D&md5=460beb4f3c08023d54c72e7c772464b1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Femboj.2012.173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2012.173%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DP.%2BH.%26aulast%3DKoroniak%26aufirst%3DK.%26aulast%3DHogl%26aufirst%3DS.%26aulast%3DColombo%26aufirst%3DA.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DVolbracht%26aufirst%3DC.%26aulast%3DSchepers%26aufirst%3DU.%26aulast%3DImhof%26aufirst%3DA.%26aulast%3DHoffmeister%26aufirst%3DA.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DBrase%26aufirst%3DS.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26atitle%3DSecretome%2520protein%2520enrichment%2520identifies%2520physiological%2520BACE1%2520protease%2520substrates%2520in%2520neurons%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D3157%26epage%3D3168%26doi%3D10.1038%2Femboj.2012.173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wessels, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lines, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozley, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furtek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupre, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shering, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M. F.</span></span> <span> </span><span class="NLM_article-title">Cognitive outcomes in trials of two BACE inhibitors in Alzheimer’s disease</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1002/alz.12164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Falz.12164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=33049114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BB3s7gslelsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&pages=1483-1492&author=A.+M.+Wesselsauthor=C.+Linesauthor=R.+A.+Sternauthor=J.+Kostauthor=T.+Vossauthor=L.+H.+Mozleyauthor=C.+Furtekauthor=Y.+Mukaiauthor=P.+S.+Aisenauthor=J.+L.+Cummingsauthor=P.+N.+Tariotauthor=B.+Vellasauthor=N.+Dupreauthor=C.+Randolphauthor=D.+Michelsonauthor=S.+W.+Andersenauthor=C.+Sheringauthor=J.+R.+Simsauthor=M.+F.+Egan&title=Cognitive+outcomes+in+trials+of+two+BACE+inhibitors+in+Alzheimer%E2%80%99s+disease&doi=10.1002%2Falz.12164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease</span></div><div class="casAuthors">Wessels Alette M; Andersen Scott W; Sims John R; Lines Christopher; Kost James; Voss Tiffini; Mozley Lyn Harper; Furtek Christine; Mukai Yuki; Dupre Nicole; Michelson David; Egan Michael F; Stern Robert A; Aisen Paul S; Cummings Jeffrey L; Tariot Pierre N; Vellas Bruno; Randolph Christopher; Shering Craig</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1483-1492</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  The APECS and AMARANTH trials showed that beta-secretase (BACE) inhibitors verubecestat and lanabecestat failed to slow cognitive and functional decline in individuals with prodromal or early Alzheimer's disease.  Here, the performance on secondary and exploratory cognitive measures in both studies is reported.  METHODS:  APECS (verubecestat) and AMARANTH (lanabecestat) were randomized, double-blind, placebo-controlled, parallel-group, 104-week clinical trials conducted by different sponsors.  Measures included the 3-Domain Composite Cognition Score (CCS-3D), Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), Letter/Category Fluency, and Digit Symbol Coding.  RESULTS:  Verubecestat showed worsening on the CCS-3D Total Score, Episodic Memory, and Attention/Processing Speed domains.  Lanabecestat showed worsening on the RBANS Total Score, Immediate Memory, and Visuospatial/Constructional Indexes.  Both BACE inhibitors showed worsening on Digit Symbol Coding and improvements on Letter/Category Fluency.  DISCUSSION:  In both studies, many measures showed treatment-associated cognitive worsening, whereas verbal fluency tasks showed improvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDzIKAQTpERszK395ZObgVfW6udTcc2eZmHG1tosx1Irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3s7gslelsA%253D%253D&md5=a6283201cc86fea79a538948fc730e31</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Falz.12164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Falz.12164%26sid%3Dliteratum%253Aachs%26aulast%3DWessels%26aufirst%3DA.%2BM.%26aulast%3DLines%26aufirst%3DC.%26aulast%3DStern%26aufirst%3DR.%2BA.%26aulast%3DKost%26aufirst%3DJ.%26aulast%3DVoss%26aufirst%3DT.%26aulast%3DMozley%26aufirst%3DL.%2BH.%26aulast%3DFurtek%26aufirst%3DC.%26aulast%3DMukai%26aufirst%3DY.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DDupre%26aufirst%3DN.%26aulast%3DRandolph%26aufirst%3DC.%26aulast%3DMichelson%26aufirst%3DD.%26aulast%3DAndersen%26aufirst%3DS.%2BW.%26aulast%3DShering%26aufirst%3DC.%26aulast%3DSims%26aufirst%3DJ.%2BR.%26aulast%3DEgan%26aufirst%3DM.%2BF.%26atitle%3DCognitive%2520outcomes%2520in%2520trials%2520of%2520two%2520BACE%2520inhibitors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2020%26volume%3D16%26spage%3D1483%26epage%3D1492%26doi%3D10.1002%2Falz.12164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H. L.</span></span> <span> </span><span class="NLM_article-title">BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer’s disease</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6765</span>– <span class="NLM_lpage">6813</span>, <span class="refDoi"> DOI: 10.1039/C3CS60460H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1039%2FC3CS60460H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=24691405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6765-6813&author=A.+K.+Ghoshauthor=H.+L.+Osswald&title=BACE1+%28beta-secretase%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC3CS60460H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Osswald, Heather L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6765-6813</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">BACE1 (β-secretase, memapsin 2, Asp2) has emerged as a promising target for the treatment of Alzheimer's disease.  BACE1 is an aspartic protease which functions in the first step of the pathway leading to the prodn. and deposition of amyloid-β peptide (Aβ).  Its gene deletion showed only mild phenotypes.  BACE1 inhibition has direct implications in the Alzheimer's disease pathol. without largely affecting viability.  However, inhibiting BACE1 selectively in vivo has presented many challenges to medicinal chemists.  Since its identification in 2000, inhibitors covering many different structural classes have been designed and developed.  These inhibitors can be largely classified as either peptidomimetic or non-peptidic inhibitors.  Progress in these fields resulted in inhibitors that contain many targeted drug-like characteristics.  In this review, we describe structure-based design strategies and evolution of a wide range of BACE1 inhibitors including compds. that have been shown to reduce brain Aβ, rescue the cognitive decline in transgenic AD mice and inhibitor drug candidates that are currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri59_pgGAbxLVg90H21EOLACvtfcHk0lg_GriGzn1USg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ&md5=dab445bf7efb6fdc0c80e032d3bb0071</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2FC3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60460H%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DBACE1%2520%2528beta-secretase%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6765%26epage%3D6813%26doi%3D10.1039%2FC3CS60460H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeever, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of beta-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4156</span>– <span class="NLM_lpage">4180</span>, <span class="refDoi"> DOI: 10.1021/jm301659n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure-based+design+of+beta-site+APP+cleaving+enzyme+1+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301659n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Yuan, Jing; Venkatraman, Shankar; Zheng, Yajun; McKeever, Brian M.; Dillard, Lawrence W.; Singh, Suresh B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4156-4180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis asserts that excess prodn. or reduced clearance of the amyloid-β (Aβ) peptides in the brain initiates a sequence of events that ultimately lead to Alzheimer's disease dementia.  The Aβ hypothesis has identified BACE1 as a therapeutic target to treat Alzheimer's and led to medicinal chem. efforts to design its inhibitors both in the pharmaceutical industry and in academia.  This review summarizes two distinct categories of inhibitors designed based on conformational states of "closed" and "open" forms of the enzyme.  In each category the inhibitors are classified based on the core catalytic interaction group or the aspartyl binding motif (ABM).  This review covers the description of inhibitors in each ABM class with X-ray crystal structures of key compds., their binding modes, related structure-activity data highlighting potency advances, and addnl. properties such as selectivity profile, P-gp efflux, pharmacokinetic, and pharmacodynamic data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLs7KN_eIzbVg90H21EOLACvtfcHk0lg_GriGzn1USg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D&md5=b703f57572b737b47658d86f5b730087</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520beta-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180%26doi%3D10.1021%2Fjm301659n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C. L.</span></span> <span> </span><span class="NLM_article-title">Strategies to optimize the brain availability of central nervous system drug candidates</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1517/17460441.2011.564158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1517%2F17460441.2011.564158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=22646015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVKmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=371-381&author=T.+T.+Wagerauthor=A.+Villalobosauthor=P.+R.+Verhoestauthor=X.+Houauthor=C.+L.+Shaffer&title=Strategies+to+optimize+the+brain+availability+of+central+nervous+system+drug+candidates&doi=10.1517%2F17460441.2011.564158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies to optimize the brain availability of central nervous system drug candidates</span></div><div class="casAuthors">Wager, Travis T.; Villalobos, Anabella; Verhoest, Patrick R.; Hou, Xinjun; Shaffer, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-381</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Access to the CNS is essential for most neurotherapeutics to elicit their effects.  Leveraging design strategies incorporating physicochem. properties, in vitro and in vivo assays to predict and measure brain penetration, and brain delivery approaches may enable the drug discovery community to improve access of drug candidates into the CNS compartment.Areas covered: This article reviews aspects of the most recent mol. design, in vitro and in vivo strategies, and delivery technologies to optimize the unbound brain concns. (C b,u) of CNS mols.  Through this, the article provides insight into recent ideas and concepts in CNS drug mol. design, methods for evaluating CNS drug exposures and alternative approaches to maximize drug access to neurocompartments.Expert opinion: The most pharmacol. relevant measure in assessing a compd.'s pharmacodynamic response in the CNS is its C b,u.  The utilization of emerging design strategies, together with in vitro and in vivo assays, may enable the design of mols. with optimal C b,u:C p,u (C p,u, unbound plasma concn.) and appropriate C b,u, to elicit a biol. response from the neurotherapeutic target.  Where drug properties intrinsically render a compd. CNS impaired, using novel CNS delivery approaches may result in sufficient C b,u to furnish a biol. response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs2ijS8dIydLVg90H21EOLACvtfcHk0lg_GriGzn1USg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVKmsbw%253D&md5=09a2b8b06bdbdc63db728416cb01081f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F17460441.2011.564158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2011.564158%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DStrategies%2520to%2520optimize%2520the%2520brain%2520availability%2520of%2520central%2520nervous%2520system%2520drug%2520candidates%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D371%26epage%3D381%26doi%3D10.1517%2F17460441.2011.564158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekaran, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Will, Y.</span></span> <span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">434</span>, <span class="refDoi"> DOI: 10.1021/cn100007x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes&doi=10.1021%2Fcn100007x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0ljz2JjwFHD5Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434%26doi%3D10.1021%2Fcn100007x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mireles, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Morais, S. M.</span></span> <span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1124/dmd.107.017434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system&doi=10.1124%2Fdmd.107.017434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0ljz2JjwFHD5Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275%26doi%3D10.1124%2Fdmd.107.017434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosea, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callegari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianfrogna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hop, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasman, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laperle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maclin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedza, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahematpura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raunig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spracklin, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Deusen, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walens, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasgar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span> <span> </span><span class="NLM_article-title">The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1124/dmd.104.001230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1124%2Fdmd.104.001230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=15502009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlentw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=165-174&author=A.+Doranauthor=R.+S.+Obachauthor=B.+J.+Smithauthor=N.+A.+Hoseaauthor=S.+Beckerauthor=E.+Callegariauthor=C.+Chenauthor=X.+Chenauthor=E.+Chooauthor=J.+Cianfrognaauthor=L.+M.+Coxauthor=J.+P.+Gibbsauthor=M.+A.+Gibbsauthor=H.+Hatchauthor=C.+E.+Hopauthor=I.+N.+Kasmanauthor=J.+Laperleauthor=J.+Liuauthor=X.+Liuauthor=M.+Logmanauthor=D.+Maclinauthor=F.+M.+Nedzaauthor=F.+Nelsonauthor=E.+Olsonauthor=S.+Rahematpuraauthor=D.+Raunigauthor=S.+Rogersauthor=K.+Schmidtauthor=D.+K.+Spracklinauthor=M.+Szewcauthor=M.+Troutmanauthor=E.+Tsengauthor=M.+Tuauthor=J.+W.+Van+Deusenauthor=K.+Venkatakrishnanauthor=G.+Walensauthor=E.+Q.+Wangauthor=D.+Wongauthor=A.+S.+Yasgarauthor=C.+Zhang&title=The+impact+of+P-glycoprotein+on+the+disposition+of+drugs+targeted+for+indications+of+the+central+nervous+system%3A+evaluation+using+the+MDR1A%2F1B+knockout+mouse+model&doi=10.1124%2Fdmd.104.001230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model</span></div><div class="casAuthors">Doran, Angela; Obach, R. Scott; Smith, Bill J.; Hosea, Natilie A.; Becker, Stacey; Callegari, Ernesto; Chen, Cuiping; Chen, Xi; Choo, Edna; Cianfrogna, Julie; Cox, Loretta M.; Gibbs, John P.; Gibbs, Megan A.; Hatch, Heather; Hop, Cornelis E. C. A.; Kasman, Ilana N.; LaPerle, Jennifer; Liu, JianHua; Liu, Xingrong; Logman, Michael; Maclin, Debra; Nedza, Frank M.; Nelson, Frederick; Olson, Emily; Rahematpura, Sandhya; Raunig, David; Rogers, Sabrinia; Schmidt, Kari; Spracklin, Douglas K.; Szewc, Mark; Troutman, Matthew; Tseng, Elaine; Tu, Meihua; Van Deusen, Jeffrey W.; Venkatakrishnan, Karthik; Walens, Gary; Wang, Ellen Q.; Wong, Diane; Yasgar, Adam S.; Zhang, Chenghong</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-174</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-two structurally diverse drugs used for the treatment of various conditions of the central nervous system (CNS), along with two active metabolites, and eight non-CNS drugs were measured in brain, plasma, and cerebrospinal fluid in the P-glycoprotein (P-gp) knockout mouse model after s.c. administration, and the data were compared with corresponding data obtained in wild-type mice.  Total brain-to-plasma (B/P) ratios for the CNS agents ranged from 0.060 to 24.  Of the 34 CNS-active agents, only 7 demonstrated B/P area under the plasma concn. curve ratios between P-gp knockout and wild-type mice that did not differ significantly from unity.  Most of the remaining drugs demonstrated 1.1- to 2.6-fold greater B/P ratios in P-gp knockout mice vs. wild-type mice.  Three, risperidone, its active metabolite 9-hydroxyrisperidone, and metoclopramide, showed marked differences in B/P ratios between knockout and wild-type mice (6.6- to 17-fold).  Differences in B/P ratios and cerebrospinal fluid/plasma ratios between wild-type and knockout animals were correlated.  Through the use of this model, it appears that most CNS-active agents demonstrate at least some P-gp-mediated transport that can affect brain concns.  However, the impact for the majority of agents is probably minor.  The example of risperidone illustrates that even good P-gp substrates can still be clin. useful CNS-active agents.  However, for such agents, unbound plasma concns. may need to be greater than values projected using receptor affinity data to achieve adequate receptor occupancy for effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCLikZvvYtAbVg90H21EOLACvtfcHk0lgrWAmojhpNSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlentw%253D%253D&md5=58acf489206dfeaaa96da4329e403710</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001230%26sid%3Dliteratum%253Aachs%26aulast%3DDoran%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DHosea%26aufirst%3DN.%2BA.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DCox%26aufirst%3DL.%2BM.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DGibbs%26aufirst%3DM.%2BA.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DHop%26aufirst%3DC.%2BE.%26aulast%3DKasman%26aufirst%3DI.%2BN.%26aulast%3DLaperle%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLogman%26aufirst%3DM.%26aulast%3DMaclin%26aufirst%3DD.%26aulast%3DNedza%26aufirst%3DF.%2BM.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DOlson%26aufirst%3DE.%26aulast%3DRahematpura%26aufirst%3DS.%26aulast%3DRaunig%26aufirst%3DD.%26aulast%3DRogers%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DSzewc%26aufirst%3DM.%26aulast%3DTroutman%26aufirst%3DM.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DVan%2BDeusen%26aufirst%3DJ.%2BW.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26aulast%3DWalens%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DE.%2BQ.%26aulast%3DWong%26aufirst%3DD.%26aulast%3DYasgar%26aufirst%3DA.%2BS.%26aulast%3DZhang%26aufirst%3DC.%26atitle%3DThe%2520impact%2520of%2520P-glycoprotein%2520on%2520the%2520disposition%2520of%2520drugs%2520targeted%2520for%2520indications%2520of%2520the%2520central%2520nervous%2520system%253A%2520evaluation%2520using%2520the%2520MDR1A%252F1B%2520knockout%2520mouse%2520model%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D165%26epage%3D174%26doi%3D10.1124%2Fdmd.104.001230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raub, T. J.</span></span> <span> </span><span class="NLM_article-title">P-glycoprotein recognition of substrates and circumvention through rational drug design</span>. <i>Mol. Pharmceutics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1021/mp0500871</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp0500871" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlagu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=3-25&author=T.+J.+Raub&title=P-glycoprotein+recognition+of+substrates+and+circumvention+through+rational+drug+design&doi=10.1021%2Fmp0500871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design</span></div><div class="casAuthors">Raub, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is now well recognized that membrane efflux transporters, esp. P-glycoprotein (P-gp; ABCB1), play a role in detg. the absorption, distribution, metab., excretion, and toxicol. behaviors of some drugs and mols. in development.  An investment in screening structure-activity relation (SAR) is warranted in early discovery when exposure and/or target activity in an in vivo efficacy model is not achieved and P-gp efflux is identified as a rate-limiting factor.  However, the amt. of investment in SAR must be placed into perspective by assessing the risks assocd. with the intended therapeutic target, the potency and margin of safety of the compd., the intended patient population(s), and the market competition.  The task of rationally designing a chem. strategy for circumventing a limiting P-gp interaction can be daunting.  The necessity of retaining biol. potency and metabolic stability places restrictions on what can be done, and the factors for P-gp recognition of substrates are complicated and poorly understood.  The parameters within the assays that affect overall pump efficiency or net efflux, such as passive diffusion, membrane partitioning, and mol. interaction between pump and substrate, should be understood when interpreting data sets assocd. with chem. around a scaffold.  No single, functional group alone is often the cause, but one group can accentuate the recognition points existing within a scaffold.  This can be likened to a rheostat, rather than an on/off switch, where addn. or removal of a key group can increase or decrease the pumping efficiency.  The most practical approach to de-emphasize the limiting effects of P-gp on a particular scaffold is to increase passive diffusion.  Efflux pumping efficiency may be overcome when passive diffusion is fast enough.  Eliminating, or substituting with fewer, groups that solvate in water, or decreasing their hydrogen bonding capacity, and adding halogen groups can increase passive diffusion.  Reducing mol. size, replacing electroneg. atoms, blocking or masking H-bond donors with N-alkylation or bulky flanking groups, introducing constrained conformation, or by promoting intramol. hydrogen bonds are all examples of steps to take.  This review discusses our understanding of how P-gp recognizes and pumps compds. as substrates and describes cases where structural changes were made in a chem. scaffold to circumvent the effects of P-gp interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRbEgPosNnxrVg90H21EOLACvtfcHk0lgrWAmojhpNSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlagu7%252FP&md5=cc89be920dfa0e32edb994be94626aa5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fmp0500871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp0500871%26sid%3Dliteratum%253Aachs%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26atitle%3DP-glycoprotein%2520recognition%2520of%2520substrates%2520and%2520circumvention%2520through%2520rational%2520drug%2520design%26jtitle%3DMol.%2520Pharmceutics%26date%3D2006%26volume%3D3%26spage%3D3%26epage%3D25%26doi%3D10.1021%2Fmp0500871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahar
Doan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wring, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shampine, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serabjit-Singh, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adkison, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polli, J. W.</span></span> <span> </span><span class="NLM_article-title">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">1029</span>– <span class="NLM_lpage">1037</span>, <span class="refDoi"> DOI: 10.1124/jpet.102.039255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1124%2Fjpet.102.039255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=12438524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=1029-1037&author=K.+M.+Mahar%0ADoanauthor=J.+E.+Humphreysauthor=L.+O.+Websterauthor=S.+A.+Wringauthor=L.+J.+Shampineauthor=C.+J.+Serabjit-Singhauthor=K.+K.+Adkisonauthor=J.+W.+Polli&title=Passive+permeability+and+P-glycoprotein-mediated+efflux+differentiate+central+nervous+system+%28CNS%29+and+non-CNS+marketed+drugs&doi=10.1124%2Fjpet.102.039255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span></div><div class="casAuthors">Mahar Doan Kelly M; Humphreys Joan E; Webster Lindsey O; Wring Stephen A; Shampine Larry J; Serabjit-Singh Cosette J; Adkison Kimberly K; Polli Joseph W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1029-37</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Membrane permeability and P-glycoprotein (Pgp) can be limiting factors for blood-brain barrier penetration.  The objectives of this study were to determine whether there are differences in the in vitro permeability, Pgp substrate profiles, and physicochemical properties of drugs for central nervous system (CNS) and non-CNS indications, and whether these differences are useful criteria in selecting compounds for drug development.  Apparent permeability (P(app)) and Pgp substrate profiles for 93 CNS (n = 48) and non-CNS (n = 45) drugs were determined by monolayer efflux.  Calcein-AM inhibition assays were used to supplement the efflux results.  The CNS set (2 of 48, 4.2%) had a 7-fold lower incidence of passive permeability values <150 nm/s compared with the non-CNS set (13 of 45, 28.9%).  The majority of drugs (72.0%, 67 of 93) were not Pgp substrates; however, 49.5% (46 of 93) were positive in the calcein-AM assay when tested at 100 microM.  The CNS drug set (n = 7 of 48, 14.6%) had a 3-fold lower incidence of Pgp-mediated efflux than the non-CNS drug set (n = 19 of 45, 42.2%).  Analysis of 18 physicochemical properties revealed that the CNS drug set had fewer hydrogen bond donors, fewer positive charges, greater lipophilicity, lower polar surface area, and reduced flexibility compared with the non-CNS group (p < 0.05), properties that enhance membrane permeability.  This study on a large, diverse set of marketed compounds clearly demonstrates that permeability, Pgp-mediated efflux, and certain physicochemical properties are factors that differentiate CNS and non-CNS drugs.  For CNS delivery, a drug should ideally have an in vitro passive permeability >150 nm/s and not be a good (B --> A/A --> B ratio <2.5) Pgp substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_HiV1Xqt18Vf1XRtfYM0dfW6udTcc2ebu7Vipbtd287ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D&md5=b841902aa8502de47c1e1603c80e09fb</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039255%26sid%3Dliteratum%253Aachs%26aulast%3DMahar%2BDoan%26aufirst%3DK.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DShampine%26aufirst%3DL.%2BJ.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26aulast%3DAdkison%26aufirst%3DK.%2BK.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DPassive%2520permeability%2520and%2520P-glycoprotein-mediated%2520efflux%2520differentiate%2520central%2520nervous%2520system%2520%2528CNS%2529%2520and%2520non-CNS%2520marketed%2520drugs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D1029%26epage%3D1037%26doi%3D10.1124%2Fjpet.102.039255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span> <span> </span><span class="NLM_article-title">Structural modifications that alter the P-glycoprotein efflux properties of compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4877</span>– <span class="NLM_lpage">4895</span>, <span class="refDoi"> DOI: 10.1021/jm201136z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=S.+A.+Hitchcock&title=Structural+modifications+that+alter+the+P-glycoprotein+efflux+properties+of+compounds&doi=10.1021%2Fjm201136z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span></div><div class="casAuthors">Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4877-4895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This perspective is focused on structural modifications and strategies that can be applied during compd. optimization in order to modulate the P-glycoprotein efflux properties of small mols. with a particular emphasis on implications for CNS penetration. The precise mol. interactions that confer P-glycoprotein efflux remain relatively poorly defined. The promiscuous nature of P-glycoprotein efflux renders the rational circumvention of efflux, while simultaneously optimizing compds. for eficacy, safety, and pharmacokinetic properties, an extremely challenging undertaking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_5RBtwgb-rVg90H21EOLACvtfcHk0lhci9gQanvqyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D&md5=6c5dffbb11db6fa893ff3c50fe7778cc</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-glycoprotein%2520efflux%2520properties%2520of%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895%26doi%3D10.1021%2Fjm201136z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Didziapetris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Japertas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrauskas, A.</span></span> <span> </span><span class="NLM_article-title">Classification analysis of P-glycoprotein substrate specificity</span>. <i>J. Drug Targeting</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1080/10611860310001648248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1080%2F10611860310001648248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=15203928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFOjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=391-406&author=R.+Didziapetrisauthor=P.+Japertasauthor=A.+Avdeefauthor=A.+Petrauskas&title=Classification+analysis+of+P-glycoprotein+substrate+specificity&doi=10.1080%2F10611860310001648248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Classification Analysis of P-Glycoprotein Substrate Specificity</span></div><div class="casAuthors">Didziapetris, Remigijus; Japertas, Pranas; Avdeef, Alex; Petrauskas, Alanas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">391-406</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Prediction of P-glycoprotein substrate specificity (SPGP) can be viewed as a constituent part of a compd.'s "pharmaceutical profiling" in drug design.  This task is difficult to achieve due to several factors that raised many contradictory opinions: (i) the disparity between the SPGP values obtained in different assays, (ii) the confusion between Pgp substrates and inhibitors, (iii) the confusion between lipophilicity and amphiphilicity of Pgp substrates, and (iv) the dilemma of describing class-specific relationships when Pgp has no binding sites of high ligand specificity.  In this work, the authors compiled SPGP data for 1000 compds.  All data were represented in a binary format, assigning SPGP = 1 for substrates and SPGP = 0 for nonsubstrates.  Each value was ranked according to the reliability of exptl. assay.  Two data sets were considered.  Set 1 included 220 compds. with SPGP from polarized transport across MDR1 transfected cell monolayers.  Set 2 included the entire list of 1000 compds., with SPGP values of generally lower reliability.  Both sets were analyzed using a stepwise classification structure-activity relationship (C-SAR) method, leading to derivation of simple rules for crude estn. of SPGP values.  The obtained rules are based on the following factors: (i) compd.'s size expressed through molar wt. or vol., (ii) H-accepting given by the Abraham's β (that can be crudely approximated by the sum of O and N atoms), and (iii) ionization given by the acid and base pKa values.  Very roughly, SPGP can be estd. by the "rule of fours".  Compds. with (N + O) ≥ 8, MW > 400 and acid pKa > 4 are likely to be Pgp substrates, whereas compds. with (N+O) ≤ 4, MW < 400 and base pKa < 8 are likely to be nonsubstrates.  The obtained results support the view that Pgp functioning can be compared to a complex "mini-pharmacokinetic" system with fuzzy specificity.  This system can be described by a probabilistic version of Abraham's solvation equation, suggesting a certain similarity between Pgp transport and chromatog. retention.  The chromatog. model does not work in the case of "marginal" compds. with properties close to the "global" physicochem. cut-offs.  In the latter case various class-specific rules must be considered.  These can be assocd. with the "amphiphilicity" and "biol. similarity" of compds.  The definition of class-specific effects entails construction of the knowledge base that can be very useful in ADME profiling of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsvKJmruZ7RLVg90H21EOLACvtfcHk0liOaSrNGdxaHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFOjs7k%253D&md5=5b7ea95eb2d9faded5645481c1330f03</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1080%2F10611860310001648248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10611860310001648248%26sid%3Dliteratum%253Aachs%26aulast%3DDidziapetris%26aufirst%3DR.%26aulast%3DJapertas%26aufirst%3DP.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DPetrauskas%26aufirst%3DA.%26atitle%3DClassification%2520analysis%2520of%2520P-glycoprotein%2520substrate%2520specificity%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D2003%26volume%3D11%26spage%3D391%26epage%3D406%26doi%3D10.1080%2F10611860310001648248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norinder, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, M.</span></span> <span> </span><span class="NLM_article-title">Computational approaches to the prediction of the blood-brain distribution</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(02)00005-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2FS0169-409X%2802%2900005-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=11922949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD38Xitlartbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=291-313&author=U.+Norinderauthor=M.+Haeberlein&title=Computational+approaches+to+the+prediction+of+the+blood-brain+distribution&doi=10.1016%2FS0169-409X%2802%2900005-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Computational approaches to the prediction of the blood-brain distribution</span></div><div class="casAuthors">Norinder, Ulf; Haeberlein, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-313</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  This review attempts to summarize present knowledge related to the theor. modeling of drug transport across the blood-brain barrier.  Several computational protocols are described ranging from quantum mechanics-based approaches through mol. mechanics-related techniques to simple and fast procedures based on only the 2-D graph of the investigated structures.  Amazingly, few descriptors have been shown to influence the derived relationships in a significant manner and a cornerstone in most of the described models are terms describing hydrogen bonding.  A very quick quant. assessment of the brain partitioning of a compd. has also been devised using the following two rules: If N+O (the no. of nitrogen and oxygen atoms) in a mol. is less than or equal to five, it has a high chance of entering the brain.  The second rule predicts that if log P-(N+O) is pos. then log BB is pos.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy9Yd_Pc0M07Vg90H21EOLACvtfcHk0liOaSrNGdxaHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xitlartbg%253D&md5=cc689594714a0afb9f67917c77530d8c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2802%2900005-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252802%252900005-4%26sid%3Dliteratum%253Aachs%26aulast%3DNorinder%26aufirst%3DU.%26aulast%3DHaeberlein%26aufirst%3DM.%26atitle%3DComputational%2520approaches%2520to%2520the%2520prediction%2520of%2520the%2520blood-brain%2520distribution%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D291%26epage%3D313%26doi%3D10.1016%2FS0169-409X%2802%2900005-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, D. E.</span></span> <span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. prediction of intestinal absorption</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">814</span>, <span class="refDoi"> DOI: 10.1021/js9804011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1021%2Fjs9804011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10430547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVCqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=807-814&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+1.+prediction+of+intestinal+absorption&doi=10.1021%2Fjs9804011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Calculation of Polar Molecular Surface Area and Its Application to the Prediction of Transport Phenomena. 1. Prediction of Intestinal Absorption</span></div><div class="casAuthors">Clark, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">807-814</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A method for the rapid computation of polar mol. surface area (PSA) is described.  It is shown that consideration of only a single conformer when computing PSA gives an excellent correlation with intestinal absorption data-as good as previously reported methods employing multiple conformers.  Circumventing a time-consuming conformational anal. opens the possibility of computationally screening large nos. of compds. for problems relating to absorption prior to synthesis.  The robustness of the criterion for identifying poorly absorbed compds. (PSA ≥ 140 Å2) is illustrated through its application to a diverse test set of 74 drugs.  The PSA-based method is also compared to an exptl. method for absorption prediction recently described in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQFZqLLPfnWLVg90H21EOLACvtfcHk0liOaSrNGdxaHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVCqtbw%253D&md5=8692bd27f4b5b5c5f250379678a75693</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjs9804011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs9804011%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25201.%2520prediction%2520of%2520intestinal%2520absorption%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D807%26epage%3D814%26doi%3D10.1021%2Fjs9804011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aronov, A. M.</span></span> <span> </span><span class="NLM_article-title">Ligand structural aspects of hERG channel blockade</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1113</span>– <span class="NLM_lpage">1127</span>, <span class="refDoi"> DOI: 10.2174/156802608785700061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.2174%2F156802608785700061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=18782007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1113-1127&author=A.+M.+Aronov&title=Ligand+structural+aspects+of+hERG+channel+blockade&doi=10.2174%2F156802608785700061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand structural aspects of hERG channel blockade</span></div><div class="casAuthors">Aronov, Alex M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1113-1127</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sudden death as a side effect of action of non-antiarrhythmic drugs is a major pharmacol. safety concern facing the pharmaceutical industry and the health regulatory authorities.  A no. of drugs have been withdrawn from the market in recent years due to cardiovascular toxicity assocd. with undesirable blockade of hERG potassium channel.  Pharmaceuticals of widely varying structure have been shown to interact with hERG.  Defining the mol. features that confer hERG inhibitory activity has therefore become a focus of considerable computational and statistical modeling efforts.  Some of the approaches are aimed primarily at filtering out potential hERG blockers in the context of virtual libraries, while others involve understanding structure-activity relationships governing hERG-drug interactions.  The ability of models to produce structural hypotheses that can be tested by the project teams has become the key prerequisite driving their organization-wide adoption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOveNNzD-TbLVg90H21EOLACvtfcHk0ljP2lWUnwCi1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrjE&md5=86bf7e5819d6ce234f850e17b7f397dd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F156802608785700061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785700061%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26atitle%3DLigand%2520structural%2520aspects%2520of%2520hERG%2520channel%2520blockade%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1113%26epage%3D1127%26doi%3D10.2174%2F156802608785700061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möbitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desrayaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Discovery of cyclic sulfone hydroxyethylamines as potent and selective beta-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid beta-peptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3364</span>– <span class="NLM_lpage">3386</span>, <span class="refDoi"> DOI: 10.1021/jm300069y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300069y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVCqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3364-3386&author=H.+Rueegerauthor=R.+Lueoendauthor=O.+Rogelauthor=J.+M.+Rondeauauthor=H.+M%C3%B6bitzauthor=R.+Machauerauthor=L.+Jacobsonauthor=M.+Staufenbielauthor=S.+Desrayaudauthor=U.+Neumann&title=Discovery+of+cyclic+sulfone+hydroxyethylamines+as+potent+and+selective+beta-site+APP-cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+structure-based+design+and+in+vivo+reduction+of+amyloid+beta-peptides&doi=10.1021%2Fjm300069y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Cyclic Sulfone Hydroxyethylamines as Potent and Selective β-Site APP-Cleaving Enzyme 1 (BACE1) Inhibitors: Structure-Based Design and in Vivo Reduction of Amyloid β-Peptides</span></div><div class="casAuthors">Rueeger, Heinrich; Lueoend, Rainer; Rogel, Olivier; Rondeau, Jean-Michel; Mobitz, Henrik; Machauer, Rainer; Jacobson, Laura; Staufenbiel, Matthias; Desrayaud, Sandrine; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3364-3386</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based design of a series of cyclic hydroxyethylamine BACE1 inhibitors allowed the rational incorporation of prime- and nonprime-side fragments to a central core template without any amide functionality.  The core scaffold selection and the structure-activity relationship development were supported by mol. modeling studies and by x-ray anal. of BACE1 complexes with various ligands to expedite the optimization of the series.  The direct extension from P1-aryl- and heteroaryl moieties into the S3 binding pocket allowed the enhancement of potency and selectivity over cathepsin D.  Restraining the design and synthesis of compds. to a physicochem. property space consistent with central nervous system drugs led to inhibitors with improved blood-brain barrier permeability.  Guided by structure-based optimization, highly potent compds. were obtained, such as I, with enzymic and cellular IC50 values of 2 and 50 nM, resp., and with >200-fold selectivity over cathepsin D.  Pharmacodynamic studies in APP51/16 transgenic mice at oral doses of 180 μmol/kg demonstrated significant redn. of brain Aβ levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9V9NMxnGHFbVg90H21EOLACvtfcHk0ljP2lWUnwCi1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVCqsLs%253D&md5=f7f4862b9ce1c682dfc2c7dba52d904f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm300069y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300069y%26sid%3Dliteratum%253Aachs%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DLueoend%26aufirst%3DR.%26aulast%3DRogel%26aufirst%3DO.%26aulast%3DRondeau%26aufirst%3DJ.%2BM.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DJacobson%26aufirst%3DL.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DDiscovery%2520of%2520cyclic%2520sulfone%2520hydroxyethylamines%2520as%2520potent%2520and%2520selective%2520beta-site%2520APP-cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520structure-based%2520design%2520and%2520in%2520vivo%2520reduction%2520of%2520amyloid%2520beta-peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3364%26epage%3D3386%26doi%3D10.1021%2Fjm300069y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desrayaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möbitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure based design and in vivo reduction of amyloid β-peptides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5300</span>– <span class="NLM_lpage">5306</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.07.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.bmcl.2013.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=23981898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKqsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5300-5306&author=H.+Rueegerauthor=R.+Lueoendauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=L.+H.+Jacobsonauthor=M.+Staufenbielauthor=S.+Desrayaudauthor=J.-M.+Rondeauauthor=H.+M%C3%B6bitzauthor=U.+Neumann&title=Discovery+of+cyclic+sulfoxide+hydroxyethylamines+as+potent+and+selective+%CE%B2-site+APP-cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+structure+based+design+and+in+vivo+reduction+of+amyloid+%CE%B2-peptides&doi=10.1016%2Fj.bmcl.2013.07.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: Structure based design and in vivo reduction of amyloid β-peptides</span></div><div class="casAuthors">Rueeger, Heinrich; Lueoend, Rainer; Machauer, Rainer; Veenstra, Siem Jacob; Jacobson, Laura Helen; Staufenbiel, Matthias; Desrayaud, Sandrine; Rondeau, Jean-Michel; Mobitz, Henrik; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5300-5306</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous structure based optimization in our labs. led to the identification of a novel, high-affinity cyclic sulfone hydroxyethylamine-derived inhibitor such as 1 that lowers CNS-derived Aβ following oral administration to transgenic APP51/16 mice.  Herein we report SAR development in the S3 and S2' subsites of BACE1 for cyclic sulfoxide hydroxyethyl amine inhibitors, the synthetic approaches employed in this effort, and in vivo data for optimized compd. such as 11d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbOR1eszn-oLVg90H21EOLACvtfcHk0lhSIQbu-CM_pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKqsbnM&md5=76495275df6859f9ec9dcee05eebb25e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DLueoend%26aufirst%3DR.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DRondeau%26aufirst%3DJ.-M.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DDiscovery%2520of%2520cyclic%2520sulfoxide%2520hydroxyethylamines%2520as%2520potent%2520and%2520selective%2520%25CE%25B2-site%2520APP-cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520structure%2520based%2520design%2520and%2520in%2520vivo%2520reduction%2520of%2520amyloid%2520%25CE%25B2-peptides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5300%26epage%3D5306%26doi%3D10.1016%2Fj.bmcl.2013.07.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylvester, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aharony, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andisik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folmer, R. H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geschwindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koether, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumrine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauger, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spear, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, G.</span></span> <span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5912</span>– <span class="NLM_lpage">5925</span>, <span class="refDoi"> DOI: 10.1021/jm070829p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+A.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.-L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency&doi=10.1021%2Fjm070829p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0lhSIQbu-CM_pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%2BA.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925%26doi%3D10.1021%2Fjm070829p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span> <span> </span><span class="NLM_article-title">Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6314</span>– <span class="NLM_lpage">6323</span>, <span class="refDoi"> DOI: 10.1021/jm9006752</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjtrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichaud&title=Aminoimidazoles+as+potent+and+selective+human+beta-secretase+%28BACE1%29+inhibitors&doi=10.1021%2Fjm9006752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoimidazoles as potent and selective human β-secretase (BACE1) inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Barnes, Keith; Johnson, Matthew; Hui, Yu; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Olland, Andrea; Bard, Jonathan; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6314-6323</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminoimidazoles as potent and selective human β-secretase inhibitors was reported.  These analogs demonstrated low nanomolar potency for BACE1 in a FRET assay, exhibited comparable activity in a cell-based (ELISA) assay, and showed >100× selectivity for the other structurally related aspartyl proteases BACE2, cathepsin D, renin, and pepsin.  The design strategy was supported by mol. modeling studies based on the co-crystal structure of HTS-hit I (R1 = R2 = H) in the BACE1 active site.  These strategies enabled integration of pyridine and pyrimidine groups onto I (R1 = R2 = H) extending deep into the S3 region of the BACE1 binding pocket and enhancing the ligand's potency.  Compd. (R)-I (R1 = CF3O, R2 = 2-fluoro-3-pyridinyl) displayed an IC50 value for BACE1 of 20 nM, cellular activity of 90 nM, and >100-fold selectivity over related aspartyl proteases.  Acute oral administration of (R)-I (R1 = CF3O, R2 = 2-fluoro-3-pyridinyl) at 30 mg/kg resulted in a significant 71% redn. of plasma Aβ40 measured at the 6 h time point in a Tg2576 mouse model (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFckRJKaaEOrVg90H21EOLACvtfcHk0lic5KO921Bz-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjtrvM&md5=ffab7cd593b9574711891bded74bf486</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520selective%2520human%2520beta-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323%26doi%3D10.1021%2Fjm9006752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, N.</span>; <span class="NLM_string-name">Ueda, K.</span>; <span class="NLM_string-name">Itoh, N.</span>; <span class="NLM_string-name">Suzuki, S.</span>; <span class="NLM_string-name">Sakaguchi, G.</span>; <span class="NLM_string-name">Kato, A.</span>; <span class="NLM_string-name">Yukimasa, A.</span>; <span class="NLM_string-name">Hori, A.</span>; <span class="NLM_string-name">Koriyama, Y.</span>; <span class="NLM_string-name">Haraguchi, H.</span>; <span class="NLM_string-name">Yasui, K.</span>; <span class="NLM_string-name">Kanda, Y.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-aminodihydrothiazine derivatives as β-secretase inhibitors</span>. <span class="NLM_patent">WO2007049532A1</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=N.+Kobayashi&author=K.+Ueda&author=N.+Itoh&author=S.+Suzuki&author=G.+Sakaguchi&author=A.+Kato&author=A.+Yukimasa&author=A.+Hori&author=Y.+Koriyama&author=H.+Haraguchi&author=K.+Yasui&author=Y.+Kanda&title=Preparation+of+2-aminodihydrothiazine+derivatives+as+%CE%B2-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DN.%26atitle%3DPreparation%2520of%25202-aminodihydrothiazine%2520derivatives%2520as%2520%25CE%25B2-secretase%2520inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukhdeo, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellingboe, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manas, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohse, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, J.</span></span> <span> </span><span class="NLM_article-title">Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1′ substrate binding pocket</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">771</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.bmcl.2007.11.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=18068983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFWrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=767-771&author=L.+D.+Jenningsauthor=D.+C.+Coleauthor=J.+R.+Stockauthor=M.+N.+Sukhdeoauthor=J.+W.+Ellingboeauthor=R.+Cowlingauthor=G.+Jinauthor=E.+S.+Manasauthor=K.+Y.+Fanauthor=M.+S.+Malamasauthor=B.+L.+Harrisonauthor=S.+Jacobsenauthor=R.+Chopraauthor=P.+A.+Lohseauthor=W.+J.+Mooreauthor=M.+M.+O%E2%80%99Donnellauthor=Y.+Huauthor=A.+J.+Robichaudauthor=M.+J.+Turnerauthor=E.+Wagnerauthor=J.+Bard&title=Acylguanidine+inhibitors+of+beta-secretase%3A+optimization+of+the+pyrrole+ring+substituents+extending+into+the+S1%E2%80%B2+substrate+binding+pocket&doi=10.1016%2Fj.bmcl.2007.11.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Acylguanidine inhibitors of β-secretase: Optimization of the pyrrole ring substituents extending into the S'1 substrate binding pocket</span></div><div class="casAuthors">Jennings, Lee D.; Cole, Derek C.; Stock, Joseph R.; Sukhdeo, Mohani N.; Ellingboe, John W.; Cowling, Rebecca; Jin, Guixian; Manas, Eric S.; Fan, Kristi Y.; Malamas, Michael S.; Harrison, Boyd L.; Jacobsen, Steve; Chopra, Rajiv; Lohse, Peter A.; Moore, William J.; O'Donnell, Mary-Margaret; Hu, Yun; Robichaud, Albert J.; Turner, M. James; Wagner, Erik; Bard, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">767-771</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The proteolytic enzyme β-secretase (BACE-1) produces amyloid β (Aβ) peptide, the primary constituent of neurofibrillary plaques, implicated in Alzheimer's disease, by cleavage of the amyloid precursor protein.  A small mol. inhibitor of BACE-1, (diaminomethylene)-2,5-diphenyl-1H-pyrrole-1-acetamide (1, BACE-1 IC50 = 3.7 μM), was recently described, representing a new small mol. lead.  Initial SAR investigation demonstrated the potential of accessing the nearby S3 and S 1 ' substrate binding pockets of the BACE-1 enzyme by building substituents off one of the Ph substituents and guanidinyl functional group.  We report here the optimization of guanidinyl functional group substituents on 1, leading to potent submicromolar BACE-1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg9cKbJVVi2rVg90H21EOLACvtfcHk0lgiUqM9pM7CUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFWrsQ%253D%253D&md5=3e06401a53234f4c8ad63d896e29e0f6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.043%26sid%3Dliteratum%253Aachs%26aulast%3DJennings%26aufirst%3DL.%2BD.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DStock%26aufirst%3DJ.%2BR.%26aulast%3DSukhdeo%26aufirst%3DM.%2BN.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DManas%26aufirst%3DE.%2BS.%26aulast%3DFan%26aufirst%3DK.%2BY.%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DLohse%26aufirst%3DP.%2BA.%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DM.%2BM.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26aulast%3DTurner%26aufirst%3DM.%2BJ.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DBard%26aufirst%3DJ.%26atitle%3DAcylguanidine%2520inhibitors%2520of%2520beta-secretase%253A%2520optimization%2520of%2520the%2520pyrrole%2520ring%2520substituents%2520extending%2520into%2520the%2520S1%25E2%2580%25B2%2520substrate%2520binding%2520pocket%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D767%26epage%3D771%26doi%3D10.1016%2Fj.bmcl.2007.11.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0lgiUqM9pM7CUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borders, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brier, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevorkyan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komjathy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaught, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winneroski, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span> <span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Abeta pharmacodynamic responses in mice, dogs, and humans</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1210</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4129-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1523%2FJNEUROSCI.4129-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=25609634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1199-1210&author=P.+C.+Mayauthor=B.+A.+Willisauthor=S.+L.+Loweauthor=R.+A.+Deanauthor=S.+A.+Monkauthor=P.+J.+Cockeauthor=J.+E.+Audiaauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+A.+Brierauthor=D.+O.+Calligaroauthor=T.+A.+Dayauthor=L.+Ereshefskyauthor=J.+A.+Ericksonauthor=H.+Gevorkyanauthor=C.+R.+Gonzalesauthor=D.+E.+Jamesauthor=S.+S.+Jheeauthor=S.+F.+Komjathyauthor=L.+Liauthor=T.+D.+Lindstromauthor=B.+M.+Mathesauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=G.+M.+Vaughtauthor=B.+M.+Watsonauthor=L.+L.+Winneroskiauthor=Z.+Yangauthor=D.+J.+Mergott&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+Abeta+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.4129-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span></div><div class="casAuthors">May, Patrick C.; Willis, Brian A.; Lowe, Stephen L.; Dean, Robert A.; Monk, Scott A.; Cocke, Patrick J.; Audia, James E.; Boggs, Leonard N.; Borders, Anthony R.; Brier, Richard A.; Calligaro, David O.; Day, Theresa A.; Ereshefsky, Larry; Erickso, Jon A.; Gevorkyan, Hykop; Gonzales, Celedon R.; James, Douglas E.; Jhee, Stanford S.; Komjathy, Steven F.; Li, Linglin; Lindstrom, Terry D.; Mathe, Brian M.; Martenyi, Ferenc; Sheehan, Scott M.; Stout, Stephanie L.; Timm, David E.; Vaught, Grant M.; Watson, Brian M.; Winneroski, Leonard L.; Yang, Zhixiang; Mergott, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1199-1210, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).  Therefore, the development of potent and selective inhibitors of BACE1 has been a focus of many drug discovery efforts in academia and industry.  Herein, we report the nonclin. and early clin. development of LY2886721, a BACE1 active site inhibitor that reached phase 2 clin. trials in AD.  LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclin. animal models.  Similar potent and persistent amyloid β lowering was obsd. in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects.  Collectively, these data add support for BACE1 inhibition as an effective means of amyloid lowering and as an attractive target for potential disease modification therapy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDFLhcsiUDLVg90H21EOLACvtfcHk0lj_k5j4ERCI_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D&md5=7e16cc00767a8af4da7dd17b6e40e8f5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4129-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4129-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26aulast%3DGevorkyan%26aufirst%3DH.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DJames%26aufirst%3DD.%2BE.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DKomjathy%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DVaught%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520Abeta%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D1199%26epage%3D1210%26doi%3D10.1523%2FJNEUROSCI.4129-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith
Labell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greg Hall, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span> <span> </span><span class="NLM_article-title">Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">16507</span>– <span class="NLM_lpage">16516</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith%0ALabellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-beta+in+humans+with+an+orally+available%2C+non-peptidic+beta-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lj_k5j4ERCI_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLabell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-beta%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520beta-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">1,4-Oxazine beta-secretase 1 (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8216</span>– <span class="NLM_lpage">8235</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Martinez-Lamencaauthor=M.+Van+Goolauthor=A.+Garcia-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+beta-secretase+1+%28BACE1%29+inhibitors%3A+from+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0lggZEXnNdho_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarcia-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520beta-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931) - a beta-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29+-+a+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0lj2ku7G3NXxBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529%2520-%2520a%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2678</span>– <span class="NLM_lpage">2702</span>, <span class="refDoi"> DOI: 10.1021/jm501833t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501833t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2678-2702&author=C.+R.+Butlerauthor=M.+A.+Brodneyauthor=E.+M.+Beckauthor=G.+Barreiroauthor=C.+E.+Nolanauthor=F.+Panauthor=F.+Vajdosauthor=K.+Parrisauthor=A.+H.+Vargheseauthor=C.+J.+Helalauthor=R.+Liraauthor=S.+D.+Doranauthor=D.+R.+Riddellauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=L.+A.+Martinez-Alsinaauthor=K.+Ogilvieauthor=J.+C.+Murrayauthor=J.+M.+Youngauthor=K.+Atchisonauthor=A.+Robshawauthor=C.+Gonzalesauthor=J.+Wangauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Discovery+of+a+series+of+efficient%2C+centrally+efficacious+BACE1+inhibitors+through+structure-based+drug+design&doi=10.1021%2Fjm501833t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></div><div class="casAuthors">Butler, Christopher R.; Brodney, Michael A.; Beck, Elizabeth M.; Barreiro, Gabriela; Nolan, Charles E.; Pan, Feng; Vajdos, Felix; Parris, Kevin; Varghese, Alison H.; Helal, Christopher J.; Lira, Ricardo; Doran, Shawn D.; Riddell, David R.; Buzon, Leanne M.; Dutra, Jason K.; Martinez-Alsina, Luis A.; Ogilvie, Kevin; Murray, John C.; Young, Joseph M.; Atchison, Kevin; Robshaw, Ashley; Gonzales, Cathleen; Wang, Jinlong; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metab., and excretion (ADME) properties.  In this paper, the authors describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or neg. impacting brain penetration and ADME alignment, as exemplified by I.  Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog.  In addn., chronic treatment in aged PS1/APP mice effects a decrease in the no. and size of Aβ-derived plaques.  Most importantly, evaluation of I in a 2-wk exploratory toxicol. study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histol. findings in the eye, issues obsd. with earlier BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNT62AGyml7Vg90H21EOLACvtfcHk0lj2ku7G3NXxBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D&md5=ac2a6fd661f7e9fd8b925deffd5e1010</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520efficient%252C%2520centrally%2520efficacious%2520BACE1%2520inhibitors%2520through%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2678%26epage%3D2702%26doi%3D10.1021%2Fjm501833t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, R. T.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harried, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minatti, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span> <span> </span><span class="NLM_article-title">An orally available BACE1 inhibitor that affords robust CNS Abeta reduction without cardiovascular liabilities</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1021/ml500458t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500458t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=210-215&author=Y.+Chengauthor=J.+Brownauthor=T.+C.+Juddauthor=P.+Lopezauthor=W.+Qianauthor=T.+S.+Powersauthor=J.+J.+Chenauthor=M.+D.+Bartbergerauthor=K.+Chenauthor=R.+T.+Dunnauthor=O.+Epsteinauthor=R.+T.+Fremeauauthor=S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=Y.+Luoauthor=A.+E.+Minattiauthor=V.+F.+Patelauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=M.+M.+Weissauthor=P.+H.+Wenauthor=R.+D.+Whiteauthor=D.+A.+Whittingtonauthor=X.+M.+Zhengauthor=S.+Wood&title=An+orally+available+BACE1+inhibitor+that+affords+robust+CNS+Abeta+reduction+without+cardiovascular+liabilities&doi=10.1021%2Fml500458t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities</span></div><div class="casAuthors">Cheng, Yuan; Brown, James; Judd, Ted C.; Lopez, Patricia; Qian, Wenyuan; Powers, Timothy S.; Chen, Jian Jeffrey; Bartberger, Michael D.; Chen, Kui; Dunn, Robert T.; Epstein, Oleg; Fremeau, Robert T.; Harried, Scott; Hickman, Dean; Hitchcock, Stephen A.; Luo, Yi; Minatti, Ana Elena; Patel, Vinod F.; Vargas, Hugo M.; Wahl, Robert C.; Weiss, Matthew M.; Wen, Paul H.; White, Ryan D.; Whittington, Douglas A.; Zheng, Xiao Mei; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-215</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 inhibition to prevent Aβ peptide formation is considered to be a potential route to a disease-modifying treatment for Alzheimer's disease.  Previous efforts in our lab. using a combined structure- and property-based approach have resulted in the identification of aminooxazoline xanthenes as potent BACE1 inhibitors.  Herein, we report further optimization leading to the discovery of inhibitor 15 as an orally available and highly efficacious BACE1 inhibitor that robustly reduces CSF and brain Aβ levels in both rats and nonhuman primates.  In addn., compd. 15 exhibited low activity on the hERG ion channel and was well tolerated in an integrated cardiovascular safety model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbH-0fLNUlbrVg90H21EOLACvtfcHk0lg5hiItIyOxfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI&md5=bd8e5a33d06a51646873c4c43d01b003</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fml500458t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500458t%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHarried%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMinatti%26aufirst%3DA.%2BE.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZheng%26aufirst%3DX.%2BM.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DAn%2520orally%2520available%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520Abeta%2520reduction%2520without%2520cardiovascular%2520liabilities%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D210%26epage%3D215%26doi%3D10.1021%2Fml500458t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlstrom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustavsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radesater, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploeger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueters, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falting, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">41245</span>– <span class="NLM_lpage">41257</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.409110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1074%2Fjbc.M112.409110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=23048024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGjs7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=41245-41257&author=F.+Jeppssonauthor=S.+Eketjallauthor=J.+Jansonauthor=S.+Karlstromauthor=S.+Gustavssonauthor=L.+L.+Olssonauthor=A.+C.+Radesaterauthor=B.+Ploegerauthor=G.+Cebersauthor=K.+Kolmodinauthor=B.+M.+Swahnauthor=S.+von+Bergauthor=T.+Buetersauthor=J.+Falting&title=Discovery+of+AZD3839%2C+a+potent+and+selective+BACE1+inhibitor+clinical+candidate+for+the+treatment+of+Alzheimer+disease&doi=10.1074%2Fjbc.M112.409110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease</span></div><div class="casAuthors">Jeppsson, Fredrik; Eketjaell, Susanna; Janson, Juliette; Karlstroem, Sofia; Gustavsson, Susanne; Olsson, Lise-Lotte; Radesaeter, Ann-Cathrine; Ploeger, Bart; Cebers, Gvido; Kolmodin, Karin; Swahn, Britt-Marie; von Berg, Stefan; Bueters, Tjerk; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">41245-41257</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is one of the key enzymes involved in the processing of the amyloid precursor protein (APP) and formation of amyloid β peptide (Aβ) species.  Because cerebral deposition of Aβ species might be crit. for the pathogenesis of Alzheimer disease, BACE1 has emerged as a key target for the treatment of this disease.  Here, the authors report the discovery and comprehensive preclin. characterization of AZD3839, a potent and selective inhibitor of human BACE1.  AZD3839 was identified using fragment-based screening and structure-based design.  In a concn.-dependent manner, AZD3839 inhibited BACE1 activity in a biochem. fluorescence resonance energy transfer (FRET) assay, Aβ and sAPPβ release from modified and wild-type human SH-SY5Y cells and mouse N2A cells as well as from mouse and guinea pig primary cortical neurons.  Selectivity against BACE2 and cathepsin D was 14 and >1000-fold, resp.  AZD3839 exhibited dose- and time-dependent lowering of plasma, brain, and cerebrospinal fluid Aβ levels in mouse, guinea pig, and non-human primate.  Pharmacokinetic/pharmacodynamic analyses of mouse and guinea pig data showed a good correlation between the potency of AZD3839 in primary cortical neurons and in vivo brain effects.  These results suggest that AZD3839 effectively reduces the levels of Aβ in brain, CSF, and plasma in several preclin. species.  It might, therefore, have disease-modifying potential in the treatment of Alzheimer disease and related dementias.  Based on the overall pharmacol. profile and its drug like properties, AZD3839 has been progressed into Phase 1 clin. trials in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi56XzYm8WhLVg90H21EOLACvtfcHk0lj7Y3GzwZUqAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGjs7fE&md5=dd328c2e0b3de730de30f1e249f2403e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.409110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.409110%26sid%3Dliteratum%253Aachs%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DEketjall%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKarlstrom%26aufirst%3DS.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DRadesater%26aufirst%3DA.%2BC.%26aulast%3DPloeger%26aufirst%3DB.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DFalting%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520AZD3839%252C%2520a%2520potent%2520and%2520selective%2520BACE1%2520inhibitor%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D41245%26epage%3D41257%26doi%3D10.1074%2Fjbc.M112.409110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schechter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A.</span></span> <span> </span><span class="NLM_article-title">On the size of the active site in proteases. I. papain</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(67)80055-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2FS0006-291X%2867%2980055-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=6035483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1967&pages=157-162&author=I.+Schechterauthor=A.+Berger&title=On+the+size+of+the+active+site+in+proteases.+I.+papain&doi=10.1016%2FS0006-291X%2867%2980055-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">On the size of the active site in proteases.  I.  Papain</span></div><div class="casAuthors">Schechter, Israel; Berger, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-62</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The action of papain on 40 diastereoisomeric peptides of alanine, ranging in length from Ala2 to Ala6, was studied to investigate the size of the active site.  The variations observed in the rates of hydrolysis lead to the conclusion that papain has a large active site which extends over ∼25 A. and can be divided into 7 "subsites," each accommodating 1 amino acid residue of the peptide substrate.  The subsites are located on both sides of the catalytic site, 4 on the one side and 3 on the other.  It is postulated that a long "groove" analogous to that found by x-ray analysis in lysozyme is present.  The substrate is believed to fit into the groove, binding to several subsites of specific geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_kZeRVAOVyrVg90H21EOLACvtfcHk0lj7Y3GzwZUqAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D&md5=a58ceccdbb5cc5c021af06912835f77c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2867%2980055-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252867%252980055-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DOn%2520the%2520size%2520of%2520the%2520active%2520site%2520in%2520proteases.%2520I.%2520papain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1967%26volume%3D27%26spage%3D157%26epage%3D162%26doi%3D10.1016%2FS0006-291X%2867%2980055-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlijanian, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albright, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span> <span> </span><span class="NLM_article-title">Targeting the BACE1 active site flap leads to a potent inhibitor that elicits robust brain Aβ reduction in rodents</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00432</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00432" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=271-276&author=Y.-J.+Wuauthor=J.+Guernonauthor=F.+Yangauthor=L.+Snyderauthor=J.+Shiauthor=A.+McClureauthor=R.+Rajamaniauthor=H.+Parkauthor=A.+Ngauthor=H.+Lewisauthor=C.+Y.+Changauthor=D.+Camacauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Targeting+the+BACE1+active+site+flap+leads+to+a+potent+inhibitor+that+elicits+robust+brain+A%CE%B2+reduction+in+rodents&doi=10.1021%2Facsmedchemlett.5b00432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Yang, Fukang; Snyder, Lawrence; Shi, Jianliang; McClure, Andrea; Rajamani, Ramkumar; Park, Hyunsoo; Ng, Alicia; Lewis, Hal; Chang, Chieh Ying; Camac, Dan; Toyn, Jeremy H.; Ahlijanian, Michael K.; Albright, Charles F.; Macor, John E.; Thompson, Lorin A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-276</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By targeting the flap backbone of the BACE1 active site, the authors discovered 6-dimethylisoxazole-substituted biaryl aminothiazine I with 34-fold improved BACE1 inhibitory activity over the lead compd.  The cocrystal structure of I bound to the active site indicated two hydrogen-bond interactions between the dimethylisoxazole and threonine 72 and glutamine 73 of the flap.  Incorporation of the dimethylisoxazole substitution onto the related aminothiazine carboxamide series led to pyrazine-carboxamide II as a very potent BACE1 inhibitor (IC50 < 1 nM).  This compd. demonstrated robust brain Aβ redn. in rat dose-response studies.  Thus, compd. II may be useful in testing the amyloid hypothesis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9dTGWVgGmmrVg90H21EOLACvtfcHk0lhWoG_AFhCdRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D&md5=b1bd7b0b6cb22ca8d2f49807b905daa9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00432%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DSnyder%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DTargeting%2520the%2520BACE1%2520active%2520site%2520flap%2520leads%2520to%2520a%2520potent%2520inhibitor%2520that%2520elicits%2520robust%2520brain%2520A%25CE%25B2%2520reduction%2520in%2520rodents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D271%26epage%3D276%26doi%3D10.1021%2Facsmedchemlett.5b00432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travagli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollastrini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabellieri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Power, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">BACE1 inhibitors: a head group scan on a series of amides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4239</span>– <span class="NLM_lpage">4243</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.bmcl.2013.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=23735744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFaktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4239-4243&author=T.+J.+Wolteringauthor=W.+Wostlauthor=H.+Hilpertauthor=M.+Rogers-Evansauthor=E.+Pinardauthor=A.+Maywegauthor=M.+Gobelauthor=D.+W.+Bannerauthor=J.+Benzauthor=M.+Travagliauthor=M.+Pollastriniauthor=G.+Marconiauthor=E.+Gabellieriauthor=W.+Gubaauthor=H.+Mauserauthor=M.+Andreiniauthor=H.+Jacobsenauthor=E.+Powerauthor=R.+Narquizian&title=BACE1+inhibitors%3A+a+head+group+scan+on+a+series+of+amides&doi=10.1016%2Fj.bmcl.2013.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 inhibitors: A head group scan on a series of amides</span></div><div class="casAuthors">Woltering, Thomas J.; Wostl, Wolfgang; Hilpert, Hans; Rogers-Evans, Mark; Pinard, Emmanuel; Mayweg, Alexander; Gobel, Martin; Banner, David W.; Benz, Jorg; Travagli, Massimiliano; Pollastrini, Martina; Marconi, Guido; Gabellieri, Emanuele; Guba, Wolfgang; Mauser, Harald; Andreini, Matteo; Jacobsen, Helmut; Power, Eoin; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4239-4243</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of amides bearing a variety of amidine head groups was investigated as BACE1 inhibitors with respect to inhibitory activity in a BACE1 enzyme as well as a cell-based assay.  Detn. of their basicity as well as their properties as substrates of P-glycoprotein revealed that a 2-amino-1,3-oxazine head group would be a suitable starting point for further development of brain penetrating compds. for potential Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEF94wd3_rd7Vg90H21EOLACvtfcHk0lhWoG_AFhCdRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFaktLk%253D&md5=3da315c76199617083b762ea111057fd</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMayweg%26aufirst%3DA.%26aulast%3DGobel%26aufirst%3DM.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DTravagli%26aufirst%3DM.%26aulast%3DPollastrini%26aufirst%3DM.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DGabellieri%26aufirst%3DE.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DPower%26aufirst%3DE.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3DBACE1%2520inhibitors%253A%2520a%2520head%2520group%2520scan%2520on%2520a%2520series%2520of%2520amides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4239%26epage%3D4243%26doi%3D10.1016%2Fj.bmcl.2013.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krummenacher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozmen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergadano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochstrasser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David-Pierson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">beta-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3980</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=beta-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0lgtRdGzZJEqag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3Dbeta-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voegtle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2195</span>– <span class="NLM_lpage">2200</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.bmcl.2018.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=29764741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1Crt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2195-2200&author=S.+J.+Veenstraauthor=H.+Rueegerauthor=M.+Voegtleauthor=R.+Lueoendauthor=P.+Holzerauthor=K.+Hurthauthor=M.+Tintelnot-Blomleyauthor=M.+Frederiksenauthor=J.+M.+Rondeauauthor=L.+Jacobsonauthor=M.+Staufenbielauthor=U.+Neumannauthor=R.+Machauer&title=Discovery+of+amino-1%2C4-oxazines+as+potent+BACE-1+inhibitors&doi=10.1016%2Fj.bmcl.2018.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors</span></div><div class="casAuthors">Veenstra, Siem Jakob; Rueeger, Heinrich; Voegtle, Markus; Lueoend, Rainer; Holzer, Philipp; Hurth, Konstanze; Tintelnot-Blomley, Marina; Frederiksen, Mathias; Rondeau, Jean-Michel; Jacobson, Laura; Staufenbiel, Matthias; Neumann, Ulf; Machauer, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2195-2200</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">(Pyridinecarbonylamino)phenyl aminooxazine-derived β-site amyloid precursor protein-cleaving enzyme 1 (BACE-1) inhibitors such as I were prepd. as potential anti-Alzheimer's agents and tested for inhibition of BACE-1 and for their efflux ratio in human p-glycoprotein-contg. cells as a measure of permeation through the blood-brain barrier.  The crystal structure of the complex of a racemic aminooxazine with BACE-1 was detd. by X-ray crystallog.  I reduced Aβ levels in the forebrains of mice by 20% and 63% at 30 μmol/kg and 100 μmol/kg oral doses, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJdRw9y0Bfc7Vg90H21EOLACvtfcHk0lgtRdGzZJEqag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1Crt7s%253D&md5=af32916a3a27b475aa0e9264a3217a8f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DVoegtle%26aufirst%3DM.%26aulast%3DLueoend%26aufirst%3DR.%26aulast%3DHolzer%26aufirst%3DP.%26aulast%3DHurth%26aufirst%3DK.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DRondeau%26aufirst%3DJ.%2BM.%26aulast%3DJacobson%26aufirst%3DL.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DMachauer%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520amino-1%252C4-oxazines%2520as%2520potent%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2195%26epage%3D2200%26doi%3D10.1016%2Fj.bmcl.2018.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann-Roder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span> <span> </span><span class="NLM_article-title">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Fcmdc.200700059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=17530727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1100-1115&author=M.+Morgenthalerauthor=E.+Schweizerauthor=A.+Hoffmann-Roderauthor=F.+Beniniauthor=R.+E.+Martinauthor=G.+Jaeschkeauthor=B.+Wagnerauthor=H.+Fischerauthor=S.+Bendelsauthor=D.+Zimmerliauthor=J.+Schneiderauthor=F.+Diederichauthor=M.+Kansyauthor=K.+Muller&title=Predicting+and+tuning+physicochemical+properties+in+lead+optimization%3A+amine+basicities&doi=10.1002%2Fcmdc.200700059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span></div><div class="casAuthors">Morgenthaler, Martin; Schweizer, Eliane; Hoffmann-Roder, Anja; Benini, Fausta; Martin, Rainer E.; Jaeschke, Georg; Wagner, Bjorn; Fischer, Holger; Bendels, Stefanie; Zimmerli, Daniel; Schneider, Josef; Diederich, Francois; Kansy, Manfred; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1100-1115</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  This review describes simple and useful concepts for predicting and tuning the pKa values of basic amine centers, a crucial step in the optimization of phys. and ADME properties of many lead structures in drug-discovery research.  The article starts with a case study of tricyclic thrombin inhibitors featuring a tertiary amine center with pKa values that can be tuned over a wide range, from the usual value of around 10 to below 2 by (remote) neighboring functionalities commonly encountered in medicinal chem.  Next, the changes in pKa of acyclic and cyclic amines upon substitution by fluorine, oxygen, nitrogen, and sulfur functionalities, as well as carbonyl and carboxyl derivs. are systematically analyzed, leading to the derivation of simple rules for pKa prediction.  Electronic and stereoelectronic effects in cyclic amines are discussed, and the emerging computational methods for pKa predictions are briefly surveyed.  The rules for tuning amine basicities should not only be of interest in drug-discovery research, but also to the development of new crop-protection agents, new amine ligands for organometallic complexes, and in particular, to the growing field of amine-based organocatalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodsWRMtrxWPbVg90H21EOLACvtfcHk0lgTn037gUmQZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D&md5=478b70744312c01d3a43cf435d9598de</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700059%26sid%3Dliteratum%253Aachs%26aulast%3DMorgenthaler%26aufirst%3DM.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DHoffmann-Roder%26aufirst%3DA.%26aulast%3DBenini%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DPredicting%2520and%2520tuning%2520physicochemical%2520properties%2520in%2520lead%2520optimization%253A%2520amine%2520basicities%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1100%26epage%3D1115%26doi%3D10.1002%2Fcmdc.200700059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den Bossche, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span> <span> </span><span class="NLM_article-title">Optimization of 1,4-oxazine beta-secretase 1 (BACE1) inhibitors toward a clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5292</span>– <span class="NLM_lpage">5303</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00304</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVCgt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5292-5303&author=H.+J.+M.+Gijsenauthor=S.+A.+Alonso+de+Diegoauthor=M.+De+Cleynauthor=A.+Garcia-Molinaauthor=G.+J.+Macdonaldauthor=C.+Martinez-Lamencaauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=F.+J.+R.+Romboutsauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=S.+Van+Brandtauthor=D.+Van+den+Bosscheauthor=M.+Van+Goolauthor=N.+Austinauthor=H.+Borghysauthor=D.+Dhuyvetterauthor=D.+Moechars&title=Optimization+of+1%2C4-oxazine+beta-secretase+1+%28BACE1%29+inhibitors+toward+a+clinical+candidate&doi=10.1021%2Facs.jmedchem.8b00304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate</span></div><div class="casAuthors">Gijsen, Harrie J. M.; Alonso de Diego, Sergio A.; De Cleyn, Michel; Garcia-Molina, Aranzazu; Macdonald, Gregor J.; Martinez-Lamenca, Carolina; Oehlrich, Daniel; Prokopcova, Hana; Rombouts, Frederik J. R.; Surkyn, Michel; Trabanco, Andres A.; Van Brandt, Sven; Van den Bossche, Dries; Van Gool, Michiel; Austin, Nigel; Borghys, Herman; Dhuyvetter, Deborah; Moechars, Diederik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5292-5303</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In previous studies, the introduction of electron withdrawing groups to 1,4-oxazine BACE1 inhibitors reduced the pKa of the amidine group, resulting in compd. 2 that showed excellent in vivo efficacy, lowering Aβ levels in brain and CSF.  However, a suboptimal cardiovascular safety margin, based on QTc prolongation, prevented further progression.  Further optimization resulted in the replacement of the 2-fluoro substituent by a CF3-group, which reduced hERG inhibition.  This has led to compd. 3, with an improved cardiovascular safety margin and sufficiently safe in GLP toxicity studies to progress into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF682roZxPn7Vg90H21EOLACvtfcHk0lgTn037gUmQZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVCgt7zP&md5=f6e061004a3c5ad98b817ddd198940c7</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00304%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DGarcia-Molina%26aufirst%3DA.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVan%2Bden%2BBossche%26aufirst%3DD.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DMoechars%26aufirst%3DD.%26atitle%3DOptimization%2520of%25201%252C4-oxazine%2520beta-secretase%25201%2520%2528BACE1%2529%2520inhibitors%2520toward%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5292%26epage%3D5303%26doi%3D10.1021%2Facs.jmedchem.8b00304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Badiger, S.</span>; <span class="NLM_string-name">Chebrolu, M.</span>; <span class="NLM_string-name">Hurth, K.</span>; <span class="NLM_string-name">Jacquier, S.</span>; <span class="NLM_string-name">Lueoend, R. M.</span>; <span class="NLM_string-name">Machauer, R.</span>; <span class="NLM_string-name">Rueeger, H.</span>; <span class="NLM_string-name">Tintelnot-Blomley, M.</span>; <span class="NLM_string-name">Veenstra, S. J.</span>; <span class="NLM_string-name">Voegtle, M.</span></span> <span> </span><span class="NLM_article-title">Novel heterocyclic derivatives as BACE inhibitors and their preparation and use in the treatment of neurological disorders</span>. <span class="NLM_patent">WO2012095469A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+Badiger&author=M.+Chebrolu&author=K.+Hurth&author=S.+Jacquier&author=R.+M.+Lueoend&author=R.+Machauer&author=H.+Rueeger&author=M.+Tintelnot-Blomley&author=S.+J.+Veenstra&author=M.+Voegtle&title=Novel+heterocyclic+derivatives+as+BACE+inhibitors+and+their+preparation+and+use+in+the+treatment+of+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBadiger%26aufirst%3DS.%26atitle%3DNovel%2520heterocyclic%2520derivatives%2520as%2520BACE%2520inhibitors%2520and%2520their%2520preparation%2520and%2520use%2520in%2520the%2520treatment%2520of%2520neurological%2520disorders%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanja, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jivkov, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacology of BACE inhibitor CNP520</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">P433</span>– <span class="NLM_lpage">P434</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2016.06.831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.jalz.2016.06.831" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=P433-P434&author=U.+Neumannauthor=L.+H.+Jacobsonauthor=L.+Perrotauthor=K.+Beltzauthor=B.+Voggauthor=I.+Brzakauthor=D.+Tanjaauthor=V.+Trappeauthor=C.+Kollyauthor=W.+Frieauffauthor=V.+Dubostauthor=M.+N.+Jivkovauthor=D.+Theilauthor=M.+Staufenbielauthor=D.+R.+Shimshek&title=Preclinical+pharmacology+of+BACE+inhibitor+CNP520&doi=10.1016%2Fj.jalz.2016.06.831"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2016.06.831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2016.06.831%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DTanja%26aufirst%3DD.%26aulast%3DTrappe%26aufirst%3DV.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DDubost%26aufirst%3DV.%26aulast%3DJivkov%26aufirst%3DM.%2BN.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26atitle%3DPreclinical%2520pharmacology%2520of%2520BACE%2520inhibitor%2520CNP520%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2016%26volume%3D12%26spage%3DP433%26epage%3DP434%26doi%3D10.1016%2Fj.jalz.2016.06.831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curphey, T. J.</span></span> <span> </span><span class="NLM_article-title">Thionation with the reagent combination of phosphorus pentasulfide and hexamethyldisiloxane</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">6461</span>– <span class="NLM_lpage">6473</span>, <span class="refDoi"> DOI: 10.1021/jo0256742</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0256742" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVyms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=6461-6473&author=T.+J.+Curphey&title=Thionation+with+the+reagent+combination+of+phosphorus+pentasulfide+and+hexamethyldisiloxane&doi=10.1021%2Fjo0256742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Thionation with the reagent combination of phosphorus pentasulfide and hexamethyldisiloxane</span></div><div class="casAuthors">Curphey, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6461-6473</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The combination of P4S10 and hexamethyldisiloxane efficiently converts esters, lactones, amides, lactams, and ketones to their corresponding thiono derives.  In the presence of elemental sulfur, 3-oxo esters are converted to dithiolethiones by this reagent.  Yields are comparable to or superior to those obtained with Lawesson's reagent.  The method has the advantage that reagent-derived byproducts may be removed by a simple hydrolytic workup or by filtration through silica gel, rather than by chromatog., as required for Lawesson's reagent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotz2rC56sh4rVg90H21EOLACvtfcHk0lhPyF2RnVj4Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVyms7o%253D&md5=25e6316aefe299e38b0c531dac7d9a2c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjo0256742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0256742%26sid%3Dliteratum%253Aachs%26aulast%3DCurphey%26aufirst%3DT.%2BJ.%26atitle%3DThionation%2520with%2520the%2520reagent%2520combination%2520of%2520phosphorus%2520pentasulfide%2520and%2520hexamethyldisiloxane%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D6461%26epage%3D6473%26doi%3D10.1021%2Fjo0256742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fliri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eschenmoser, A.</span></span> <span> </span><span class="NLM_article-title">Poly(dipeptamidinium)-Salze: Definition und Methoden zur präparativen Herstellung</span>. <i>Helv. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1224</span>– <span class="NLM_lpage">1262</span>, <span class="refDoi"> DOI: 10.1002/hlca.19860690530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Fhlca.19860690530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADyaL2sXkvFOju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1986&pages=1224-1262&author=H.+Moserauthor=A.+Fliriauthor=A.+Steigerauthor=G.+Costelloauthor=J.+Schreiberauthor=A.+Eschenmoser&title=Poly%28dipeptamidinium%29-Salze%3A+Definition+und+Methoden+zur+pr%C3%A4parativen+Herstellung&doi=10.1002%2Fhlca.19860690530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(dipeptamidinium) salts:  definition and methods of preparation</span></div><div class="casAuthors">Moser, Heinz; Fliri, Anton; Steiger, Arthur; Costello, Gerard; Schreiber, Jakob; Eschenmoser, Albert</div><div class="citationInfo"><span class="NLM_cas:title">Helvetica Chimica Acta</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1224-62</span>CODEN:
                <span class="NLM_cas:coden">HCACAV</span>;
        ISSN:<span class="NLM_cas:issn">0018-019X</span>.
    </div><div class="casAbstract">Poly(dipeptamidines) are polypeptide derivs. in which the carbonyl O of each second backbone amide group is replaced by an imine N atom.  Homodipeptidic poly(dipeptamidinium) salts in the Ala-Gly and Phe-Gly series, e.g. I (n = 1-5) and II (n = 1, 2, 3), resp., were prepd. and they were characterized by 1H and 13C NMR spectroscopy.  The method of prepn. included a stepwise construction of defined lower oligomers.  In the Ala-Gly series, a one-step polycondensation procedure gave polymers contg. an av. of ca. 20 dipeptamidinium units.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2aOIuFCSID7Vg90H21EOLACvtfcHk0lh6Nsg6qzfNMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXkvFOju7w%253D&md5=b3a71ba731b834dfda6433229c2ed6ee</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fhlca.19860690530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.19860690530%26sid%3Dliteratum%253Aachs%26aulast%3DMoser%26aufirst%3DH.%26aulast%3DFliri%26aufirst%3DA.%26aulast%3DSteiger%26aufirst%3DA.%26aulast%3DCostello%26aufirst%3DG.%26aulast%3DSchreiber%26aufirst%3DJ.%26aulast%3DEschenmoser%26aufirst%3DA.%26atitle%3DPoly%2528dipeptamidinium%2529-Salze%253A%2520Definition%2520und%2520Methoden%2520zur%2520pr%25C3%25A4parativen%2520Herstellung%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D1986%26volume%3D69%26spage%3D1224%26epage%3D1262%26doi%3D10.1002%2Fhlca.19860690530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span> <span> </span><span class="NLM_article-title">Asymmetric iodolactamization induced by chiral oxazolidine auxiliary</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">7906</span>– <span class="NLM_lpage">7909</span>, <span class="refDoi"> DOI: 10.1021/jo0488006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0488006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlSis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=7906-7909&author=M.+Shenauthor=C.+Li&title=Asymmetric+iodolactamization+induced+by+chiral+oxazolidine+auxiliary&doi=10.1021%2Fjo0488006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric iodolactamization induced by chiral oxazolidine auxiliary</span></div><div class="casAuthors">Shen, Meihua; Li, Chaozhong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7906-7909</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Asym. iodolactamization reaction of unsatd. amides with oxazolidines as the chiral auxiliaries were investigated.  With (4S)-4-((2R)-2-butyl)-2,2-dimethyloxazolidine as the auxiliary and LiH as the base, a no. of unsatd. amides underwent iodolactamization smoothly to afford γ- and δ-lactams, e.g., I, in good yields and diastereoselectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS6M8I-IBERbVg90H21EOLACvtfcHk0lh6Nsg6qzfNMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlSis74%253D&md5=b9a5f2ccb6f79bd3dab59f710ab3cfff</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjo0488006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0488006%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DAsymmetric%2520iodolactamization%2520induced%2520by%2520chiral%2520oxazolidine%2520auxiliary%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D7906%26epage%3D7909%26doi%3D10.1021%2Fjo0488006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gataullin, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afon’kin, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatykhov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spirikhin, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdrakhmanov, I. B.</span></span> <span> </span><span class="NLM_article-title">Iodocyclization of N-(2-nitrophenyl)- and N-phenyl-N′-[2-(alk-1-enyl)phenyl]ethanimidamides</span>. <i>Mendeleev Commun.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1070/MC2001v011n05ABEH001490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1070%2FMC2001v011n05ABEH001490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=201-202&author=R.+R.+Gataullinauthor=I.+S.+Afon%E2%80%99kinauthor=A.+A.+Fatykhovauthor=L.+V.+Spirikhinauthor=I.+B.+Abdrakhmanov&title=Iodocyclization+of+N-%282-nitrophenyl%29-+and+N-phenyl-N%E2%80%B2-%5B2-%28alk-1-enyl%29phenyl%5Dethanimidamides&doi=10.1070%2FMC2001v011n05ABEH001490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1070%2FMC2001v011n05ABEH001490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1070%252FMC2001v011n05ABEH001490%26sid%3Dliteratum%253Aachs%26aulast%3DGataullin%26aufirst%3DR.%2BR.%26aulast%3DAfon%25E2%2580%2599kin%26aufirst%3DI.%2BS.%26aulast%3DFatykhov%26aufirst%3DA.%2BA.%26aulast%3DSpirikhin%26aufirst%3DL.%2BV.%26aulast%3DAbdrakhmanov%26aufirst%3DI.%2BB.%26atitle%3DIodocyclization%2520of%2520N-%25282-nitrophenyl%2529-%2520and%2520N-phenyl-N%25E2%2580%25B2-%255B2-%2528alk-1-enyl%2529phenyl%255Dethanimidamides%26jtitle%3DMendeleev%2520Commun.%26date%3D2001%26volume%3D11%26spage%3D201%26epage%3D202%26doi%3D10.1070%2FMC2001v011n05ABEH001490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brauer, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roßenbach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepper, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stelzer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häusler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, W. S.</span></span> <span> </span><span class="NLM_article-title">Water soluble phosphines: part XIII. chiral phosphine ligands with amino acid moieties</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>598</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/S0022-328X(99)00689-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2FS0022-328X%2899%2900689-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslyrs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=598&publication_year=2000&pages=116-126&author=D.+J.+Brauerauthor=S.+Schenkauthor=S.+Ro%C3%9Fenbachauthor=M.+Tepperauthor=O.+Stelzerauthor=T.+H%C3%A4uslerauthor=W.+S.+Sheldrick&title=Water+soluble+phosphines%3A+part+XIII.+chiral+phosphine+ligands+with+amino+acid+moieties&doi=10.1016%2FS0022-328X%2899%2900689-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Water soluble phosphines. Part XIII. Chiral phosphine ligands with amino acid moieties</span></div><div class="casAuthors">Brauer, D. J.; Schenk, S.; Rossenbach, S.; Tepper, M.; Stelzer, O.; Hausler, T.; Sheldrick, W. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">598</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">116-126</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">Nucleophilic phosphination of the potassium or sodium salt of the fluorophenylalanines or -glycines with potassium phosphides Ph(R)PK (R = Me, Ph) yields chiral phosphine ligands, e.g. 2-Ph2PC6H4CH(NH2)CO2H (I), with amino acid moieties.  The x-ray structure of I.2H2O (space group Pbca) has been detd. showing a betaine type structure for the amino acid moiety.  The α-Me derivs. of the phosphinophenylglycines were obtained in an analogous manner.  Ortho- and para-Fluoroacetophenones have been employed as starting material for the syntheses of α-[4-fluorophenyl]-α-methylglycine and its ortho-isomer, the x-ray structure of monohydrate of 2-FC6H4C(Me)(NH2)CO2H has been detd. (space group P‾1).  The N-acetyl and ester derivs. are accessible using std. procedures.  Resoln. of the diastereomeric salt obtained from (S)-(+)-2-hydroxymethylpyrrolidine and racem-2-FC6H4C(Me)(NHAc)CO2H (II) by fractionated crystn. yielded the (S,R)-isomer.  The abs. configuration of (S,R)-II salt with 2-hydroxymethylpyrrolidine was detd. by x-ray structural anal. (space group P212121).  Cleavage of (S,R)-salt with hydrochloric acid gave enantiopure (R)-II [α]d20 = -30.9° (c = 1, CH3OH).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzKurCzbmH6rVg90H21EOLACvtfcHk0lh6Nsg6qzfNMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslyrs78%253D&md5=1b7dc678adbc68c91c931b6906bc7bd8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS0022-328X%2899%2900689-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-328X%252899%252900689-0%26sid%3Dliteratum%253Aachs%26aulast%3DBrauer%26aufirst%3DD.%2BJ.%26aulast%3DSchenk%26aufirst%3DS.%26aulast%3DRo%25C3%259Fenbach%26aufirst%3DS.%26aulast%3DTepper%26aufirst%3DM.%26aulast%3DStelzer%26aufirst%3DO.%26aulast%3DH%25C3%25A4usler%26aufirst%3DT.%26aulast%3DSheldrick%26aufirst%3DW.%2BS.%26atitle%3DWater%2520soluble%2520phosphines%253A%2520part%2520XIII.%2520chiral%2520phosphine%2520ligands%2520with%2520amino%2520acid%2520moieties%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2000%26volume%3D598%26spage%3D116%26epage%3D126%26doi%3D10.1016%2FS0022-328X%2899%2900689-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9156</span>– <span class="NLM_lpage">9169</span>, <span class="refDoi"> DOI: 10.1021/jm300598e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.+H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm300598e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Huang, Hongbing; La, Daniel S.; Cheng, Alan C.; Whittington, Douglas A.; Patel, Vinod F.; Chen, Kui; Dineen, Thomas A.; Epstein, Oleg; Graceffa, Russell; Hickman, Dean; Kiang, Y.-H.; Louie, Steven; Luo, Yi; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9156-9169</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure- and property-based drug design approach was employed to identify aminooxazoline xanthenes as potent and selective human β-secretase inhibitors.  These compds. exhibited good isolated enzyme, cell potency, and selectivity against the structurally related aspartyl protease cathepsin D.  Our efforts resulted in the identification of a potent, orally bioavailable CNS penetrant compd. that exhibited in vivo efficacy.  A single oral dose of compd. (I) resulted in a significant redn. of CNS Aβ40 in naive rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDEYfU4moxMbVg90H21EOLACvtfcHk0ljPZoBCNB93tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ&md5=0ecd50ec1ea82a058e499bb712c45272</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.%2BH.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169%26doi%3D10.1021%2Fjm300598e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Box, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, D.</span></span> <span> </span><span class="NLM_article-title">High-throughput measurement of pKa values in a mixed-buffer linear pH gradient system</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">892</span>, <span class="refDoi"> DOI: 10.1021/ac020329y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac020329y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1yksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2003&pages=883-892&author=K.+Boxauthor=C.+Bevanauthor=J.+Comerauthor=A.+Hillauthor=R.+Allenauthor=D.+Reynolds&title=High-throughput+measurement+of+pKa+values+in+a+mixed-buffer+linear+pH+gradient+system&doi=10.1021%2Fac020329y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Measurement of pKa Values in a Mixed-Buffer Linear pH Gradient System</span></div><div class="casAuthors">Box, Karl; Bevan, Christopher; Comer, John; Hill, Alan; Allen, Ruth; Reynolds, Derek</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">883-892</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A procedure is described for measuring pKa values in a short time, e.g., 4 min/assay.  Samples, as 10 mM solns., are prepd. in DMSO in 96-well plates.  A flowing pH gradient is produced by mixing two buffer solns. contg. mixts. of weak acids and bases that do not absorb significantly in the UV above 250 nm.  The sample soln. is dild. with water and then injected directly into the flowing gradient, which then passes through a diode array spectrophotometer measuring in the UV wavelength range.  The buffer has been formulated so that its acid-base titrn. curve is linear over a wide pH range, such that the pH of the gradient is a linear function of time.  The soln. pH in the measurement flow cell is therefore proportional to the time elapsed since the start of gradient generation.  The sample's pKa values are calcd. from the change in UV absorbance at multiple wavelengths as a function of pH.  The pKa values of 71 drugs have been measured, and results compare well with values measured by pH-metric or traditional UV methods.  Rules are suggested for the rapid inspection of data and the choice of method for the calcn. of pKa from the data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGtjb6-Ri9arVg90H21EOLACvtfcHk0lgPRAsUZSVYKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1yksg%253D%253D&md5=4050d66a7c92550c1efd346e76c392d9</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fac020329y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac020329y%26sid%3Dliteratum%253Aachs%26aulast%3DBox%26aufirst%3DK.%26aulast%3DBevan%26aufirst%3DC.%26aulast%3DComer%26aufirst%3DJ.%26aulast%3DHill%26aufirst%3DA.%26aulast%3DAllen%26aufirst%3DR.%26aulast%3DReynolds%26aufirst%3DD.%26atitle%3DHigh-throughput%2520measurement%2520of%2520pKa%2520values%2520in%2520a%2520mixed-buffer%2520linear%2520pH%2520gradient%2520system%26jtitle%3DAnal.%2520Chem.%26date%3D2003%26volume%3D75%26spage%3D883%26epage%3D892%26doi%3D10.1021%2Fac020329y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span> <span> </span><span class="NLM_article-title">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-beta and neuroinflammation in APP transgenic mice</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">44</span> <span class="refDoi"> DOI: 10.1186/s13024-015-0033-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1186%2Fs13024-015-0033-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=26336937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=U.+Neumannauthor=H.+Rueegerauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=R.+M.+Lueoendauthor=M.+Tintelnot-Blomleyauthor=G.+Laueauthor=K.+Beltzauthor=B.+Voggauthor=P.+Schmidauthor=W.+Frieauffauthor=D.+R.+Shimshekauthor=M.+Staufenbielauthor=L.+H.+Jacobson&title=A+novel+BACE+inhibitor+NB-360+shows+a+superior+pharmacological+profile+and+robust+reduction+of+amyloid-beta+and+neuroinflammation+in+APP+transgenic+mice&doi=10.1186%2Fs13024-015-0033-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice</span></div><div class="casAuthors">Neumann, Ulf; Rueeger, Heinrich; Machauer, Rainer; Veenstra, Siem Jacob; Lueoend, Rainer M.; Tintelnot-Blomley, Marina; Laue, Grit; Beltz, Karen; Vogg, Barbara; Schmid, Peter; Frieauff, Wilfried; Shimshek, Derya R.; Staufenbiel, Matthias; Jacobson, Laura H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44/1-44/15</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease (AD) is the most common form of dementia, the no. of affected individuals is rising, with significant impacts for healthcare systems.  Current symptomatic treatments delay, but do not halt, disease progression.  Genetic evidence points to aggregation and deposition of amyloid-β (Aβ) in the brain being causal for the neurodegeneration and dementia typical of AD.  Approaches to target Aβ via inhibition of γ-secretase or passive antibody therapy have not yet resulted in substantial clin. benefits.  Inhibition of BACE1 (β-secretase) has proven a challenging concept, but recent BACE1inhibitors can enter the brain sufficiently well to lower Aβ.  However, failures with the first clin. BACE1 inhibitors have highlighted the need to generate compds. with appropriate efficacy and safety profiles, since long treatment periods are expected to be necessary in humans.  Results: Treatment with NB-360, a potent and brain penetrable BACE-1 inhibitor can completely block the progression of Aβ deposition in the brains of APP transgenic mice, a model for amyloid pathol.  We furthermore show that almost complete redn. of Aβ was achieved also in rats and in dogs, suggesting that these findings are translational across species and can be extrapolated to humans.  Amyloid pathol. may be an initial step in a complex pathol. cascade; therefore we investigated the effect of BACE-1 inhibition on neuroinflammation, a prominent downstream feature of the disease.  NB-360 stopped accumulation of activated inflammatory cells in the brains of APP transgenic mice.  Upon chronic treatment of APP transgenic mice, patches of gray hairs appeared.  Conclusions: In a rapidly developing field, the data on NB-360 broaden the chem. space and expand knowledge on the properties that are needed to make a BACE-1 inhibitor potent and safe enough for long-term use in patients.  Due to its excellent brain penetration, reasonable oral doses of NB-360 were sufficient to completely block amyloid-β deposition in an APP transgenic mouse model.  Data across species suggest similar treatment effects can possibly be achieved in humans.  The reduced neuroinflammation upon amyloid redn. by NB-360 treatment supports the notion that targeting amyloid-β pathol. can have beneficial downstream effects on the progression of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJLgu8zl8_LVg90H21EOLACvtfcHk0lgPRAsUZSVYKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D&md5=728407859709d7de57d68bfdc374fe85</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1186%2Fs13024-015-0033-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-015-0033-8%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DLueoend%26aufirst%3DR.%2BM.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DLaue%26aufirst%3DG.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26atitle%3DA%2520novel%2520BACE%2520inhibitor%2520NB-360%2520shows%2520a%2520superior%2520pharmacological%2520profile%2520and%2520robust%2520reduction%2520of%2520amyloid-beta%2520and%2520neuroinflammation%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DMol.%2520Neurodegener.%26date%3D2015%26volume%3D10%26doi%3D10.1186%2Fs13024-015-0033-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serneels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fort, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span> <span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10658</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0liPDufWOXA6mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawiec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">21917</span> <span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+K.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0liPDufWOXA6mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doelemeyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurbrugg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neddermann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span> <span> </span><span class="NLM_article-title">Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor-treated APP transgenic mice</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2016.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.neurobiolaging.2016.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=27459925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BC2s3ks1Gntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=50-60&author=N.+Beckmannauthor=A.+Doelemeyerauthor=S.+Zurbruggauthor=K.+Bigotauthor=D.+Theilauthor=W.+Frieauffauthor=C.+Kollyauthor=P.+Moulinauthor=D.+Neddermannauthor=R.+Kreutzerauthor=L.+Perrotauthor=I.+Brzakauthor=L.+H.+Jacobsonauthor=M.+Staufenbielauthor=U.+Neumannauthor=D.+R.+Shimshek&title=Longitudinal+noninvasive+magnetic+resonance+imaging+of+brain+microhemorrhages+in+BACE+inhibitor-treated+APP+transgenic+mice&doi=10.1016%2Fj.neurobiolaging.2016.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor-treated APP transgenic mice</span></div><div class="casAuthors">Beckmann Nicolau; Doelemeyer Arno; Bigot Karine; Theil Diethilde; Frieauff Wilfried; Kolly Carine; Moulin Pierre; Kreutzer Robert; Zurbruegg Stefan; Perrot Ludovic; Brzak Irena; Jacobson Laura H; Staufenbiel Matthias; Neumann Ulf; Neddermann Daniel; Shimshek Derya R</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of aging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Currently, several immunotherapies and BACE (Beta Site APP Cleaving Enzyme) inhibitor approaches are being tested in the clinic for the treatment of Alzheimer's disease.  A crucial mechanism-related safety concern is the exacerbation of microhemorrhages, which are already present in the majority of Alzheimer patients.  To investigate potential safety liabilities of long-term BACE inhibitor therapy, we used aged amyloid precursor protein (APP) transgenic mice (APP23), which robustly develop cerebral amyloid angiopathy.  T2*-weighted magnetic resonance imaging (MRI), a translational method applicable in preclinical and clinical studies, was used for the detection of microhemorrhages throughout the entire brain, with subsequent histological validation.  Three-dimensional reconstruction based on in vivo MRI and serial Perls' stained sections demonstrated a one-to-one matching of the lesions thus allowing for their histopathological characterization.  MRI detected small Perls' positive areas with a high spatial resolution.  Our data demonstrate that volumetric assessment by noninvasive MRI is well suited to monitor cerebral microhemorrhages in vivo.  Furthermore, 3 months treatment of aged APP23 with the potent BACE-inhibitor NB-360 did not exacerbate microhemorrhages in contrast to Aβ-antibody β1.  These results substantiate the safe use of BACE inhibitors regarding microhemorrhages in long-term clinical studies for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeVeW4ul5-qOvW160gIxP_fW6udTcc2eYqfOlMskyh1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3ks1Gntw%253D%253D&md5=4cffb9cbd7b2bb606e702c9fa01506b4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2016.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2016.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DBeckmann%26aufirst%3DN.%26aulast%3DDoelemeyer%26aufirst%3DA.%26aulast%3DZurbrugg%26aufirst%3DS.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DMoulin%26aufirst%3DP.%26aulast%3DNeddermann%26aufirst%3DD.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26atitle%3DLongitudinal%2520noninvasive%2520magnetic%2520resonance%2520imaging%2520of%2520brain%2520microhemorrhages%2520in%2520BACE%2520inhibitor-treated%2520APP%2520transgenic%2520mice%26jtitle%3DNeurobiol.%2520Aging%26date%3D2016%26volume%3D45%26spage%3D50%26epage%3D60%26doi%3D10.1016%2Fj.neurobiolaging.2016.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasler, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopfert, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joos, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderstichele, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoops, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaeser, S. A.</span></span> <span> </span><span class="NLM_article-title">Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">701</span>– <span class="NLM_lpage">709</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2016.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.jalz.2016.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=27750032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADC%252BC2srhtlGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=701-709&author=J.+Schelleauthor=L.+M.+Haslerauthor=J.+C.+Gopfertauthor=T.+O.+Joosauthor=H.+Vandersticheleauthor=E.+Stoopsauthor=E.+M.+Mandelkowauthor=U.+Neumannauthor=D.+R.+Shimshekauthor=M.+Staufenbielauthor=M.+Juckerauthor=S.+A.+Kaeser&title=Prevention+of+tau+increase+in+cerebrospinal+fluid+of+APP+transgenic+mice+suggests+downstream+effect+of+BACE1+inhibition&doi=10.1016%2Fj.jalz.2016.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition</span></div><div class="casAuthors">Schelle Juliane; Hasler Lisa M; Gopfert Jens C; Joos Thomas O; Vanderstichele Hugo; Stoops Erik; Mandelkow Eva-Maria; Neumann Ulf; Shimshek Derya R; Staufenbiel Matthias; Jucker Mathias; Kaeser Stephan A</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">701-709</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  The inhibition of the β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) is a main therapeutic approach for the treatment of Alzheimer's disease (AD).  We previously reported an age-related increase of tau protein in the cerebrospinal fluid (CSF) of amyloid β (Aβ) precursor protein (APP) transgenic mice.  METHODS:  APP transgenic mice were treated with a potent BACE1 inhibitor.  CSF tau and CSF Aβ levels were assessed.  A novel high-sensitivity tau sandwich immunoassay was developed.  RESULTS:  We demonstrate that long-term BACE1 inhibition prevents CSF tau increase both in early-depositing APP transgenic mice and APP transgenic mice with moderate Aβ pathology.  DISCUSSION:  Our results demonstrate that BACE1 inhibition not only reduces Aβ generation but also downstream AD pathophysiology.  The tight correlation between Aβ aggregation in brain and CSF tau levels renders CSF tau a valuable marker to predict the effectiveness of BACE1 inhibitors in current clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcReT51ZB6VkgMuCWE5mhx1RfW6udTcc2eYqfOlMskyh1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srhtlGiuw%253D%253D&md5=4bd6f56822620e536fc53e4727d1ae70</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2016.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2016.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DHasler%26aufirst%3DL.%2BM.%26aulast%3DGopfert%26aufirst%3DJ.%2BC.%26aulast%3DJoos%26aufirst%3DT.%2BO.%26aulast%3DVanderstichele%26aufirst%3DH.%26aulast%3DStoops%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DKaeser%26aufirst%3DS.%2BA.%26atitle%3DPrevention%2520of%2520tau%2520increase%2520in%2520cerebrospinal%2520fluid%2520of%2520APP%2520transgenic%2520mice%2520suggests%2520downstream%2520effect%2520of%2520BACE1%2520inhibition%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2017%26volume%3D13%26spage%3D701%26epage%3D709%26doi%3D10.1016%2Fj.jalz.2016.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bacioglu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maia, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preische, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaeser, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweighauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eninger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahle, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maetzler, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span> <span> </span><span class="NLM_article-title">Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2016.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.neuron.2016.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=27292537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWlt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2016&pages=56-66&author=M.+Baciogluauthor=L.+F.+Maiaauthor=O.+Preischeauthor=J.+Schelleauthor=A.+Apelauthor=S.+A.+Kaeserauthor=M.+Schweighauserauthor=T.+Eningerauthor=M.+Lambertauthor=A.+Pilottoauthor=D.+R.+Shimshekauthor=U.+Neumannauthor=P.+J.+Kahleauthor=M.+Staufenbielauthor=M.+Neumannauthor=W.+Maetzlerauthor=J.+Kuhleauthor=M.+Jucker&title=Neurofilament+light+chain+in+blood+and+CSF+as+marker+of+disease+progression+in+mouse+models+and+in+neurodegenerative+diseases&doi=10.1016%2Fj.neuron.2016.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases</span></div><div class="casAuthors">Bacioglu, Mehtap; Maia, Luis F.; Preische, Oliver; Schelle, Juliane; Apel, Anja; Kaeser, Stephan A.; Schweighauser, Manuel; Eninger, Timo; Lambert, Marius; Pilotto, Andrea; Shimshek, Derya R.; Neumann, Ulf; Kahle, Philipp J.; Staufenbiel, Matthias; Neumann, Manuela; Maetzler, Walter; Kuhle, Jens; Jucker, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-66</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A majority of current disease-modifying therapeutic approaches for age-related neurodegenerative diseases target their characteristic proteopathic lesions (α-synuclein, Tau, Aβ).  To monitor such treatments, fluid biomarkers reflecting the underlying disease process are crucial.  We found robust increases of neurofilament light chain (NfL) in CSF and blood in murine models of α-synucleinopathies, tauopathy, and β-amyloidosis.  Blood and CSF NfL levels were strongly correlated, and NfL increases coincided with the onset and progression of the corresponding proteopathic lesions in brain.  Exptl. induction of α-synuclein lesions increased CSF and blood NfL levels, while blocking Aβ lesions attenuated the NfL increase.  Consistently, we also found NfL increases in CSF and blood of human α-synucleinopathies, tauopathies, and Alzheimer's disease.  Our results suggest that CSF and particularly blood NfL can serve as a reliable and easily accessible biomarker to monitor disease progression and treatment response in mouse models and potentially in human proteopathic neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf8eoPBMrdhLVg90H21EOLACvtfcHk0lgbDyzfFuMGtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWlt7k%253D&md5=0a712222ac53afcaf6d1a6b998389978</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DBacioglu%26aufirst%3DM.%26aulast%3DMaia%26aufirst%3DL.%2BF.%26aulast%3DPreische%26aufirst%3DO.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DApel%26aufirst%3DA.%26aulast%3DKaeser%26aufirst%3DS.%2BA.%26aulast%3DSchweighauser%26aufirst%3DM.%26aulast%3DEninger%26aufirst%3DT.%26aulast%3DLambert%26aufirst%3DM.%26aulast%3DPilotto%26aufirst%3DA.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DKahle%26aufirst%3DP.%2BJ.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DNeumann%26aufirst%3DM.%26aulast%3DMaetzler%26aufirst%3DW.%26aulast%3DKuhle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26atitle%3DNeurofilament%2520light%2520chain%2520in%2520blood%2520and%2520CSF%2520as%2520marker%2520of%2520disease%2520progression%2520in%2520mouse%2520models%2520and%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNeuron%26date%3D2016%26volume%3D91%26spage%3D56%26epage%3D66%26doi%3D10.1016%2Fj.neuron.2016.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegenast-Braun, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritschi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaeser, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jährling, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eicke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skodras, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beschorner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermueller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häsler, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfer, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueggler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodt, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span> <span> </span><span class="NLM_article-title">Early Aβ reduction prevents progression of cerebral amyloid angiopathy</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1002/ana.25562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1002%2Fana.25562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=31359452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsl2htrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2019&pages=561-571&author=J.+Schelleauthor=B.+M.+Wegenast-Braunauthor=S.+K.+Fritschiauthor=S.+A.+Kaeserauthor=N.+J%C3%A4hrlingauthor=D.+Eickeauthor=A.+Skodrasauthor=N.+Beschornerauthor=U.+Obermuellerauthor=L.+M.+H%C3%A4slerauthor=D.+P.+Wolferauthor=T.+Muegglerauthor=D.+R.+Shimshekauthor=U.+Neumannauthor=H.+U.+Dodtauthor=M.+Staufenbielauthor=M.+Jucker&title=Early+A%CE%B2+reduction+prevents+progression+of+cerebral+amyloid+angiopathy&doi=10.1002%2Fana.25562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Early Aβ reduction prevents progression of cerebral amyloid angiopathy</span></div><div class="casAuthors">Schelle, Juliane; Wegenast-Braun, Bettina M.; Fritschi, Sarah K.; Kaeser, Stephan A.; Jaehrling, Nina; Eicke, Daniel; Skodras, Angelos; Beschorner, Natalie; Obermueller, Ulrike; Haesler, Lisa M.; Wolfer, David P.; Mueggler, Thomas; Shimshek, Derya R.; Neumann, Ulf; Dodt, Hans-Ulrich; Staufenbiel, Matthias; Jucker, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">561-571</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : Clin. trials targeting β-amyloid peptides (Aβ) for Alzheimer disease (AD) failed for arguable reasons that include selecting the wrong stages of AD pathophysiol. or Aβ being the wrong target.  Targeting Aβ to prevent cerebral amyloid angiopathy (CAA) has not been rigorously followed, although the causal role of Aβ for CAA and related hemorrhages is undisputed.  CAA occurs with normal aging and to various degrees in AD, where its impact and treatment is confounded by the presence of parenchymal Aβ deposition.  Methods : APPDutch mice develop CAA in the absence of parenchymal amyloid, mimicking hereditary cerebral hemorrhage with amyloidosis Dutch type (HCHWA-D).  Mice were treated with a β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor.  We used 3-dimensional ultramicroscopy and immunoassays for visualizing CAA and assessing Aβ in cerebrospinal fluid (CSF) and brain.  Results : CAA onset in mice was at 22 to 24 mo, first in frontal leptomeningeal and superficial cortical vessels followed by vessels penetrating the cortical layers.  CSF Aβ increased with aging followed by a decrease of both Aβ40 and Aβ42 upon CAA onset, supporting the idea that combined redn. of CSF Aβ40 and Aβ42 is a specific biomarker for vascular amyloid.  BACE1 inhibitor treatment starting at CAA onset and continuing for 4 mo revealed a 90% Aβ redn. in CSF and largely prevented CAA progression and assocd. pathologies.  Interpretation : This is the first study showing that Aβ redn. at early disease time points largely prevents CAA in the absence of parenchymal amyloid.  Our observation provides a preclin. basis for Aβ-reducing treatments in patients at risk of CAA and in presymptomatic HCHWA-D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfJpMLjOqMAbVg90H21EOLACvtfcHk0lhk_IoCxvbgPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsl2htrfI&md5=d22a231201c9b8132160be8a1bc0b56a</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fana.25562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.25562%26sid%3Dliteratum%253Aachs%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DWegenast-Braun%26aufirst%3DB.%2BM.%26aulast%3DFritschi%26aufirst%3DS.%2BK.%26aulast%3DKaeser%26aufirst%3DS.%2BA.%26aulast%3DJ%25C3%25A4hrling%26aufirst%3DN.%26aulast%3DEicke%26aufirst%3DD.%26aulast%3DSkodras%26aufirst%3DA.%26aulast%3DBeschorner%26aufirst%3DN.%26aulast%3DObermueller%26aufirst%3DU.%26aulast%3DH%25C3%25A4sler%26aufirst%3DL.%2BM.%26aulast%3DWolfer%26aufirst%3DD.%2BP.%26aulast%3DMueggler%26aufirst%3DT.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DDodt%26aufirst%3DH.%2BU.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJucker%26aufirst%3DM.%26atitle%3DEarly%2520A%25CE%25B2%2520reduction%2520prevents%2520progression%2520of%2520cerebral%2520amyloid%2520angiopathy%26jtitle%3DAnn.%2520Neurol.%26date%3D2019%26volume%3D86%26spage%3D561%26epage%3D571%26doi%3D10.1002%2Fana.25562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esterházy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutzer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechsteiner, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobeli, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prummer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieske, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marselli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr-Conte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebersold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliorini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, M.</span></span> <span> </span><span class="NLM_article-title">Bace2 is a beta cell-enriched protease that regulates pancreatic beta cell function and mass</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2011.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.cmet.2011.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=21907142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=365-377&author=D.+Esterh%C3%A1zyauthor=I.+Stutzerauthor=H.+Wangauthor=M.+P.+Rechsteinerauthor=J.+Beauchampauthor=H.+Dobeliauthor=H.+Hilpertauthor=H.+Matileauthor=M.+Prummerauthor=A.+Schmidtauthor=N.+Lieskeauthor=B.+Boehmauthor=L.+Marselliauthor=D.+Boscoauthor=J.+Kerr-Conteauthor=R.+Aebersoldauthor=G.+A.+Spinasauthor=H.+Mochauthor=C.+Miglioriniauthor=M.+Stoffel&title=Bace2+is+a+beta+cell-enriched+protease+that+regulates+pancreatic+beta+cell+function+and+mass&doi=10.1016%2Fj.cmet.2011.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass</span></div><div class="casAuthors">Esterhazy, Daria; Stuetzer, Ina; Wang, Haiyan; Rechsteiner, Markus P.; Beauchamp, Jeremy; Doebeli, Heinz; Hilpert, Hans; Matile, Hugues; Prummer, Michael; Schmidt, Alexander; Lieske, Nora; Boehm, Bernhard; Marselli, Lorella; Bosco, Domenico; Kerr-Conte, Julie; Aebersold, Ruedi; Spinas, Giatgen Andreia; Moch, Holger; Migliorini, Cristiano; Stoffel, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Decreased β cell mass and function are hallmarks of type 2 diabetes.  Here we identified, through a siRNA screen, beta site amyloid precursor protein cleaving enzyme 2 (Bace2) as the sheddase of the proproliferative plasma membrane protein Tmem27 in murine and human β cells.  Mice with functionally inactive Bace2 and insulin-resistant mice treated with a newly identified Bace2 inhibitor both display augmented β cell mass and improved control of glucose homeostasis due to increased insulin levels.  These results implicate Bace2 in the control of β cell maintenance and provide a rational strategy to inhibit this protease for the expansion of functional pancreatic β cell mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNmw-BllVxx7Vg90H21EOLACvtfcHk0lif2EMawY8HKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM&md5=489e20b2d997eb0cbaff195819e35d64</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DEsterh%25C3%25A1zy%26aufirst%3DD.%26aulast%3DStutzer%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRechsteiner%26aufirst%3DM.%2BP.%26aulast%3DBeauchamp%26aufirst%3DJ.%26aulast%3DDobeli%26aufirst%3DH.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DPrummer%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DLieske%26aufirst%3DN.%26aulast%3DBoehm%26aufirst%3DB.%26aulast%3DMarselli%26aufirst%3DL.%26aulast%3DBosco%26aufirst%3DD.%26aulast%3DKerr-Conte%26aufirst%3DJ.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSpinas%26aufirst%3DG.%2BA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DMigliorini%26aufirst%3DC.%26aulast%3DStoffel%26aufirst%3DM.%26atitle%3DBace2%2520is%2520a%2520beta%2520cell-enriched%2520protease%2520that%2520regulates%2520pancreatic%2520beta%2520cell%2520function%2520and%2520mass%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D14%26spage%3D365%26epage%3D377%26doi%3D10.1016%2Fj.cmet.2011.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matafora, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farris, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restuccia, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonoldi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachi, A.</span></span> <span> </span><span class="NLM_article-title">Amyloid aggregates accumulate in melanoma metastasis modulating YAP activity</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>, <span class="NLM_elocation-id">e50446</span> <span class="refDoi"> DOI: 10.15252/embr.202050446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.15252%2Fembr.202050446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=32749065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFWiurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&author=V.+Mataforaauthor=F.+Farrisauthor=U.+Restucciaauthor=S.+Tamburriauthor=G.+Martanoauthor=C.+Bernardelliauthor=A.+Sofiaauthor=F.+Pisatiauthor=F.+Casagrandeauthor=L.+Lazzariauthor=S.+Marsoniauthor=E.+Bonoldiauthor=A.+Bachi&title=Amyloid+aggregates+accumulate+in+melanoma+metastasis+modulating+YAP+activity&doi=10.15252%2Fembr.202050446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid aggregates accumulate in melanoma metastasis modulating YAP activity</span></div><div class="casAuthors">Matafora, Vittoria; Farris, Francesco; Restuccia, Umberto; Tamburri, Simone; Martano, Giuseppe; Bernardelli, Clara; Sofia, Andrea; Pisati, Federica; Casagrande, Francesca; Lazzari, Luca; Marsoni, Silvia; Bonoldi, Emanuela; Bachi, Angela</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e50446</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Melanoma progression is generally assocd. with increased transcriptional activity mediated by the Yes-assocd. protein (YAP).  Mech. signals from the extracellular matrix are sensed by YAP, which then activates the expression of proliferative genes, promoting melanoma progression and drug resistance.  Which extracellular signals induce mechanotransduction, and how this is mediated, is not completely understood.  Here, using secretome analyses, we reveal the extracellular accumulation of amyloidogenic proteins, i.e. premelanosome protein (PMEL), in metastatic melanoma, together with proteins that assist amyloid maturation into fibrils.  We also confirm the accumulation of amyloid-like aggregates, similar to those detected in Alzheimer disease, in metastatic cell lines, as well as in human melanoma biopsies.  Mechanistically, beta-secretase 2 (BACE2) regulates the maturation of these aggregates, which in turn induce YAP activity.  We also demonstrate that recombinant PMEL fibrils are sufficient to induce mechanotransduction, triggering YAP signaling.  Finally, we demonstrate that BACE inhibition affects cell proliferation and increases drug sensitivity, highlighting the importance of amyloids for melanoma survival, and the use of beta-secretase inhibitors as potential therapeutic approach for metastatic melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL7-L9ZX0oZLVg90H21EOLACvtfcHk0lif2EMawY8HKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFWiurzN&md5=373c8a8cf3a71e67edeec495049b8e9d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.15252%2Fembr.202050446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembr.202050446%26sid%3Dliteratum%253Aachs%26aulast%3DMatafora%26aufirst%3DV.%26aulast%3DFarris%26aufirst%3DF.%26aulast%3DRestuccia%26aufirst%3DU.%26aulast%3DTamburri%26aufirst%3DS.%26aulast%3DMartano%26aufirst%3DG.%26aulast%3DBernardelli%26aufirst%3DC.%26aulast%3DSofia%26aufirst%3DA.%26aulast%3DPisati%26aufirst%3DF.%26aulast%3DCasagrande%26aufirst%3DF.%26aulast%3DLazzari%26aufirst%3DL.%26aulast%3DMarsoni%26aufirst%3DS.%26aulast%3DBonoldi%26aufirst%3DE.%26aulast%3DBachi%26aufirst%3DA.%26atitle%3DAmyloid%2520aggregates%2520accumulate%2520in%2520melanoma%2520metastasis%2520modulating%2520YAP%2520activity%26jtitle%3DEMBO%2520Rep.%26date%3D2020%26volume%3D21%26doi%3D10.15252%2Fembr.202050446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ufer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouzade-Dominguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huledal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lüönd, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avrameas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezous, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vormfelde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Lopez, C.</span></span> <span> </span><span class="NLM_article-title">The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer’s disease</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e9316</span> <span class="refDoi"> DOI: 10.15252/emmm.201809316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.15252%2Femmm.201809316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=30224383" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=U.+Neumannauthor=M.+Uferauthor=L.+H.+Jacobsonauthor=M.+L.+Rouzade-Dominguezauthor=G.+Huledalauthor=C.+Kollyauthor=R.+M.+L%C3%BC%C3%B6ndauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=K.+Hurthauthor=H.+Rueegerauthor=M.+Tintelnot-Blomleyauthor=M.+Staufenbielauthor=D.+R.+Shimshekauthor=L.+Perrotauthor=W.+Frieauffauthor=V.+Dubostauthor=H.+Schillerauthor=B.+Voggauthor=K.+Beltzauthor=A.+Avrameasauthor=S.+Kretzauthor=N.+Pezousauthor=J.+M.+Rondeauauthor=N.+Beckmannauthor=A.+Hartmannauthor=S.+Vormfeldeauthor=O.+J.+Davidauthor=B.+Galliauthor=R.+Ramosauthor=A.+Grafauthor=C.+Lopez+Lopez&title=The+BACE-1+inhibitor+CNP520+for+prevention+trials+in+Alzheimer%E2%80%99s+disease&doi=10.15252%2Femmm.201809316"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.15252%2Femmm.201809316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201809316%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DUfer%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DRouzade-Dominguez%26aufirst%3DM.%2BL.%26aulast%3DHuledal%26aufirst%3DG.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DL%25C3%25BC%25C3%25B6nd%26aufirst%3DR.%2BM.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DHurth%26aufirst%3DK.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DDubost%26aufirst%3DV.%26aulast%3DSchiller%26aufirst%3DH.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DAvrameas%26aufirst%3DA.%26aulast%3DKretz%26aufirst%3DS.%26aulast%3DPezous%26aufirst%3DN.%26aulast%3DRondeau%26aufirst%3DJ.%2BM.%26aulast%3DBeckmann%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DVormfelde%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DO.%2BJ.%26aulast%3DGalli%26aufirst%3DB.%26aulast%3DRamos%26aufirst%3DR.%26aulast%3DGraf%26aufirst%3DA.%26aulast%3DLopez%2BLopez%26aufirst%3DC.%26atitle%3DThe%2520BACE-1%2520inhibitor%2520CNP520%2520for%2520prevention%2520trials%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2018%26volume%3D10%26doi%3D10.15252%2Femmm.201809316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinkovic, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorostkar, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rammes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunnersen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herms, J.</span></span> <span> </span><span class="NLM_article-title">Beta-site amyloid precursor protein cleaving enzyme 1 inhibition impairs synaptic plasticity via seizure protein 6</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2016.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1016%2Fj.biopsych.2016.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=28129943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Wmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2018&pages=428-437&author=K.+Zhuauthor=X.+Xiangauthor=S.+Filserauthor=P.+Marinkovicauthor=M.+M.+Dorostkarauthor=S.+Cruxauthor=U.+Neumannauthor=D.+R.+Shimshekauthor=G.+Rammesauthor=C.+Haassauthor=S.+F.+Lichtenthalerauthor=J.+M.+Gunnersenauthor=J.+Herms&title=Beta-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibition+impairs+synaptic+plasticity+via+seizure+protein+6&doi=10.1016%2Fj.biopsych.2016.12.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6</span></div><div class="casAuthors">Zhu, Kaichuan; Xiang, Xianyuan; Filser, Severin; Marinkovic, Petar; Dorostkar, Mario M.; Crux, Sophie; Neumann, Ulf; Shimshek, Derya R.; Rammes, Gerhard; Haass, Christian; Lichtenthaler, Stefan F.; Gunnersen, Jenny M.; Herms, Jochen</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">428-437</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) is a promising drug target for the treatment of Alzheimer's disease.  Prolonged BACE1 inhibition interferes with structural and functional synaptic plasticity in mice, most likely by altering the metab. of BACE1 substrates.  Seizure protein 6 (SEZ6) is predominantly cleaved by BACE1, and Sez6 knockout mice share some phenotypes with BACE1 inhibitor-treated mice.  We investigated whether SEZ6 is involved in BACE1 inhibition-induced structural and functional synaptic alterations.  The function of NB-360, a novel blood-brain barrier penetrant and orally available BACE1 inhibitor, was verified by immunoblotting.  In vivo microscopy was applied to monitor the impact of long-term pharmacol. BACE1 inhibition on dendritic spines in the cerebral cortex of constitutive and conditional Sez6 knockout mice.  Finally, synaptic functions were characterized using electrophysiol. field recordings in hippocampal slices.  BACE1 enzymic activity was strongly suppressed by NB-360.  Prolonged NB-360 treatment caused a reversible spine d. redn. in wild-type mice, but it did not affect Sez6-/- mice.  Knocking out Sez6 in a small subset of mature neurons also prevented the structural postsynaptic changes induced by BACE1 inhibition.  Hippocampal long-term potentiation was decreased in both chronic BACE1 inhibitor-treated wild-type mice and vehicle-treated Sez6-/- mice.  However, chronic NB-360 treatment did not alter long-term potentiation in CA1 neurons of Sez6-/- mice.  Our results suggest that SEZ6 plays an important role in maintaining normal dendritic spine dynamics.  Furthermore, SEZ6 is involved in BACE1 inhibition-induced structural and functional synaptic alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbwoQtwevkW7Vg90H21EOLACvtfcHk0lh-DZW6OtntvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Wmur0%253D&md5=ae10070b21bd6bc8e425d5cdadcf24ed</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2016.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2016.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DXiang%26aufirst%3DX.%26aulast%3DFilser%26aufirst%3DS.%26aulast%3DMarinkovic%26aufirst%3DP.%26aulast%3DDorostkar%26aufirst%3DM.%2BM.%26aulast%3DCrux%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DRammes%26aufirst%3DG.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DGunnersen%26aufirst%3DJ.%2BM.%26aulast%3DHerms%26aufirst%3DJ.%26atitle%3DBeta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibition%2520impairs%2520synaptic%2520plasticity%2520via%2520seizure%2520protein%25206%26jtitle%3DBiol.%2520Psychiatry%26date%3D2018%26volume%3D83%26spage%3D428%26epage%3D437%26doi%3D10.1016%2Fj.biopsych.2016.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span> <span> </span><span class="NLM_article-title">The β-secretase (BACE) inhibitor NB-360 in preclinical models: from amyloid-β reduction to downstream disease-relevant effects</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">3435</span>– <span class="NLM_lpage">3446</span>, <span class="refDoi"> DOI: 10.1111/bph.14582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1111%2Fbph.14582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=30657591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksVKgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=3435-3446&author=U.+Neumannauthor=R.+Machauerauthor=D.+R.+Shimshek&title=The+%CE%B2-secretase+%28BACE%29+inhibitor+NB-360+in+preclinical+models%3A+from+amyloid-%CE%B2+reduction+to+downstream+disease-relevant+effects&doi=10.1111%2Fbph.14582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">The beta-secretase (BACE) inhibitor NB-360 in preclinical models: From amyloid-beta reduction to downstream disease-relevant effects</span></div><div class="casAuthors">Neumann, Ulf; Machauer, Rainer; Shimshek, Derya R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3435-3446</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Inhibition of beta-secretase 1 (BACE-1; also known as beta-site amyloid precursor protein-cleaving enzyme-1) is a current approach to fight the amyloid-beta deposition in the brains of patients with Alzheimer's disease, and a no. of BACE-1 inhibitors are being tested in clin. trials.  The BACE-1 inhibitor NB-360, although not a clin. compd., turned out to be a valuable pharmacol. tool to investigate the effects of BACE-1 inhibition on the deposition of different Abeta species in amyloid precursor protein (APP) transgenic mice.  Furthermore, chronic animal studies with NB-360 revealed relationships between BACE-1 inhibition, Abeta deposition, and Abeta-related downstream effects on neuroinflammation, neuronal function, and markers of neurodegeneration.  NB-360 effects on the processing of physiol. BACE-1 substrates as well as on nonenzymic BACE-1 functions have been investigated, complementing studies in BACE-1 knockout mice.  Because NB-360 is also an inhibitor for BACE-2, nonclin. studies in adult animals revealed physiol. effects of BACE-2 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt8UxHHDJ5W7Vg90H21EOLACvtfcHk0lh-DZW6OtntvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksVKgtbc%253D&md5=c4eb569d90d8627fafbffd59a0577b88</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1111%2Fbph.14582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14582%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26atitle%3DThe%2520%25CE%25B2-secretase%2520%2528BACE%2529%2520inhibitor%2520NB-360%2520in%2520preclinical%2520models%253A%2520from%2520amyloid-%25CE%25B2%2520reduction%2520to%2520downstream%2520disease-relevant%2520effects%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D176%26spage%3D3435%26epage%3D3446%26doi%3D10.1111%2Fbph.14582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wohnsland, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, B.</span></span> <span> </span><span class="NLM_article-title">High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">930</span>, <span class="refDoi"> DOI: 10.1021/jm001020e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm001020e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFSltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=923-930&author=F.+Wohnslandauthor=B.+Faller&title=High-throughput+permeability+pH+profile+and+high-throughput+alkane%2Fwater+log+P+with+artificial+membranes&doi=10.1021%2Fjm001020e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Permeability pH Profile and High-Throughput Alkane/Water log P with Artificial Membranes</span></div><div class="casAuthors">Wohnsland, Frank; Faller, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">923-930</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This study reports on a novel, high-throughput assay, designed to predict passive, transcellular permeability in early drug discovery.  The assay is carried out in 96-well microtiterplates and measures the ability of compds. to diffuse from a donor to an acceptor compartment which are sepd. by a 9-10 μm hexadecane liq. layer.  A set of 32 well-characterized, chem. diverse drugs was used to validate the method.  The permeability values derived from the flux factors between donor and acceptor compartments show a good correlation with gastrointestinal absorption in humans.  For comparison, correlations based on exptl. or calcd. octanol/water distribution coeffs. (log Do/w,6.8) were significantly lower.  In addn., this simple and robust assay allows detn. of pH permeability profiles, crit. information to predict gastrointestinal absorption of ionizable drugs and difficult to obtain from cell culture expts.  Correction for the unstirred water layer effect allows to differentiate between effective and intrinsic membrane permeability and opens up the dynamic range of the method.  In addn., alkane/water partition coeffs. can be derived from intrinsic membrane permeabilities, making this assay the first high-throughput method able to measure alkane/water log P in the microtiterplate format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXoYADWFOUn7Vg90H21EOLACvtfcHk0ljzSJFUCxRxUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFSltA%253D%253D&md5=de19e881e03d62d48a8acfea729790b4</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm001020e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001020e%26sid%3Dliteratum%253Aachs%26aulast%3DWohnsland%26aufirst%3DF.%26aulast%3DFaller%26aufirst%3DB.%26atitle%3DHigh-throughput%2520permeability%2520pH%2520profile%2520and%2520high-throughput%2520alkane%252Fwater%2520log%2520P%2520with%2520artificial%2520membranes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D923%26epage%3D930%26doi%3D10.1021%2Fjm001020e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanessian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayrakdarian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moitessier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roggo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermeier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paganetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betschart, C.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5175</span>– <span class="NLM_lpage">5190</span>, <span class="refDoi"> DOI: 10.1021/jm050142+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050142%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtV2ltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5175-5190&author=S.+Hanessianauthor=H.+Yunauthor=Y.+Houauthor=G.+Yangauthor=M.+Bayrakdarianauthor=E.+Therrienauthor=N.+Moitessierauthor=S.+Roggoauthor=S.+Veenstraauthor=M.+Tintelnot-Blomleyauthor=J.+M.+Rondeauauthor=C.+Ostermeierauthor=A.+Straussauthor=P.+Ramageauthor=P.+Paganettiauthor=U.+Neumannauthor=C.+Betschart&title=Structure-based+design%2C+synthesis%2C+and+memapsin+2+%28BACE%29+inhibitory+activity+of+carbocyclic+and+heterocyclic+peptidomimetics&doi=10.1021%2Fjm050142%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design, Synthesis, and Memapsin 2 (BACE) Inhibitory Activity of Carbocyclic and Heterocyclic Peptidomimetics</span></div><div class="casAuthors">Hanessian, Stephen; Yun, Hongying; Hou, Yihua; Yang, Gaoqiang; Bayrakdarian, Malken; Therrien, Eric; Moitessier, Nicolas; Roggo, Silvio; Veenstra, Siem; Tintelnot-Blomley, Marina; Rondeau, Jean-Michel; Ostermeier, Christian; Strauss, Andre; Ramage, Paul; Paganetti, Paolo; Neumann, Ulf; Betschart, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5175-5190</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. modeling based on the x-ray crystal structure of the Tang-Ghosh heptapeptide inhibitor I (OM99-2) of BACE led to the design and synthesis of a series of constrained P1' analogs.  A cyclopentane ring was incorporated in I spanning the P1' Ala Me group and the adjacent methylene carbon atom of the chain.  Progressive truncation at the P2'-P4' sites led to a potent truncated analog II with good selectivity over cathepsin D.  Using the same backbone replacement concept, a series of cyclopentane, cyclopentanone, THF, pyrrolidine, and pyrrolidinone analogs were synthesized with considerable variation at the P and P' sites.  For example, the cyclopentanone and 2-pyrrolidinone analogs III and IV, resp., showed low nM BACE inhibition.  X-ray cocrystal structures of II and III revealed excellent convergence with the original inhibitor I structure while providing new insights into other interactions which could be exploited for future modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv6Z9WHgqtN7Vg90H21EOLACvtfcHk0ljzSJFUCxRxUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtV2ltb0%253D&md5=64c7ab4dd70d22e01f26900d325520f4</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm050142%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050142%252B%26sid%3Dliteratum%253Aachs%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DYun%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DBayrakdarian%26aufirst%3DM.%26aulast%3DTherrien%26aufirst%3DE.%26aulast%3DMoitessier%26aufirst%3DN.%26aulast%3DRoggo%26aufirst%3DS.%26aulast%3DVeenstra%26aufirst%3DS.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DRondeau%26aufirst%3DJ.%2BM.%26aulast%3DOstermeier%26aufirst%3DC.%26aulast%3DStrauss%26aufirst%3DA.%26aulast%3DRamage%26aufirst%3DP.%26aulast%3DPaganetti%26aufirst%3DP.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DBetschart%26aufirst%3DC.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520memapsin%25202%2520%2528BACE%2529%2520inhibitory%2520activity%2520of%2520carbocyclic%2520and%2520heterocyclic%2520peptidomimetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5175%26epage%3D5190%26doi%3D10.1021%2Fjm050142%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">795</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1107/S0021889893005588</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1107%2FS0021889893005588" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADyaK2cXptFeltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1993&pages=795-800&author=W.+Kabsch&title=Automatic+processing+of+rotation+diffraction+data+from+crystals+of+initially+unknown+symmetry+and+cell+constants&doi=10.1107%2FS0021889893005588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">795-800</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    </div><div class="casAbstract">An algorithm was developed for the automatic interpretation of a given set of obsd. reciprocal-lattice points.  It exts. a reduced cell and assigns indexes to each reflection by a graph-theor. implementation of the local indexing method.  All possible symmetries of the obsd. lattice compatible with the metric of the reduced cell are recognized and reported, together with the unit-cell consts. and the linear index transformation relating the conventional to the reduced cell.  This algorithm was incorporated into the program XDS (K., 1988), which is now able to process single-crystal area-detector data without prior knowledge of the symmetry and the unit-cell consts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD1lV8_7cDv7Vg90H21EOLACvtfcHk0lilwY0f1Mu8VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXptFeltw%253D%253D&md5=2b703225206ce99af0d7e38acf6d75b3</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1107%2FS0021889893005588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889893005588%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DAutomatic%2520processing%2520of%2520rotation%2520diffraction%2520data%2520from%2520crystals%2520of%2520initially%2520unknown%2520symmetry%2520and%2520cell%2520constants%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1993%26volume%3D26%26spage%3D795%26epage%3D800%26doi%3D10.1107%2FS0021889893005588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreyer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, K. U.</span></span> <span> </span><span class="NLM_article-title">APRV - a program for automated data processing, refinement and visualization</span>. <i>Acta Crystallogr. D Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1679</span>– <span class="NLM_lpage">1682</span>, <span class="refDoi"> DOI: 10.1107/S0907444904015215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1107%2FS0907444904015215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=15333953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvF2jtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1679-1682&author=M.+Kroemerauthor=M.+K.+Dreyerauthor=K.+U.+Wendt&title=APRV+-+a+program+for+automated+data+processing%2C+refinement+and+visualization&doi=10.1107%2FS0907444904015215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">APRV - a program for automated data processing, refinement and visualization</span></div><div class="casAuthors">Kroemer, Markus; Dreyer, Matthias K.; Wendt, K. Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1679-1682</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">APRV (Automatic Processing, Refinement and Visualization) is a new program that enables high-throughput batch processing of crystallog. data.  The program combines processing of raw diffraction images, initial structure refinement and visual inspection of resulting electron d. into a seamless one-step procedure, during which all relevant parameters are refined automatically.  It is controlled by a user-friendly graphical interface, facilitating operation by non-experts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDNt2Xkbqo2rVg90H21EOLACvtfcHk0lilwY0f1Mu8VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvF2jtbs%253D&md5=11d9bb311938b7b53a32e5fba6d56724</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1107%2FS0907444904015215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904015215%26sid%3Dliteratum%253Aachs%26aulast%3DKroemer%26aufirst%3DM.%26aulast%3DDreyer%26aufirst%3DM.%2BK.%26aulast%3DWendt%26aufirst%3DK.%2BU.%26atitle%3DAPRV%2520-%2520a%2520program%2520for%2520automated%2520data%2520processing%252C%2520refinement%2520and%2520visualization%26jtitle%3DActa%2520Crystallogr.%2520D%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1679%26epage%3D1682%26doi%3D10.1107%2FS0907444904015215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brünger, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clore, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLano, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gros, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuszewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilges, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, G. L.</span></span> <span> </span><span class="NLM_article-title">Crystallography & NMR system: A new software suite for macromolecular structure determination</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">921</span>, <span class="refDoi"> DOI: 10.1107/S0907444998003254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1107%2FS0907444998003254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=9757107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A280%3ADyaK1cvjslKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=905-921&author=A.+T.+Br%C3%BCngerauthor=P.+D.+Adamsauthor=G.+M.+Cloreauthor=W.+L.+DeLanoauthor=P.+Grosauthor=R.+W.+Grosse-Kunstleveauthor=J.+S.+Jiangauthor=J.+Kuszewskiauthor=M.+Nilgesauthor=N.+S.+Pannuauthor=R.+J.+Readauthor=L.+M.+Riceauthor=T.+Simonsonauthor=G.+L.+Warren&title=Crystallography+%26+NMR+system%3A+A+new+software+suite+for+macromolecular+structure+determination&doi=10.1107%2FS0907444998003254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallography & NMR system: A new software suite for macromolecular structure determination</span></div><div class="casAuthors">Brunger A T; Adams P D; Clore G M; DeLano W L; Gros P; Grosse-Kunstleve R W; Jiang J S; Kuszewski J; Nilges M; Pannu N S; Read R J; Rice L M; Simonson T; Warren G L</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">905-21</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">A new software suite, called Crystallography & NMR System (CNS), has been developed for macromolecular structure determination by X-ray crystallography or solution nuclear magnetic resonance (NMR) spectroscopy.  In contrast to existing structure-determination programs, the architecture of CNS is highly flexible, allowing for extension to other structure-determination methods, such as electron microscopy and solid-state NMR spectroscopy.  CNS has a hierarchical structure: a high-level hypertext markup language (HTML) user interface, task-oriented user input files, module files, a symbolic structure-determination language (CNS language), and low-level source code.  Each layer is accessible to the user.  The novice user may just use the HTML interface, while the more advanced user may use any of the other layers.  The source code will be distributed, thus source-code modification is possible.  The CNS language is sufficiently powerful and flexible that many new algorithms can be easily implemented in the CNS language without changes to the source code.  The CNS language allows the user to perform operations on data structures, such as structure factors, electron-density maps, and atomic properties.  The power of the CNS language has been demonstrated by the implementation of a comprehensive set of crystallographic procedures for phasing, density modification and refinement.  User-friendly task-oriented input files are available for nearly all aspects of macromolecular structure determination by X-ray crystallography and solution NMR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAeLCFcGBdlx0LsK7uFuY7fW6udTcc2eZrV1J7BpE3e7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvjslKhsw%253D%253D&md5=37afee1b07ac44d3f3730a39061b4e79</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1107%2FS0907444998003254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444998003254%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCnger%26aufirst%3DA.%2BT.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DClore%26aufirst%3DG.%2BM.%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26aulast%3DGros%26aufirst%3DP.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DJiang%26aufirst%3DJ.%2BS.%26aulast%3DKuszewski%26aufirst%3DJ.%26aulast%3DNilges%26aufirst%3DM.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRice%26aufirst%3DL.%2BM.%26aulast%3DSimonson%26aufirst%3DT.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26atitle%3DCrystallography%2520%2526%2520NMR%2520system%253A%2520A%2520new%2520software%2520suite%2520for%2520macromolecular%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1998%26volume%3D54%26spage%3D905%26epage%3D921%26doi%3D10.1107%2FS0907444998003254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr. D Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljftS7jZnsZPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%2520D%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1E','PDB','7B1E'); return false;">PDB: 7B1E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FGY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FGY','PDB','6FGY'); return false;">PDB: 6FGY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1P" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1P','PDB','7B1P'); return false;">PDB: 7B1P</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1Q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1Q','PDB','7B1Q'); return false;">PDB: 7B1Q</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i51"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02143">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_56040"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c02143?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02143</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Preparation details and analytical data for compounds <b>4</b>, <i>rac-</i><b>20</b>, <i>rac</i>-(3<i>R</i>*,6<i>R</i>*)<i>-</i><b>38a–d</b>, <i>rac</i>-(3<i>R</i>*,6<i>S</i>*)<i>-</i><b>38e</b>, <i>rac</i><b>-49</b>, and <b>50</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02143/suppl_file/jm0c02143_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02143/suppl_file/jm0c02143_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02143/suppl_file/jm0c02143_si_001.pdf">jm0c02143_si_001.pdf (1.61 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02143/suppl_file/jm0c02143_si_002.csv">jm0c02143_si_002.csv (2.29 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Crystal structure coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with the accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1E">7B1E</a> (<b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1P">7B1P</a> (<b>38a</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7B1Q">7B1Q</a> (<b>54</b>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c02143&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c02143%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-8%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c02143" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679916abde2f21be","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
